<?xml version="1.0" ?>
<document id="consensus_test">
  <sentence id="s0" text="In the present study, we characterize negative regulation of transcription by RNA polymerase II inhibition activity of the brain-permeable compound AK7 and examine the efficacy of this small molecule in models of Parkinson's disease, amyotrophic lateral sclerosis and cerebral ischemia.">
    <entity charOffset="38-95" id="s0.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="268-285" id="s0.e1" ontology_id="HP_0002637" text="cerebral ischemia" type="HP"/>
    <pair e1="s0.e0" e2="s0.e1" id="s0.p0" relation="true"/>
  </sentence>
  <sentence id="s1" text="Results after perturbing positive regulation of peptidyl-serine phosphorylation activity suggests its involvement in cancer cell migration, proliferation, and cytoskeleton remodeling which makes it a potential therapeutic target for cancer treatments">
    <entity charOffset="25-79" id="s1.e0" ontology_id="GO_0033138" text="positive regulation of peptidyl-serine phosphorylation" type="GO"/>
    <entity charOffset="117-123" id="s1.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1.e0" e2="s1.e1" id="s1.p0" relation="true"/>
  </sentence>
  <sentence id="s2" text="positive regulation of peptidyl-serine phosphorylation is also known for its dual role in cancer as pro- and anti-proliferative in addition to metastasis.">
    <entity charOffset="0-54" id="s2.e0" ontology_id="GO_0033138" text="positive regulation of peptidyl-serine phosphorylation" type="GO"/>
    <entity charOffset="90-96" id="s2.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2.e0" e2="s2.e1" id="s2.p0" relation="true"/>
  </sentence>
  <sentence id="s3" text="The interaction required the tumor necrosis factor receptor-associated factor domain of protein deubiquitination and the central region of UVSSA and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA.">
    <entity charOffset="29-34" id="s3.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="88-112" id="s3.e1" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <pair e1="s3.e0" e2="s3.e1" id="s3.p0" relation="true"/>
  </sentence>
  <sentence id="s4" text="In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of negative regulation of protein phosphorylation repeat expansions.">
    <entity charOffset="66-79" id="s4.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="335-381" id="s4.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4.e0" e2="s4.e1" id="s4.p0" relation="true"/>
  </sentence>
  <sentence id="s5" text="Identifying genetic risk alleles for ovarian cancer has had a significant negative regulation of transcription by RNA polymerase II on disease prevention strategies; for example it is now routine clinical practice for individuals with germline double-strand break repair via homologous recombination and mitotic cytokinesis mutations to undergo risk reducing salpingo-oophorectomy.">
    <entity charOffset="45-51" id="s5.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="244-299" id="s5.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s5.e0" e2="s5.e1" id="s5.p0" relation="true"/>
  </sentence>
  <sentence id="s6" text="Identifying genetic risk alleles for ovarian cancer has had a significant negative regulation of transcription by RNA polymerase II on disease prevention strategies; for example it is now routine clinical practice for individuals with germline double-strand break repair via homologous recombination and mitotic cytokinesis mutations to undergo risk reducing salpingo-oophorectomy.">
    <entity charOffset="45-51" id="s6.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="304-323" id="s6.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s6.e0" e2="s6.e1" id="s6.p0" relation="true"/>
  </sentence>
  <sentence id="s7" text="We then validated the anti-nucleosome disassembly antibody specificity by analyzing additional 305 pediatric and adult meningiomas of various subtypes and 15 non-meningioma clear cell tumors by SMARCE1 immunohistochemistry.">
    <entity charOffset="27-49" id="s7.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="119-129" id="s7.e1" ontology_id="HP_0002858" text="meningioma" type="HP"/>
    <pair e1="s7.e0" e2="s7.e1" id="s7.p0" relation="false"/>
  </sentence>
  <sentence id="s8" text="We then validated the anti-nucleosome disassembly antibody specificity by analyzing additional 305 pediatric and adult meningiomas of various subtypes and 15 non-meningioma clear cell tumors by SMARCE1 immunohistochemistry.">
    <entity charOffset="27-49" id="s8.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="184-190" id="s8.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s8.e0" e2="s8.e1" id="s8.p0" relation="true"/>
  </sentence>
  <sentence id="s9" text="Machine learning search further revealed that the likelihood of signal transduction-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and protein phosphorylation, low or no change in E2F1 and FGFR1, and high or no change in positive regulation of protein phosphorylation.">
    <entity charOffset="64-83" id="s9.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="100-106" id="s9.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s9.e0" e2="s9.e1" id="s9.p0" relation="false"/>
  </sentence>
  <sentence id="s10" text="Machine learning search further revealed that the likelihood of signal transduction-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and protein phosphorylation, low or no change in E2F1 and FGFR1, and high or no change in positive regulation of protein phosphorylation.">
    <entity charOffset="100-106" id="s10.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="310-356" id="s10.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s10.e0" e2="s10.e1" id="s10.p0" relation="true"/>
  </sentence>
  <sentence id="s11" text="Machine learning search further revealed that the likelihood of signal transduction-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and protein phosphorylation, low or no change in E2F1 and FGFR1, and high or no change in positive regulation of protein phosphorylation.">
    <entity charOffset="100-106" id="s11.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="224-247" id="s11.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s11.e0" e2="s11.e1" id="s11.p0" relation="true"/>
  </sentence>
  <sentence id="s12" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="208-220" id="s12.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="561-567" id="s12.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s12.e0" e2="s12.e1" id="s12.p0" relation="false"/>
  </sentence>
  <sentence id="s13" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="244-269" id="s13.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="561-567" id="s13.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s13.e0" e2="s13.e1" id="s13.p0" relation="false"/>
  </sentence>
  <sentence id="s14" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="343-374" id="s14.e0" ontology_id="GO_0060070" text="canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="561-567" id="s14.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s14.e0" e2="s14.e1" id="s14.p0" relation="false"/>
  </sentence>
  <sentence id="s15" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="388-429" id="s15.e0" ontology_id="GO_2000300" text="regulation of synaptic vesicle exocytosis" type="GO"/>
    <entity charOffset="561-567" id="s15.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s15.e0" e2="s15.e1" id="s15.p0" relation="true"/>
  </sentence>
  <sentence id="s16" text="We found that both mRNA and protein levels of transcription by RNA polymerase II and its transcriptional activity were significantly higher in ER/PR-ve signal transduction+ve breast cancer samples compared to normal breast tissues.">
    <entity charOffset="46-80" id="s16.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="184-190" id="s16.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s16.e0" e2="s16.e1" id="s16.p0" relation="true"/>
  </sentence>
  <sentence id="s17" text="We found that both mRNA and protein levels of transcription by RNA polymerase II and its transcriptional activity were significantly higher in ER/PR-ve signal transduction+ve breast cancer samples compared to normal breast tissues.">
    <entity charOffset="153-172" id="s17.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="184-190" id="s17.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s17.e0" e2="s17.e1" id="s17.p0" relation="true"/>
  </sentence>
  <sentence id="s18" text="Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including positive regulation of protein phosphorylation, IGFR, and E2F1, are under transcriptional control of NRF1.">
    <entity charOffset="63-69" id="s18.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="102-148" id="s18.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s18.e0" e2="s18.e1" id="s18.p0" relation="true"/>
  </sentence>
  <sentence id="s19" text="Promoters of several genes from the KEGG signal transduction+ breast cancer pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the transcription by RNA polymerase II motif.">
    <entity charOffset="41-60" id="s19.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="69-75" id="s19.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s19.e0" e2="s19.e1" id="s19.p0" relation="true"/>
  </sentence>
  <sentence id="s20" text="Promoters of several genes from the KEGG signal transduction+ breast cancer pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the transcription by RNA polymerase II motif.">
    <entity charOffset="69-75" id="s20.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="154-188" id="s20.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s20.e0" e2="s20.e1" id="s20.p0" relation="true"/>
  </sentence>
  <sentence id="s21" text="Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of transcription by RNA polymerase II as a valuable biomarker for breast cancer diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target HER2+ breast cancer">
    <entity charOffset="128-162" id="s21.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="198-204" id="s21.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s21.e0" e2="s21.e1" id="s21.p0" relation="true"/>
  </sentence>
  <sentence id="s22" text="Birt-Hogg-Dub (negative regulation of transcription by RNA polymerase II) syndrome is a rare genetic disorder characterized by cutaneous fibrofolliculomas, pulmonary cysts and renal cell carcinomas.">
    <entity charOffset="16-73" id="s22.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="177-198" id="s22.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s22.e0" e2="s22.e1" id="s22.p0" relation="false"/>
  </sentence>
  <sentence id="s23" text="This case of adult-diagnosed phospholipid transport deficiency was characterized by slowly progressive peripheral neuropathy masquerading CMT in addition to muscular symptoms.">
    <entity charOffset="29-51" id="s23.e0" ontology_id="GO_0015914" text="phospholipid transport" type="GO"/>
    <entity charOffset="103-113" id="s23.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s23.e0" e2="s23.e1" id="s23.p0" relation="false"/>
  </sentence>
  <sentence id="s24" text="An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (negative regulation of cytokine production) silencing in human colorectal cancer.">
    <entity charOffset="110-152" id="s24.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="184-190" id="s24.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s24.e0" e2="s24.e1" id="s24.p0" relation="true"/>
  </sentence>
  <sentence id="s25" text="CHD4 knockdown activates silenced negative regulation of cytokine productions, revealing their role for blunting colorectal cancer cell proliferation, invasion, and metastases.">
    <entity charOffset="34-76" id="s25.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="124-130" id="s25.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s25.e0" e2="s25.e1" id="s25.p0" relation="true"/>
  </sentence>
  <sentence id="s26" text="To date, researchers have discovered that positive regulation of transcription by RNA polymerase II deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis (IPF), and lung cancer.">
    <entity charOffset="42-99" id="s26.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="419-425" id="s26.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s26.e0" e2="s26.e1" id="s26.p0" relation="true"/>
  </sentence>
  <sentence id="s27" text="VLCFA-containing lipids accumulate in X-fatty acid beta-oxidation patients, although the effect of ABCD1-deficiency on each lipid species in the central nervous system has not been fully characterized.">
    <entity charOffset="40-65" id="s27.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="145-152" id="s27.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s27.e0" e2="s27.e1" id="s27.p0" relation="false"/>
  </sentence>
  <sentence id="s28" text="X-linked spondylo-epiphyseal dysplasia tarda (regulation of transcription, DNA-templated) is an X-linked recessive, late-onset, progressive skeletal disorder characterized by mild-to-moderate short-trunked short stature.">
    <entity charOffset="46-88" id="s28.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="206-219" id="s28.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s28.e0" e2="s28.e1" id="s28.p0" relation="false"/>
  </sentence>
  <sentence id="s29" text="We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (response to hypoxia) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).">
    <entity charOffset="162-181" id="s29.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="225-234" id="s29.e1" ontology_id="HP_0025301" text="nocturnal" type="HP"/>
    <pair e1="s29.e0" e2="s29.e1" id="s29.p0" relation="false"/>
  </sentence>
  <sentence id="s30" text="We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (response to hypoxia) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).">
    <entity charOffset="162-181" id="s30.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="248-256" id="s30.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s30.e0" e2="s30.e1" id="s30.p0" relation="true"/>
  </sentence>
  <sentence id="s31" text="Our findings provide exploratory evidence for hypermethylation of the key tumour suppressor gene cellular response to DNA damage stimulus being implicated in smoking-associated colorectal carcinogenesis.">
    <entity charOffset="74-80" id="s31.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="97-137" id="s31.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s31.e0" e2="s31.e1" id="s31.p0" relation="true"/>
  </sentence>
  <sentence id="s32" text="Our analyses identified 15 CpG sites within the cellular response to DNA damage stimulus 1A promoter that were significantly hypermethylated and 14 CpG loci within the NFATC1 gene body that were significantly hypomethylated (pLIS&amp;lt;1  10&lt;sup&gt;-5&lt;/sup&gt; ) in the tumours of active smokers.">
    <entity charOffset="48-88" id="s32.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="264-270" id="s32.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s32.e0" e2="s32.e1" id="s32.p0" relation="true"/>
  </sentence>
  <sentence id="s33" text="Overall, our results suggest that PQQ neuroprotection may be mediated by the inhibition of mitochondrial dysfunction and oxidative stress as well as by the gene modulation of apoptotic mitochondrial changes and Ndufs4">
    <entity charOffset="91-116" id="s33.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="175-206" id="s33.e1" ontology_id="GO_0008637" text="apoptotic mitochondrial changes" type="GO"/>
    <pair e1="s33.e0" e2="s33.e1" id="s33.p0" relation="false"/>
  </sentence>
  <sentence id="s34" text="Using clinical blood samples, we compared the diagnostic values of serum exosomal cellular response to zinc ion starvation levels between malignant pancreatic cancer patients (n=24) and benign pancreatic disease patients (n=32, AUC=.89), and between biliary disease patients (n=32, AUC=.8112) and healthy controls (n=46, AUC=.8931).">
    <entity charOffset="82-122" id="s34.e0" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <entity charOffset="159-165" id="s34.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s34.e0" e2="s34.e1" id="s34.p0" relation="true"/>
  </sentence>
  <sentence id="s35" text="In conclusion, exosomal cellular response to zinc ion starvation promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer">
    <entity charOffset="24-64" id="s35.e0" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <entity charOffset="74-80" id="s35.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s35.e0" e2="s35.e1" id="s35.p0" relation="true"/>
  </sentence>
  <sentence id="s36" text="By combining meta-analysis results and identification of two unrelated HCM patients with homozygous cardiac muscle hypertrophy truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124)">
    <entity charOffset="100-126" id="s36.e0" ontology_id="GO_0003300" text="cardiac muscle hypertrophy" type="GO"/>
    <entity charOffset="301-320" id="s36.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s36.e0" e2="s36.e1" id="s36.p0" relation="true"/>
  </sentence>
  <sentence id="s37" text="The aim of this study was to explore the relationship between gamma-aminobutyric acid catabolic process and the prognosis of patients with ovarian cancer (OC).">
    <entity charOffset="62-103" id="s37.e0" ontology_id="GO_0009450" text="gamma-aminobutyric acid catabolic process" type="GO"/>
    <entity charOffset="147-153" id="s37.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s37.e0" e2="s37.e1" id="s37.p0" relation="true"/>
  </sentence>
  <sentence id="s38" text="In survival analyses, we found that gamma-aminobutyric acid catabolic process was positively linked to prognosis in patients with OC, particularly in those with serous ovarian cancer (SOC).">
    <entity charOffset="36-77" id="s38.e0" ontology_id="GO_0009450" text="gamma-aminobutyric acid catabolic process" type="GO"/>
    <entity charOffset="176-182" id="s38.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s38.e0" e2="s38.e1" id="s38.p0" relation="true"/>
  </sentence>
  <sentence id="s39" text="Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (myelination, Onegative regulation of epithelial cell proliferation 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.">
    <entity charOffset="64-75" id="s39.e0" ontology_id="GO_0042552" text="myelination" type="GO"/>
    <entity charOffset="156-169" id="s39.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s39.e0" e2="s39.e1" id="s39.p0" relation="false"/>
  </sentence>
  <sentence id="s40" text="Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (myelination, Onegative regulation of epithelial cell proliferation 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.">
    <entity charOffset="78-130" id="s40.e0" ontology_id="GO_0050680" text="negative regulation of epithelial cell proliferation" type="GO"/>
    <entity charOffset="156-169" id="s40.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s40.e0" e2="s40.e1" id="s40.p0" relation="false"/>
  </sentence>
  <sentence id="s41" text="c.886G&amp;gt;T is a novel idiopathic congenital nystagmusinducing mutation in the regulation of neuron projection development gene.">
    <entity charOffset="45-54" id="s41.e0" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <entity charOffset="80-123" id="s41.e1" ontology_id="GO_0010975" text="regulation of neuron projection development" type="GO"/>
    <pair e1="s41.e0" e2="s41.e1" id="s41.p0" relation="true"/>
  </sentence>
  <sentence id="s42" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, transcription-coupled nucleotide-excision repair, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.">
    <entity charOffset="79-97" id="s42.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="121-169" id="s42.e1" ontology_id="GO_0006283" text="transcription-coupled nucleotide-excision repair" type="GO"/>
    <pair e1="s42.e0" e2="s42.e1" id="s42.p0" relation="true"/>
  </sentence>
  <sentence id="s43" text="A cation transport complex mutation analogous to a lysosomal transport allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.">
    <entity charOffset="2-18" id="s43.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="108-124" id="s43.e1" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <pair e1="s43.e0" e2="s43.e1" id="s43.p0" relation="true"/>
  </sentence>
  <sentence id="s44" text="A cation transport complex mutation analogous to a lysosomal transport allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.">
    <entity charOffset="51-70" id="s44.e0" ontology_id="GO_0007041" text="lysosomal transport" type="GO"/>
    <entity charOffset="108-124" id="s44.e1" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <pair e1="s44.e0" e2="s44.e1" id="s44.p0" relation="true"/>
  </sentence>
  <sentence id="s45" text="A rare syndromic form of intellectual disability with impaired speech was recently found associated with mutations in sister chromatid biorientation (chromosome alignment-maintaining phosphoprotein 1), the protein product of which is directly involved in microtubule-kinetochore attachment.">
    <entity charOffset="25-48" id="s45.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="118-148" id="s45.e1" ontology_id="GO_0031134" text="sister chromatid biorientation" type="GO"/>
    <pair e1="s45.e0" e2="s45.e1" id="s45.p0" relation="true"/>
  </sentence>
  <sentence id="s46" text="Through whole-exome sequencing in six unrelated nonconsanguineous families having a sporadic case of intellectual disability, we identified six novel de novo truncating mutations in sister chromatid biorientation: c.1880C&amp;gt;G p.(Ser627*), c.1489C&amp;gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&amp;gt;A; p.(Trp348*), c.1002G&amp;gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).">
    <entity charOffset="84-92" id="s46.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="182-212" id="s46.e1" ontology_id="GO_0031134" text="sister chromatid biorientation" type="GO"/>
    <pair e1="s46.e0" e2="s46.e1" id="s46.p0" relation="false"/>
  </sentence>
  <sentence id="s47" text="These findings implicate for the first time perturbed TGF- signaling in the negative regulation of transcription by RNA polymerase II of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in retinal disease and may offer additional therapeutic opportunities for genetically heterogeneous disorders presently only treatable with gene therapy">
    <entity charOffset="77-134" id="s47.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="138-157" id="s47.e1" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <pair e1="s47.e0" e2="s47.e1" id="s47.p0" relation="false"/>
  </sentence>
  <sentence id="s48" text="Brain malformations described in association with 22q11.2 deletion syndrome include polymicrogyria, cerebellar hypoplasia, megacisterna magna, and agenesis of the corpus callosum (acetyl-CoA metabolic process), although these are rare.">
    <entity charOffset="84-98" id="s48.e0" ontology_id="HP_0002126" text="polymicrogyria" type="HP"/>
    <entity charOffset="180-208" id="s48.e1" ontology_id="GO_0006084" text="acetyl-CoA metabolic process" type="GO"/>
    <pair e1="s48.e0" e2="s48.e1" id="s48.p0" relation="false"/>
  </sentence>
  <sentence id="s49" text="The four large extracellular domains of positive regulation of cell-matrix adhesion and its association with the extracellular matrix makes it an attractive target for future cancer therapies.">
    <entity charOffset="40-83" id="s49.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="175-181" id="s49.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s49.e0" e2="s49.e1" id="s49.p0" relation="true"/>
  </sentence>
  <sentence id="s50" text="Translational research suggests that positive regulation of cell-matrix adhesion may be targeted with antibodies to improve tumor control and survival in a variety of murine models and cancer types.">
    <entity charOffset="37-80" id="s50.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="185-191" id="s50.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s50.e0" e2="s50.e1" id="s50.p0" relation="true"/>
  </sentence>
  <sentence id="s51" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (regulation of transcription by RNA polymerase II, skeletal system development, LFNG, HES7) and autosomal dominant (negative regulation of transcription by RNA polymerase II) inheritance.">
    <entity charOffset="103-122" id="s51.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="124-172" id="s51.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s51.e0" e2="s51.e1" id="s51.p0" relation="true"/>
  </sentence>
  <sentence id="s52" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (regulation of transcription by RNA polymerase II, skeletal system development, LFNG, HES7) and autosomal dominant (negative regulation of transcription by RNA polymerase II) inheritance.">
    <entity charOffset="103-122" id="s52.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="239-296" id="s52.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s52.e0" e2="s52.e1" id="s52.p0" relation="false"/>
  </sentence>
  <sentence id="s53" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (regulation of transcription by RNA polymerase II, skeletal system development, LFNG, HES7) and autosomal dominant (negative regulation of transcription by RNA polymerase II) inheritance.">
    <entity charOffset="103-122" id="s53.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="174-201" id="s53.e1" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="s53.e0" e2="s53.e1" id="s53.p0" relation="true"/>
  </sentence>
  <sentence id="s54" text="The correlation between the tumor size and the amount of sister chromatid cohesion secretion could be examined in this study, and showed a significant positive correlation in a tumor size-dependent manner.">
    <entity charOffset="28-33" id="s54.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="57-82" id="s54.e1" ontology_id="GO_0007062" text="sister chromatid cohesion" type="GO"/>
    <pair e1="s54.e0" e2="s54.e1" id="s54.p0" relation="true"/>
  </sentence>
  <sentence id="s55" text="We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="30-69" id="s55.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="325-345" id="s55.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s55.e0" e2="s55.e1" id="s55.p0" relation="false"/>
  </sentence>
  <sentence id="s56" text="There are two different phenotypes of patients with protein localization to plasma membrane mutations: the severe form, caused by null mutations and leading to the classical MIA-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and hair abnormalities.">
    <entity charOffset="52-91" id="s56.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="321-339" id="s56.e1" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <pair e1="s56.e0" e2="s56.e1" id="s56.p0" relation="true"/>
  </sentence>
  <sentence id="s57" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="37-50" id="s57.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="102-125" id="s57.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s57.e0" e2="s57.e1" id="s57.p0" relation="false"/>
  </sentence>
  <sentence id="s58" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="37-50" id="s58.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="219-247" id="s58.e1" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <pair e1="s58.e0" e2="s58.e1" id="s58.p0" relation="true"/>
  </sentence>
  <sentence id="s59" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="70-81" id="s59.e0" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <entity charOffset="219-247" id="s59.e1" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <pair e1="s59.e0" e2="s59.e1" id="s59.p0" relation="false"/>
  </sentence>
  <sentence id="s60" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="70-81" id="s60.e0" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <entity charOffset="102-125" id="s60.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s60.e0" e2="s60.e1" id="s60.p0" relation="true"/>
  </sentence>
  <sentence id="s61" text="A MMP9 inhibitor significantly inhibited cell invasion and migration in regulation of cell shape-HIF-1 axis-induced lung cancer.">
    <entity charOffset="72-96" id="s61.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="122-128" id="s61.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s61.e0" e2="s61.e1" id="s61.p0" relation="true"/>
  </sentence>
  <sentence id="s62" text="We report a case of 2-year old child who presented with small bone osteomyelitis involving bilateral feet and was later diagnosed to have autosomal recessive superoxide metabolic process due to mutation in NCF1 gene">
    <entity charOffset="138-157" id="s62.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="158-186" id="s62.e1" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <pair e1="s62.e0" e2="s62.e1" id="s62.p0" relation="false"/>
  </sentence>
  <sentence id="s63" text="Haploinsufficiency of protein deubiquitination in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-46" id="s63.e0" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <entity charOffset="233-260" id="s63.e1" ontology_id="HP_0002079" text="hypoplastic corpus callosum" type="HP"/>
    <pair e1="s63.e0" e2="s63.e1" id="s63.p0" relation="true"/>
  </sentence>
  <sentence id="s64" text="Its restricted expression in normal tissues and unique early upregulation during tumor development make microvillus organization an excellent candidate as a new clinical marker of HCC">
    <entity charOffset="81-86" id="s64.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="104-128" id="s64.e1" ontology_id="GO_0032528" text="microvillus organization" type="GO"/>
    <pair e1="s64.e0" e2="s64.e1" id="s64.p0" relation="false"/>
  </sentence>
  <sentence id="s65" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="103-145" id="s65.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="296-315" id="s65.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s65.e0" e2="s65.e1" id="s65.p0" relation="false"/>
  </sentence>
  <sentence id="s66" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="103-145" id="s66.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="274-291" id="s66.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s66.e0" e2="s66.e1" id="s66.p0" relation="true"/>
  </sentence>
  <sentence id="s67" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="103-145" id="s67.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="249-272" id="s67.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s67.e0" e2="s67.e1" id="s67.p0" relation="true"/>
  </sentence>
  <sentence id="s68" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="159-190" id="s68.e0" ontology_id="GO_0051259" text="protein complex oligomerization" type="GO"/>
    <entity charOffset="225-247" id="s68.e1" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <pair e1="s68.e0" e2="s68.e1" id="s68.p0" relation="true"/>
  </sentence>
  <sentence id="s69" text="In addition, forced expression of positive regulation of DNA-binding transcription factor activity-c in ER-negative breast cancer cell lines inhibited stimuli-induced peripheral nervous system development-B activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.">
    <entity charOffset="34-98" id="s69.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="123-129" id="s69.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s69.e0" e2="s69.e1" id="s69.p0" relation="false"/>
  </sentence>
  <sentence id="s70" text="In addition, forced expression of positive regulation of DNA-binding transcription factor activity-c in ER-negative breast cancer cell lines inhibited stimuli-induced peripheral nervous system development-B activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.">
    <entity charOffset="123-129" id="s70.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="167-204" id="s70.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s70.e0" e2="s70.e1" id="s70.p0" relation="false"/>
  </sentence>
  <sentence id="s71" text="Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast cancer cells with a negative effect on EGFR phosphorylation and angiogenesis-dependent downstream signaling pathway activation.">
    <entity charOffset="149-155" id="s71.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="213-225" id="s71.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s71.e0" e2="s71.e1" id="s71.p0" relation="true"/>
  </sentence>
  <sentence id="s72" text="The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.">
    <entity charOffset="4-68" id="s72.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="94-100" id="s72.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s72.e0" e2="s72.e1" id="s72.p0" relation="true"/>
  </sentence>
  <sentence id="s73" text="The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.">
    <entity charOffset="106-120" id="s73.e0" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <entity charOffset="245-285" id="s73.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s73.e0" e2="s73.e1" id="s73.p0" relation="true"/>
  </sentence>
  <sentence id="s74" text="The positive regulation of DNA-binding transcription factor activity/RANKL axis emerges as a key regulator of breast cancer initiation, progression, and metastasis.">
    <entity charOffset="4-68" id="s74.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="117-123" id="s74.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s74.e0" e2="s74.e1" id="s74.p0" relation="true"/>
  </sentence>
  <sentence id="s75" text="Patients did not present with visual impairment as observed in a previously reported SPG57 family (c.316C&amp;gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in ER to Golgi vesicle-mediated transport complex formation/function and a possible phenotype correlation to variant location.">
    <entity charOffset="30-47" id="s75.e0" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <entity charOffset="221-259" id="s75.e1" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <pair e1="s75.e0" e2="s75.e1" id="s75.p0" relation="false"/>
  </sentence>
  <sentence id="s76" text="Our study expands the genetic heterogeneity of negative regulation of gene expression and RTT-like phenotypes.">
    <entity charOffset="30-43" id="s76.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="47-85" id="s76.e1" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <pair e1="s76.e0" e2="s76.e1" id="s76.p0" relation="false"/>
  </sentence>
  <sentence id="s77" text="In zebrafish, downregulation of negative regulation of phosphatase activity expression leads to an abnormal eye phenotype and defective light-induced locomotor response.">
    <entity charOffset="32-75" id="s77.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="99-111" id="s77.e1" ontology_id="HP_0000478" text="abnormal eye" type="HP"/>
    <pair e1="s77.e0" e2="s77.e1" id="s77.p0" relation="true"/>
  </sentence>
  <sentence id="s78" text="However, the underlying mechanism of signal transduction function is unclear in endometrial hyperplasia and cancer.">
    <entity charOffset="37-56" id="s78.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="108-114" id="s78.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s78.e0" e2="s78.e1" id="s78.p0" relation="true"/>
  </sentence>
  <sentence id="s79" text="In an effort to identify new mutations responsible for DBA, we performed whole-exome sequencing analysis of 48 patients with no documented mutations/deletions in our first screening and identified a de novo splicing error mutation in rRNA processing and a frameshift deletion in RPS27 in sporadic patients with DBA.">
    <entity charOffset="234-249" id="s79.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="288-296" id="s79.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s79.e0" e2="s79.e1" id="s79.p0" relation="false"/>
  </sentence>
  <sentence id="s80" text="The purpose of the present study was to evaluate the expression of Lin28A, let-7a, and negative regulation of transcription by RNA polymerase II in human papillary thyroid carcinoma (PTC) and to investigate their potential mechanisms in the progression of PTC.">
    <entity charOffset="87-144" id="s80.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="154-181" id="s80.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s80.e0" e2="s80.e1" id="s80.p0" relation="true"/>
  </sentence>
  <sentence id="s81" text="BACKGROUND miRNA catabolic process is a gene involved in many biological processes, including development, glucose metabolism, and tumorigenesis.">
    <entity charOffset="11-34" id="s81.e0" ontology_id="GO_0010587" text="miRNA catabolic process" type="GO"/>
    <entity charOffset="131-136" id="s81.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s81.e0" e2="s81.e1" id="s81.p0" relation="true"/>
  </sentence>
  <sentence id="s82" text="Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, negative regulation of transcription by RNA polymerase II, and negative regulation of transcription, DNA-templated.">
    <entity charOffset="39-44" id="s82.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="173-230" id="s82.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s82.e0" e2="s82.e1" id="s82.p0" relation="false"/>
  </sentence>
  <sentence id="s83" text="Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, negative regulation of transcription by RNA polymerase II, and negative regulation of transcription, DNA-templated.">
    <entity charOffset="39-44" id="s83.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="236-287" id="s83.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s83.e0" e2="s83.e1" id="s83.p0" relation="false"/>
  </sentence>
  <sentence id="s84" text="However, there is considerable clinical heterogeneity among patients, and the molecular basis for the evolution of immunodeficiency into microtubule-based process/AML remains unknown.">
    <entity charOffset="40-53" id="s84.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="137-162" id="s84.e1" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <pair e1="s84.e0" e2="s84.e1" id="s84.p0" relation="false"/>
  </sentence>
  <sentence id="s85" text="Mutations in sodium ion transport, a Na&lt;sup&gt;+&lt;/sup&gt; dependent OH&lt;sup&gt;-&lt;/sup&gt; transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial corneal dystrophy (extracellular matrix organization), the two most common forms of endothelial degeneration.">
    <entity charOffset="13-33" id="s85.e0" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <entity charOffset="170-187" id="s85.e1" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <pair e1="s85.e0" e2="s85.e1" id="s85.p0" relation="false"/>
  </sentence>
  <sentence id="s86" text="Mutations in sodium ion transport, a Na&lt;sup&gt;+&lt;/sup&gt; dependent OH&lt;sup&gt;-&lt;/sup&gt; transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial corneal dystrophy (extracellular matrix organization), the two most common forms of endothelial degeneration.">
    <entity charOffset="170-187" id="s86.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="189-222" id="s86.e1" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <pair e1="s86.e0" e2="s86.e1" id="s86.p0" relation="false"/>
  </sentence>
  <sentence id="s87" text="A further XX male, ascertained because of intellectual disability, carried a de novo nodal signaling pathway duplication at Xq27.1, involving sex determination.">
    <entity charOffset="42-65" id="s87.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="142-159" id="s87.e1" ontology_id="GO_0007530" text="sex determination" type="GO"/>
    <pair e1="s87.e0" e2="s87.e1" id="s87.p0" relation="true"/>
  </sentence>
  <sentence id="s88" text="We analyzed, by conventional and molecular cytogenetics, 19 novel positive regulation of gene expression-negative unrelated 46,XX subjects both familial and sporadic, with isolated DSD.">
    <entity charOffset="66-104" id="s88.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="157-165" id="s88.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s88.e0" e2="s88.e1" id="s88.p0" relation="false"/>
  </sentence>
  <sentence id="s89" text="However, there was no research elucidating the genetic association of entire positive regulation of cholesterol transport pathway with ovarian cancer susceptibility.">
    <entity charOffset="77-121" id="s89.e0" ontology_id="GO_0032376" text="positive regulation of cholesterol transport" type="GO"/>
    <entity charOffset="143-149" id="s89.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s89.e0" e2="s89.e1" id="s89.p0" relation="false"/>
  </sentence>
  <sentence id="s90" text="Therefore, we conducted genotyping for 17 SNPs of six NER core genes (&lt;i&gt;XPA, XPC, XPG, nucleotide-excision repair, ERCC2&lt;/i&gt;, and &lt;i&gt;ERCC4&lt;/i&gt;) in 89 ovarian cancer cases and 356 cancer-free controls.">
    <entity charOffset="88-114" id="s90.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="159-165" id="s90.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s90.e0" e2="s90.e1" id="s90.p0" relation="true"/>
  </sentence>
  <sentence id="s91" text="However, to date the genetic cause remains unknown in around 40% of positive regulation of transcription, DNA-templated cases, suggesting genetic heterogeneity and involvement of other genes.">
    <entity charOffset="68-119" id="s91.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="146-159" id="s91.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s91.e0" e2="s91.e1" id="s91.p0" relation="false"/>
  </sentence>
  <sentence id="s92" text="Fundus imaging demonstrated that R172W mice developed severe clinical signs of disease nearly identical to those seen in human MD patients, including retinal degeneration, retinal pigment epithlium (carbohydrate metabolic process) defects and loss of the choriocapillaris.">
    <entity charOffset="150-170" id="s92.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="199-229" id="s92.e1" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <pair e1="s92.e0" e2="s92.e1" id="s92.p0" relation="false"/>
  </sentence>
  <sentence id="s93" text="Concerning angiogenesis G2548A polymorphism, our results showed that the OR of obesity associated with 2548 AA/GG was 1.87[1.106-2.78] P=.028 vs 1.41[1.035-1.85] P=.045 for 223AA/GG polymorphism.">
    <entity charOffset="11-23" id="s93.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="79-86" id="s93.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s93.e0" e2="s93.e1" id="s93.p0" relation="true"/>
  </sentence>
  <sentence id="s94" text="Here, we investigated the biological functions and clinical significance of negative regulation of receptor recycling44 in human esophageal cancer (HEC).">
    <entity charOffset="76-117" id="s94.e0" ontology_id="GO_0001920" text="negative regulation of receptor recycling" type="GO"/>
    <entity charOffset="140-146" id="s94.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s94.e0" e2="s94.e1" id="s94.p0" relation="true"/>
  </sentence>
  <sentence id="s95" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and MYLK (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s95.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="190-242" id="s95.e1" ontology_id="GO_0030838" text="positive regulation of actin filament polymerization" type="GO"/>
    <pair e1="s95.e0" e2="s95.e1" id="s95.p0" relation="false"/>
  </sentence>
  <sentence id="s96" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and MYLK (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="302-348" id="s96.e0" ontology_id="GO_0032388" text="positive regulation of intracellular transport" type="GO"/>
    <entity charOffset="378-389" id="s96.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s96.e0" e2="s96.e1" id="s96.p0" relation="false"/>
  </sentence>
  <sentence id="s97" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="100-131" id="s97.e0" ontology_id="GO_0006883" text="cellular sodium ion homeostasis" type="GO"/>
    <entity charOffset="356-368" id="s97.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s97.e0" e2="s97.e1" id="s97.p0" relation="true"/>
  </sentence>
  <sentence id="s98" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="100-131" id="s98.e0" ontology_id="GO_0006883" text="cellular sodium ion homeostasis" type="GO"/>
    <entity charOffset="216-225" id="s98.e1" ontology_id="HP_0001284" text="areflexia" type="HP"/>
    <pair e1="s98.e0" e2="s98.e1" id="s98.p0" relation="true"/>
  </sentence>
  <sentence id="s99" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="100-131" id="s99.e0" ontology_id="GO_0006883" text="cellular sodium ion homeostasis" type="GO"/>
    <entity charOffset="208-214" id="s99.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s99.e0" e2="s99.e1" id="s99.p0" relation="true"/>
  </sentence>
  <sentence id="s100" text="Mutations in the gene encoding the single transmembrane receptor multiple epidermal growth factor-like domain 10 (homotypic cell-cell adhesion) cause an autosomal recessive congenital muscle disease in humans.">
    <entity charOffset="114-142" id="s100.e0" ontology_id="GO_0034109" text="homotypic cell-cell adhesion" type="GO"/>
    <entity charOffset="153-172" id="s100.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s100.e0" e2="s100.e1" id="s100.p0" relation="true"/>
  </sentence>
  <sentence id="s101" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="181-210" id="s101.e0" ontology_id="GO_0043087" text="regulation of GTPase activity" type="GO"/>
    <entity charOffset="297-309" id="s101.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s101.e0" e2="s101.e1" id="s101.p0" relation="true"/>
  </sentence>
  <sentence id="s102" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="239-270" id="s102.e0" ontology_id="GO_0060070" text="canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="297-309" id="s102.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s102.e0" e2="s102.e1" id="s102.p0" relation="true"/>
  </sentence>
  <sentence id="s103" text="The present findings did not identify copy number variation and mutations in positive regulation of NF-kappaB transcription factor activity; therefore, excluding the possibility of EDAinitiated ectodermal dysplasia syndrome.">
    <entity charOffset="77-139" id="s103.e0" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <entity charOffset="195-215" id="s103.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s103.e0" e2="s103.e1" id="s103.p0" relation="false"/>
  </sentence>
  <sentence id="s104" text="The canonical Wnt signaling pathway p.G213S mutation was confirmed to be the etiological cause of tooth agenesis and ectodermal dysplasia as previously described.">
    <entity charOffset="4-35" id="s104.e0" ontology_id="GO_0060070" text="canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="117-137" id="s104.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s104.e0" e2="s104.e1" id="s104.p0" relation="true"/>
  </sentence>
  <sentence id="s105" text="The present study screened pathogenic genes, ectodysplasinA (positive regulation of NF-kappaB transcription factor activity) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.">
    <entity charOffset="62-124" id="s105.e0" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <entity charOffset="252-270" id="s105.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s105.e0" e2="s105.e1" id="s105.p0" relation="true"/>
  </sentence>
  <sentence id="s106" text="All these findings implied the important roles of fructose 6-phosphate metabolic process expression in lung cancer development and progression and the potential use of the methylation status detected in FBP1 promoter region as a novel predictor for prognosis and therapeutic target for NSCLC patients">
    <entity charOffset="50-88" id="s106.e0" ontology_id="GO_0006002" text="fructose 6-phosphate metabolic process" type="GO"/>
    <entity charOffset="108-114" id="s106.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s106.e0" e2="s106.e1" id="s106.p0" relation="true"/>
  </sentence>
  <sentence id="s107" text="Moreover, a series of pyruvate metabolic process gain-of-function and rescore experiments were carried out in breast cancer MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and tumor formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.">
    <entity charOffset="22-48" id="s107.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="278-283" id="s107.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s107.e0" e2="s107.e1" id="s107.p0" relation="true"/>
  </sentence>
  <sentence id="s108" text="We found that NTS inhibits monocyte chemotaxis- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.">
    <entity charOffset="27-46" id="s108.e0" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <entity charOffset="51-57" id="s108.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s108.e0" e2="s108.e1" id="s108.p0" relation="true"/>
  </sentence>
  <sentence id="s109" text="Main complications were due to anemia and ineffective erythropoiesis [osteoporosis (8/9, 89%), cholelithiasis (21/30, 70%), pulmonary arterial hypertension (L-phenylalanine catabolic process) (6/25, 24%)] and iron overload [hypothyroidism (9/24, 38%), and diabetes mellitus (6/32, 19%)].">
    <entity charOffset="124-155" id="s109.e0" ontology_id="HP_0002092" text="pulmonary arterial hypertension" type="HP"/>
    <entity charOffset="157-190" id="s109.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s109.e0" e2="s109.e1" id="s109.p0" relation="false"/>
  </sentence>
  <sentence id="s110" text="Main complications were due to anemia and ineffective erythropoiesis [osteoporosis (8/9, 89%), cholelithiasis (21/30, 70%), pulmonary arterial hypertension (L-phenylalanine catabolic process) (6/25, 24%)] and iron overload [hypothyroidism (9/24, 38%), and diabetes mellitus (6/32, 19%)].">
    <entity charOffset="157-190" id="s110.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="224-238" id="s110.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s110.e0" e2="s110.e1" id="s110.p0" relation="false"/>
  </sentence>
  <sentence id="s111" text="Here, we show that ablating or silencing the transcription factor negative regulation of transcription by RNA polymerase II ameliorates pathology in several forms of muscular dystrophy.">
    <entity charOffset="66-123" id="s111.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="166-184" id="s111.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s111.e0" e2="s111.e1" id="s111.p0" relation="false"/>
  </sentence>
  <sentence id="s112" text="Mutations of the five genes (ARHGEF5, biological_process, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.">
    <entity charOffset="38-56" id="s112.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="126-132" id="s112.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s112.e0" e2="s112.e1" id="s112.p0" relation="true"/>
  </sentence>
  <sentence id="s113" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, negative regulation of transcription by RNA polymerase II and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s113.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="148-205" id="s113.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s113.e0" e2="s113.e1" id="s113.p0" relation="false"/>
  </sentence>
  <sentence id="s114" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.">
    <entity charOffset="50-64" id="s114.e0" ontology_id="HP_0009919" text="retinoblastoma" type="HP"/>
    <entity charOffset="183-229" id="s114.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s114.e0" e2="s114.e1" id="s114.p0" relation="true"/>
  </sentence>
  <sentence id="s115" text="Here we present a case of a 3-year-old boy with compound heterozygous missense mutations in the negative regulation of centrosome duplication gene manifesting features of both JBTS and NPHP syndromes, with neonatal onset of end-stage renal disease (ESRD) and associated microcephaly.">
    <entity charOffset="96-141" id="s115.e0" ontology_id="GO_0010826" text="negative regulation of centrosome duplication" type="GO"/>
    <entity charOffset="270-282" id="s115.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s115.e0" e2="s115.e1" id="s115.p0" relation="true"/>
  </sentence>
  <sentence id="s116" text="EEF1A2 gene is highly expressed in the central nervous system and positive regulation of lipid kinase activity knockout mice show the neuronal degeneration.">
    <entity charOffset="39-46" id="s116.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="66-110" id="s116.e1" ontology_id="GO_0090218" text="positive regulation of lipid kinase activity" type="GO"/>
    <pair e1="s116.e0" e2="s116.e1" id="s116.p0" relation="false"/>
  </sentence>
  <sentence id="s117" text="Novel targets ANTXR1 and positive regulation of Wnt signaling pathway were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated phosphatidylinositol phosphorylation cell.">
    <entity charOffset="25-69" id="s117.e0" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="176-181" id="s117.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s117.e0" e2="s117.e1" id="s117.p0" relation="false"/>
  </sentence>
  <sentence id="s118" text="Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by actin cytoskeleton reorganization and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-tumor function of miR-493.">
    <entity charOffset="81-114" id="s118.e0" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <entity charOffset="201-206" id="s118.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s118.e0" e2="s118.e1" id="s118.p0" relation="true"/>
  </sentence>
  <sentence id="s119" text="Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, protein O-linked mannosylation, LARGE, GDP-mannose biosynthetic process, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenomuscle organ developments of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="20-50" id="s119.e0" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <entity charOffset="264-284" id="s119.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s119.e0" e2="s119.e1" id="s119.p0" relation="true"/>
  </sentence>
  <sentence id="s120" text="Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, protein O-linked mannosylation, LARGE, GDP-mannose biosynthetic process, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenomuscle organ developments of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="67-97" id="s120.e0" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <entity charOffset="264-284" id="s120.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s120.e0" e2="s120.e1" id="s120.p0" relation="true"/>
  </sentence>
  <sentence id="s121" text="Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, protein O-linked mannosylation, LARGE, GDP-mannose biosynthetic process, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenomuscle organ developments of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="106-138" id="s121.e0" ontology_id="GO_0009298" text="GDP-mannose biosynthetic process" type="GO"/>
    <entity charOffset="264-284" id="s121.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s121.e0" e2="s121.e1" id="s121.p0" relation="true"/>
  </sentence>
  <sentence id="s122" text="Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, protein O-linked mannosylation, LARGE, GDP-mannose biosynthetic process, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenomuscle organ developments of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="161-191" id="s122.e0" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <entity charOffset="264-284" id="s122.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s122.e0" e2="s122.e1" id="s122.p0" relation="true"/>
  </sentence>
  <sentence id="s123" text="We also demonstrate that tumor-associated transcription by RNA polymerase IIs induce the expression of genes associated with an aggressive phenotype in primary lung cancer cells and selectively promote their dissemination rather than local growth.">
    <entity charOffset="42-76" id="s123.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="165-171" id="s123.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s123.e0" e2="s123.e1" id="s123.p0" relation="false"/>
  </sentence>
  <sentence id="s124" text="We show that the tumor microenvironment modulates transcription by RNA polymerase II gene expression and identify a four-gene MSC signature that is functionally implicated in promoting metastasis.">
    <entity charOffset="17-22" id="s124.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="50-84" id="s124.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s124.e0" e2="s124.e1" id="s124.p0" relation="true"/>
  </sentence>
  <sentence id="s125" text="Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (ion transport).">
    <entity charOffset="63-82" id="s125.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="643-656" id="s125.e1" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <pair e1="s125.e0" e2="s125.e1" id="s125.p0" relation="false"/>
  </sentence>
  <sentence id="s126" text="protein polyubiquitination potentially controls cancer metastasis through regulation of negative regulation of retrograde protein transport, ER to cytosol levels.">
    <entity charOffset="0-26" id="s126.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="48-54" id="s126.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s126.e0" e2="s126.e1" id="s126.p0" relation="true"/>
  </sentence>
  <sentence id="s127" text="protein polyubiquitination potentially controls cancer metastasis through regulation of negative regulation of retrograde protein transport, ER to cytosol levels.">
    <entity charOffset="48-54" id="s127.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-154" id="s127.e1" ontology_id="GO_1904153" text="negative regulation of retrograde protein transport, ER to cytosol" type="GO"/>
    <pair e1="s127.e0" e2="s127.e1" id="s127.p0" relation="true"/>
  </sentence>
  <sentence id="s128" text="Loss of protein polyubiquitination was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (plasminogen activation) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.">
    <entity charOffset="8-34" id="s128.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="330-336" id="s128.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s128.e0" e2="s128.e1" id="s128.p0" relation="true"/>
  </sentence>
  <sentence id="s129" text="Loss of protein polyubiquitination was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (plasminogen activation) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.">
    <entity charOffset="198-220" id="s129.e0" ontology_id="GO_0031639" text="plasminogen activation" type="GO"/>
    <entity charOffset="330-336" id="s129.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s129.e0" e2="s129.e1" id="s129.p0" relation="false"/>
  </sentence>
  <sentence id="s130" text="The enriched genes included proteolysis, SERPINE2, response to bacterium, aging, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.">
    <entity charOffset="28-39" id="s130.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="100-105" id="s130.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s130.e0" e2="s130.e1" id="s130.p0" relation="false"/>
  </sentence>
  <sentence id="s131" text="The enriched genes included proteolysis, SERPINE2, response to bacterium, aging, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.">
    <entity charOffset="51-72" id="s131.e0" ontology_id="GO_0009617" text="response to bacterium" type="GO"/>
    <entity charOffset="100-105" id="s131.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s131.e0" e2="s131.e1" id="s131.p0" relation="true"/>
  </sentence>
  <sentence id="s132" text="The enriched genes included proteolysis, SERPINE2, response to bacterium, aging, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.">
    <entity charOffset="74-79" id="s132.e0" ontology_id="GO_0007568" text="aging" type="GO"/>
    <entity charOffset="100-105" id="s132.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s132.e0" e2="s132.e1" id="s132.p0" relation="true"/>
  </sentence>
  <sentence id="s133" text="The enriched genes included proteolysis, SERPINE2, response to bacterium, aging, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.">
    <entity charOffset="100-105" id="s133.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="131-171" id="s133.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s133.e0" e2="s133.e1" id="s133.p0" relation="true"/>
  </sentence>
  <sentence id="s134" text="The enriched genes included proteolysis, SERPINE2, response to bacterium, aging, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.">
    <entity charOffset="100-105" id="s134.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="177-234" id="s134.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s134.e0" e2="s134.e1" id="s134.p0" relation="false"/>
  </sentence>
  <sentence id="s135" text="In the present study, western blotting was used to verified the expression of Tlymphocyte CaSR and pathway proteins, including phosphorylated extracellular signalregulated kinase (PERK)1/2 and phosphorylated cJun Nterminal kinase (PJNK), and used cytometric bead array to detect the secretion of interleukin (IL)4, IL6, IL10 and tumor necrosis factor (negative regulation of transcription by RNA polymerase II) in AMI onset, the results demonstrated that they were all increased.">
    <entity charOffset="338-343" id="s135.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="361-418" id="s135.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s135.e0" e2="s135.e1" id="s135.p0" relation="false"/>
  </sentence>
  <sentence id="s136" text="lipid biosynthetic process phosphorylates purine nucleobase metabolic process/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain tumor cell growth and survival.">
    <entity charOffset="0-26" id="s136.e0" ontology_id="GO_0008610" text="lipid biosynthetic process" type="GO"/>
    <entity charOffset="206-211" id="s136.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s136.e0" e2="s136.e1" id="s136.p0" relation="true"/>
  </sentence>
  <sentence id="s137" text="lipid biosynthetic process phosphorylates purine nucleobase metabolic process/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain tumor cell growth and survival.">
    <entity charOffset="42-77" id="s137.e0" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <entity charOffset="206-211" id="s137.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s137.e0" e2="s137.e1" id="s137.p0" relation="true"/>
  </sentence>
  <sentence id="s138" text="Knock-in of nonphosphorylatable purine nucleobase metabolic process/2 mutants, which have uninhibited activity, in brain tumor cells under energy stress exhausts cellular ATP and NADPH and increases reactive oxygen species levels, thereby promoting cell apoptosis.">
    <entity charOffset="32-67" id="s138.e0" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <entity charOffset="121-126" id="s138.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s138.e0" e2="s138.e1" id="s138.p0" relation="true"/>
  </sentence>
  <sentence id="s139" text="Mutations in ganglioside-induced differentiation-associated-protein 1 (mitochondrial fission) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).">
    <entity charOffset="71-92" id="s139.e0" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <entity charOffset="172-191" id="s139.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s139.e0" e2="s139.e1" id="s139.p0" relation="true"/>
  </sentence>
  <sentence id="s140" text="Our study expands the mutational spectrum of mitochondrial fission-related CMT disease with the identification of new and unreported GDAP1 variants and demonstrates the predominance of the axonal form of neuropathy in CMT disease associated with GDAP1.">
    <entity charOffset="45-66" id="s140.e0" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <entity charOffset="204-214" id="s140.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s140.e0" e2="s140.e1" id="s140.p0" relation="true"/>
  </sentence>
  <sentence id="s141" text="Here, a novel animal model was used to study how epidermal growth factor receptor signaling pathway-6 affects tumor development.">
    <entity charOffset="49-99" id="s141.e0" ontology_id="GO_0007173" text="epidermal growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="110-115" id="s141.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s141.e0" e2="s141.e1" id="s141.p0" relation="true"/>
  </sentence>
  <sentence id="s142" text="The KSHV viral homolog of interleukin-6 gene (epidermal growth factor receptor signaling pathway-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood.">
    <entity charOffset="46-96" id="s142.e0" ontology_id="GO_0007173" text="epidermal growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="131-136" id="s142.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s142.e0" e2="s142.e1" id="s142.p0" relation="true"/>
  </sentence>
  <sentence id="s143" text="The KSHV viral homolog of interleukin-6 gene (epidermal growth factor receptor signaling pathway-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood.">
    <entity charOffset="46-96" id="s143.e0" ontology_id="GO_0007173" text="epidermal growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="177-183" id="s143.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s143.e0" e2="s143.e1" id="s143.p0" relation="true"/>
  </sentence>
  <sentence id="s144" text="Additional validation efforts and functional studies are warranted to demonstrate whether negative regulation of translational initiation is a novel tumor suppressor gene and a potential therapeutic target for pancreatic cancer">
    <entity charOffset="90-137" id="s144.e0" ontology_id="GO_0045947" text="negative regulation of translational initiation" type="GO"/>
    <entity charOffset="149-154" id="s144.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s144.e0" e2="s144.e1" id="s144.p0" relation="false"/>
  </sentence>
  <sentence id="s145" text="In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-cytoskeleton organization, from primary tumor tissue.">
    <entity charOffset="59-66" id="s145.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="86-111" id="s145.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s145.e0" e2="s145.e1" id="s145.p0" relation="false"/>
  </sentence>
  <sentence id="s146" text="In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-cytoskeleton organization, from primary tumor tissue.">
    <entity charOffset="86-111" id="s146.e0" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <entity charOffset="126-131" id="s146.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s146.e0" e2="s146.e1" id="s146.p0" relation="false"/>
  </sentence>
  <sentence id="s147" text="FGD is a heterogeneous disorder for which causal mutations have been identified in MC2R, MRAP, G1/S transition of mitotic cell cycle and TXNRD2.">
    <entity charOffset="9-22" id="s147.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="95-132" id="s147.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s147.e0" e2="s147.e1" id="s147.p0" relation="false"/>
  </sentence>
  <sentence id="s148" text="Here, we summarize thecellular functions of negative regulation of neuron apoptotic process, itsroles in the nervous system, and its link to multiple neurodegenerative diseases, with a particular focus dedicated to recent lysosome-related mechanistic developments">
    <entity charOffset="45-92" id="s148.e0" ontology_id="GO_0043524" text="negative regulation of neuron apoptotic process" type="GO"/>
    <entity charOffset="152-178" id="s148.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s148.e0" e2="s148.e1" id="s148.p0" relation="true"/>
  </sentence>
  <sentence id="s149" text="&lt;i&gt;In silico&lt;/i&gt; human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with negative regulation of transcription by RNA polymerase II, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates &lt;i&gt;PrKD1&lt;/i&gt; gene expression.">
    <entity charOffset="110-116" id="s149.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="199-256" id="s149.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s149.e0" e2="s149.e1" id="s149.p0" relation="true"/>
  </sentence>
  <sentence id="s150" text="Because we had demonstrated that protein phosphorylation is the only known kinase to phosphorylate threonine 120 (T120) of beta-catenin in prostate cancer resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of &lt;i&gt;PrKD1&lt;/i&gt;.">
    <entity charOffset="33-56" id="s150.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="148-154" id="s150.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s150.e0" e2="s150.e1" id="s150.p0" relation="false"/>
  </sentence>
  <sentence id="s151" text="Down regulation of Protein Kinase D1 (protein phosphorylation), a novel serine threonine kinase, in prostate, gastric, breast and colon cancers in humans leads to disease progression.">
    <entity charOffset="38-61" id="s151.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="136-142" id="s151.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s151.e0" e2="s151.e1" id="s151.p0" relation="true"/>
  </sentence>
  <sentence id="s152" text="Somatic genetic rearrangements that juxtapose the positive regulation of transcription, DNA-templated DNA binding domain to the transcriptional activation domain of other transcription factors deregulate PAX3 function and contribute to the pathogenesis of the soft tissue cancers alveolar rhabdomyosarcoma and biphenotypic sinonasal sarcoma.">
    <entity charOffset="50-101" id="s152.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="289-305" id="s152.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s152.e0" e2="s152.e1" id="s152.p0" relation="true"/>
  </sentence>
  <sentence id="s153" text="Overexpression of biological_process in rodent models recapitulates several aspects of neuropathy, and reduction of Pmp22 in such models results in amelioration of the neuropathy phenotype.">
    <entity charOffset="18-36" id="s153.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="87-97" id="s153.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s153.e0" e2="s153.e1" id="s153.p0" relation="false"/>
  </sentence>
  <sentence id="s154" text="Mutations of the succinate dehydrogenase (choline catabolic process) complex subunits (A, B, C, D, and SDHAF2) have been implicated in predicting metastatic behavior and in identifying possible paraganglioma syndromes.">
    <entity charOffset="42-67" id="s154.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="194-207" id="s154.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s154.e0" e2="s154.e1" id="s154.p0" relation="true"/>
  </sentence>
  <sentence id="s155" text="In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (biological_process), early B cell factor 2 (positive regulation of cold-induced thermogenesis), crystallin, alpha B (CRYAB) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).">
    <entity charOffset="107-125" id="s155.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="235-240" id="s155.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s155.e0" e2="s155.e1" id="s155.p0" relation="true"/>
  </sentence>
  <sentence id="s156" text="In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (biological_process), early B cell factor 2 (positive regulation of cold-induced thermogenesis), crystallin, alpha B (CRYAB) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).">
    <entity charOffset="151-200" id="s156.e0" ontology_id="GO_0120162" text="positive regulation of cold-induced thermogenesis" type="GO"/>
    <entity charOffset="235-240" id="s156.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s156.e0" e2="s156.e1" id="s156.p0" relation="true"/>
  </sentence>
  <sentence id="s157" text="Genome-wide association studies have identified SNPs near negative regulation of neuron projection development at 10q21.2 that are associated with both breast cancer risk and mammographic density.">
    <entity charOffset="58-110" id="s157.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="159-165" id="s157.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s157.e0" e2="s157.e1" id="s157.p0" relation="true"/>
  </sentence>
  <sentence id="s158" text="Luciferase assays did not identify SNPs that affect transactivation of negative regulation of neuron projection development, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast cancer.">
    <entity charOffset="71-123" id="s158.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="271-277" id="s158.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s158.e0" e2="s158.e1" id="s158.p0" relation="false"/>
  </sentence>
  <sentence id="s159" text="Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).">
    <entity charOffset="111-136" id="s159.e0" ontology_id="GO_0006546" text="glycine catabolic process" type="GO"/>
    <entity charOffset="230-245" id="s159.e1" ontology_id="HP_0002154" text="hyperglycinemia" type="HP"/>
    <pair e1="s159.e0" e2="s159.e1" id="s159.p0" relation="true"/>
  </sentence>
  <sentence id="s160" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, visual perception, receptor-mediated endocytosis, SLC4A11, TACSTD2, TGFBI, and vitamin K biosynthetic process genes.">
    <entity charOffset="10-29" id="s160.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="74-91" id="s160.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s160.e0" e2="s160.e1" id="s160.p0" relation="true"/>
  </sentence>
  <sentence id="s161" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, visual perception, receptor-mediated endocytosis, SLC4A11, TACSTD2, TGFBI, and vitamin K biosynthetic process genes.">
    <entity charOffset="10-29" id="s161.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="93-122" id="s161.e1" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <pair e1="s161.e0" e2="s161.e1" id="s161.p0" relation="true"/>
  </sentence>
  <sentence id="s162" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, visual perception, receptor-mediated endocytosis, SLC4A11, TACSTD2, TGFBI, and vitamin K biosynthetic process genes.">
    <entity charOffset="10-29" id="s162.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="153-183" id="s162.e1" ontology_id="GO_0042371" text="vitamin K biosynthetic process" type="GO"/>
    <pair e1="s162.e0" e2="s162.e1" id="s162.p0" relation="true"/>
  </sentence>
  <sentence id="s163" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.">
    <entity charOffset="101-111" id="s163.e0" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <entity charOffset="229-271" id="s163.e1" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <pair e1="s163.e0" e2="s163.e1" id="s163.p0" relation="true"/>
  </sentence>
  <sentence id="s164" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.">
    <entity charOffset="229-271" id="s164.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="322-328" id="s164.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s164.e0" e2="s164.e1" id="s164.p0" relation="true"/>
  </sentence>
  <sentence id="s165" text="transforming growth factor beta activation was dispensable in the late steps of carcinoma cell metastasis that follow tumor cell intravasation, including vascular arrest, extravasation, and tissue colonization.">
    <entity charOffset="0-42" id="s165.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="118-123" id="s165.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s165.e0" e2="s165.e1" id="s165.p0" relation="true"/>
  </sentence>
  <sentence id="s166" text="Knockdown of transforming growth factor beta activation in all tested cell lines led to significant inhibition of tumor cell intravasation, but did not affect primary tumor growth.">
    <entity charOffset="13-55" id="s166.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="114-119" id="s166.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s166.e0" e2="s166.e1" id="s166.p0" relation="true"/>
  </sentence>
  <sentence id="s167" text="All tumors were positive for anion transport-bicarbonate transport, CK18, PAX 8, antimitochondrial antigen, and SDHB.">
    <entity charOffset="4-10" id="s167.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="29-44" id="s167.e1" ontology_id="GO_0006820" text="anion transport" type="GO"/>
    <pair e1="s167.e0" e2="s167.e1" id="s167.p0" relation="true"/>
  </sentence>
  <sentence id="s168" text="All tumors were positive for anion transport-bicarbonate transport, CK18, PAX 8, antimitochondrial antigen, and SDHB.">
    <entity charOffset="4-10" id="s168.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="45-66" id="s168.e1" ontology_id="GO_0015701" text="bicarbonate transport" type="GO"/>
    <pair e1="s168.e0" e2="s168.e1" id="s168.p0" relation="true"/>
  </sentence>
  <sentence id="s169" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), positive regulation of cell adhesion and positive regulation of transcription by RNA polymerase II RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="142-148" id="s169.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="251-308" id="s169.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s169.e0" e2="s169.e1" id="s169.p0" relation="false"/>
  </sentence>
  <sentence id="s170" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), positive regulation of cell adhesion and positive regulation of transcription by RNA polymerase II RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="182-202" id="s170.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="210-246" id="s170.e1" ontology_id="GO_0045785" text="positive regulation of cell adhesion" type="GO"/>
    <pair e1="s170.e0" e2="s170.e1" id="s170.p0" relation="true"/>
  </sentence>
  <sentence id="s171" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), positive regulation of cell adhesion and positive regulation of transcription by RNA polymerase II RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="182-202" id="s171.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="251-308" id="s171.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s171.e0" e2="s171.e1" id="s171.p0" relation="false"/>
  </sentence>
  <sentence id="s172" text="Altogether, our data strongly suggest that mutations in cilium organization cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.">
    <entity charOffset="56-75" id="s172.e0" ontology_id="GO_0044782" text="cilium organization" type="GO"/>
    <entity charOffset="160-169" id="s172.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s172.e0" e2="s172.e1" id="s172.p0" relation="true"/>
  </sentence>
  <sentence id="s173" text="Altogether, our data strongly suggest that mutations in cilium organization cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.">
    <entity charOffset="56-75" id="s173.e0" ontology_id="GO_0044782" text="cilium organization" type="GO"/>
    <entity charOffset="174-182" id="s173.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s173.e0" e2="s173.e1" id="s173.p0" relation="true"/>
  </sentence>
  <sentence id="s174" text="Our most significant AM association was upstream of nucleosome assembly, a gene implicated in ovarian and breast cancers (rs11604207, p=1.610).">
    <entity charOffset="52-71" id="s174.e0" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <entity charOffset="113-119" id="s174.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s174.e0" e2="s174.e1" id="s174.p0" relation="true"/>
  </sentence>
  <sentence id="s175" text="Accordingly, overexpression of the A mutants in EC cells harboring wild-type PPP2R1A increased anchorage-independent growth and tumor formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3, positive regulation of protein phosphorylation, and mTOR/p70S6K signaling pathways.">
    <entity charOffset="129-134" id="s175.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="231-277" id="s175.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s175.e0" e2="s175.e1" id="s175.p0" relation="false"/>
  </sentence>
  <sentence id="s176" text="By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in protein dephosphorylation.">
    <entity charOffset="138-146" id="s176.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="230-255" id="s176.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s176.e0" e2="s176.e1" id="s176.p0" relation="true"/>
  </sentence>
  <sentence id="s177" text="In a patient with clinical features of mitotic metaphase plate congression syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.">
    <entity charOffset="39-74" id="s177.e0" ontology_id="GO_0007080" text="mitotic metaphase plate congression" type="GO"/>
    <entity charOffset="107-128" id="s177.e1" ontology_id="HP_0004467" text="preauricular fistulas" type="HP"/>
    <pair e1="s177.e0" e2="s177.e1" id="s177.p0" relation="false"/>
  </sentence>
  <sentence id="s178" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, negative regulation of angiogenesis, BMP1, positive regulation of cell proliferation, protein peptidyl-prolyl isomerization).">
    <entity charOffset="99-118" id="s178.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="205-246" id="s178.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s178.e0" e2="s178.e1" id="s178.p0" relation="true"/>
  </sentence>
  <sentence id="s179" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, negative regulation of angiogenesis, BMP1, positive regulation of cell proliferation, protein peptidyl-prolyl isomerization).">
    <entity charOffset="99-118" id="s179.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="248-285" id="s179.e1" ontology_id="GO_0000413" text="protein peptidyl-prolyl isomerization" type="GO"/>
    <pair e1="s179.e0" e2="s179.e1" id="s179.p0" relation="true"/>
  </sentence>
  <sentence id="s180" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, negative regulation of angiogenesis, BMP1, positive regulation of cell proliferation, protein peptidyl-prolyl isomerization).">
    <entity charOffset="99-118" id="s180.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="162-197" id="s180.e1" ontology_id="GO_0016525" text="negative regulation of angiogenesis" type="GO"/>
    <pair e1="s180.e0" e2="s180.e1" id="s180.p0" relation="true"/>
  </sentence>
  <sentence id="s181" text="Recently, endoplasmic reticulum organization, a gene that encodes TRIC-B, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with autosomal recessive OI.">
    <entity charOffset="10-44" id="s181.e0" ontology_id="GO_0007029" text="endoplasmic reticulum organization" type="GO"/>
    <entity charOffset="216-235" id="s181.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s181.e0" e2="s181.e1" id="s181.p0" relation="true"/>
  </sentence>
  <sentence id="s182" text="Mutations in the mitochondrial alanyl-transfer (t)RNA synthetase 2 (mitochondrial respiratory chain complex assembly; OMIM 612035) have been linked to leukoencephalopathy recently.">
    <entity charOffset="68-116" id="s182.e0" ontology_id="GO_0033108" text="mitochondrial respiratory chain complex assembly" type="GO"/>
    <entity charOffset="151-170" id="s182.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s182.e0" e2="s182.e1" id="s182.p0" relation="true"/>
  </sentence>
  <sentence id="s183" text="We report a case with novel mitochondrial respiratory chain complex assembly gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L">
    <entity charOffset="28-76" id="s183.e0" ontology_id="GO_0033108" text="mitochondrial respiratory chain complex assembly" type="GO"/>
    <entity charOffset="219-232" id="s183.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s183.e0" e2="s183.e1" id="s183.p0" relation="false"/>
  </sentence>
  <sentence id="s184" text="Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&amp;gt;T variant (p.Ser162Leu) in protein O-linked glycosylation detected by exome sequencing.">
    <entity charOffset="130-147" id="s184.e0" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <entity charOffset="256-286" id="s184.e1" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <pair e1="s184.e0" e2="s184.e1" id="s184.p0" relation="true"/>
  </sentence>
  <sentence id="s185" text="OBJECTIVES We hypothesised that p16 G1/S transition of mitotic cell cycle methylation might have a role in cancer development driven by HPV16, mainly in the presence of intact E1/E2 genes.">
    <entity charOffset="36-73" id="s185.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="107-113" id="s185.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s185.e0" e2="s185.e1" id="s185.p0" relation="false"/>
  </sentence>
  <sentence id="s186" text="BACKGROUND Epigenetic modifications in host cells, like p16 G1/S transition of mitotic cell cycle methylation, have been considered as putative complementary mechanisms for cancer development.">
    <entity charOffset="60-97" id="s186.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="173-179" id="s186.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s186.e0" e2="s186.e1" id="s186.p0" relation="false"/>
  </sentence>
  <sentence id="s187" text="Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="72-78" id="s187.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="124-173" id="s187.e1" ontology_id="GO_0046929" text="negative regulation of neurotransmitter secretion" type="GO"/>
    <pair e1="s187.e0" e2="s187.e1" id="s187.p0" relation="true"/>
  </sentence>
  <sentence id="s188" text="Chemical inhibition of epigenetic regulatory proteins BrdT and positive regulation of transcription elongation from RNA polymerase II promoter is emerging as a promising therapeutic strategy in contraception, cancer, and heart disease.">
    <entity charOffset="63-142" id="s188.e0" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="209-215" id="s188.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s188.e0" e2="s188.e1" id="s188.p0" relation="true"/>
  </sentence>
  <sentence id="s189" text="However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between proteolysisT/T mice and wild-type mice.">
    <entity charOffset="49-69" id="s189.e0" ontology_id="HP_0002625" text="deep vein thrombosis" type="HP"/>
    <entity charOffset="217-228" id="s189.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s189.e0" e2="s189.e1" id="s189.p0" relation="false"/>
  </sentence>
  <sentence id="s190" text="DNA was extracted from paraffin-embedded tumor specimens from the patients and peripheral blood lymphocytes from the controls and used for regulation of cysteine-type endopeptidase activity/fat cell differentiation genotyping.">
    <entity charOffset="41-46" id="s190.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="139-189" id="s190.e1" ontology_id="GO_2000116" text="regulation of cysteine-type endopeptidase activity" type="GO"/>
    <pair e1="s190.e0" e2="s190.e1" id="s190.p0" relation="true"/>
  </sentence>
  <sentence id="s191" text="DNA was extracted from paraffin-embedded tumor specimens from the patients and peripheral blood lymphocytes from the controls and used for regulation of cysteine-type endopeptidase activity/fat cell differentiation genotyping.">
    <entity charOffset="41-46" id="s191.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="190-214" id="s191.e1" ontology_id="GO_0045444" text="fat cell differentiation" type="GO"/>
    <pair e1="s191.e0" e2="s191.e1" id="s191.p0" relation="true"/>
  </sentence>
  <sentence id="s192" text="Cervical cancer patients with genotypes GA/AA in negative regulation of Wnt signaling pathway SNP rs12918952 were associated with parametrium invasion and pelvic lymph node metastasis.">
    <entity charOffset="9-15" id="s192.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="49-93" id="s192.e1" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <pair e1="s192.e0" e2="s192.e1" id="s192.p0" relation="true"/>
  </sentence>
  <sentence id="s193" text="Whole-genome sequencing documented two rare truncating variants in blood coagulation, a gene associated with a type of autosomal recessive AOS that recurrently features periventricular calcification and impaired neurodevelopment.">
    <entity charOffset="67-84" id="s193.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="119-138" id="s193.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s193.e0" e2="s193.e1" id="s193.p0" relation="true"/>
  </sentence>
  <sentence id="s194" text="Our findings establish that defective protein folding function underlies a recognizable encephalopathy and drives accelerated microtubule polymerization and enhanced microtubule stability, underscoring an additional cause of altered microtubule dynamics with negative regulation of transcription by RNA polymerase II on neuronal function and survival in the developing brain">
    <entity charOffset="38-53" id="s194.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="88-102" id="s194.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s194.e0" e2="s194.e1" id="s194.p0" relation="true"/>
  </sentence>
  <sentence id="s195" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="86-92" id="s195.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="242-266" id="s195.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s195.e0" e2="s195.e1" id="s195.p0" relation="false"/>
  </sentence>
  <sentence id="s196" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="172-195" id="s196.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="328-337" id="s196.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s196.e0" e2="s196.e1" id="s196.p0" relation="false"/>
  </sentence>
  <sentence id="s197" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="197-240" id="s197.e0" ontology_id="GO_0060561" text="apoptotic process involved in morphogenesis" type="GO"/>
    <entity charOffset="328-337" id="s197.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s197.e0" e2="s197.e1" id="s197.p0" relation="true"/>
  </sentence>
  <sentence id="s198" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="271-299" id="s198.e0" ontology_id="GO_0001913" text="T cell mediated cytotoxicity" type="GO"/>
    <entity charOffset="328-337" id="s198.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s198.e0" e2="s198.e1" id="s198.p0" relation="true"/>
  </sentence>
  <sentence id="s199" text="The alterations of ATM and T cell mediated cytotoxicity are associated with the progression of tumor from CIN to Stage I/II, thus implying their role in early invasiveness.">
    <entity charOffset="27-55" id="s199.e0" ontology_id="GO_0001913" text="T cell mediated cytotoxicity" type="GO"/>
    <entity charOffset="95-100" id="s199.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s199.e0" e2="s199.e1" id="s199.p0" relation="true"/>
  </sentence>
  <sentence id="s200" text="positive regulation of protein phosphorylation, a mitochondrial serine/threonine kinase, is the product of a gene mutated in an autosomal recessive form of Parkinson disease.">
    <entity charOffset="0-46" id="s200.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="128-147" id="s200.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s200.e0" e2="s200.e1" id="s200.p0" relation="false"/>
  </sentence>
  <sentence id="s201" text="Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as adsl, mbd5, learning, and tsc1b.">
    <entity charOffset="94-100" id="s201.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="122-130" id="s201.e1" ontology_id="GO_0007612" text="learning" type="GO"/>
    <pair e1="s201.e0" e2="s201.e1" id="s201.p0" relation="true"/>
  </sentence>
  <sentence id="s202" text="Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (blood coagulation), tumor necrosis factor (TNF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) are implicated in the pathology of rheumatoid arthritis (RA).">
    <entity charOffset="98-115" id="s202.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="119-124" id="s202.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s202.e0" e2="s202.e1" id="s202.p0" relation="true"/>
  </sentence>
  <sentence id="s203" text="Our data suggest that mutations of the androgen metabolic process gene are the main causes of posterior hypospadias and seem to affect the semen quality of adult patients, whereas mutations in AR and androgen biosynthetic process gene were rare in these hypospadias patients.">
    <entity charOffset="39-65" id="s203.e0" ontology_id="GO_0008209" text="androgen metabolic process" type="GO"/>
    <entity charOffset="104-115" id="s203.e1" ontology_id="HP_0000047" text="hypospadias" type="HP"/>
    <pair e1="s203.e0" e2="s203.e1" id="s203.p0" relation="true"/>
  </sentence>
  <sentence id="s204" text="Our data suggest that mutations of the androgen metabolic process gene are the main causes of posterior hypospadias and seem to affect the semen quality of adult patients, whereas mutations in AR and androgen biosynthetic process gene were rare in these hypospadias patients.">
    <entity charOffset="104-115" id="s204.e0" ontology_id="HP_0000047" text="hypospadias" type="HP"/>
    <entity charOffset="200-229" id="s204.e1" ontology_id="GO_0006702" text="androgen biosynthetic process" type="GO"/>
    <pair e1="s204.e0" e2="s204.e1" id="s204.p0" relation="true"/>
  </sentence>
  <sentence id="s205" text="Recently, it has been demonstrated that, mutations of sensory perception of sound are associated with profound nonsyndromic hearing impairment at the sensory perception of sound locus.">
    <entity charOffset="54-81" id="s205.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="102-110" id="s205.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s205.e0" e2="s205.e1" id="s205.p0" relation="false"/>
  </sentence>
  <sentence id="s206" text="Recently, it has been demonstrated that, mutations of sensory perception of sound are associated with profound nonsyndromic hearing impairment at the sensory perception of sound locus.">
    <entity charOffset="124-142" id="s206.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="150-177" id="s206.e1" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <pair e1="s206.e0" e2="s206.e1" id="s206.p0" relation="true"/>
  </sentence>
  <sentence id="s207" text="A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, mitochondrial respiratory chain complex I assembly and mitochondrial respiratory chain complex I assembly, confirming that Histiocytoid CM is genetically heterogeneous.">
    <entity charOffset="107-157" id="s207.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="261-274" id="s207.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s207.e0" e2="s207.e1" id="s207.p0" relation="false"/>
  </sentence>
  <sentence id="s208" text="A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, mitochondrial respiratory chain complex I assembly and mitochondrial respiratory chain complex I assembly, confirming that Histiocytoid CM is genetically heterogeneous.">
    <entity charOffset="162-212" id="s208.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="261-274" id="s208.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s208.e0" e2="s208.e1" id="s208.p0" relation="true"/>
  </sentence>
  <sentence id="s209" text="Today, more than a dozen human negative regulation of endothelial cell proliferation missense mutations have been described, all found in patients with severe cardiac arrhythmias.">
    <entity charOffset="31-84" id="s209.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="159-178" id="s209.e1" ontology_id="HP_0011675" text="cardiac arrhythmias" type="HP"/>
    <pair e1="s209.e0" e2="s209.e1" id="s209.p0" relation="true"/>
  </sentence>
  <sentence id="s210" text="Hypomorphic cellular response to DNA damage stimulus mutations in males are typically associated with anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID).">
    <entity charOffset="12-52" id="s210.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="113-133" id="s210.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s210.e0" e2="s210.e1" id="s210.p0" relation="true"/>
  </sentence>
  <sentence id="s211" text="As rare polymorphisms have been described in IKBKG and polygenic inheritance remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing cellular response to DNA damage stimulus-ID variants">
    <entity charOffset="55-76" id="s211.e0" ontology_id="HP_0010982" text="polygenic inheritance" type="HP"/>
    <entity charOffset="257-297" id="s211.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s211.e0" e2="s211.e1" id="s211.p0" relation="true"/>
  </sentence>
  <sentence id="s212" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, triglyceride metabolic process, triglyceride metabolic process, positive regulation of lipoprotein lipase activity).">
    <entity charOffset="10-30" id="s212.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="235-285" id="s212.e1" ontology_id="GO_0051006" text="positive regulation of lipoprotein lipase activity" type="GO"/>
    <pair e1="s212.e0" e2="s212.e1" id="s212.p0" relation="true"/>
  </sentence>
  <sentence id="s213" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, triglyceride metabolic process, triglyceride metabolic process, positive regulation of lipoprotein lipase activity).">
    <entity charOffset="10-30" id="s213.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="134-162" id="s213.e1" ontology_id="GO_0006631" text="fatty acid metabolic process" type="GO"/>
    <pair e1="s213.e0" e2="s213.e1" id="s213.p0" relation="false"/>
  </sentence>
  <sentence id="s214" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, triglyceride metabolic process, triglyceride metabolic process, positive regulation of lipoprotein lipase activity).">
    <entity charOffset="10-30" id="s214.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="171-201" id="s214.e1" ontology_id="GO_0006641" text="triglyceride metabolic process" type="GO"/>
    <pair e1="s214.e0" e2="s214.e1" id="s214.p0" relation="true"/>
  </sentence>
  <sentence id="s215" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, triglyceride metabolic process, triglyceride metabolic process, positive regulation of lipoprotein lipase activity).">
    <entity charOffset="10-30" id="s215.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="203-233" id="s215.e1" ontology_id="GO_0006641" text="triglyceride metabolic process" type="GO"/>
    <pair e1="s215.e0" e2="s215.e1" id="s215.p0" relation="true"/>
  </sentence>
  <sentence id="s216" text="Consistent with this pattern of activity, polr1c and transcription, DNA-templated homozygous mutant zebrafish exhibit cartilage hypoplasia and cranioskeletal anomalies characteristic of humans with Treacher Collins syndrome.">
    <entity charOffset="53-81" id="s216.e0" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <entity charOffset="149-167" id="s216.e1" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <pair e1="s216.e0" e2="s216.e1" id="s216.p0" relation="true"/>
  </sentence>
  <sentence id="s217" text="Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) regulation of transcription, DNA-templated deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.">
    <entity charOffset="125-167" id="s217.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="252-271" id="s217.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s217.e0" e2="s217.e1" id="s217.p0" relation="false"/>
  </sentence>
  <sentence id="s218" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal biological_process) in whom two novel craniofacial suture morphogenesis mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="130-140" id="s218.e0" ontology_id="HP_0012833" text="unilateral" type="HP"/>
    <entity charOffset="219-252" id="s218.e1" ontology_id="GO_0097094" text="craniofacial suture morphogenesis" type="GO"/>
    <pair e1="s218.e0" e2="s218.e1" id="s218.p0" relation="true"/>
  </sentence>
  <sentence id="s219" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="215-260" id="s219.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="582-592" id="s219.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s219.e0" e2="s219.e1" id="s219.p0" relation="false"/>
  </sentence>
  <sentence id="s220" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="268-291" id="s220.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="582-592" id="s220.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s220.e0" e2="s220.e1" id="s220.p0" relation="false"/>
  </sentence>
  <sentence id="s221" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="313-331" id="s221.e0" ontology_id="GO_0000278" text="mitotic cell cycle" type="GO"/>
    <entity charOffset="582-592" id="s221.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s221.e0" e2="s221.e1" id="s221.p0" relation="false"/>
  </sentence>
  <sentence id="s222" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="398-424" id="s222.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="582-592" id="s222.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s222.e0" e2="s222.e1" id="s222.p0" relation="false"/>
  </sentence>
  <sentence id="s223" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="454-500" id="s223.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="702-707" id="s223.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s223.e0" e2="s223.e1" id="s223.p0" relation="true"/>
  </sentence>
  <sentence id="s224" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="454-500" id="s224.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="582-592" id="s224.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s224.e0" e2="s224.e1" id="s224.p0" relation="false"/>
  </sentence>
  <sentence id="s225" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="510-535" id="s225.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="702-707" id="s225.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s225.e0" e2="s225.e1" id="s225.p0" relation="false"/>
  </sentence>
  <sentence id="s226" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, nucleosome assembly), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="93-138" id="s226.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="330-340" id="s226.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s226.e0" e2="s226.e1" id="s226.p0" relation="true"/>
  </sentence>
  <sentence id="s227" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, nucleosome assembly), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="219-238" id="s227.e0" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <entity charOffset="330-340" id="s227.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s227.e0" e2="s227.e1" id="s227.p0" relation="false"/>
  </sentence>
  <sentence id="s228" text="Mutations in carbohydrate metabolic process, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later protein dephosphorylation, result in hereditary spastic paraplegia accompanied by intellectual deficits.">
    <entity charOffset="13-43" id="s228.e0" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <entity charOffset="137-144" id="s228.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s228.e0" e2="s228.e1" id="s228.p0" relation="true"/>
  </sentence>
  <sentence id="s229" text="Possible candidate genes in 6q14 for intellectual disability might be FILIP1, DNA damage response, signal transduction by p53 class mediator, HTR1B, and SNX14">
    <entity charOffset="37-60" id="s229.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="78-140" id="s229.e1" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <pair e1="s229.e0" e2="s229.e1" id="s229.p0" relation="true"/>
  </sentence>
  <sentence id="s230" text="protein polyubiquitination plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive muscle organ development 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="0-26" id="s230.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="159-178" id="s230.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s230.e0" e2="s230.e1" id="s230.p0" relation="false"/>
  </sentence>
  <sentence id="s231" text="TNF-related apoptosis-inducing ligand (positive regulation of apoptotic process) was initially described to induce apoptosis of tumor cells and/or virally infected cells, although sparing normal cells, and has been implicated in the pathogenesis of HIV disease.">
    <entity charOffset="39-79" id="s231.e0" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <entity charOffset="128-133" id="s231.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s231.e0" e2="s231.e1" id="s231.p0" relation="false"/>
  </sentence>
  <sentence id="s232" text="In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped activation of cysteine-type endopeptidase activity involved in apoptotic process (rs61918808), protein desumoylation (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.">
    <entity charOffset="164-170" id="s232.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="213-293" id="s232.e1" ontology_id="GO_0006919" text="activation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <pair e1="s232.e0" e2="s232.e1" id="s232.p0" relation="false"/>
  </sentence>
  <sentence id="s233" text="In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped activation of cysteine-type endopeptidase activity involved in apoptotic process (rs61918808), protein desumoylation (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.">
    <entity charOffset="164-170" id="s233.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="308-329" id="s233.e1" ontology_id="GO_0016926" text="protein desumoylation" type="GO"/>
    <pair e1="s233.e0" e2="s233.e1" id="s233.p0" relation="true"/>
  </sentence>
  <sentence id="s234" text="Notably, in two lung cancer models with positive regulation of cell proliferation amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.">
    <entity charOffset="40-81" id="s234.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="105-110" id="s234.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s234.e0" e2="s234.e1" id="s234.p0" relation="true"/>
  </sentence>
  <sentence id="s235" text="In cell assays, lucitanib potently inhibited the growth of tumor cell lines with amplified positive regulation of cell proliferation or mutated/amplified FGFR2.">
    <entity charOffset="59-64" id="s235.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="91-132" id="s235.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s235.e0" e2="s235.e1" id="s235.p0" relation="true"/>
  </sentence>
  <sentence id="s236" text="Lucitanib is a small molecule inhibitor of vascular endothelial growth factor (VEGF) receptors 1 to 3 (VEGFR1 to 3), platelet derived growth factor / (PDGFR/) and positive regulation of cell proliferation-3 tyrosine kinases and has demonstrated activity in a phase I/II clinical study, with objective RECIST responses in breast cancer patients with FGFR1 or FGF3/4/19 gene amplification, as well as in patients anticipated to benefit from anti-angiogenic agents.">
    <entity charOffset="167-208" id="s236.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="332-338" id="s236.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s236.e0" e2="s236.e1" id="s236.p0" relation="true"/>
  </sentence>
  <sentence id="s237" text="Increasing evidence has shown that WT1-interacting protein (response to hypoxia) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in cancer is unknown.">
    <entity charOffset="60-79" id="s237.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="183-189" id="s237.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s237.e0" e2="s237.e1" id="s237.p0" relation="true"/>
  </sentence>
  <sentence id="s238" text="Here, we investigated the role and mechanism of response to hypoxia in cell proliferation and tumorigenesis of non-small-cell lung cancer (NSCLC).">
    <entity charOffset="48-67" id="s238.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="131-137" id="s238.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s238.e0" e2="s238.e1" id="s238.p0" relation="true"/>
  </sentence>
  <sentence id="s239" text="We confirmed previous studies showing that tumor necrosis factor alpha (negative regulation of transcription by RNA polymerase II-) induced reactivation of infectious virus, and by analyzing expression of the progenitor cell marker CD34 as well as myeloid cell differentiation markers in IE&lt;sup&gt;+&lt;/sup&gt; cells after treatment with TNF-, we showed that TNF- induced transcriptional reactivation of IE gene expression independently of differentiation.">
    <entity charOffset="43-48" id="s239.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="72-129" id="s239.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s239.e0" e2="s239.e1" id="s239.p0" relation="false"/>
  </sentence>
  <sentence id="s240" text="IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and positive regulation of protein phosphorylation signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.&lt;b&gt;Conclusions:&lt;/b&gt; miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.">
    <entity charOffset="54-60" id="s240.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="110-156" id="s240.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s240.e0" e2="s240.e1" id="s240.p0" relation="false"/>
  </sentence>
  <sentence id="s241" text="Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (cysteine metabolic process), successfully delays the onset of motor deficits, improves longevity, and rescues some of the cerebellar abnormalities (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick type C (NPC).">
    <entity charOffset="152-178" id="s241.e0" ontology_id="GO_0006534" text="cysteine metabolic process" type="GO"/>
    <entity charOffset="274-298" id="s241.e1" ontology_id="HP_0001317" text="cerebellar abnormalities" type="HP"/>
    <pair e1="s241.e0" e2="s241.e1" id="s241.p0" relation="false"/>
  </sentence>
  <sentence id="s242" text="We identified a highly significant enrichment of de novo variants in regulation of neuron differentiation, establishing their role in early-onset epilepsy, and we provide additional support for the prior assignment of L-glutamate transmembrane transport.">
    <entity charOffset="69-105" id="s242.e0" ontology_id="GO_0045664" text="regulation of neuron differentiation" type="GO"/>
    <entity charOffset="146-154" id="s242.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s242.e0" e2="s242.e1" id="s242.p0" relation="true"/>
  </sentence>
  <sentence id="s243" text="We identified a highly significant enrichment of de novo variants in regulation of neuron differentiation, establishing their role in early-onset epilepsy, and we provide additional support for the prior assignment of L-glutamate transmembrane transport.">
    <entity charOffset="146-154" id="s243.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="218-253" id="s243.e1" ontology_id="GO_0015813" text="L-glutamate transmembrane transport" type="GO"/>
    <pair e1="s243.e0" e2="s243.e1" id="s243.p0" relation="true"/>
  </sentence>
  <sentence id="s244" text="The brains of &lt;i&gt;biological_process&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; epidermis development had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.">
    <entity charOffset="17-35" id="s244.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="80-113" id="s244.e1" ontology_id="HP_0002079" text="hypoplasia of the corpus callosum" type="HP"/>
    <pair e1="s244.e0" e2="s244.e1" id="s244.p0" relation="true"/>
  </sentence>
  <sentence id="s245" text="A heterozygous mutation (c.643C&amp;gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene creatine transmembrane transport (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.">
    <entity charOffset="99-131" id="s245.e0" ontology_id="GO_0015881" text="creatine transmembrane transport" type="GO"/>
    <entity charOffset="255-264" id="s245.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s245.e0" e2="s245.e1" id="s245.p0" relation="true"/>
  </sentence>
  <sentence id="s246" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and leukocyte migration We confirmed V(D)J recombination expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s246.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="357-376" id="s246.e1" ontology_id="GO_0050900" text="leukocyte migration" type="GO"/>
    <pair e1="s246.e0" e2="s246.e1" id="s246.p0" relation="true"/>
  </sentence>
  <sentence id="s247" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and leukocyte migration We confirmed V(D)J recombination expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s247.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="390-409" id="s247.e1" ontology_id="GO_0033151" text="V(D)J recombination" type="GO"/>
    <pair e1="s247.e0" e2="s247.e1" id="s247.p0" relation="false"/>
  </sentence>
  <sentence id="s248" text="SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in G protein-coupled receptor signaling pathway, while abnormalities of SNORD115-regulation of Ral protein signal transduction suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.">
    <entity charOffset="128-172" id="s248.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="285-297" id="s248.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s248.e0" e2="s248.e1" id="s248.p0" relation="false"/>
  </sentence>
  <sentence id="s249" text="SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in G protein-coupled receptor signaling pathway, while abnormalities of SNORD115-regulation of Ral protein signal transduction suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.">
    <entity charOffset="206-251" id="s249.e0" ontology_id="GO_0032485" text="regulation of Ral protein signal transduction" type="GO"/>
    <entity charOffset="285-297" id="s249.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s249.e0" e2="s249.e1" id="s249.p0" relation="true"/>
  </sentence>
  <sentence id="s250" text="SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (G protein-coupled receptor signaling pathway) if environmentally triggered.">
    <entity charOffset="337-349" id="s250.e0" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <entity charOffset="419-463" id="s250.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s250.e0" e2="s250.e1" id="s250.p0" relation="false"/>
  </sentence>
  <sentence id="s251" text="The polo family serine threonine kinase protein phosphorylation has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.">
    <entity charOffset="40-63" id="s251.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="118-124" id="s251.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s251.e0" e2="s251.e1" id="s251.p0" relation="true"/>
  </sentence>
  <sentence id="s252" text="The polo family serine threonine kinase protein phosphorylation has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.">
    <entity charOffset="40-63" id="s252.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="198-203" id="s252.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s252.e0" e2="s252.e1" id="s252.p0" relation="false"/>
  </sentence>
  <sentence id="s253" text="Our results validate Plk4 as a therapeutic target in cancer patients and reveal a new role for Plk4 in regulating Arp2/3 complex-mediated actin nucleation/3-mediated actin cytoskeletal rearrangement.">
    <entity charOffset="53-59" id="s253.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-154" id="s253.e1" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <pair e1="s253.e0" e2="s253.e1" id="s253.p0" relation="true"/>
  </sentence>
  <sentence id="s254" text="Polymorphisms in the biological_process gene have been linked to congenital heart anomalies and intellectual disabilities.">
    <entity charOffset="21-39" id="s254.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="96-121" id="s254.e1" ontology_id="HP_0001249" text="intellectual disabilities" type="HP"/>
    <pair e1="s254.e0" e2="s254.e1" id="s254.p0" relation="true"/>
  </sentence>
  <sentence id="s255" text="mitochondrial respiratory chain complex I assembly encodes a complex I-specific assembly factor and mutations in this gene result in complex I deficiency, infantile onset encephalomyopathy and Leigh syndrome.">
    <entity charOffset="0-50" id="s255.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="155-170" id="s255.e1" ontology_id="HP_0003593" text="infantile onset" type="HP"/>
    <pair e1="s255.e0" e2="s255.e1" id="s255.p0" relation="true"/>
  </sentence>
  <sentence id="s256" text="Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to clathrin coat assembly gene IQCB1, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome">
    <entity charOffset="78-100" id="s256.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="185-202" id="s256.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s256.e0" e2="s256.e1" id="s256.p0" relation="false"/>
  </sentence>
  <sentence id="s257" text="In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (inflammatory response) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (regulation of signaling receptor activity)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).">
    <entity charOffset="61-67" id="s257.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="301-342" id="s257.e1" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <pair e1="s257.e0" e2="s257.e1" id="s257.p0" relation="true"/>
  </sentence>
  <sentence id="s258" text="In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (inflammatory response) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (regulation of signaling receptor activity)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).">
    <entity charOffset="61-67" id="s258.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="98-119" id="s258.e1" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <pair e1="s258.e0" e2="s258.e1" id="s258.p0" relation="true"/>
  </sentence>
  <sentence id="s259" text="In fact, telomere maintenance via telomerase has been considered as a candidate cancer susceptibility gene.">
    <entity charOffset="9-44" id="s259.e0" ontology_id="GO_0007004" text="telomere maintenance via telomerase" type="GO"/>
    <entity charOffset="80-86" id="s259.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s259.e0" e2="s259.e1" id="s259.p0" relation="true"/>
  </sentence>
  <sentence id="s260" text="We show that genetic defects in visual perception cause moderate-to-severe sensorineural hearing impairment.">
    <entity charOffset="32-49" id="s260.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="89-107" id="s260.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s260.e0" e2="s260.e1" id="s260.p0" relation="true"/>
  </sentence>
  <sentence id="s261" text="It has been proposed that transcobalamin 2 (cobalamin transport) and the transcobalamin 2 receptor (TCN2R) are associated with idiopathic recurrent spontaneous abortion (RSA).">
    <entity charOffset="44-63" id="s261.e0" ontology_id="GO_0015889" text="cobalamin transport" type="GO"/>
    <entity charOffset="148-168" id="s261.e1" ontology_id="HP_0005268" text="spontaneous abortion" type="HP"/>
    <pair e1="s261.e0" e2="s261.e1" id="s261.p0" relation="false"/>
  </sentence>
  <sentence id="s262" text="The present study was designed to survey the mutation spectrum of common pathogenic genes (transcription initiation from RNA polymerase II promoter, OPA3 and mtDNA genes) and to analyze the genotype-phenotype characteristics of Chinese patients with suspected childhood-onset hereditary optic neuropathy.">
    <entity charOffset="91-147" id="s262.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="293-303" id="s262.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s262.e0" e2="s262.e1" id="s262.p0" relation="false"/>
  </sentence>
  <sentence id="s263" text="This study expanded the transcription initiation from RNA polymerase II promoter mutation spectrum, and our results showed that OPA1 mutation is another common cause of childhood-onset hereditary optic neuropathy in Chinese pediatric patients, especially those with disease onset during preschool age">
    <entity charOffset="24-80" id="s263.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="202-212" id="s263.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s263.e0" e2="s263.e1" id="s263.p0" relation="true"/>
  </sentence>
  <sentence id="s264" text="Finally, we demonstrate that negative regulation of transcription by RNA polymerase II expression is elevated in luminal breast cancer cells and luminal breast cancer tissues as compared with other breast cancer subtypes.">
    <entity charOffset="29-86" id="s264.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="128-134" id="s264.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s264.e0" e2="s264.e1" id="s264.p0" relation="true"/>
  </sentence>
  <sentence id="s265" text="We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in ion transmembrane transport and persistent hypotonia, encephalopathy, growth failure, and severe intellectual disability.">
    <entity charOffset="135-162" id="s265.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="189-203" id="s265.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s265.e0" e2="s265.e1" id="s265.p0" relation="true"/>
  </sentence>
  <sentence id="s266" text="T cell-produced TNF and IL-17A further contribute to bone loss in hyperparathyroidism, while T cell production of the anabolic Wingless integration site (Wnt) ligand, negative regulation of fat cell differentiation, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).">
    <entity charOffset="66-85" id="s266.e0" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <entity charOffset="167-214" id="s266.e1" ontology_id="GO_0045599" text="negative regulation of fat cell differentiation" type="GO"/>
    <pair e1="s266.e0" e2="s266.e1" id="s266.p0" relation="false"/>
  </sentence>
  <sentence id="s267" text="We hypothesized therefore that some children with hypercalciuria and kidney stones harbor a calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules variant that inappropriately increases gene expression.">
    <entity charOffset="50-64" id="s267.e0" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <entity charOffset="92-174" id="s267.e1" ontology_id="GO_0016338" text="calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules" type="GO"/>
    <pair e1="s267.e0" e2="s267.e1" id="s267.p0" relation="true"/>
  </sentence>
  <sentence id="s268" text="Our data suggest that children with the negative regulation of transcription by RNA polymerase II binding site within the calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules risk haplotype have a higher likelihood of hypercalciuria and kidney stones.">
    <entity charOffset="40-97" id="s268.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="248-262" id="s268.e1" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <pair e1="s268.e0" e2="s268.e1" id="s268.p0" relation="false"/>
  </sentence>
  <sentence id="s269" text="Our data suggest that children with the negative regulation of transcription by RNA polymerase II binding site within the calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules risk haplotype have a higher likelihood of hypercalciuria and kidney stones.">
    <entity charOffset="122-204" id="s269.e0" ontology_id="GO_0016338" text="calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules" type="GO"/>
    <entity charOffset="248-262" id="s269.e1" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <pair e1="s269.e0" e2="s269.e1" id="s269.p0" relation="true"/>
  </sentence>
  <sentence id="s270" text="To test this hypothesis, we sequenced the calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules risk haplotype in a cohort of children with idiopathic hypercalciuria and kidney stones.">
    <entity charOffset="42-124" id="s270.e0" ontology_id="GO_0016338" text="calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules" type="GO"/>
    <entity charOffset="180-194" id="s270.e1" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <pair e1="s270.e0" e2="s270.e1" id="s270.p0" relation="true"/>
  </sentence>
  <sentence id="s271" text="Usher syndrome (USH) is the most common cause of inherited deaf-blindness, manifested as USH1, sensory perception of sound and USH3 clinical types.">
    <entity charOffset="64-73" id="s271.e0" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <entity charOffset="95-122" id="s271.e1" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <pair e1="s271.e0" e2="s271.e1" id="s271.p0" relation="false"/>
  </sentence>
  <sentence id="s272" text="Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either positive regulation of gene expression (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).">
    <entity charOffset="23-41" id="s272.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="89-127" id="s272.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s272.e0" e2="s272.e1" id="s272.p0" relation="true"/>
  </sentence>
  <sentence id="s273" text="uPA may enhance the migratory and invasive capabilities of endometrial tumor cells by the phosphorylation of ERK1/2, positive regulation of protein phosphorylation and p38 molecules.">
    <entity charOffset="71-76" id="s273.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="117-163" id="s273.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s273.e0" e2="s273.e1" id="s273.p0" relation="true"/>
  </sentence>
  <sentence id="s274" text="mitochondrion organization mutations are associated with a distinct form of early-onset parkinsonism characterized by rapid and severe disease progression and early cognitive decline; the pathological features were striking and reminiscent of diffuse Lewy body disease.">
    <entity charOffset="0-26" id="s274.e0" ontology_id="GO_0007005" text="mitochondrion organization" type="GO"/>
    <entity charOffset="88-100" id="s274.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s274.e0" e2="s274.e1" id="s274.p0" relation="true"/>
  </sentence>
  <sentence id="s275" text="Targeted deletion of positive regulation of cell proliferation in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and increased bone resorption, mimicking the severe OI phenotype in humans with homozygous positive regulation of cell proliferation mutations.">
    <entity charOffset="21-62" id="s275.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="159-184" id="s275.e1" ontology_id="HP_0002797" text="increased bone resorption" type="HP"/>
    <pair e1="s275.e0" e2="s275.e1" id="s275.p0" relation="true"/>
  </sentence>
  <sentence id="s276" text="Targeted deletion of positive regulation of cell proliferation in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and increased bone resorption, mimicking the severe OI phenotype in humans with homozygous positive regulation of cell proliferation mutations.">
    <entity charOffset="159-184" id="s276.e0" ontology_id="HP_0002797" text="increased bone resorption" type="HP"/>
    <entity charOffset="246-287" id="s276.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s276.e0" e2="s276.e1" id="s276.p0" relation="false"/>
  </sentence>
  <sentence id="s277" text="Amyotrophic lateral sclerosis (signal transduction) is a devastating adult-onset progressive neurodegenerative disease characterized by upper and lower motoneuron degeneration.">
    <entity charOffset="31-50" id="s277.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="93-118" id="s277.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s277.e0" e2="s277.e1" id="s277.p0" relation="false"/>
  </sentence>
  <sentence id="s278" text="Finally, we report that 9 retained cytotoxicity against several pediatric cancer cell lines with EC&lt;sub&gt;50&lt;/sub&gt; values comparable to central nervous system development inhibitor (BETi) clinical candidates">
    <entity charOffset="74-80" id="s278.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-168" id="s278.e1" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <pair e1="s278.e0" e2="s278.e1" id="s278.p0" relation="true"/>
  </sentence>
  <sentence id="s279" text="Taken together, our data provide insight into the molecular pathways of dominantly and recessively acting chloride transport missense mutations suggesting that the site of subcellular protein quality control as well as the rate and degree of mutant protein degradation are ultimately responsible for the distinct retinal disease phenotypes in BD and ARB">
    <entity charOffset="106-124" id="s279.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="313-328" id="s279.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s279.e0" e2="s279.e1" id="s279.p0" relation="true"/>
  </sentence>
  <sentence id="s280" text="Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous camera-type eye morphogenesis splicing mutation c.2968-2A&amp;gt;T (p.Val990Cysfs*13).">
    <entity charOffset="110-124" id="s280.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="197-226" id="s280.e1" ontology_id="GO_0048593" text="camera-type eye morphogenesis" type="GO"/>
    <pair e1="s280.e0" e2="s280.e1" id="s280.p0" relation="true"/>
  </sentence>
  <sentence id="s281" text="Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous camera-type eye morphogenesis splicing mutation c.2968-2A&amp;gt;T (p.Val990Cysfs*13).">
    <entity charOffset="129-148" id="s281.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="197-226" id="s281.e1" ontology_id="GO_0048593" text="camera-type eye morphogenesis" type="GO"/>
    <pair e1="s281.e0" e2="s281.e1" id="s281.p0" relation="true"/>
  </sentence>
  <sentence id="s282" text="In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in camera-type eye morphogenesis (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.">
    <entity charOffset="101-130" id="s282.e0" ontology_id="GO_0048593" text="camera-type eye morphogenesis" type="GO"/>
    <entity charOffset="221-235" id="s282.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s282.e0" e2="s282.e1" id="s282.p0" relation="true"/>
  </sentence>
  <sentence id="s283" text="RESULTS A nonsynonymous mutation at ovine Chr3:193,691,195, which generated a glycine-to-arginine amino acid change within the predicted organic anion transport protein, was significantly associated with hyperbilirubinemia and predicted to be deleterious.">
    <entity charOffset="137-160" id="s283.e0" ontology_id="GO_0015711" text="organic anion transport" type="GO"/>
    <entity charOffset="204-222" id="s283.e1" ontology_id="HP_0002904" text="hyperbilirubinemia" type="HP"/>
    <pair e1="s283.e0" e2="s283.e1" id="s283.p0" relation="true"/>
  </sentence>
  <sentence id="s284" text="positive regulation of cell proliferation deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-41" id="s284.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="253-263" id="s284.e1" ontology_id="HP_0000400" text="large ears" type="HP"/>
    <pair e1="s284.e0" e2="s284.e1" id="s284.p0" relation="false"/>
  </sentence>
  <sentence id="s285" text="positive regulation of cell proliferation deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-41" id="s285.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="238-251" id="s285.e1" ontology_id="HP_0000490" text="deep-set eyes" type="HP"/>
    <pair e1="s285.e0" e2="s285.e1" id="s285.p0" relation="true"/>
  </sentence>
  <sentence id="s286" text="positive regulation of cell proliferation deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-41" id="s286.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="302-311" id="s286.e1" ontology_id="HP_0001007" text="hirsutism" type="HP"/>
    <pair e1="s286.e0" e2="s286.e1" id="s286.p0" relation="true"/>
  </sentence>
  <sentence id="s287" text="These results expand the genetic heterogeneity of EKVP and the human disease phenotypes associated with signal transduction mutations.">
    <entity charOffset="33-46" id="s287.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="104-123" id="s287.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s287.e0" e2="s287.e1" id="s287.p0" relation="false"/>
  </sentence>
  <sentence id="s288" text="Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic heterogeneity, most often transmitted in an autosomal dominant manner, caused by mutations in GJB3 and cell-cell signaling genes encoding connexins (Cx)31 and 30.3, respectively.">
    <entity charOffset="99-112" id="s288.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="202-221" id="s288.e1" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <pair e1="s288.e0" e2="s288.e1" id="s288.p0" relation="true"/>
  </sentence>
  <sentence id="s289" text="positive regulation of transcription, DNA-templated-R142C is a mutation that was reported to be associated with atrial septal defect (ASD) and atrioventricular (AV) block in 13-patients from one family.">
    <entity charOffset="0-51" id="s289.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="112-132" id="s289.e1" ontology_id="HP_0001631" text="atrial septal defect" type="HP"/>
    <pair e1="s289.e0" e2="s289.e1" id="s289.p0" relation="true"/>
  </sentence>
  <sentence id="s290" text="Up to this time, only heterozygous mutations of extracellular matrix organization gene have been reported in human and related to: (1) multiple epiphyseal dysplasia muscle organ development 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.">
    <entity charOffset="48-81" id="s290.e0" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <entity charOffset="144-164" id="s290.e1" ontology_id="HP_0002656" text="epiphyseal dysplasia" type="HP"/>
    <pair e1="s290.e0" e2="s290.e1" id="s290.p0" relation="true"/>
  </sentence>
  <sentence id="s291" text="In clinical specimens, elevated LAMB3 expression correlated with poorer survival in lung cancer patients with an oncogenic positive regulation of protein phosphorylation gene signature, suggesting a novel candidate biomarker in this disease setting.">
    <entity charOffset="89-95" id="s291.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="123-169" id="s291.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s291.e0" e2="s291.e1" id="s291.p0" relation="true"/>
  </sentence>
  <sentence id="s292" text="Silencing of FAK or endodermal cell differentiation recapitulated the synthetic lethal effects of miR-1298 expression in KRAS-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.">
    <entity charOffset="20-51" id="s292.e0" ontology_id="GO_0035987" text="endodermal cell differentiation" type="GO"/>
    <entity charOffset="133-139" id="s292.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s292.e0" e2="s292.e1" id="s292.p0" relation="true"/>
  </sentence>
  <sentence id="s293" text="Mutations in antibacterial humoral response (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.">
    <entity charOffset="13-43" id="s293.e0" ontology_id="GO_0019731" text="antibacterial humoral response" type="GO"/>
    <entity charOffset="166-178" id="s293.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s293.e0" e2="s293.e1" id="s293.p0" relation="true"/>
  </sentence>
  <sentence id="s294" text="spindle organization knockout ferrets exhibit severe microcephaly (25-40% decreases in brain weight), reflecting reduced cortical surface area without significant change in cortical thickness, as has been found in human patients&lt;sup&gt;3,4&lt;/sup&gt;, suggesting that loss of 'cortical units' has occurred.">
    <entity charOffset="0-20" id="s294.e0" ontology_id="GO_0007051" text="spindle organization" type="GO"/>
    <entity charOffset="53-65" id="s294.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s294.e0" e2="s294.e1" id="s294.p0" relation="true"/>
  </sentence>
  <sentence id="s295" text="We demonstrate multicellular organism development genomic heterogeneity in more than 75% of patients, including inactivation of regulation of cyclin-dependent protein serine/threonine kinase activity and TP53, and mutations affecting mitogen-activated protein kinase genes.">
    <entity charOffset="15-49" id="s295.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="58-71" id="s295.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s295.e0" e2="s295.e1" id="s295.p0" relation="false"/>
  </sentence>
  <sentence id="s296" text="We demonstrate multicellular organism development genomic heterogeneity in more than 75% of patients, including inactivation of regulation of cyclin-dependent protein serine/threonine kinase activity and TP53, and mutations affecting mitogen-activated protein kinase genes.">
    <entity charOffset="58-71" id="s296.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="128-199" id="s296.e1" ontology_id="GO_0000079" text="regulation of cyclin-dependent protein serine/threonine kinase activity" type="GO"/>
    <pair e1="s296.e0" e2="s296.e1" id="s296.p0" relation="false"/>
  </sentence>
  <sentence id="s297" text="Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in hepatocellular carcinoma (HCC) have been reported.">
    <entity charOffset="33-38" id="s297.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="107-164" id="s297.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s297.e0" e2="s297.e1" id="s297.p0" relation="true"/>
  </sentence>
  <sentence id="s298" text="In conclusion, we present an oncogenic role of FAM83H in liver cancer, which is closely associated with the oncogene negative regulation of transcription by RNA polymerase II.">
    <entity charOffset="63-69" id="s298.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="117-174" id="s298.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s298.e0" e2="s298.e1" id="s298.p0" relation="true"/>
  </sentence>
  <sentence id="s299" text="negative regulation of transcription by RNA polymerase II overexpression rescued the inhibition of liver cancer cell proliferation, migration, and invasion by miR498, indicating that ZEB2 acts as a downstream effector of miR498 in liver cancer cells.">
    <entity charOffset="0-57" id="s299.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="105-111" id="s299.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s299.e0" e2="s299.e1" id="s299.p0" relation="true"/>
  </sentence>
  <sentence id="s300" text="Heterozygous missense mutations in mitotic cytokinesis have been associated with autism spectrum disorder.">
    <entity charOffset="35-54" id="s300.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="81-87" id="s300.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s300.e0" e2="s300.e1" id="s300.p0" relation="false"/>
  </sentence>
  <sentence id="s301" text="RNF170 is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory ataxia (protein ubiquitination), a disease characterized by neurodegeneration in the posterior columns of the spinal cord.">
    <entity charOffset="262-268" id="s301.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="270-292" id="s301.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s301.e0" e2="s301.e1" id="s301.p0" relation="false"/>
  </sentence>
  <sentence id="s302" text="Although the 4 PKPs displayed different levels and patterns of subcellular distribution in tumors, there was a positive correlation between immunoreactivity for desmosome assembly and PKP3, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.">
    <entity charOffset="91-96" id="s302.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="161-179" id="s302.e1" ontology_id="GO_0002159" text="desmosome assembly" type="GO"/>
    <pair e1="s302.e0" e2="s302.e1" id="s302.p0" relation="true"/>
  </sentence>
  <sentence id="s303" text="In contrast, strong desmosome assembly immunoreactivity was observed in 85.7% of metastatic tumors.">
    <entity charOffset="20-38" id="s303.e0" ontology_id="GO_0002159" text="desmosome assembly" type="GO"/>
    <entity charOffset="92-97" id="s303.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s303.e0" e2="s303.e1" id="s303.p0" relation="true"/>
  </sentence>
  <sentence id="s304" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (negative regulation of transcription by RNA polymerase II, positive regulation of transcription, DNA-templated, MLXIPL) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s304.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="306-357" id="s304.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s304.e0" e2="s304.e1" id="s304.p0" relation="false"/>
  </sentence>
  <sentence id="s305" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (negative regulation of transcription by RNA polymerase II, positive regulation of transcription, DNA-templated, MLXIPL) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s305.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="247-304" id="s305.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s305.e0" e2="s305.e1" id="s305.p0" relation="true"/>
  </sentence>
  <sentence id="s306" text="This includes unaffected women who have completed their family and have RAD51C, strand invasion, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.">
    <entity charOffset="80-95" id="s306.e0" ontology_id="GO_0042148" text="strand invasion" type="GO"/>
    <entity charOffset="187-193" id="s306.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s306.e0" e2="s306.e1" id="s306.p0" relation="true"/>
  </sentence>
  <sentence id="s307" text="Arp2/3 complex-mediated actin nucleation mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).">
    <entity charOffset="0-40" id="s307.e0" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <entity charOffset="122-128" id="s307.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s307.e0" e2="s307.e1" id="s307.p0" relation="true"/>
  </sentence>
  <sentence id="s308" text="Our results indicate that Arp2/3 complex-mediated actin nucleation mutations cause multiple congenital anomalies and intellectual disability accompanied by arthrogryposis multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable">
    <entity charOffset="26-66" id="s308.e0" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <entity charOffset="117-140" id="s308.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s308.e0" e2="s308.e1" id="s308.p0" relation="true"/>
  </sentence>
  <sentence id="s309" text="Hereditary hypotrichosis simplex (protein O-linked glycosylation via serine) is a form of nonsyndromic inherited hair loss disorders without characteristic hair shaft changes, which has marked genetic and clinical heterogeneity.">
    <entity charOffset="11-24" id="s309.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="34-75" id="s309.e1" ontology_id="GO_0018242" text="protein O-linked glycosylation via serine" type="GO"/>
    <pair e1="s309.e0" e2="s309.e1" id="s309.p0" relation="false"/>
  </sentence>
  <sentence id="s310" text="Hereditary hypotrichosis simplex (protein O-linked glycosylation via serine) is a form of nonsyndromic inherited hair loss disorders without characteristic hair shaft changes, which has marked genetic and clinical heterogeneity.">
    <entity charOffset="34-75" id="s310.e0" ontology_id="GO_0018242" text="protein O-linked glycosylation via serine" type="GO"/>
    <entity charOffset="214-227" id="s310.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s310.e0" e2="s310.e1" id="s310.p0" relation="false"/>
  </sentence>
  <sentence id="s311" text="Using human neuroblastoma SH-SY5Y cells, we found that the neuroprotective function of activation of MAPK activity is blocked by CHRNA7 knockdown using RNA interference.">
    <entity charOffset="12-25" id="s311.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="87-114" id="s311.e1" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <pair e1="s311.e0" e2="s311.e1" id="s311.p0" relation="true"/>
  </sentence>
  <sentence id="s312" text="Mutations in human crumbs 1 (&lt;i&gt;establishment or maintenance of cell polarity&lt;/i&gt;) are a major cause of retinal diseases that lead to blindness.">
    <entity charOffset="32-77" id="s312.e0" ontology_id="GO_0007163" text="establishment or maintenance of cell polarity" type="GO"/>
    <entity charOffset="134-143" id="s312.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s312.e0" e2="s312.e1" id="s312.p0" relation="true"/>
  </sentence>
  <sentence id="s313" text="by reactivating pre-existing anti-tumor immune responses against neural crest cell fate specification antigens.">
    <entity charOffset="34-39" id="s313.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="65-101" id="s313.e1" ontology_id="GO_0014036" text="neural crest cell fate specification" type="GO"/>
    <pair e1="s313.e0" e2="s313.e1" id="s313.p0" relation="false"/>
  </sentence>
  <sentence id="s314" text="After exclusive analysis of 10 common variations of three hearing loss-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of striated muscle contraction, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.">
    <entity charOffset="58-70" id="s314.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="147-174" id="s314.e1" ontology_id="GO_0006941" text="striated muscle contraction" type="GO"/>
    <pair e1="s314.e0" e2="s314.e1" id="s314.p0" relation="true"/>
  </sentence>
  <sentence id="s315" text="In this study, the correlation between H19 and vitamin D receptor (negative regulation of transcription by RNA polymerase II) signaling and the underlying mechanisms in colon cancer were investigated both in vitro and in vivo.">
    <entity charOffset="67-124" id="s315.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="175-181" id="s315.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s315.e0" e2="s315.e1" id="s315.p0" relation="true"/>
  </sentence>
  <sentence id="s316" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="83-101" id="s316.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="274-289" id="s316.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s316.e0" e2="s316.e1" id="s316.p0" relation="false"/>
  </sentence>
  <sentence id="s317" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="177-187" id="s317.e0" ontology_id="HP_0000773" text="short ribs" type="HP"/>
    <entity charOffset="274-289" id="s317.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s317.e0" e2="s317.e1" id="s317.p0" relation="false"/>
  </sentence>
  <sentence id="s318" text="In conclusion, steroid biosynthetic process 4217C&amp;gt;A polymorphism may not be associated with the development of hyperammonemia in Japanese population">
    <entity charOffset="15-43" id="s318.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="114-128" id="s318.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s318.e0" e2="s318.e1" id="s318.p0" relation="true"/>
  </sentence>
  <sentence id="s319" text="Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (steroid biosynthetic process) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of hyperammonemia during valproic acid-based therapy.">
    <entity charOffset="68-96" id="s319.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="201-215" id="s319.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s319.e0" e2="s319.e1" id="s319.p0" relation="false"/>
  </sentence>
  <sentence id="s320" text="Among all premature deaths, contributions of cerebrovascular disease (stroke), ischemic heart disease (IHD), chronic obstructive pulmonary disease (intracellular protein transport), lung cancer (LC) and acute lower respiratory infections (ALRIs) were 51.70, 26.26, 11.77, 9.45 and 0.82%, respectively.">
    <entity charOffset="148-179" id="s320.e0" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <entity charOffset="187-193" id="s320.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s320.e0" e2="s320.e1" id="s320.p0" relation="false"/>
  </sentence>
  <sentence id="s321" text="ER to Golgi vesicle-mediated transport-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.">
    <entity charOffset="0-38" id="s321.e0" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <entity charOffset="120-143" id="s321.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s321.e0" e2="s321.e1" id="s321.p0" relation="false"/>
  </sentence>
  <sentence id="s322" text="Xenograft pancreatic tumors derived from high biological_process-positive regulation of cell proliferation expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.">
    <entity charOffset="21-26" id="s322.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="65-106" id="s322.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s322.e0" e2="s322.e1" id="s322.p0" relation="false"/>
  </sentence>
  <sentence id="s323" text="Xenograft pancreatic tumors derived from high biological_process-positive regulation of cell proliferation expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.">
    <entity charOffset="21-26" id="s323.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="46-64" id="s323.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s323.e0" e2="s323.e1" id="s323.p0" relation="true"/>
  </sentence>
  <sentence id="s324" text="Mutations in the D40/KNL1/CASC5 gene, which was initially characterized as a gene involved in chromosomal translocation in leukemia and as a member of the cancer/testis gene family, was later found to encode a kinetochore protein essential for mitotic cell division and to cause centrosome duplication.">
    <entity charOffset="155-161" id="s324.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="279-301" id="s324.e1" ontology_id="GO_0051298" text="centrosome duplication" type="GO"/>
    <pair e1="s324.e0" e2="s324.e1" id="s324.p0" relation="true"/>
  </sentence>
  <sentence id="s325" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from monoubiquitinated histone H2A deubiquitination- and transcription, DNA-templated-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="150-196" id="s325.e0" ontology_id="GO_0035522" text="monoubiquitinated histone H2A deubiquitination" type="GO"/>
    <entity charOffset="336-361" id="s325.e1" ontology_id="HP_0001249" text="intellectual disabilities" type="HP"/>
    <pair e1="s325.e0" e2="s325.e1" id="s325.p0" relation="false"/>
  </sentence>
  <sentence id="s326" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from monoubiquitinated histone H2A deubiquitination- and transcription, DNA-templated-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="150-196" id="s326.e0" ontology_id="GO_0035522" text="monoubiquitinated histone H2A deubiquitination" type="GO"/>
    <entity charOffset="253-265" id="s326.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s326.e0" e2="s326.e1" id="s326.p0" relation="true"/>
  </sentence>
  <sentence id="s327" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from monoubiquitinated histone H2A deubiquitination- and transcription, DNA-templated-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="202-230" id="s327.e0" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <entity charOffset="253-265" id="s327.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s327.e0" e2="s327.e1" id="s327.p0" relation="true"/>
  </sentence>
  <sentence id="s328" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from monoubiquitinated histone H2A deubiquitination- and transcription, DNA-templated-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="202-230" id="s328.e0" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <entity charOffset="336-361" id="s328.e1" ontology_id="HP_0001249" text="intellectual disabilities" type="HP"/>
    <pair e1="s328.e0" e2="s328.e1" id="s328.p0" relation="true"/>
  </sentence>
  <sentence id="s329" text="Our findings open new opportunities for targeted therapy, as tumors with osteoblast differentiation oncogenic activation, and subsequent PTCH1 overexpression, might be sensitive to sonic hedgehog pathway inhibitors">
    <entity charOffset="61-67" id="s329.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="73-99" id="s329.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s329.e0" e2="s329.e1" id="s329.p0" relation="true"/>
  </sentence>
  <sentence id="s330" text="During drug discovery efforts targeting inhibition of cytochrome P450 11B2 (C21-steroid hormone biosynthetic process)-mediated production of aldosterone as a therapeutic approach for the treatment of chronic kidney disease and hypertension, (&lt;i&gt;S&lt;/i&gt;)-6-(5-fluoro-4-(1-hydroxyethyl)pyridin-3-yl)-3,4-dihydro-1,8-naphthyridine-1(&lt;i&gt;2H&lt;/i&gt;)-carboxamide (1) was identified as a potent and selective inhibitor of CYP11B2.">
    <entity charOffset="76-116" id="s330.e0" ontology_id="GO_0006700" text="C21-steroid hormone biosynthetic process" type="GO"/>
    <entity charOffset="227-239" id="s330.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s330.e0" e2="s330.e1" id="s330.p0" relation="true"/>
  </sentence>
  <sentence id="s331" text="In order to address these questions, we searched for alterations in G protein-coupled receptor signaling pathway, adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway, and EDN1 in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.">
    <entity charOffset="68-112" id="s331.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="294-306" id="s331.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s331.e0" e2="s331.e1" id="s331.p0" relation="true"/>
  </sentence>
  <sentence id="s332" text="In order to address these questions, we searched for alterations in G protein-coupled receptor signaling pathway, adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway, and EDN1 in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.">
    <entity charOffset="114-187" id="s332.e0" ontology_id="GO_0007193" text="adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="294-306" id="s332.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s332.e0" e2="s332.e1" id="s332.p0" relation="true"/>
  </sentence>
  <sentence id="s333" text="Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.&lt;b&gt;Results:&lt;/b&gt; One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in &lt;i&gt;IDH1&lt;/i&gt; A variant in &lt;i&gt;aspartate catabolic process&lt;/i&gt;, c.357A&amp;gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.">
    <entity charOffset="191-207" id="s333.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="239-266" id="s333.e1" ontology_id="GO_0006533" text="aspartate catabolic process" type="GO"/>
    <pair e1="s333.e0" e2="s333.e1" id="s333.p0" relation="true"/>
  </sentence>
  <sentence id="s334" text="Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.&lt;b&gt;Results:&lt;/b&gt; One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in &lt;i&gt;IDH1&lt;/i&gt; A variant in &lt;i&gt;aspartate catabolic process&lt;/i&gt;, c.357A&amp;gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.">
    <entity charOffset="239-266" id="s334.e0" ontology_id="GO_0006533" text="aspartate catabolic process" type="GO"/>
    <entity charOffset="353-358" id="s334.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s334.e0" e2="s334.e1" id="s334.p0" relation="false"/>
  </sentence>
  <sentence id="s335" text="The novel potential autism susceptibility genes phosphatidylserine biosynthetic process and epidermal growth factor receptor signaling pathway were uncovered and warrant further genetic and functional analyses.">
    <entity charOffset="20-26" id="s335.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="48-87" id="s335.e1" ontology_id="GO_0006659" text="phosphatidylserine biosynthetic process" type="GO"/>
    <pair e1="s335.e0" e2="s335.e1" id="s335.p0" relation="false"/>
  </sentence>
  <sentence id="s336" text="The novel potential autism susceptibility genes phosphatidylserine biosynthetic process and epidermal growth factor receptor signaling pathway were uncovered and warrant further genetic and functional analyses.">
    <entity charOffset="20-26" id="s336.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="92-142" id="s336.e1" ontology_id="GO_0007173" text="epidermal growth factor receptor signaling pathway" type="GO"/>
    <pair e1="s336.e0" e2="s336.e1" id="s336.p0" relation="true"/>
  </sentence>
  <sentence id="s337" text="These results highlight CRAFT as a systems-level framework for target discovery and suggest peptidyl-tyrosine phosphorylation blockade as a novel therapeutic strategy in epilepsy.">
    <entity charOffset="92-125" id="s337.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="170-178" id="s337.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s337.e0" e2="s337.e1" id="s337.p0" relation="true"/>
  </sentence>
  <sentence id="s338" text="Subsequently, we identified another homozygous variant in 2 of the 10 probands with microphthalmia we specifically screened for mutations in retinoic acid biosynthetic process.">
    <entity charOffset="84-98" id="s338.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="141-175" id="s338.e1" ontology_id="GO_0002138" text="retinoic acid biosynthetic process" type="GO"/>
    <pair e1="s338.e0" e2="s338.e1" id="s338.p0" relation="true"/>
  </sentence>
  <sentence id="s339" text="Our data support the very recent and independent identification of retinoic acid biosynthetic process as a disease gene in microphthalmia.">
    <entity charOffset="67-101" id="s339.e0" ontology_id="GO_0002138" text="retinoic acid biosynthetic process" type="GO"/>
    <entity charOffset="123-137" id="s339.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s339.e0" e2="s339.e1" id="s339.p0" relation="true"/>
  </sentence>
  <sentence id="s340" text="This report identifies the first breast cancer risk locus specific to a mitotic cytokinesis mutation background.">
    <entity charOffset="40-46" id="s340.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="72-91" id="s340.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s340.e0" e2="s340.e1" id="s340.p0" relation="true"/>
  </sentence>
  <sentence id="s341" text="We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including positive regulation of cell proliferation, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="s341.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="139-180" id="s341.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s341.e0" e2="s341.e1" id="s341.p0" relation="true"/>
  </sentence>
  <sentence id="s342" text="DNA samples from 3,881 breast cancer affected and 4,330 unaffected BRCA2 mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of double-strand break repair via homologous recombination/2 were genotyped and available for analysis.">
    <entity charOffset="30-36" id="s342.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="168-223" id="s342.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s342.e0" e2="s342.e1" id="s342.p0" relation="true"/>
  </sentence>
  <sentence id="s343" text="This comprehensive update of novel and previously reported breast cancer susceptibility loci contributes to the establishment of a panel of SNPs that modify breast cancer risk in mitotic cytokinesis mutation carriers.">
    <entity charOffset="66-72" id="s343.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="179-198" id="s343.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s343.e0" e2="s343.e1" id="s343.p0" relation="true"/>
  </sentence>
  <sentence id="s344" text="To comprehensively identify breast cancer risk modifying loci for mitotic cytokinesis mutation carriers, we conducted a deep replication of an ongoing GWAS discovery study.">
    <entity charOffset="35-41" id="s344.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="66-85" id="s344.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s344.e0" e2="s344.e1" id="s344.p0" relation="true"/>
  </sentence>
  <sentence id="s345" text="Misregulation of vascular endothelial growth factorA (negative regulation of transcription by RNA polymerase IIA) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian cancer.">
    <entity charOffset="55-112" id="s345.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="272-278" id="s345.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s345.e0" e2="s345.e1" id="s345.p0" relation="false"/>
  </sentence>
  <sentence id="s346" text="Through the examination of 48 candidate genes known to be responsible for autosomal recessive SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (positive regulation of mitochondrial fission).">
    <entity charOffset="74-93" id="s346.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="264-308" id="s346.e1" ontology_id="GO_0090141" text="positive regulation of mitochondrial fission" type="GO"/>
    <pair e1="s346.e0" e2="s346.e1" id="s346.p0" relation="true"/>
  </sentence>
  <sentence id="s347" text="Spastic paraplegia (intraciliary transport) muscle organ development 28 is an autosomal recessive SPG caused by mutations in the positive regulation of mitochondrial fission gene.">
    <entity charOffset="20-42" id="s347.e0" ontology_id="GO_0042073" text="intraciliary transport" type="GO"/>
    <entity charOffset="78-97" id="s347.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s347.e0" e2="s347.e1" id="s347.p0" relation="false"/>
  </sentence>
  <sentence id="s348" text="Spastic paraplegia (intraciliary transport) muscle organ development 28 is an autosomal recessive SPG caused by mutations in the positive regulation of mitochondrial fission gene.">
    <entity charOffset="78-97" id="s348.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="129-173" id="s348.e1" ontology_id="GO_0090141" text="positive regulation of mitochondrial fission" type="GO"/>
    <pair e1="s348.e0" e2="s348.e1" id="s348.p0" relation="true"/>
  </sentence>
  <sentence id="s349" text="Therefore our study identifies a compartmentalized PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/AKT/GSK3 signaling axis at cilia in positive regulation of cell proliferation-dependent medulloblastoma that is regulated by protein processing involved in protein targeting to mitochondrion to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression">
    <entity charOffset="115-156" id="s349.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="167-182" id="s349.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s349.e0" e2="s349.e1" id="s349.p0" relation="false"/>
  </sentence>
  <sentence id="s350" text="Therefore our study identifies a compartmentalized PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/AKT/GSK3 signaling axis at cilia in positive regulation of cell proliferation-dependent medulloblastoma that is regulated by protein processing involved in protein targeting to mitochondrion to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression">
    <entity charOffset="204-269" id="s350.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="282-287" id="s350.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s350.e0" e2="s350.e1" id="s350.p0" relation="true"/>
  </sentence>
  <sentence id="s351" text="PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-protein processing involved in protein targeting to mitochondrion partially rescued cilia loss in Inpp5e-null tumor cells in vitro.">
    <entity charOffset="84-149" id="s351.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="194-199" id="s351.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s351.e0" e2="s351.e1" id="s351.p0" relation="true"/>
  </sentence>
  <sentence id="s352" text="Conditional deletion of protein processing involved in protein targeting to mitochondrion in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.">
    <entity charOffset="24-89" id="s352.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="151-166" id="s352.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s352.e0" e2="s352.e1" id="s352.p0" relation="false"/>
  </sentence>
  <sentence id="s353" text="Sonic Hedgehog (positive regulation of cell proliferation) signaling at primary cilia drives the proliferation and progression of a subset of medulloblastomas, the most common malignant paediatric brain tumor.">
    <entity charOffset="16-57" id="s353.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="203-208" id="s353.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s353.e0" e2="s353.e1" id="s353.p0" relation="true"/>
  </sentence>
  <sentence id="s354" text="Here, we reveal INPP5E promotes positive regulation of cell proliferation signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="32-73" id="s354.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="216-221" id="s354.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s354.e0" e2="s354.e1" id="s354.p0" relation="false"/>
  </sentence>
  <sentence id="s355" text="In addition, we also found that upregulation of the negative regulation of neuron projection developmentl gene resulted in the inhibition of tumor cell invasion and metastasis.">
    <entity charOffset="52-104" id="s355.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="141-146" id="s355.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s355.e0" e2="s355.e1" id="s355.p0" relation="true"/>
  </sentence>
  <sentence id="s356" text="However, there is no study concerning the specific role of negative regulation of neuron projection development1 in the development and progression of lung cancer.">
    <entity charOffset="59-111" id="s356.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="156-162" id="s356.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s356.e0" e2="s356.e1" id="s356.p0" relation="true"/>
  </sentence>
  <sentence id="s357" text="In the present study, we found that the negative regulation of neuron projection developmentl gene was significantly downregulated in human lung cancer and lung cancer cells.">
    <entity charOffset="40-92" id="s357.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="145-151" id="s357.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s357.e0" e2="s357.e1" id="s357.p0" relation="false"/>
  </sentence>
  <sentence id="s358" text="When the negative regulation of neuron projection developmentl gene was upregulated, we found that the proliferation of lung cancer cells was significantly inhibited, the cells were arrested in the G0/G1phase, the apoptosis of cells was observed, the expression of the caspase family of genes was altered with mainly the activation of caspase-3and-9, and Bcl-2/Bax ratio was significantly imbalanced.">
    <entity charOffset="9-61" id="s358.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="125-131" id="s358.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s358.e0" e2="s358.e1" id="s358.p0" relation="true"/>
  </sentence>
  <sentence id="s359" text="As a brand new tumor-suppressor gene, the expression of negative regulation of neuron projection development1 gene has been revealed to be downregulated or absent in many malignant tumors.">
    <entity charOffset="56-108" id="s359.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="181-187" id="s359.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s359.e0" e2="s359.e1" id="s359.p0" relation="true"/>
  </sentence>
  <sentence id="s360" text="In dogs, myotonia is associated with mutations in muscle contraction.">
    <entity charOffset="9-17" id="s360.e0" ontology_id="HP_0002486" text="myotonia" type="HP"/>
    <entity charOffset="50-68" id="s360.e1" ontology_id="GO_0006936" text="muscle contraction" type="GO"/>
    <pair e1="s360.e0" e2="s360.e1" id="s360.p0" relation="true"/>
  </sentence>
  <sentence id="s361" text="Recently, loss-of-function mutations in positive regulation of retrograde protein transport, ER to cytosol were reported in association with severe developmental delay, deafness and dystonia.">
    <entity charOffset="40-106" id="s361.e0" ontology_id="GO_1904154" text="positive regulation of retrograde protein transport, ER to cytosol" type="GO"/>
    <entity charOffset="182-190" id="s361.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s361.e0" e2="s361.e1" id="s361.p0" relation="true"/>
  </sentence>
  <sentence id="s362" text="&lt;b&gt;Results&lt;/b&gt;: bile acid metabolic process overexpression was significantly associated with advanced tumor status (&lt;i&gt;P&lt;/i&gt;=0.001), advanced positive regulation of cysteine-type endopeptidase activity involved in apoptotic process status (&lt;i&gt;P&lt;/i&gt;=0.036), increased vascular invasion (&lt;i&gt;P&lt;/i&gt;=0.026) and increased perineural invasion (&lt;i&gt;P&lt;/i&gt;=0.004).">
    <entity charOffset="16-43" id="s362.e0" ontology_id="GO_0008206" text="bile acid metabolic process" type="GO"/>
    <entity charOffset="102-107" id="s362.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s362.e0" e2="s362.e1" id="s362.p0" relation="true"/>
  </sentence>
  <sentence id="s363" text="Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in protein phosphorylation, NRAS, KIT, and NF1.">
    <entity charOffset="46-65" id="s363.e0" ontology_id="HP_0012056" text="cutaneous melanomas" type="HP"/>
    <entity charOffset="88-111" id="s363.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s363.e0" e2="s363.e1" id="s363.p0" relation="true"/>
  </sentence>
  <sentence id="s364" text="Six genes (ACOX2, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, visual perception, PSPH, sterol biosynthetic process, TYMS) were differentially expressed by bile acid metabolic process among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="18-111" id="s364.e0" ontology_id="GO_0006977" text="DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" type="GO"/>
    <entity charOffset="257-263" id="s364.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s364.e0" e2="s364.e1" id="s364.p0" relation="true"/>
  </sentence>
  <sentence id="s365" text="Six genes (ACOX2, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, visual perception, PSPH, sterol biosynthetic process, TYMS) were differentially expressed by bile acid metabolic process among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="113-130" id="s365.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="257-263" id="s365.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s365.e0" e2="s365.e1" id="s365.p0" relation="true"/>
  </sentence>
  <sentence id="s366" text="Six genes (ACOX2, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, visual perception, PSPH, sterol biosynthetic process, TYMS) were differentially expressed by bile acid metabolic process among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="138-165" id="s366.e0" ontology_id="GO_0016126" text="sterol biosynthetic process" type="GO"/>
    <entity charOffset="257-263" id="s366.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s366.e0" e2="s366.e1" id="s366.p0" relation="false"/>
  </sentence>
  <sentence id="s367" text="Thus, &lt;i&gt;JPH3&lt;/i&gt; was identified as a novel negative regulation of cytokine production methylated in colorectal and gastric tumors which promotes mitochondrial-mediated apoptosis, also as a potential metastasis and survival biomarker for digestive cancers">
    <entity charOffset="44-86" id="s367.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="248-254" id="s367.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s367.e0" e2="s367.e1" id="s367.p0" relation="true"/>
  </sentence>
  <sentence id="s368" text="Overexpression of protein targeting to membrane in gastric cancer was verified at both transcriptional and translational levels.">
    <entity charOffset="18-47" id="s368.e0" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <entity charOffset="59-65" id="s368.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s368.e0" e2="s368.e1" id="s368.p0" relation="true"/>
  </sentence>
  <sentence id="s369" text="Cellular studies showed that protein targeting to membrane could induce an aggressive phenotype in gastric cancer cells and that its expression was correlated with markers of the epithelial-mesenchymal transition (cytokine production).">
    <entity charOffset="29-58" id="s369.e0" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <entity charOffset="107-113" id="s369.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s369.e0" e2="s369.e1" id="s369.p0" relation="true"/>
  </sentence>
  <sentence id="s370" text="Cellular studies showed that protein targeting to membrane could induce an aggressive phenotype in gastric cancer cells and that its expression was correlated with markers of the epithelial-mesenchymal transition (cytokine production).">
    <entity charOffset="107-113" id="s370.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="214-233" id="s370.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s370.e0" e2="s370.e1" id="s370.p0" relation="false"/>
  </sentence>
  <sentence id="s371" text="In addition, we verified the co-expression of and interplay between Rab3IP and regulation of transcription, DNA-templated during gastric cancer progression.">
    <entity charOffset="79-121" id="s371.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="137-143" id="s371.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s371.e0" e2="s371.e1" id="s371.p0" relation="true"/>
  </sentence>
  <sentence id="s372" text="Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, cation transport, biological_process, and rundataxin.">
    <entity charOffset="77-83" id="s372.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="91-107" id="s372.e1" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <pair e1="s372.e0" e2="s372.e1" id="s372.p0" relation="true"/>
  </sentence>
  <sentence id="s373" text="Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, cation transport, biological_process, and rundataxin.">
    <entity charOffset="77-83" id="s373.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="109-127" id="s373.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s373.e0" e2="s373.e1" id="s373.p0" relation="true"/>
  </sentence>
  <sentence id="s374" text="Only a few genes, including SMARCA4, polyamine catabolic process, ZNF44 and muscle organ development, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.">
    <entity charOffset="37-64" id="s374.e0" ontology_id="GO_0006598" text="polyamine catabolic process" type="GO"/>
    <entity charOffset="219-224" id="s374.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s374.e0" e2="s374.e1" id="s374.p0" relation="false"/>
  </sentence>
  <sentence id="s375" text="Only a few genes, including SMARCA4, polyamine catabolic process, ZNF44 and muscle organ development, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.">
    <entity charOffset="76-100" id="s375.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="219-224" id="s375.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s375.e0" e2="s375.e1" id="s375.p0" relation="true"/>
  </sentence>
  <sentence id="s376" text="It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (positive regulation of protein phosphorylation) in breast cancer and lead to resistance to cetuximab in ovarian cancer.">
    <entity charOffset="97-143" id="s376.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="155-161" id="s376.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s376.e0" e2="s376.e1" id="s376.p0" relation="true"/>
  </sentence>
  <sentence id="s377" text="PKD1 and protein phosphorylation germline mutations are found in patients with autosomal dominant polycystic kidney disease (ADPKD).">
    <entity charOffset="9-32" id="s377.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="109-123" id="s377.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s377.e0" e2="s377.e1" id="s377.p0" relation="true"/>
  </sentence>
  <sentence id="s378" text="Biallelic ion transmembrane transport mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, developmental delay (DD)/intellectual disability (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.">
    <entity charOffset="10-37" id="s378.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="203-226" id="s378.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s378.e0" e2="s378.e1" id="s378.p0" relation="true"/>
  </sentence>
  <sentence id="s379" text="The importance of PKC enzymes in Purkinje neuron health is apparent as mutations in phosphorylation (encoding PKC) cause cerebellar ataxia.">
    <entity charOffset="84-99" id="s379.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="122-139" id="s379.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s379.e0" e2="s379.e1" id="s379.p0" relation="true"/>
  </sentence>
  <sentence id="s380" text="RHOA, transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor signaling pathway, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="6-64" id="s380.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="338-343" id="s380.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s380.e0" e2="s380.e1" id="s380.p0" relation="true"/>
  </sentence>
  <sentence id="s381" text="RHOA, transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor signaling pathway, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="66-124" id="s381.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="338-343" id="s381.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s381.e0" e2="s381.e1" id="s381.p0" relation="true"/>
  </sentence>
  <sentence id="s382" text="RHOA, transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor signaling pathway, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="133-185" id="s382.e0" ontology_id="GO_0010991" text="negative regulation of SMAD protein complex assembly" type="GO"/>
    <entity charOffset="338-343" id="s382.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s382.e0" e2="s382.e1" id="s382.p0" relation="true"/>
  </sentence>
  <sentence id="s383" text="RHOA, transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor signaling pathway, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="205-262" id="s383.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="338-343" id="s383.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s383.e0" e2="s383.e1" id="s383.p0" relation="true"/>
  </sentence>
  <sentence id="s384" text="Our study aimed to investigate the roles and possible regulatory mechanism of miR-1277 in the development of hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="109-133" id="s384.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="135-171" id="s384.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s384.e0" e2="s384.e1" id="s384.p0" relation="false"/>
  </sentence>
  <sentence id="s385" text="This is the first report of a successful application of pentose-phosphate shunt, oxidative branch for hearing loss in Iran.">
    <entity charOffset="56-97" id="s385.e0" ontology_id="GO_0009051" text="pentose-phosphate shunt, oxidative branch" type="GO"/>
    <entity charOffset="102-114" id="s385.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s385.e0" e2="s385.e1" id="s385.p0" relation="false"/>
  </sentence>
  <sentence id="s386" text="Recent studies have linked mutations in the sensory perception of smell (sensory perception of smell) and SLC24A5 (ion transport5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (ion transmembrane transport), respectively.">
    <entity charOffset="44-71" id="s386.e0" ontology_id="GO_0007608" text="sensory perception of smell" type="GO"/>
    <entity charOffset="202-210" id="s386.e1" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <pair e1="s386.e0" e2="s386.e1" id="s386.p0" relation="true"/>
  </sentence>
  <sentence id="s387" text="Recent studies have linked mutations in the sensory perception of smell (sensory perception of smell) and SLC24A5 (ion transport5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (ion transmembrane transport), respectively.">
    <entity charOffset="73-100" id="s387.e0" ontology_id="GO_0007608" text="sensory perception of smell" type="GO"/>
    <entity charOffset="202-210" id="s387.e1" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <pair e1="s387.e0" e2="s387.e1" id="s387.p0" relation="true"/>
  </sentence>
  <sentence id="s388" text="Recent studies have linked mutations in the sensory perception of smell (sensory perception of smell) and SLC24A5 (ion transport5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (ion transmembrane transport), respectively.">
    <entity charOffset="115-128" id="s388.e0" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <entity charOffset="202-210" id="s388.e1" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <pair e1="s388.e0" e2="s388.e1" id="s388.p0" relation="true"/>
  </sentence>
  <sentence id="s389" text="Recent studies have linked mutations in the sensory perception of smell (sensory perception of smell) and SLC24A5 (ion transport5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (ion transmembrane transport), respectively.">
    <entity charOffset="202-210" id="s389.e0" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <entity charOffset="212-239" id="s389.e1" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <pair e1="s389.e0" e2="s389.e1" id="s389.p0" relation="false"/>
  </sentence>
  <sentence id="s390" text="This arrangement is required for filament formation and is directed by an ordered ZP-N/ZP-C linker that is not observed in ZP2 but is conserved in the sequence of deafness/Crohn's disease-associated homopolymeric glycoproteins -tectorin (cell-matrix adhesion) and glycoprotein 2 (GP2).">
    <entity charOffset="163-171" id="s390.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="239-259" id="s390.e1" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <pair e1="s390.e0" e2="s390.e1" id="s390.p0" relation="false"/>
  </sentence>
  <sentence id="s391" text="A risk score of 4, 4, 6, 6, 7, or 6 was assigned to diabetes, baseline estimated small GTPase mediated signal transduction&amp;lt;45mL/min/1.73m, hypertension, repeated contrast exposure, congestive heart failure, and persistent renal injury (defined as an elevation of serum creatinine 25% at 3 months), respectively.">
    <entity charOffset="81-122" id="s391.e0" ontology_id="GO_0007264" text="small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="146-158" id="s391.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s391.e0" e2="s391.e1" id="s391.p0" relation="false"/>
  </sentence>
  <sentence id="s392" text="Gain-of-function mutations in the human cation transport gene cause three clinical types of autosomal dominant distal arthrogryposis.">
    <entity charOffset="40-56" id="s392.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="111-117" id="s392.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s392.e0" e2="s392.e1" id="s392.p0" relation="true"/>
  </sentence>
  <sentence id="s393" text="Gain-of-function mutations in the human cation transport gene cause three clinical types of autosomal dominant distal arthrogryposis.">
    <entity charOffset="40-56" id="s393.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="118-132" id="s393.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s393.e0" e2="s393.e1" id="s393.p0" relation="true"/>
  </sentence>
  <sentence id="s394" text="Pathogenic sequence variants in the Sorting Nexin 10 (endosome organization) gene have been associated with autosomal recessive osteopetrosis (androgen catabolic process) in human.">
    <entity charOffset="54-75" id="s394.e0" ontology_id="GO_0007032" text="endosome organization" type="GO"/>
    <entity charOffset="108-127" id="s394.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s394.e0" e2="s394.e1" id="s394.p0" relation="true"/>
  </sentence>
  <sentence id="s395" text="In our study, we aim to investigate whether variants of KCNA1, KCNA2, and regulation of ion transmembrane transport genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.">
    <entity charOffset="74-115" id="s395.e0" ontology_id="GO_0034765" text="regulation of ion transmembrane transport" type="GO"/>
    <entity charOffset="170-180" id="s395.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s395.e0" e2="s395.e1" id="s395.p0" relation="false"/>
  </sentence>
  <sentence id="s396" text="These results suggest that negative regulation of erythrocyte differentiation and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as blood coagulation and can be promising for developing therapies to combat phosphatidylinositol phosphorylation invasion">
    <entity charOffset="27-77" id="s396.e0" ontology_id="GO_0045647" text="negative regulation of erythrocyte differentiation" type="GO"/>
    <entity charOffset="118-123" id="s396.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s396.e0" e2="s396.e1" id="s396.p0" relation="false"/>
  </sentence>
  <sentence id="s397" text="These results suggest that negative regulation of erythrocyte differentiation and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as blood coagulation and can be promising for developing therapies to combat phosphatidylinositol phosphorylation invasion">
    <entity charOffset="118-123" id="s397.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="207-224" id="s397.e1" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <pair e1="s397.e0" e2="s397.e1" id="s397.p0" relation="false"/>
  </sentence>
  <sentence id="s398" text="In the present study, we sought to identify the factors involved in the RAR&amp;amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (blood coagulation) in hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="130-135" id="s398.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="195-212" id="s398.e1" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <pair e1="s398.e0" e2="s398.e1" id="s398.p0" relation="true"/>
  </sentence>
  <sentence id="s399" text="The musculo-aponeurotic fibrosarcoma oncogene homolog B (negative regulation of erythrocyte differentiation) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;amp;alpha; while MAFF inhibited it.">
    <entity charOffset="24-36" id="s399.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="57-107" id="s399.e1" ontology_id="GO_0045647" text="negative regulation of erythrocyte differentiation" type="GO"/>
    <pair e1="s399.e0" e2="s399.e1" id="s399.p0" relation="true"/>
  </sentence>
  <sentence id="s400" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="116-121" id="s400.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="202-212" id="s400.e1" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <pair e1="s400.e0" e2="s400.e1" id="s400.p0" relation="true"/>
  </sentence>
  <sentence id="s401" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="116-121" id="s401.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="157-198" id="s401.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="s401.e0" e2="s401.e1" id="s401.p0" relation="true"/>
  </sentence>
  <sentence id="s402" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with phosphatidylinositol biosynthetic process recognition of CCL18 may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="57-62" id="s402.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-125" id="s402.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="s402.e0" e2="s402.e1" id="s402.p0" relation="true"/>
  </sentence>
  <sentence id="s403" text="Fungal immunomodulatory protein from &lt;i&gt;Nectria haematococca&lt;/i&gt; (positive regulation of transcription from RNA polymerase II promoter by glucose-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options.">
    <entity charOffset="66-145" id="s403.e0" ontology_id="GO_0000432" text="positive regulation of transcription from RNA polymerase II promoter by glucose" type="GO"/>
    <entity charOffset="226-231" id="s403.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s403.e0" e2="s403.e1" id="s403.p0" relation="true"/>
  </sentence>
  <sentence id="s404" text="To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, negative regulation of protein phosphorylation, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.">
    <entity charOffset="208-213" id="s404.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="264-310" id="s404.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s404.e0" e2="s404.e1" id="s404.p0" relation="true"/>
  </sentence>
  <sentence id="s405" text="Although isolated cases of adult protein phosphorylation have been reported in Nigerians; to the chloride transport of our knowledge, this case is the first to be reported in the paediatric age group in Nigeria.">
    <entity charOffset="9-23" id="s405.e0" ontology_id="HP_0003745" text="isolated cases" type="HP"/>
    <entity charOffset="33-56" id="s405.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s405.e0" e2="s405.e1" id="s405.p0" relation="false"/>
  </sentence>
  <sentence id="s406" text="Perhaps unusually for autosomal recessive diseases, heterozygotes for mutations in protein glycosylation manifest many biological variations.">
    <entity charOffset="22-41" id="s406.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="83-104" id="s406.e1" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <pair e1="s406.e0" e2="s406.e1" id="s406.p0" relation="false"/>
  </sentence>
  <sentence id="s407" text="Mice lacking positive regulation of glycolytic process in the liver exhibit hypolipidemia and reduced levels of liver triglycerides, along with impaired hepatic lipogenesis.">
    <entity charOffset="13-54" id="s407.e0" ontology_id="GO_0045821" text="positive regulation of glycolytic process" type="GO"/>
    <entity charOffset="76-89" id="s407.e1" ontology_id="HP_0045014" text="hypolipidemia" type="HP"/>
    <pair e1="s407.e0" e2="s407.e1" id="s407.p0" relation="false"/>
  </sentence>
  <sentence id="s408" text="We describe a previously unreported syndrome characterized by secondary (post-natal) microcephaly with fronto-temporal negative regulation of protein kinase activity hypoplasia, multiple pituitary hormone deficiency, seizures, severe visual impairment and abnormalities of the kidneys and urinary tract in a highly consanguineous family with six affected children.">
    <entity charOffset="119-165" id="s408.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="234-251" id="s408.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s408.e0" e2="s408.e1" id="s408.p0" relation="false"/>
  </sentence>
  <sentence id="s409" text="The progressive neurological abnormalities, congenital hypopituitarism and post-retinal visual pathway dysfunction in affected individuals demonstrates for the first time the essential role of response to hypoxia in the development of the hypothalamo-pituitary axis, post-natal brain growth, and visual and renal function in humans.">
    <entity charOffset="16-42" id="s409.e0" ontology_id="HP_0000707" text="neurological abnormalities" type="HP"/>
    <entity charOffset="193-212" id="s409.e1" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <pair e1="s409.e0" e2="s409.e1" id="s409.p0" relation="true"/>
  </sentence>
  <sentence id="s410" text="Here we describe novel sequence variants in protein dephosphorylation (c.1168C&amp;gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.">
    <entity charOffset="44-69" id="s410.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="202-217" id="s410.e1" ontology_id="HP_0010628" text="facial weakness" type="HP"/>
    <pair e1="s410.e0" e2="s410.e1" id="s410.p0" relation="true"/>
  </sentence>
  <sentence id="s411" text="Our findings enlarge the spectrum of tubulinopathies and emphasize that mutations of biological_process should be considered in patients with congenital non-progressive facial palsy.">
    <entity charOffset="85-103" id="s411.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="169-181" id="s411.e1" ontology_id="HP_0010628" text="facial palsy" type="HP"/>
    <pair e1="s411.e0" e2="s411.e1" id="s411.p0" relation="true"/>
  </sentence>
  <sentence id="s412" text="Here we show that mitochondrial Sirtuin5 (protein deacetylation), which mediates lysine desuccinylation, deglutarylation, and demalonylation, plays a role in colorectal cancer (CRC) glutamine metabolic rewiring.">
    <entity charOffset="42-63" id="s412.e0" ontology_id="GO_0006476" text="protein deacetylation" type="GO"/>
    <entity charOffset="169-175" id="s412.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s412.e0" e2="s412.e1" id="s412.p0" relation="true"/>
  </sentence>
  <sentence id="s413" text="High expression of Chemokine receptor 4 (G protein-coupled receptor signaling pathway) is important in tumor invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung cancer (NSCLC).">
    <entity charOffset="41-85" id="s413.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="198-204" id="s413.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s413.e0" e2="s413.e1" id="s413.p0" relation="true"/>
  </sentence>
  <sentence id="s414" text="Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (regulation of ferrochelatase activity).">
    <entity charOffset="13-19" id="s414.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="139-176" id="s414.e1" ontology_id="GO_0010722" text="regulation of ferrochelatase activity" type="GO"/>
    <pair e1="s414.e0" e2="s414.e1" id="s414.p0" relation="true"/>
  </sentence>
  <sentence id="s415" text="In the present article, we describe an infant who smelt of ketones during examination and who was diagnosed with transient NDM caused by a regulation of gene expression by genetic imprinting mutation, accompanied by ketoacidosis.">
    <entity charOffset="139-190" id="s415.e0" ontology_id="GO_0006349" text="regulation of gene expression by genetic imprinting" type="GO"/>
    <entity charOffset="216-228" id="s415.e1" ontology_id="HP_0001993" text="ketoacidosis" type="HP"/>
    <pair e1="s415.e0" e2="s415.e1" id="s415.p0" relation="false"/>
  </sentence>
  <sentence id="s416" text="TRAPPC9 gene mutations have been linked recently to autosomal recessive mental retardation 13 (cerebral cortex development; MIM#613192) with only eight families reported world-wide.">
    <entity charOffset="52-71" id="s416.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="95-122" id="s416.e1" ontology_id="GO_0021987" text="cerebral cortex development" type="GO"/>
    <pair e1="s416.e0" e2="s416.e1" id="s416.p0" relation="false"/>
  </sentence>
  <sentence id="s417" text="The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, protein polyubiquitination, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.">
    <entity charOffset="4-9" id="s417.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="71-97" id="s417.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s417.e0" e2="s417.e1" id="s417.p0" relation="true"/>
  </sentence>
  <sentence id="s418" text="Mutations in negative regulation of keratinocyte proliferation cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome.">
    <entity charOffset="13-62" id="s418.e0" ontology_id="GO_0010839" text="negative regulation of keratinocyte proliferation" type="GO"/>
    <entity charOffset="136-159" id="s418.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s418.e0" e2="s418.e1" id="s418.p0" relation="true"/>
  </sentence>
  <sentence id="s419" text="These results demonstrate that Piccolo contributes to tumor aggressiveness in ESCC, likely by stabilizing positive regulation of protein phosphorylation and promoting EGFR-dependent signaling.">
    <entity charOffset="60-74" id="s419.e0" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <entity charOffset="106-152" id="s419.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s419.e0" e2="s419.e1" id="s419.p0" relation="true"/>
  </sentence>
  <sentence id="s420" text="These results indicated that the HFD aggravates BDE47-inhibited testosterone production through hyperinsulinemia, and the accumulation of testicular BDE47 that induces the up-regulation of DAX-1 and the subsequent down-regulation of steroidogenic proteins, i.e., digestion and 3-HSD, in Leydig cells">
    <entity charOffset="96-112" id="s420.e0" ontology_id="HP_0000842" text="hyperinsulinemia" type="HP"/>
    <entity charOffset="263-272" id="s420.e1" ontology_id="GO_0007586" text="digestion" type="GO"/>
    <pair e1="s420.e0" e2="s420.e1" id="s420.p0" relation="false"/>
  </sentence>
  <sentence id="s421" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.">
    <entity charOffset="66-77" id="s421.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="530-578" id="s421.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s421.e0" e2="s421.e1" id="s421.p0" relation="true"/>
  </sentence>
  <sentence id="s422" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.">
    <entity charOffset="66-77" id="s422.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="436-493" id="s422.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s422.e0" e2="s422.e1" id="s422.p0" relation="true"/>
  </sentence>
  <sentence id="s423" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.">
    <entity charOffset="66-77" id="s423.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="259-313" id="s423.e1" ontology_id="GO_1903225" text="negative regulation of endodermal cell differentiation" type="GO"/>
    <pair e1="s423.e0" e2="s423.e1" id="s423.p0" relation="true"/>
  </sentence>
  <sentence id="s424" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.">
    <entity charOffset="66-77" id="s424.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="495-515" id="s424.e1" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <pair e1="s424.e0" e2="s424.e1" id="s424.p0" relation="false"/>
  </sentence>
  <sentence id="s425" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.">
    <entity charOffset="66-77" id="s425.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="217-257" id="s425.e1" ontology_id="GO_0032836" text="glomerular basement membrane development" type="GO"/>
    <pair e1="s425.e0" e2="s425.e1" id="s425.p0" relation="true"/>
  </sentence>
  <sentence id="s426" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.">
    <entity charOffset="66-77" id="s426.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="330-358" id="s426.e1" ontology_id="GO_0001781" text="neutrophil apoptotic process" type="GO"/>
    <pair e1="s426.e0" e2="s426.e1" id="s426.p0" relation="false"/>
  </sentence>
  <sentence id="s427" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.">
    <entity charOffset="66-77" id="s427.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="146-201" id="s427.e1" ontology_id="GO_1901796" text="regulation of signal transduction by p53 class mediator" type="GO"/>
    <pair e1="s427.e0" e2="s427.e1" id="s427.p0" relation="true"/>
  </sentence>
  <sentence id="s428" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.">
    <entity charOffset="66-77" id="s428.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="398-427" id="s428.e1" ontology_id="GO_0043087" text="regulation of GTPase activity" type="GO"/>
    <pair e1="s428.e0" e2="s428.e1" id="s428.p0" relation="false"/>
  </sentence>
  <sentence id="s429" text="In gene-level analyses, G2/M transition of mitotic cell cycle, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="24-61" id="s429.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="142-148" id="s429.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s429.e0" e2="s429.e1" id="s429.p0" relation="true"/>
  </sentence>
  <sentence id="s430" text="Functional inhibition of activation of innate immune response and its receptors abrogated HMGB1-induced angiogenic properties of ECs co-cultured with tumour cells.">
    <entity charOffset="25-61" id="s430.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="150-156" id="s430.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s430.e0" e2="s430.e1" id="s430.p0" relation="true"/>
  </sentence>
  <sentence id="s431" text="Together, our findings suggest that in CRC positive regulation of cell proliferation suppresses tumor progression by regulating YAP/TAZ activity">
    <entity charOffset="43-84" id="s431.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="96-101" id="s431.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s431.e0" e2="s431.e1" id="s431.p0" relation="true"/>
  </sentence>
  <sentence id="s432" text="A case with creatine biosynthetic process deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.">
    <entity charOffset="12-41" id="s432.e0" ontology_id="GO_0006601" text="creatine biosynthetic process" type="GO"/>
    <entity charOffset="130-138" id="s432.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s432.e0" e2="s432.e1" id="s432.p0" relation="true"/>
  </sentence>
  <sentence id="s433" text="In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (cell adhesion mediated by integrin) were also found in the anatomical structure morphogenesis&lt;sup&gt;-/-&lt;/sup&gt; rabbits, showing that the disrupted balance between HFs and SGs may respond to hypotrichosis of ECTD-9 in an animal model and clinically.">
    <entity charOffset="103-137" id="s433.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="290-303" id="s433.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s433.e0" e2="s433.e1" id="s433.p0" relation="false"/>
  </sentence>
  <sentence id="s434" text="In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (cell adhesion mediated by integrin) were also found in the anatomical structure morphogenesis&lt;sup&gt;-/-&lt;/sup&gt; rabbits, showing that the disrupted balance between HFs and SGs may respond to hypotrichosis of ECTD-9 in an animal model and clinically.">
    <entity charOffset="162-196" id="s434.e0" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <entity charOffset="290-303" id="s434.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s434.e0" e2="s434.e1" id="s434.p0" relation="true"/>
  </sentence>
  <sentence id="s435" text="Here, the homozygous anatomical structure morphogenesis&lt;sup&gt;-/-&lt;/sup&gt; rabbits showed complete loss of hair on the head and dorsum, whereas hypotrichosis in the limbs and tail were determined in the Hoxc13&lt;sup&gt;-/-&lt;/sup&gt; rabbits.">
    <entity charOffset="21-55" id="s435.e0" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <entity charOffset="139-152" id="s435.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s435.e0" e2="s435.e1" id="s435.p0" relation="true"/>
  </sentence>
  <sentence id="s436" text="We present a family in which we found both germline and somatic mosaicism for negative regulation of transcription by RNA polymerase II.">
    <entity charOffset="56-73" id="s436.e0" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <entity charOffset="78-135" id="s436.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s436.e0" e2="s436.e1" id="s436.p0" relation="false"/>
  </sentence>
  <sentence id="s437" text="Context Multiple endocrine neoplasia muscle organ development 1 (negative regulation of transcription by RNA polymerase II) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.">
    <entity charOffset="27-36" id="s437.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="37-61" id="s437.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s437.e0" e2="s437.e1" id="s437.p0" relation="false"/>
  </sentence>
  <sentence id="s438" text="Context Multiple endocrine neoplasia muscle organ development 1 (negative regulation of transcription by RNA polymerase II) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.">
    <entity charOffset="65-122" id="s438.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="184-189" id="s438.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s438.e0" e2="s438.e1" id="s438.p0" relation="true"/>
  </sentence>
  <sentence id="s439" text="This study illustrates that germline mosaicism is important to consider in apparently sporadic de novo negative regulation of transcription by RNA polymerase II mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of somatic mosaicism in the parent with germline mosaicism">
    <entity charOffset="86-94" id="s439.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="103-160" id="s439.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s439.e0" e2="s439.e1" id="s439.p0" relation="true"/>
  </sentence>
  <sentence id="s440" text="This study illustrates that germline mosaicism is important to consider in apparently sporadic de novo negative regulation of transcription by RNA polymerase II mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of somatic mosaicism in the parent with germline mosaicism">
    <entity charOffset="103-160" id="s440.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="330-347" id="s440.e1" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <pair e1="s440.e0" e2="s440.e1" id="s440.p0" relation="false"/>
  </sentence>
  <sentence id="s441" text="Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (icosanoid metabolic process).">
    <entity charOffset="103-125" id="s441.e0" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <entity charOffset="198-225" id="s441.e1" ontology_id="GO_0006690" text="icosanoid metabolic process" type="GO"/>
    <pair e1="s441.e0" e2="s441.e1" id="s441.p0" relation="false"/>
  </sentence>
  <sentence id="s442" text="Various genes (eg, regulation of mitochondrial membrane permeability, Golgi organization, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.">
    <entity charOffset="19-68" id="s442.e0" ontology_id="GO_0046902" text="regulation of mitochondrial membrane permeability" type="GO"/>
    <entity charOffset="133-139" id="s442.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s442.e0" e2="s442.e1" id="s442.p0" relation="true"/>
  </sentence>
  <sentence id="s443" text="Various genes (eg, regulation of mitochondrial membrane permeability, Golgi organization, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.">
    <entity charOffset="70-88" id="s443.e0" ontology_id="GO_0007030" text="Golgi organization" type="GO"/>
    <entity charOffset="133-139" id="s443.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s443.e0" e2="s443.e1" id="s443.p0" relation="true"/>
  </sentence>
  <sentence id="s444" text="Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly positive regulation of transcription by RNA polymerase II and ETV1, result in alteration that responsible for oncogenic activity in prostate cancer (PC).">
    <entity charOffset="160-217" id="s444.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="301-307" id="s444.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s444.e0" e2="s444.e1" id="s444.p0" relation="true"/>
  </sentence>
  <sentence id="s445" text="Furthermore, cardiovascular risk factors such hyperthyroidism, hypertension and redox homeostasis have been identified to modulate regulation of transcription, DNA-templated driven gene regulatory networks.">
    <entity charOffset="46-61" id="s445.e0" ontology_id="HP_0000836" text="hyperthyroidism" type="HP"/>
    <entity charOffset="131-173" id="s445.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s445.e0" e2="s445.e1" id="s445.p0" relation="true"/>
  </sentence>
  <sentence id="s446" text="We describe a female proband with primordial dwarfism, skeletal dysplasia, facial dysmorphism, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in growth plate cartilage chondrocyte development, predicted to affect two of the three protein products of the gene.">
    <entity charOffset="55-73" id="s446.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="210-256" id="s446.e1" ontology_id="GO_0003431" text="growth plate cartilage chondrocyte development" type="GO"/>
    <pair e1="s446.e0" e2="s446.e1" id="s446.p0" relation="false"/>
  </sentence>
  <sentence id="s447" text="Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human ubiquitin-dependent ERAD pathway patients.">
    <entity charOffset="136-141" id="s447.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="151-183" id="s447.e1" ontology_id="GO_0030433" text="ubiquitin-dependent ERAD pathway" type="GO"/>
    <pair e1="s447.e0" e2="s447.e1" id="s447.p0" relation="false"/>
  </sentence>
  <sentence id="s448" text="Pre-citrate transport core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (positive regulation of transcription by RNA polymerase II), Kelch-like ECH-associated protein 1 (proteasomal ubiquitin-independent protein catabolic process), thioredoxin (Trx), and peroxiredoxin I (Prx I).">
    <entity charOffset="61-66" id="s448.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="159-216" id="s448.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s448.e0" e2="s448.e1" id="s448.p0" relation="false"/>
  </sentence>
  <sentence id="s449" text="Pre-citrate transport core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (positive regulation of transcription by RNA polymerase II), Kelch-like ECH-associated protein 1 (proteasomal ubiquitin-independent protein catabolic process), thioredoxin (Trx), and peroxiredoxin I (Prx I).">
    <entity charOffset="61-66" id="s449.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="256-315" id="s449.e1" ontology_id="GO_0010499" text="proteasomal ubiquitin-independent protein catabolic process" type="GO"/>
    <pair e1="s449.e0" e2="s449.e1" id="s449.p0" relation="true"/>
  </sentence>
  <sentence id="s450" text="Higher pre-citrate transport nuclear Prx I expression predicted smaller size of a resected tumor (&lt;i&gt;p&lt;/i&gt; = 0.00052; &lt;i&gt;r&lt;/i&gt; = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated nodal metastasis (&lt;i&gt;p&lt;/i&gt; = 0.0024; &lt;i&gt;r&lt;/i&gt; = -0.472).">
    <entity charOffset="11-28" id="s450.e0" ontology_id="GO_0015746" text="citrate transport" type="GO"/>
    <entity charOffset="91-96" id="s450.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s450.e0" e2="s450.e1" id="s450.p0" relation="false"/>
  </sentence>
  <sentence id="s451" text="Mutations in photoreceptor cell maintenance are a rare cause of childhood retinal dystrophy accounting for 2% of disease in this cohort, and the majority of LCA5 mutations are likely null.">
    <entity charOffset="13-43" id="s451.e0" ontology_id="GO_0045494" text="photoreceptor cell maintenance" type="GO"/>
    <entity charOffset="74-91" id="s451.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s451.e0" e2="s451.e1" id="s451.p0" relation="true"/>
  </sentence>
  <sentence id="s452" text="This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (clathrin coat assembly), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.">
    <entity charOffset="130-152" id="s452.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="197-216" id="s452.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s452.e0" e2="s452.e1" id="s452.p0" relation="false"/>
  </sentence>
  <sentence id="s453" text="Leber congenital amaurosis (clathrin coat assembly) and juvenile retinitis pigmentosa (RP) are severe hereditary diseases that causes visual impairment in infants and children.">
    <entity charOffset="28-50" id="s453.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="134-151" id="s453.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s453.e0" e2="s453.e1" id="s453.p0" relation="false"/>
  </sentence>
  <sentence id="s454" text="MVA due to biallelic fibroblast growth factor receptor signaling pathway mutations, or of unknown cause, is not associated with embryonal tumors and cells from these individuals show minimal SAC deficiency.">
    <entity charOffset="21-72" id="s454.e0" ontology_id="GO_0008543" text="fibroblast growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="138-143" id="s454.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s454.e0" e2="s454.e1" id="s454.p0" relation="true"/>
  </sentence>
  <sentence id="s455" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, positive regulation of fatty acid biosynthetic process, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s455.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="358-412" id="s455.e1" ontology_id="GO_0045723" text="positive regulation of fatty acid biosynthetic process" type="GO"/>
    <pair e1="s455.e0" e2="s455.e1" id="s455.p0" relation="true"/>
  </sentence>
  <sentence id="s456" text="Additional functional analyses suggested that mRNA splicing, via spliceosome played an oncogenic role in bladder cancer by inducing cell proliferation and suppressing apoptosis.">
    <entity charOffset="46-76" id="s456.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="113-119" id="s456.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s456.e0" e2="s456.e1" id="s456.p0" relation="true"/>
  </sentence>
  <sentence id="s457" text="The rs2042329 risk allele was also related to significantly increased expression levels of mRNA splicing, via spliceosome mRNA and protein in bladder cancer tissues from Chinese patients.">
    <entity charOffset="91-121" id="s457.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="150-156" id="s457.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s457.e0" e2="s457.e1" id="s457.p0" relation="true"/>
  </sentence>
  <sentence id="s458" text="To evaluate the effectiveness of peptide cross-linking and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, fatty acid biosynthetic process-transcription, DNA-templated, and SLC26A4 genes.">
    <entity charOffset="76-84" id="s458.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="252-280" id="s458.e1" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <pair e1="s458.e0" e2="s458.e1" id="s458.p0" relation="false"/>
  </sentence>
  <sentence id="s459" text="First, we tested whether the pretreatment of &lt;i&gt;Momordica charantia&lt;/i&gt; ethanol extract (L-methylmalonyl-CoA metabolic process) attenuates HO-induced cell death in human neuroblastoma SK-N-MC cells.">
    <entity charOffset="89-126" id="s459.e0" ontology_id="GO_0046491" text="L-methylmalonyl-CoA metabolic process" type="GO"/>
    <entity charOffset="172-185" id="s459.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s459.e0" e2="s459.e1" id="s459.p0" relation="false"/>
  </sentence>
  <sentence id="s460" text="We examined the effects of a mutation in the superoxide metabolic process gene (Sh3pxd2b(nee)) on the progression of otitis media and hearing impairment at various developmental stages.">
    <entity charOffset="45-73" id="s460.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="134-152" id="s460.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s460.e0" e2="s460.e1" id="s460.p0" relation="false"/>
  </sentence>
  <sentence id="s461" text="Congenital muscular dystrophy with mitochondrial structural abnormalities (negative regulation of epithelial cell proliferation #602541), or also called megaconial congenital muscular dystrophy, is characterized clinically by early-onset muscle wasting and severe mental retardation, and pathologically by peculiar enlarged mitochondria that are prevalent toward the periphery of the fibers but are sparse in the center on muscle biopsy.">
    <entity charOffset="75-127" id="s461.e0" ontology_id="GO_0050680" text="negative regulation of epithelial cell proliferation" type="GO"/>
    <entity charOffset="257-263" id="s461.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s461.e0" e2="s461.e1" id="s461.p0" relation="false"/>
  </sentence>
  <sentence id="s462" text="Our study suggests that miR-9 functions as a tumor suppressor in HCC progression by inhibiting a series of target genes, including the newly validated miR-9/negative regulation of translation/AKT&amp;amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.">
    <entity charOffset="45-50" id="s462.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="157-191" id="s462.e1" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <pair e1="s462.e0" e2="s462.e1" id="s462.p0" relation="true"/>
  </sentence>
  <sentence id="s463" text="Mechanically, miR-9 plays a tumor suppressive role partially through a functional miR-9/negative regulation of translation/AKT&amp;amp;ERK axis.">
    <entity charOffset="28-33" id="s463.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="88-122" id="s463.e1" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <pair e1="s463.e0" e2="s463.e1" id="s463.p0" relation="false"/>
  </sentence>
  <sentence id="s464" text="Nuclear receptor small heterodimer partner (circadian rhythm/Nr0b2) is a hepatic tumor suppressor and a critical regulator of liver function.">
    <entity charOffset="44-60" id="s464.e0" ontology_id="GO_0007623" text="circadian rhythm" type="GO"/>
    <entity charOffset="81-86" id="s464.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s464.e0" e2="s464.e1" id="s464.p0" relation="false"/>
  </sentence>
  <sentence id="s465" text="However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to nucleosome disassembly) as well as others.">
    <entity charOffset="184-195" id="s465.e0" ontology_id="HP_0002858" text="meningiomas" type="HP"/>
    <entity charOffset="207-229" id="s465.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s465.e0" e2="s465.e1" id="s465.p0" relation="true"/>
  </sentence>
  <sentence id="s466" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (nucleosome disassembly/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).">
    <entity charOffset="56-62" id="s466.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="107-129" id="s466.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s466.e0" e2="s466.e1" id="s466.p0" relation="true"/>
  </sentence>
  <sentence id="s467" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (nucleosome disassembly/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).">
    <entity charOffset="56-62" id="s467.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="143-165" id="s467.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s467.e0" e2="s467.e1" id="s467.p0" relation="true"/>
  </sentence>
  <sentence id="s468" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (nucleosome disassembly/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).">
    <entity charOffset="107-129" id="s468.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="271-276" id="s468.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s468.e0" e2="s468.e1" id="s468.p0" relation="true"/>
  </sentence>
  <sentence id="s469" text="This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated dystonia: DYT-protein homooligomerization, DYT-THAP1, DYT-tetrahydrobiopterin biosynthetic process, and DYT-GNAL">
    <entity charOffset="157-165" id="s469.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="171-198" id="s469.e1" ontology_id="GO_0051260" text="protein homooligomerization" type="GO"/>
    <pair e1="s469.e0" e2="s469.e1" id="s469.p0" relation="false"/>
  </sentence>
  <sentence id="s470" text="This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated dystonia: DYT-protein homooligomerization, DYT-THAP1, DYT-tetrahydrobiopterin biosynthetic process, and DYT-GNAL">
    <entity charOffset="157-165" id="s470.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="215-255" id="s470.e1" ontology_id="GO_0006729" text="tetrahydrobiopterin biosynthetic process" type="GO"/>
    <pair e1="s470.e0" e2="s470.e1" id="s470.p0" relation="false"/>
  </sentence>
  <sentence id="s471" text="Interestingly, heterogeneous nuclear RNA (hnRNA) for insulin and INS-positive regulation of cell proliferation, both originating from the INS promoter, were essentially undetectable in T1D pancreata, arguing for a silent INSpromoter.">
    <entity charOffset="15-28" id="s471.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="69-110" id="s471.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s471.e0" e2="s471.e1" id="s471.p0" relation="true"/>
  </sentence>
  <sentence id="s472" text="The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (glycosylation) were reported to be associated with psoriasis in western populations by genome-wide association studies.">
    <entity charOffset="72-78" id="s472.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="217-230" id="s472.e1" ontology_id="GO_0070085" text="glycosylation" type="GO"/>
    <pair e1="s472.e0" e2="s472.e1" id="s472.p0" relation="false"/>
  </sentence>
  <sentence id="s473" text="As poor differentiation and low apoptosis are closely associated with poor survival rates and a poor response to radio/chemotherapy in patients with cancer, the prognostic value of negative regulation of transcription by RNA polymerase II expression was examined in the present study and its correlation with response to temozolomide (TMZ) chemotherapy was analyzed in patients with glioma.">
    <entity charOffset="149-155" id="s473.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="181-238" id="s473.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s473.e0" e2="s473.e1" id="s473.p0" relation="true"/>
  </sentence>
  <sentence id="s474" text="High expression of negative regulation of transcription by RNA polymerase II, which was significantly associated with high pathological tumor grade and poor response to TMZ chemotherapy, was demonstrated to be an unfavorable independent prognostic factor and predicted poor survival in patients with newly diagnosed glioma.">
    <entity charOffset="19-76" id="s474.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="316-322" id="s474.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s474.e0" e2="s474.e1" id="s474.p0" relation="false"/>
  </sentence>
  <sentence id="s475" text="negative regulation of transcription by RNA polymerase II expression was analyzed by immunohistochemistry in 157 samples of newly diagnosed glioma and 63 recurrent glioblastoma cases that relapsed during TMZ chemotherapy.">
    <entity charOffset="0-57" id="s475.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="164-176" id="s475.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s475.e0" e2="s475.e1" id="s475.p0" relation="false"/>
  </sentence>
  <sentence id="s476" text="Mutations in magnesium ion homeostasis were shown to cause hypomagnesemia, seizures and intellectual disability.">
    <entity charOffset="13-38" id="s476.e0" ontology_id="GO_0010960" text="magnesium ion homeostasis" type="GO"/>
    <entity charOffset="75-83" id="s476.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s476.e0" e2="s476.e1" id="s476.p0" relation="true"/>
  </sentence>
  <sentence id="s477" text="histone H2A monoubiquitination staining was weakly positive in &amp;lt;5% of tumor cells in 4 of 66 (6%) low-grade endometrial stromal sarcomas and 1 of 18 (6%) endometrial stromal nodules and weakly to moderately positive in &amp;lt;5-40% of tumor cells in 6 of 31 (19%) leiomyosarcomas.">
    <entity charOffset="0-30" id="s477.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="131-138" id="s477.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s477.e0" e2="s477.e1" id="s477.p0" relation="true"/>
  </sentence>
  <sentence id="s478" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="23-53" id="s478.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="86-91" id="s478.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s478.e0" e2="s478.e1" id="s478.p0" relation="true"/>
  </sentence>
  <sentence id="s479" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="23-53" id="s479.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="342-348" id="s479.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s479.e0" e2="s479.e1" id="s479.p0" relation="false"/>
  </sentence>
  <sentence id="s480" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="86-91" id="s480.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="161-173" id="s480.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s480.e0" e2="s480.e1" id="s480.p0" relation="true"/>
  </sentence>
  <sentence id="s481" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="161-173" id="s481.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="342-348" id="s481.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s481.e0" e2="s481.e1" id="s481.p0" relation="false"/>
  </sentence>
  <sentence id="s482" text="histone H2A monoubiquitination immunoexpression was studied in these tumors and their morphologic mimics to assess its diagnostic utility.">
    <entity charOffset="0-30" id="s482.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="69-75" id="s482.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s482.e0" e2="s482.e1" id="s482.p0" relation="true"/>
  </sentence>
  <sentence id="s483" text="histone H2A monoubiquitination immunohistochemical staining is a highly sensitive marker for YWHAE-NUTM2 high-grade endometrial stromal sarcoma with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication">
    <entity charOffset="0-30" id="s483.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="136-143" id="s483.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s483.e0" e2="s483.e1" id="s483.p0" relation="false"/>
  </sentence>
  <sentence id="s484" text="Morphologic features of MAPK cascade-NUTM2 high-grade endometrial stromal sarcoma may overlap with other uterine sarcoma types.">
    <entity charOffset="24-36" id="s484.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="74-81" id="s484.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s484.e0" e2="s484.e1" id="s484.p0" relation="true"/>
  </sentence>
  <sentence id="s485" text="Inactivating mutations in positive regulation of NF-kappaB transcription factor activity or Edar cause hypohidrotic ectodermal dysplasia (HED), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.">
    <entity charOffset="26-88" id="s485.e0" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <entity charOffset="116-136" id="s485.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s485.e0" e2="s485.e1" id="s485.p0" relation="true"/>
  </sentence>
  <sentence id="s486" text="Citrin deficiency is an autosomal recessive metabolic disorder, which is caused by pathogenic mutations in the ATP biosynthetic process gene on chromosome 7q21.3, as the causative gene that encodes the liver type aspartate/glutamate carrier isoform 2 (AGC2).">
    <entity charOffset="24-43" id="s486.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="111-135" id="s486.e1" ontology_id="GO_0006754" text="ATP biosynthetic process" type="GO"/>
    <pair e1="s486.e0" e2="s486.e1" id="s486.p0" relation="true"/>
  </sentence>
  <sentence id="s487" text="These results indicate that transforming growth factor beta receptor signaling pathway acts as a tumor suppressor by activating negative regulation of intracellular estrogen receptor signaling pathway, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.">
    <entity charOffset="28-86" id="s487.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="97-102" id="s487.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s487.e0" e2="s487.e1" id="s487.p0" relation="true"/>
  </sentence>
  <sentence id="s488" text="These results indicate that transforming growth factor beta receptor signaling pathway acts as a tumor suppressor by activating negative regulation of intracellular estrogen receptor signaling pathway, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.">
    <entity charOffset="97-102" id="s488.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="128-200" id="s488.e1" ontology_id="GO_0033147" text="negative regulation of intracellular estrogen receptor signaling pathway" type="GO"/>
    <pair e1="s488.e0" e2="s488.e1" id="s488.p0" relation="true"/>
  </sentence>
  <sentence id="s489" text="transforming growth factor beta receptor signaling pathway has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.">
    <entity charOffset="0-58" id="s489.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="93-98" id="s489.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s489.e0" e2="s489.e1" id="s489.p0" relation="true"/>
  </sentence>
  <sentence id="s490" text="Hereditary sensory and autonomic neuropathies (HSAN) muscle organ development II are characterized by autosomal recessive inheritance, onset at birth and self-mutilating behavior.">
    <entity charOffset="53-77" id="s490.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="122-133" id="s490.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s490.e0" e2="s490.e1" id="s490.p0" relation="false"/>
  </sentence>
  <sentence id="s491" text="Tubulin alpha 8 (biological_process) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (HCC).">
    <entity charOffset="17-35" id="s491.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="72-78" id="s491.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s491.e0" e2="s491.e1" id="s491.p0" relation="true"/>
  </sentence>
  <sentence id="s492" text="The review then discusses the diseases associated with positive regulation of cell proliferation2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-96" id="s492.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="322-341" id="s492.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s492.e0" e2="s492.e1" id="s492.p0" relation="true"/>
  </sentence>
  <sentence id="s493" text="Weight gain and growth failure, the hallmarks of hypercortisolism in pediatrics, may be inconsistent, especially in negative regulation of tumor necrosis factor production-independent forms of CS.">
    <entity charOffset="49-65" id="s493.e0" ontology_id="HP_0003118" text="hypercortisolism" type="HP"/>
    <entity charOffset="116-171" id="s493.e1" ontology_id="GO_0032720" text="negative regulation of tumor necrosis factor production" type="GO"/>
    <pair e1="s493.e0" e2="s493.e1" id="s493.p0" relation="false"/>
  </sentence>
  <sentence id="s494" text="Recently, cell cycle arrest was reported to be implicated in cancer development, and many researchers investigated its biological function in the tumorigenesis of various cancers.">
    <entity charOffset="10-27" id="s494.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="146-151" id="s494.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s494.e0" e2="s494.e1" id="s494.p0" relation="true"/>
  </sentence>
  <sentence id="s495" text="High expression of circadian regulation of gene expression was positively associated with lymph node metastasis, pTNM stage and shorter overall survival (OS) in pancreatic cancer patients.">
    <entity charOffset="19-58" id="s495.e0" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <entity charOffset="172-178" id="s495.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s495.e0" e2="s495.e1" id="s495.p0" relation="true"/>
  </sentence>
  <sentence id="s496" text="In this study, we found that the expression of circadian regulation of gene expression was increased in pancreatic cancer samples compared to peri-tumor tissues.">
    <entity charOffset="47-86" id="s496.e0" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <entity charOffset="115-121" id="s496.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s496.e0" e2="s496.e1" id="s496.p0" relation="true"/>
  </sentence>
  <sentence id="s497" text="The student's t-test was used to compare negative regulation of B cell apoptotic process expression in the tumour and the adjacent normal tissues.">
    <entity charOffset="41-88" id="s497.e0" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <entity charOffset="107-113" id="s497.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s497.e0" e2="s497.e1" id="s497.p0" relation="true"/>
  </sentence>
  <sentence id="s498" text="We reinforce the potential of CASP3 as an interesting target to be explored in adult and pediatric eye development, and alert for its dual biological role in H-regulation of transcription, DNA-templated cells and tumor microenvironment">
    <entity charOffset="160-202" id="s498.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="213-218" id="s498.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s498.e0" e2="s498.e1" id="s498.p0" relation="true"/>
  </sentence>
  <sentence id="s499" text="On the whole, our findings indicated that cellular response to cortisol stimulus exhibited low expression in pancreatic cancer, and upregulation of KLF9 may inhibit the progression of pancreatic cancer.">
    <entity charOffset="42-80" id="s499.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="120-126" id="s499.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s499.e0" e2="s499.e1" id="s499.p0" relation="true"/>
  </sentence>
  <sentence id="s500" text="The purpose of the present study was to investigate the expression and functional significance of cellular response to cortisol stimulus invitro, by assessing the expression of KLF9 in pancreatic cancer tissue samples and its association with the total survival of patients and clinicopathological data.">
    <entity charOffset="98-136" id="s500.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="197-203" id="s500.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s500.e0" e2="s500.e1" id="s500.p0" relation="true"/>
  </sentence>
  <sentence id="s501" text="Using western blot analyses, we assessed cellular response to cortisol stimulus expression in human pancreatic cancer cell lines.">
    <entity charOffset="41-79" id="s501.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="111-117" id="s501.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s501.e0" e2="s501.e1" id="s501.p0" relation="true"/>
  </sentence>
  <sentence id="s502" text="In PANC-1 and BxPC-3 cells, cellular response to cortisol stimulus overexpression decreased the proliferation of pancreatic cancer cells, induced apoptosis, blocked the cell cycle at the Sphase, and inhibited the migration and invasion of tumor cells.">
    <entity charOffset="28-66" id="s502.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="124-130" id="s502.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s502.e0" e2="s502.e1" id="s502.p0" relation="true"/>
  </sentence>
  <sentence id="s503" text="As in MOPDII patients, disruption of pericentrin (Pcnt) in epidermis development caused a number of abnormalities including microcephaly, aberrant hemodynamics analyzed by in utero echocardiography, and cardiovascular anomalies; the latter being associated with mortality, as in the human condition.">
    <entity charOffset="59-80" id="s503.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="124-136" id="s503.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s503.e0" e2="s503.e1" id="s503.p0" relation="false"/>
  </sentence>
  <sentence id="s504" text="With the first biological_process (BFSP1) mutation now having been reported to cause a recessive cataract phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.">
    <entity charOffset="15-33" id="s504.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="97-105" id="s504.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s504.e0" e2="s504.e1" id="s504.p0" relation="true"/>
  </sentence>
  <sentence id="s505" text="We originally discovered vitamin K biosynthetic process as a potential tumor suppressor protein based upon reduced expression in bladder and prostate cancer specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.">
    <entity charOffset="25-55" id="s505.e0" ontology_id="GO_0042371" text="vitamin K biosynthetic process" type="GO"/>
    <entity charOffset="71-76" id="s505.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s505.e0" e2="s505.e1" id="s505.p0" relation="true"/>
  </sentence>
  <sentence id="s506" text="We originally discovered vitamin K biosynthetic process as a potential tumor suppressor protein based upon reduced expression in bladder and prostate cancer specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.">
    <entity charOffset="25-55" id="s506.e0" ontology_id="GO_0042371" text="vitamin K biosynthetic process" type="GO"/>
    <entity charOffset="150-156" id="s506.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s506.e0" e2="s506.e1" id="s506.p0" relation="true"/>
  </sentence>
  <sentence id="s507" text="Vitamin K-2 is involved in mitochondrial electron transport, xenobiotic metabolic process nuclear hormone receptor signaling and redox cycling: together these functions may form the basis for tumor suppressor function.">
    <entity charOffset="61-89" id="s507.e0" ontology_id="GO_0006805" text="xenobiotic metabolic process" type="GO"/>
    <entity charOffset="192-197" id="s507.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s507.e0" e2="s507.e1" id="s507.p0" relation="true"/>
  </sentence>
  <sentence id="s508" text="In vivo, negative regulation of nitric oxide mediated signal transduction is expressed in the stroma of solid tumours and is routinely detectable in peripheral blood of cancer patients after chemotherapy.">
    <entity charOffset="9-73" id="s508.e0" ontology_id="GO_0010751" text="negative regulation of nitric oxide mediated signal transduction" type="GO"/>
    <entity charOffset="110-116" id="s508.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s508.e0" e2="s508.e1" id="s508.p0" relation="true"/>
  </sentence>
  <sentence id="s509" text="Strikingly, negative regulation of nitric oxide mediated signal transduction reprograms the expression profile of cancer cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by EGFR signaling but hitherto rarely reported for a SASP factor.">
    <entity charOffset="12-76" id="s509.e0" ontology_id="GO_0010751" text="negative regulation of nitric oxide mediated signal transduction" type="GO"/>
    <entity charOffset="114-120" id="s509.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s509.e0" e2="s509.e1" id="s509.p0" relation="true"/>
  </sentence>
  <sentence id="s510" text="These findings designate lipid hydroxylation as a predictor of therapy response and as a tumor cell-autonomous detoxification mechanism that must be overcome to prevent drug resistance">
    <entity charOffset="25-44" id="s510.e0" ontology_id="GO_0002933" text="lipid hydroxylation" type="GO"/>
    <entity charOffset="89-94" id="s510.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s510.e0" e2="s510.e1" id="s510.p0" relation="true"/>
  </sentence>
  <sentence id="s511" text="Our results suggested that variants in positive regulation of microtubule polymerization are not common risk factors for Chinese sporadic ALS and that the frequency of variants of unknown significance in the cohort study was 0.39%">
    <entity charOffset="39-88" id="s511.e0" ontology_id="GO_0031116" text="positive regulation of microtubule polymerization" type="GO"/>
    <entity charOffset="129-137" id="s511.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s511.e0" e2="s511.e1" id="s511.p0" relation="false"/>
  </sentence>
  <sentence id="s512" text="BACKGROUND The distribution of positive regulation of cell-matrix adhesion mass and obesity-associated gene (DNA dealkylation involved in DNA repair) genes rs9939609 and rs1421085 in obese and normal ethnic Mongolians was analyzed to investigate the association of FTO gene polymorphisms with obesity and metabolic syndrome in ethnic Mongolians.">
    <entity charOffset="84-91" id="s512.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="109-148" id="s512.e1" ontology_id="GO_0006307" text="DNA dealkylation involved in DNA repair" type="GO"/>
    <pair e1="s512.e0" e2="s512.e1" id="s512.p0" relation="true"/>
  </sentence>
  <sentence id="s513" text="It has been reported that positive regulation of gene expression downstream regulated gene 1 (DNA damage response, signal transduction by p53 class mediator) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.">
    <entity charOffset="26-64" id="s513.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="209-215" id="s513.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s513.e0" e2="s513.e1" id="s513.p0" relation="true"/>
  </sentence>
  <sentence id="s514" text="It has been reported that positive regulation of gene expression downstream regulated gene 1 (DNA damage response, signal transduction by p53 class mediator) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.">
    <entity charOffset="94-156" id="s514.e0" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <entity charOffset="209-215" id="s514.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s514.e0" e2="s514.e1" id="s514.p0" relation="true"/>
  </sentence>
  <sentence id="s515" text="We examined 184 lung adenocarcinomas and observed low expression of NDRG1 in adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (regulation of signaling receptor activity), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.">
    <entity charOffset="16-35" id="s515.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="145-186" id="s515.e1" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <pair e1="s515.e0" e2="s515.e1" id="s515.p0" relation="false"/>
  </sentence>
  <sentence id="s516" text="We demonstrated that &lt;i&gt;linc-ADAL&lt;/i&gt; interacts with heterogeneous nuclear ribonucleoprotein U (regulation of alternative mRNA splicing, via spliceosome) and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis">
    <entity charOffset="53-66" id="s516.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="96-152" id="s516.e1" ontology_id="GO_0000381" text="regulation of alternative mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s516.e0" e2="s516.e1" id="s516.p0" relation="true"/>
  </sentence>
  <sentence id="s517" text="myocilin (osteoblast differentiation), optineurin (positive regulation of autophagy), WDR36 and neurotrophin-4 (ganglion mother cell fate determination) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="10-36" id="s517.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="175-183" id="s517.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s517.e0" e2="s517.e1" id="s517.p0" relation="true"/>
  </sentence>
  <sentence id="s518" text="myocilin (osteoblast differentiation), optineurin (positive regulation of autophagy), WDR36 and neurotrophin-4 (ganglion mother cell fate determination) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="51-83" id="s518.e0" ontology_id="GO_0010508" text="positive regulation of autophagy" type="GO"/>
    <entity charOffset="175-183" id="s518.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s518.e0" e2="s518.e1" id="s518.p0" relation="true"/>
  </sentence>
  <sentence id="s519" text="myocilin (osteoblast differentiation), optineurin (positive regulation of autophagy), WDR36 and neurotrophin-4 (ganglion mother cell fate determination) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="112-151" id="s519.e0" ontology_id="GO_0007402" text="ganglion mother cell fate determination" type="GO"/>
    <entity charOffset="175-183" id="s519.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s519.e0" e2="s519.e1" id="s519.p0" relation="true"/>
  </sentence>
  <sentence id="s520" text="We show here that another member of the CLCA gene family, ion transmembrane transport, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast cancer cell lines.">
    <entity charOffset="58-85" id="s520.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="190-196" id="s520.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s520.e0" e2="s520.e1" id="s520.p0" relation="true"/>
  </sentence>
  <sentence id="s521" text="In breast cancer, cytokine production facilitates invasion of surrounding tissues and correlates closely with cancer metastasis and relapse.">
    <entity charOffset="10-16" id="s521.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="18-37" id="s521.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s521.e0" e2="s521.e1" id="s521.p0" relation="false"/>
  </sentence>
  <sentence id="s522" text="Clinically, low expression of ion transmembrane transport signaled lower relapse-free survival in basal and luminal B breast cancers.">
    <entity charOffset="30-57" id="s522.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="125-131" id="s522.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s522.e0" e2="s522.e1" id="s522.p0" relation="true"/>
  </sentence>
  <sentence id="s523" text="Our results identify protein polyubiquitination as both a partner and regulator of Wnt signaling, with an important role in suppressing colon cancer development.">
    <entity charOffset="21-47" id="s523.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="142-148" id="s523.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s523.e0" e2="s523.e1" id="s523.p0" relation="true"/>
  </sentence>
  <sentence id="s524" text="Germ cell tumors (peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase) are a rare form of childhood cancer that originate from the primordial germ cell.">
    <entity charOffset="18-108" id="s524.e0" ontology_id="GO_0017186" text="peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase" type="GO"/>
    <entity charOffset="139-145" id="s524.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s524.e0" e2="s524.e1" id="s524.p0" relation="false"/>
  </sentence>
  <sentence id="s525" text="The mechanism of TMEM98 in conferring chemoresistance of hepatocellular carcinoma might be possibly through activation of the positive regulation of protein phosphorylation pathway and deactivation of p53.">
    <entity charOffset="57-81" id="s525.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="126-172" id="s525.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s525.e0" e2="s525.e1" id="s525.p0" relation="true"/>
  </sentence>
  <sentence id="s526" text="negative regulation of myelination mRNA in tumor tissues was significantly higher than nontumor tissues of patients with hepatocellular carcinoma (P &amp;lt; 0.0001).">
    <entity charOffset="0-34" id="s526.e0" ontology_id="GO_0031642" text="negative regulation of myelination" type="GO"/>
    <entity charOffset="43-48" id="s526.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s526.e0" e2="s526.e1" id="s526.p0" relation="true"/>
  </sentence>
  <sentence id="s527" text="We have revealed significant association of positive regulation of cell proliferation and cellular response to mechanical stimulus polymorphisms with breast cancer.">
    <entity charOffset="44-85" id="s527.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="157-163" id="s527.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s527.e0" e2="s527.e1" id="s527.p0" relation="true"/>
  </sentence>
  <sentence id="s528" text="We have revealed significant association of positive regulation of cell proliferation and cellular response to mechanical stimulus polymorphisms with breast cancer.">
    <entity charOffset="90-130" id="s528.e0" ontology_id="GO_0071260" text="cellular response to mechanical stimulus" type="GO"/>
    <entity charOffset="157-163" id="s528.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s528.e0" e2="s528.e1" id="s528.p0" relation="true"/>
  </sentence>
  <sentence id="s529" text="The Random Forest algorithm selected FGFR2, cellular response to mechanical stimulus and age as important breast cancer predictors.">
    <entity charOffset="44-84" id="s529.e0" ontology_id="GO_0071260" text="cellular response to mechanical stimulus" type="GO"/>
    <entity charOffset="113-119" id="s529.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s529.e0" e2="s529.e1" id="s529.p0" relation="true"/>
  </sentence>
  <sentence id="s530" text="Homozygous positive regulation of protein phosphorylation mutations cause a syndrome of 46,XX disorder of sexual development (DSD), palmoplantar keratoderma (PPK), and predisposition to squamous cell carcinoma.">
    <entity charOffset="11-57" id="s530.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="186-209" id="s530.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s530.e0" e2="s530.e1" id="s530.p0" relation="true"/>
  </sentence>
  <sentence id="s531" text="This study allowed the identification of the genetic cause of the retinal dystrophy and the establishment of a correct diagnosis in four families, including a large heterozygous deletion in spliceosomal tri-snRNP complex assembly, typically considered one of the pitfalls of this method.">
    <entity charOffset="66-83" id="s531.e0" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <entity charOffset="190-229" id="s531.e1" ontology_id="GO_0000244" text="spliceosomal tri-snRNP complex assembly" type="GO"/>
    <pair e1="s531.e0" e2="s531.e1" id="s531.p0" relation="true"/>
  </sentence>
  <sentence id="s532" text="ME attenuated the influence of APOB rs512535 and negative regulation of transcription by RNA polymerase II rs361525 on obesity risk in FMP.">
    <entity charOffset="49-106" id="s532.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="119-126" id="s532.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s532.e0" e2="s532.e1" id="s532.p0" relation="true"/>
  </sentence>
  <sentence id="s533" text="Furthermore, a high level of negative regulation of transcription by RNA polymerase II in patients with glioma acted as an independent biomarker to predict reduced survival (P=0.026).">
    <entity charOffset="29-86" id="s533.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="104-110" id="s533.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s533.e0" e2="s533.e1" id="s533.p0" relation="true"/>
  </sentence>
  <sentence id="s534" text="In A549 lung cancer cells, which endogenously express cell surface receptor signaling pathway, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s534.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="54-93" id="s534.e1" ontology_id="GO_0007166" text="cell surface receptor signaling pathway" type="GO"/>
    <pair e1="s534.e0" e2="s534.e1" id="s534.p0" relation="true"/>
  </sentence>
  <sentence id="s535" text="Though epidermis development has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, protein O-linked glycosylation and protein O-linked glycosylation were recently identified and confirmed to be additional pathogenic genes of DDD.">
    <entity charOffset="7-28" id="s535.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="83-96" id="s535.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s535.e0" e2="s535.e1" id="s535.p0" relation="false"/>
  </sentence>
  <sentence id="s536" text="Though epidermis development has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, protein O-linked glycosylation and protein O-linked glycosylation were recently identified and confirmed to be additional pathogenic genes of DDD.">
    <entity charOffset="83-96" id="s536.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="141-171" id="s536.e1" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <pair e1="s536.e0" e2="s536.e1" id="s536.p0" relation="false"/>
  </sentence>
  <sentence id="s537" text="Though epidermis development has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, protein O-linked glycosylation and protein O-linked glycosylation were recently identified and confirmed to be additional pathogenic genes of DDD.">
    <entity charOffset="83-96" id="s537.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="176-206" id="s537.e1" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <pair e1="s537.e0" e2="s537.e1" id="s537.p0" relation="false"/>
  </sentence>
  <sentence id="s538" text="Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="11-69" id="s538.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="149-157" id="s538.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s538.e0" e2="s538.e1" id="s538.p0" relation="true"/>
  </sentence>
  <sentence id="s539" text="Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="11-69" id="s539.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="313-322" id="s539.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s539.e0" e2="s539.e1" id="s539.p0" relation="true"/>
  </sentence>
  <sentence id="s540" text="Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="159-217" id="s540.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="274-282" id="s540.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s540.e0" e2="s540.e1" id="s540.p0" relation="false"/>
  </sentence>
  <sentence id="s541" text="We report here two new nonsense mutations (pGln12* and pTyr110*) in &lt;i&gt;positive regulation of cytosolic calcium ion concentration&lt;/i&gt; patients displaying nonsyndromic profound hearing loss, with no evidence of vestibular or retinal dysfunction.">
    <entity charOffset="71-129" id="s541.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="176-188" id="s541.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s541.e0" e2="s541.e1" id="s541.p0" relation="true"/>
  </sentence>
  <sentence id="s542" text="In a screen of pancreatic cancer cell lines, AsPC-1 and BxPC-3 cells expressed high levels of Gremlin1, but only AsPC-1 cells exhibited a high expression level of positive regulation of cell proliferation.">
    <entity charOffset="26-32" id="s542.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="164-205" id="s542.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s542.e0" e2="s542.e1" id="s542.p0" relation="false"/>
  </sentence>
  <sentence id="s543" text="Based on the data from the present study, it was concluded that an abnormal expression level of Gremlin1 in pancreatic cancer was induced by positive regulation of cell proliferation signaling, and that the overexpression of Gremlin1 enabled pancreatic cancer progression">
    <entity charOffset="120-126" id="s543.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="142-183" id="s543.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s543.e0" e2="s543.e1" id="s543.p0" relation="true"/>
  </sentence>
  <sentence id="s544" text="Primary human PSCs and pancreatic cancer cell lines were exposed to SHH, cyclopamine, GLI family zinc finger-1(osteoblast differentiation-1) small interfering RNA (siRNA), and Gremlin1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.">
    <entity charOffset="34-40" id="s544.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="112-138" id="s544.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s544.e0" e2="s544.e1" id="s544.p0" relation="true"/>
  </sentence>
  <sentence id="s545" text="Consequently, the disruption of sensory perception of sound in zebrafish led to a hearing impairment, like that in mammals.">
    <entity charOffset="32-59" id="s545.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="82-100" id="s545.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s545.e0" e2="s545.e1" id="s545.p0" relation="true"/>
  </sentence>
  <sentence id="s546" text="The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in DNA topological change, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.">
    <entity charOffset="129-151" id="s546.e0" ontology_id="GO_0006265" text="DNA topological change" type="GO"/>
    <entity charOffset="216-227" id="s546.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s546.e0" e2="s546.e1" id="s546.p0" relation="false"/>
  </sentence>
  <sentence id="s547" text="We present the native 3D structures of normal and PCD-causing axoneme assembly-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the heterogeneous secondary defects in RSPH1-mutant cilia.">
    <entity charOffset="62-78" id="s547.e0" ontology_id="GO_0035082" text="axoneme assembly" type="GO"/>
    <entity charOffset="274-287" id="s547.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s547.e0" e2="s547.e1" id="s547.p0" relation="true"/>
  </sentence>
  <sentence id="s548" text="Our data provide evidence for structural and functional heterogeneity in radial spokes, suggest a mechanism for the milder axoneme assembly PCD phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.">
    <entity charOffset="56-69" id="s548.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="123-139" id="s548.e1" ontology_id="GO_0035082" text="axoneme assembly" type="GO"/>
    <pair e1="s548.e0" e2="s548.e1" id="s548.p0" relation="false"/>
  </sentence>
  <sentence id="s549" text="The possible involvement of haploinsufficiency for DNA strand elongation involved in DNA replication, a DNA replication complex protein, in the short stature of the patient and her mother requires further studies.">
    <entity charOffset="51-100" id="s549.e0" ontology_id="GO_0006271" text="DNA strand elongation involved in DNA replication" type="GO"/>
    <entity charOffset="144-157" id="s549.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s549.e0" e2="s549.e1" id="s549.p0" relation="false"/>
  </sentence>
  <sentence id="s550" text="TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, regulation of transcription, DNA-templated and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.">
    <entity charOffset="101-114" id="s550.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="149-191" id="s550.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s550.e0" e2="s550.e1" id="s550.p0" relation="true"/>
  </sentence>
  <sentence id="s551" text="These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, negative regulation of transcription by RNA polymerase II rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.">
    <entity charOffset="119-176" id="s551.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="315-328" id="s551.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s551.e0" e2="s551.e1" id="s551.p0" relation="true"/>
  </sentence>
  <sentence id="s552" text="This close biochemical relationship indicates an oncogenic role for Fc-gamma receptor signaling pathway involved in phagocytosis in the physiology of cancer pathology by increasing YAP/TAZ stability">
    <entity charOffset="68-128" id="s552.e0" ontology_id="GO_0038096" text="Fc-gamma receptor signaling pathway involved in phagocytosis" type="GO"/>
    <entity charOffset="150-156" id="s552.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s552.e0" e2="s552.e1" id="s552.p0" relation="true"/>
  </sentence>
  <sentence id="s553" text="We find that Fc-gamma receptor signaling pathway involved in phagocytosis controls tumor growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.">
    <entity charOffset="13-73" id="s553.e0" ontology_id="GO_0038096" text="Fc-gamma receptor signaling pathway involved in phagocytosis" type="GO"/>
    <entity charOffset="83-88" id="s553.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s553.e0" e2="s553.e1" id="s553.p0" relation="true"/>
  </sentence>
  <sentence id="s554" text="We found that the impaired homeostatic synaptic downscaling in Fmr1 KO neurons is caused by loss-of-function dephosphorylation of an epilepsy-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, regulation of membrane depolarization.">
    <entity charOffset="133-141" id="s554.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="247-284" id="s554.e1" ontology_id="GO_0003254" text="regulation of membrane depolarization" type="GO"/>
    <pair e1="s554.e0" e2="s554.e1" id="s554.p0" relation="true"/>
  </sentence>
  <sentence id="s555" text="Humans who carry kidney development mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.">
    <entity charOffset="17-35" id="s555.e0" ontology_id="GO_0001822" text="kidney development" type="GO"/>
    <entity charOffset="54-67" id="s555.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s555.e0" e2="s555.e1" id="s555.p0" relation="true"/>
  </sentence>
  <sentence id="s556" text="Since the original description of the tRNA aminoacylation for protein translation-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
    <entity charOffset="38-81" id="s556.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="136-146" id="s556.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s556.e0" e2="s556.e1" id="s556.p0" relation="true"/>
  </sentence>
  <sentence id="s557" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s557.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="196-253" id="s557.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s557.e0" e2="s557.e1" id="s557.p0" relation="true"/>
  </sentence>
  <sentence id="s558" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s558.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="450-498" id="s558.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s558.e0" e2="s558.e1" id="s558.p0" relation="false"/>
  </sentence>
  <sentence id="s559" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s559.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="522-551" id="s559.e1" ontology_id="GO_0033693" text="neurofilament bundle assembly" type="GO"/>
    <pair e1="s559.e0" e2="s559.e1" id="s559.p0" relation="false"/>
  </sentence>
  <sentence id="s560" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s560.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="387-408" id="s560.e1" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <pair e1="s560.e0" e2="s560.e1" id="s560.p0" relation="false"/>
  </sentence>
  <sentence id="s561" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s561.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="553-590" id="s561.e1" ontology_id="GO_0001932" text="regulation of protein phosphorylation" type="GO"/>
    <pair e1="s561.e0" e2="s561.e1" id="s561.p0" relation="false"/>
  </sentence>
  <sentence id="s562" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s562.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="299-340" id="s562.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="s562.e0" e2="s562.e1" id="s562.p0" relation="false"/>
  </sentence>
  <sentence id="s563" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s563.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="176-187" id="s563.e1" ontology_id="GO_0042552" text="myelination" type="GO"/>
    <pair e1="s563.e0" e2="s563.e1" id="s563.p0" relation="false"/>
  </sentence>
  <sentence id="s564" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s564.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="196-253" id="s564.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s564.e0" e2="s564.e1" id="s564.p0" relation="false"/>
  </sentence>
  <sentence id="s565" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s565.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="268-293" id="s565.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s565.e0" e2="s565.e1" id="s565.p0" relation="false"/>
  </sentence>
  <sentence id="s566" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s566.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="415-448" id="s566.e1" ontology_id="GO_0090343" text="positive regulation of cell aging" type="GO"/>
    <pair e1="s566.e0" e2="s566.e1" id="s566.p0" relation="false"/>
  </sentence>
  <sentence id="s567" text="We successfully showed that the combination of immune cell therapy and CPA was safe, might induce tumor-specific immune responses and clinical efficacy, and was accompanied by a decreased ratio of Tregs in patients with ubiquitin-dependent protein catabolic process-positive advanced solid tumors">
    <entity charOffset="98-103" id="s567.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="220-265" id="s567.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s567.e0" e2="s567.e1" id="s567.p0" relation="true"/>
  </sentence>
  <sentence id="s568" text="Further, two SNPs independent of previously reported signals in transcription by RNA polymerase II [rs12525163 odds ratio (OR) = 1.15, P = 4.9  10(-) (4)] and 19p13.1 (rs1864112 OR = 0.84, P = 1.8  10(-) (9)) were associated with TN breast cancer.">
    <entity charOffset="64-98" id="s568.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="242-248" id="s568.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s568.e0" e2="s568.e1" id="s568.p0" relation="false"/>
  </sentence>
  <sentence id="s569" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s569.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="113-147" id="s569.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s569.e0" e2="s569.e1" id="s569.p0" relation="true"/>
  </sentence>
  <sentence id="s570" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s570.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="325-359" id="s570.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s570.e0" e2="s570.e1" id="s570.p0" relation="false"/>
  </sentence>
  <sentence id="s571" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s571.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="361-418" id="s571.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s571.e0" e2="s571.e1" id="s571.p0" relation="true"/>
  </sentence>
  <sentence id="s572" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s572.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="476-494" id="s572.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s572.e0" e2="s572.e1" id="s572.p0" relation="true"/>
  </sentence>
  <sentence id="s573" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s573.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="164-187" id="s573.e1" ontology_id="GO_0042632" text="cholesterol homeostasis" type="GO"/>
    <pair e1="s573.e0" e2="s573.e1" id="s573.p0" relation="true"/>
  </sentence>
  <sentence id="s574" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s574.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="447-474" id="s574.e1" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="s574.e0" e2="s574.e1" id="s574.p0" relation="true"/>
  </sentence>
  <sentence id="s575" text="The downstream pathways of Nodal-negative regulation of intracellular estrogen receptor signaling pathway play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in heterotaxia as well as the primary developmental defect of the AHF.">
    <entity charOffset="33-105" id="s575.e0" ontology_id="GO_0033147" text="negative regulation of intracellular estrogen receptor signaling pathway" type="GO"/>
    <entity charOffset="294-305" id="s575.e1" ontology_id="HP_0030853" text="heterotaxia" type="HP"/>
    <pair e1="s575.e0" e2="s575.e1" id="s575.p0" relation="true"/>
  </sentence>
  <sentence id="s576" text="DNA samples from eight families with autosomal recessive retinal dystrophies were subjected to genome wide homozygosity mapping (seven by SNP arrays and one by ossification markers) and genes comprised within the detected homozygous regions were analyzed by Sanger sequencing.">
    <entity charOffset="57-76" id="s576.e0" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <entity charOffset="160-172" id="s576.e1" ontology_id="GO_0001503" text="ossification" type="GO"/>
    <pair e1="s576.e0" e2="s576.e1" id="s576.p0" relation="false"/>
  </sentence>
  <sentence id="s577" text="However, acetyl-CoA biosynthetic process from pyruvate&lt;sup&gt;f/Y;&lt;/sup&gt; Cnp&lt;sup&gt;Cre/+&lt;/sup&gt; mice showed reduced fiber density and signs of axonal degeneration in both sciatic and optic nerves from 6 months of age.">
    <entity charOffset="9-54" id="s577.e0" ontology_id="GO_0006086" text="acetyl-CoA biosynthetic process from pyruvate" type="GO"/>
    <entity charOffset="137-156" id="s577.e1" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <pair e1="s577.e0" e2="s577.e1" id="s577.p0" relation="true"/>
  </sentence>
  <sentence id="s578" text="However, as a classical cell surface adhesion molecule, we found positive regulation of protein localization to plasma membrane correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant tumors.">
    <entity charOffset="65-127" id="s578.e0" ontology_id="GO_1903078" text="positive regulation of protein localization to plasma membrane" type="GO"/>
    <entity charOffset="236-241" id="s578.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s578.e0" e2="s578.e1" id="s578.p0" relation="true"/>
  </sentence>
  <sentence id="s579" text="To investigate cell proliferation-associated proteins that might participate in the responses of breast cancer cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy.">
    <entity charOffset="15-33" id="s579.e0" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <entity charOffset="104-110" id="s579.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s579.e0" e2="s579.e1" id="s579.p0" relation="false"/>
  </sentence>
  <sentence id="s580" text="Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and Wnt signaling pathway, planar cell polarity pathway along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.">
    <entity charOffset="76-127" id="s580.e0" ontology_id="GO_0060071" text="Wnt signaling pathway, planar cell polarity pathway" type="GO"/>
    <entity charOffset="176-182" id="s580.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s580.e0" e2="s580.e1" id="s580.p0" relation="true"/>
  </sentence>
  <sentence id="s581" text="Experimentally, we found that reducing expression of cell proliferation by short-hairpin RNAs (shRNAs) reduces the growth of human breast cancer cells in xenograft assays.">
    <entity charOffset="53-71" id="s581.e0" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <entity charOffset="138-144" id="s581.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s581.e0" e2="s581.e1" id="s581.p0" relation="true"/>
  </sentence>
  <sentence id="s582" text="In addition, the coexistence of high MACC1 and low NM23-negative regulation of cell migration expression and tumor budding was associated with short OS (p&amp;lt;0.001).">
    <entity charOffset="56-93" id="s582.e0" ontology_id="GO_0030336" text="negative regulation of cell migration" type="GO"/>
    <entity charOffset="109-114" id="s582.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s582.e0" e2="s582.e1" id="s582.p0" relation="false"/>
  </sentence>
  <sentence id="s583" text="We suggest that the combination of reduced positive regulation of DNA binding-H1, induced positive regulation of transcription by RNA polymerase II, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="43-77" id="s583.e0" ontology_id="GO_0043388" text="positive regulation of DNA binding" type="GO"/>
    <entity charOffset="169-174" id="s583.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s583.e0" e2="s583.e1" id="s583.p0" relation="true"/>
  </sentence>
  <sentence id="s584" text="We suggest that the combination of reduced positive regulation of DNA binding-H1, induced positive regulation of transcription by RNA polymerase II, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="43-77" id="s584.e0" ontology_id="GO_0043388" text="positive regulation of DNA binding" type="GO"/>
    <entity charOffset="304-310" id="s584.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s584.e0" e2="s584.e1" id="s584.p0" relation="true"/>
  </sentence>
  <sentence id="s585" text="We suggest that the combination of reduced positive regulation of DNA binding-H1, induced positive regulation of transcription by RNA polymerase II, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="90-147" id="s585.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="304-310" id="s585.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s585.e0" e2="s585.e1" id="s585.p0" relation="true"/>
  </sentence>
  <sentence id="s586" text="We suggest that the combination of reduced positive regulation of DNA binding-H1, induced positive regulation of transcription by RNA polymerase II, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="90-147" id="s586.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="169-174" id="s586.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s586.e0" e2="s586.e1" id="s586.p0" relation="true"/>
  </sentence>
  <sentence id="s587" text="The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-negative regulation of cell migration expression with the histopathological features of tumors in recurrence formation in eCC cases.">
    <entity charOffset="99-136" id="s587.e0" ontology_id="GO_0030336" text="negative regulation of cell migration" type="GO"/>
    <entity charOffset="187-192" id="s587.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s587.e0" e2="s587.e1" id="s587.p0" relation="false"/>
  </sentence>
  <sentence id="s588" text="Abnormalities in these pathways cause autosomal dominant polycystic kidney disease (ADPKD) and naevoid basal cell carcinoma syndrome (positive regulation of cholesterol efflux) respectively.">
    <entity charOffset="103-123" id="s588.e0" ontology_id="HP_0002671" text="basal cell carcinoma" type="HP"/>
    <entity charOffset="134-175" id="s588.e1" ontology_id="GO_0010875" text="positive regulation of cholesterol efflux" type="GO"/>
    <pair e1="s588.e0" e2="s588.e1" id="s588.p0" relation="false"/>
  </sentence>
  <sentence id="s589" text="Recent studies in RAS wild-type (WT) metastatic colorectal cancer (mCRC) suggest that the survival benefits of therapy using anti-epidermal growth factor receptor (anti-EGFR) and anti-vascular endothelial growth factor (anti-negative regulation of transcription by RNA polymerase II) antibodies combined with chemotherapy are maximized when the anti-EGFR antibody is given as first-line, followed by subsequent anti-VEGF antibody therapy.">
    <entity charOffset="59-65" id="s589.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="225-282" id="s589.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s589.e0" e2="s589.e1" id="s589.p0" relation="false"/>
  </sentence>
  <sentence id="s590" text="Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, protein monoubiquitination, DCAF4L1, and VHL in sporadic HBs, and ZNF814, G2/M transition of mitotic cell cycle, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.">
    <entity charOffset="55-118" id="s590.e0" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <entity charOffset="168-176" id="s590.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s590.e0" e2="s590.e1" id="s590.p0" relation="true"/>
  </sentence>
  <sentence id="s591" text="Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, protein monoubiquitination, DCAF4L1, and VHL in sporadic HBs, and ZNF814, G2/M transition of mitotic cell cycle, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.">
    <entity charOffset="120-146" id="s591.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="168-176" id="s591.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s591.e0" e2="s591.e1" id="s591.p0" relation="true"/>
  </sentence>
  <sentence id="s592" text="Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, protein monoubiquitination, DCAF4L1, and VHL in sporadic HBs, and ZNF814, G2/M transition of mitotic cell cycle, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.">
    <entity charOffset="168-176" id="s592.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="233-261" id="s592.e1" ontology_id="GO_0060478" text="acrosomal vesicle exocytosis" type="GO"/>
    <pair e1="s592.e0" e2="s592.e1" id="s592.p0" relation="false"/>
  </sentence>
  <sentence id="s593" text="Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, protein monoubiquitination, DCAF4L1, and VHL in sporadic HBs, and ZNF814, G2/M transition of mitotic cell cycle, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.">
    <entity charOffset="168-176" id="s593.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="194-231" id="s593.e1" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <pair e1="s593.e0" e2="s593.e1" id="s593.p0" relation="false"/>
  </sentence>
  <sentence id="s594" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and negative regulation of Wnt signaling pathway, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, mRNA splicing, via spliceosome, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="53-97" id="s594.e0" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="134-142" id="s594.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s594.e0" e2="s594.e1" id="s594.p0" relation="false"/>
  </sentence>
  <sentence id="s595" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and negative regulation of Wnt signaling pathway, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, mRNA splicing, via spliceosome, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="134-142" id="s595.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="182-212" id="s595.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s595.e0" e2="s595.e1" id="s595.p0" relation="false"/>
  </sentence>
  <sentence id="s596" text="Analyses of our original protein polyubiquitinationNA expression signatures indicated that both strands of miR-144 (miR-144-5p, the passenger strand; miR-144-3p, the guide strand) showed decreased expression in cancer tissues.">
    <entity charOffset="25-51" id="s596.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="211-217" id="s596.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s596.e0" e2="s596.e1" id="s596.p0" relation="false"/>
  </sentence>
  <sentence id="s597" text="Our results demonstrated that the overall expression of tRNA methylation significantly correlated with clinical stage (P=0.027), tumor classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&amp;lt;0.001), progesterone receptor (P=0.001), and Ki-67 (P&amp;lt;0.001).">
    <entity charOffset="56-72" id="s597.e0" ontology_id="GO_0030488" text="tRNA methylation" type="GO"/>
    <entity charOffset="129-134" id="s597.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s597.e0" e2="s597.e1" id="s597.p0" relation="true"/>
  </sentence>
  <sentence id="s598" text="tRNA methylation expression was shown to be significantly higher in breast cancer cells and tissues than in normal breast epithelial cells and tissues, at both mRNA and protein levels.">
    <entity charOffset="0-16" id="s598.e0" ontology_id="GO_0030488" text="tRNA methylation" type="GO"/>
    <entity charOffset="75-81" id="s598.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s598.e0" e2="s598.e1" id="s598.p0" relation="true"/>
  </sentence>
  <sentence id="s599" text="We genotyped a negative regulation of transcription, DNA-templated of mitochondrial SNPs using Illumina HumanExome arrays and tested for association in the Swedish schizophrenia sample (N&amp;gt; 10,000).">
    <entity charOffset="15-66" id="s599.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="164-177" id="s599.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s599.e0" e2="s599.e1" id="s599.p0" relation="false"/>
  </sentence>
  <sentence id="s600" text="To investigate the presence of specific chromosomal and gene alterations, positive regulation of sodium ion transport protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 negative regulation of phosphatase activity and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.">
    <entity charOffset="74-117" id="s600.e0" ontology_id="GO_0010765" text="positive regulation of sodium ion transport" type="GO"/>
    <entity charOffset="390-396" id="s600.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s600.e0" e2="s600.e1" id="s600.p0" relation="true"/>
  </sentence>
  <sentence id="s601" text="As an important multifunctional protein involved in regulation of mitochondrial metabolism, positive regulation of transcription by RNA polymerase II was identified as a causative gene for Parkinson's disease (PD), yet the relationship between CHCHD2 and neurodegenerative dementia is not well understood.">
    <entity charOffset="66-79" id="s601.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="92-149" id="s601.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s601.e0" e2="s601.e1" id="s601.p0" relation="true"/>
  </sentence>
  <sentence id="s602" text="The heterogeneity test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of MTHFR C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of methionine biosynthetic process A66G polymorphism.">
    <entity charOffset="4-17" id="s602.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="334-365" id="s602.e1" ontology_id="GO_0009086" text="methionine biosynthetic process" type="GO"/>
    <pair e1="s602.e0" e2="s602.e1" id="s602.p0" relation="true"/>
  </sentence>
  <sentence id="s603" text="The mutation (p.Trp211Arg), which segregates with a disease phenotype characterized by either isolated IIP/IPF, or IPF associated with lung adenocarcinoma, is located in the carbohydrate recognition domain (positive regulation of transcription by RNA polymerase II) of SP-A1 and involves a residue invariant throughout evolution, not only in SP-A1, but also in its close paralog SP-A2 and other CRD-containing proteins.">
    <entity charOffset="135-154" id="s603.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="207-264" id="s603.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s603.e0" e2="s603.e1" id="s603.p0" relation="false"/>
  </sentence>
  <sentence id="s604" text="Here we report a consanguineous Arab family from Qatar with three children having an early lethal form of arthrogryposis multiplex congenita and a novel frameshift mutation in central nervous system myelination.">
    <entity charOffset="106-120" id="s604.e0" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <entity charOffset="176-210" id="s604.e1" ontology_id="GO_0022010" text="central nervous system myelination" type="GO"/>
    <pair e1="s604.e0" e2="s604.e1" id="s604.p0" relation="true"/>
  </sentence>
  <sentence id="s605" text="The autophagy gene has been reported as a positive regulator of autophagy which is an essential mechanism for maintaining neuron homeostasis and survival and plays a key role in major adult and pediatric neurodegenerative diseases.">
    <entity charOffset="4-13" id="s605.e0" ontology_id="GO_0006914" text="autophagy" type="GO"/>
    <entity charOffset="204-230" id="s605.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s605.e0" e2="s605.e1" id="s605.p0" relation="true"/>
  </sentence>
  <sentence id="s606" text="Our exome analysis indicated the proband as a compound heterozygote for two missense variants in the autophagy gene according to a recessive mode of inheritance.">
    <entity charOffset="101-110" id="s606.e0" ontology_id="GO_0006914" text="autophagy" type="GO"/>
    <entity charOffset="141-160" id="s606.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s606.e0" e2="s606.e1" id="s606.p0" relation="false"/>
  </sentence>
  <sentence id="s607" text="Importantly, negative regulation of transcription by RNA polymerase II inhibitor Kenpaullone sensitizes breast cancer cells and xenograft tumors to Paclitaxel and improves therapeutic effects.">
    <entity charOffset="13-70" id="s607.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="111-117" id="s607.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s607.e0" e2="s607.e1" id="s607.p0" relation="true"/>
  </sentence>
  <sentence id="s608" text="Epidermal growth factor receptor tyrosine kinase inhibitors (positive regulation of protein phosphorylation-TKIs) are approved for second-line treatment of &lt;i&gt;EGFR&lt;/i&gt; wild-type (&lt;i&gt;EGFR&lt;/i&gt;-wt) nonsmall cell lung cancer (NSCLC).">
    <entity charOffset="61-107" id="s608.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="214-220" id="s608.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s608.e0" e2="s608.e1" id="s608.p0" relation="true"/>
  </sentence>
  <sentence id="s609" text="The ADAMTS18 gene is often down-regulated by hypermethylation in ccRCC-derived cell lines and primary tumors, indicating its critical role as a negative regulation of cytokine production in ccRCC.">
    <entity charOffset="102-107" id="s609.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="144-186" id="s609.e1" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <pair e1="s609.e0" e2="s609.e1" id="s609.p0" relation="true"/>
  </sentence>
  <sentence id="s610" text="ADAMTS18, located at 16q23.1, has been reported to be a critical negative regulation of cytokine production in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).">
    <entity charOffset="65-107" id="s610.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="128-133" id="s610.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s610.e0" e2="s610.e1" id="s610.p0" relation="false"/>
  </sentence>
  <sentence id="s611" text="To identify tumor suppressor genes (negative regulation of cytokine productions) silenced by hypermethylation and discover new epigenetic biomarkers for early cancer detection.">
    <entity charOffset="12-17" id="s611.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="36-78" id="s611.e1" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <pair e1="s611.e0" e2="s611.e1" id="s611.p0" relation="false"/>
  </sentence>
  <sentence id="s612" text="Further analysis revealed a reduced nucleosome disassembly expression and a complete loss of negative regulation of cell proliferation expression in tumor cells.">
    <entity charOffset="36-58" id="s612.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="149-154" id="s612.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s612.e0" e2="s612.e1" id="s612.p0" relation="true"/>
  </sentence>
  <sentence id="s613" text="Further analysis revealed a reduced nucleosome disassembly expression and a complete loss of negative regulation of cell proliferation expression in tumor cells.">
    <entity charOffset="93-134" id="s613.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="149-154" id="s613.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s613.e0" e2="s613.e1" id="s613.p0" relation="true"/>
  </sentence>
  <sentence id="s614" text="Pharmacological manipulation of peripheral CB1 signaling regulates hyperphagia in an adipocyte regulation of glycolytic process-dependent manner.">
    <entity charOffset="67-78" id="s614.e0" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <entity charOffset="95-127" id="s614.e1" ontology_id="GO_0006110" text="regulation of glycolytic process" type="GO"/>
    <pair e1="s614.e0" e2="s614.e1" id="s614.p0" relation="false"/>
  </sentence>
  <sentence id="s615" text="Conversely, skeletal system development, 6, 14, and 20 are consistently up-regulated in breast carcinomas (P = 0.005, P &amp;lt; 0.0001, P = 0.003, and P = 0.001, respectively).">
    <entity charOffset="12-39" id="s615.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="88-104" id="s615.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s615.e0" e2="s615.e1" id="s615.p0" relation="false"/>
  </sentence>
  <sentence id="s616" text="Genetic modification of a human prostate cancer cell line to induce protein polyubiquitination-101 and suppress CENPF decreased cell migration and invasion.">
    <entity charOffset="41-47" id="s616.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="68-94" id="s616.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s616.e0" e2="s616.e1" id="s616.p0" relation="false"/>
  </sentence>
  <sentence id="s617" text="Polymorphisms rs2910164 in miR-146a and rs486907 in the negative regulation of viral genome replication gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.">
    <entity charOffset="56-103" id="s617.e0" ontology_id="GO_0045071" text="negative regulation of viral genome replication" type="GO"/>
    <entity charOffset="241-249" id="s617.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s617.e0" e2="s617.e1" id="s617.p0" relation="false"/>
  </sentence>
  <sentence id="s618" text="Polymorphisms rs2910164 in miR-146a and rs486907 in the negative regulation of viral genome replication gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.">
    <entity charOffset="56-103" id="s618.e0" ontology_id="GO_0045071" text="negative regulation of viral genome replication" type="GO"/>
    <entity charOffset="176-182" id="s618.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s618.e0" e2="s618.e1" id="s618.p0" relation="true"/>
  </sentence>
  <sentence id="s619" text="In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (negative regulation of viral genome replication) in the risk of sporadic melanoma.">
    <entity charOffset="118-165" id="s619.e0" ontology_id="GO_0045071" text="negative regulation of viral genome replication" type="GO"/>
    <entity charOffset="191-199" id="s619.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s619.e0" e2="s619.e1" id="s619.p0" relation="true"/>
  </sentence>
  <sentence id="s620" text="The results reported in the present study suggest a sex-specific interaction between protein polyubiquitination-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="85-111" id="s620.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="137-145" id="s620.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s620.e0" e2="s620.e1" id="s620.p0" relation="true"/>
  </sentence>
  <sentence id="s621" text="The results reported in the present study suggest a sex-specific interaction between protein polyubiquitination-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="85-111" id="s621.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="151-157" id="s621.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s621.e0" e2="s621.e1" id="s621.p0" relation="false"/>
  </sentence>
  <sentence id="s622" text="Polo-like kinase 1 (G2/M transition of mitotic cell cycle) is overexpressed in a wide spectrum of human tumors, being frequently considered as an oncogene and an attractive cancer target.">
    <entity charOffset="20-57" id="s622.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="104-110" id="s622.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s622.e0" e2="s622.e1" id="s622.p0" relation="true"/>
  </sentence>
  <sentence id="s623" text="Two of these genes were independently mutated in more than one family with similar phenotypes, which substantiates their link to human disease (regulation of membrane repolarization in intellectual disability and UBR4 in early dementia).">
    <entity charOffset="144-181" id="s623.e0" ontology_id="GO_0060306" text="regulation of membrane repolarization" type="GO"/>
    <entity charOffset="185-208" id="s623.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s623.e0" e2="s623.e1" id="s623.p0" relation="true"/>
  </sentence>
  <sentence id="s624" text="In addition, the expression of protein polyubiquitination-214 inhibited proliferation of ESCC cells in vitro and inhibit the growth of xenograft tumor in vivo.">
    <entity charOffset="31-57" id="s624.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="145-150" id="s624.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s624.e0" e2="s624.e1" id="s624.p0" relation="true"/>
  </sentence>
  <sentence id="s625" text="Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in biological_process which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.">
    <entity charOffset="171-189" id="s625.e0" ontology_id="HP_0006644" text="thoracic dysplasia" type="HP"/>
    <entity charOffset="266-284" id="s625.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s625.e0" e2="s625.e1" id="s625.p0" relation="false"/>
  </sentence>
  <sentence id="s626" text="Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in biological_process which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.">
    <entity charOffset="266-284" id="s626.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="385-403" id="s626.e1" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <pair e1="s626.e0" e2="s626.e1" id="s626.p0" relation="true"/>
  </sentence>
  <sentence id="s627" text="There were no statistically significant associations between phospho-positive regulation of transcription, DNA-templated expression and tumor grade, presence of concurrent carcinoma in situ or hydronephrosis, or pN status.">
    <entity charOffset="69-120" id="s627.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="136-141" id="s627.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s627.e0" e2="s627.e1" id="s627.p0" relation="true"/>
  </sentence>
  <sentence id="s628" text="RNA sequencing transcriptome analysis revealed that inflammatory mediators such as tumor necrosis factor (negative regulation of transcription by RNA polymerase II)- suppressed expression of R-spondin-1 (Rspo1, a critical growth factor for intestinal epithelial cells) in Sirt6-silenced YAMC cells &lt;i&gt;in vitro&lt;/i&gt;.">
    <entity charOffset="83-88" id="s628.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="106-163" id="s628.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s628.e0" e2="s628.e1" id="s628.p0" relation="false"/>
  </sentence>
  <sentence id="s629" text="Homozygous and compound heterozygous mutations in post-embryonic development have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.">
    <entity charOffset="50-76" id="s629.e0" ontology_id="GO_0009791" text="post-embryonic development" type="GO"/>
    <entity charOffset="118-137" id="s629.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s629.e0" e2="s629.e1" id="s629.p0" relation="true"/>
  </sentence>
  <sentence id="s630" text="Homozygous and compound heterozygous mutations in post-embryonic development have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.">
    <entity charOffset="50-76" id="s630.e0" ontology_id="GO_0009791" text="post-embryonic development" type="GO"/>
    <entity charOffset="267-275" id="s630.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s630.e0" e2="s630.e1" id="s630.p0" relation="true"/>
  </sentence>
  <sentence id="s631" text="Mutations of the sigma subunit of the heterotetrameric adaptor-related protein complex 2 (AP2) impair signalling of the calcium-sensing receptor (detection of calcium ion), and cause familial hypocalciuric hypercalcaemia type 3 (FHH3).">
    <entity charOffset="147-171" id="s631.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="207-221" id="s631.e1" ontology_id="HP_0003072" text="hypercalcaemia" type="HP"/>
    <pair e1="s631.e0" e2="s631.e1" id="s631.p0" relation="false"/>
  </sentence>
  <sentence id="s632" text="We hypothesized that additional rare AP2 variants may also be associated with altered detection of calcium ion function and hypercalcaemia, and sought for these by analysing&amp;gt;111995 exomes (&amp;gt;60706 from ExAc and dbSNP, and 51289 from the Geisinger Health System-Regeneron DiscovEHR dataset, which also contains clinical data).">
    <entity charOffset="87-111" id="s632.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="125-139" id="s632.e1" ontology_id="HP_0003072" text="hypercalcaemia" type="HP"/>
    <pair e1="s632.e0" e2="s632.e1" id="s632.p0" relation="true"/>
  </sentence>
  <sentence id="s633" text="Multisystem proteinopathy (proteolysis), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (signal transduction), is mainly caused by mutation in VCP gene.">
    <entity charOffset="27-38" id="s633.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="113-136" id="s633.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s633.e0" e2="s633.e1" id="s633.p0" relation="false"/>
  </sentence>
  <sentence id="s634" text="In addition, polymorphisms in apoptosis-related genes such as protein neddylation, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and T cell mediated cytotoxicity variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="62-81" id="s634.e0" ontology_id="GO_0045116" text="protein neddylation" type="GO"/>
    <entity charOffset="227-251" id="s634.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s634.e0" e2="s634.e1" id="s634.p0" relation="true"/>
  </sentence>
  <sentence id="s635" text="In addition, polymorphisms in apoptosis-related genes such as protein neddylation, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and T cell mediated cytotoxicity variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="157-185" id="s635.e0" ontology_id="GO_0001913" text="T cell mediated cytotoxicity" type="GO"/>
    <entity charOffset="227-251" id="s635.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s635.e0" e2="s635.e1" id="s635.p0" relation="true"/>
  </sentence>
  <sentence id="s636" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="149-177" id="s636.e0" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <entity charOffset="473-485" id="s636.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s636.e0" e2="s636.e1" id="s636.p0" relation="true"/>
  </sentence>
  <sentence id="s637" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="215-236" id="s637.e0" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <entity charOffset="473-485" id="s637.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s637.e0" e2="s637.e1" id="s637.p0" relation="true"/>
  </sentence>
  <sentence id="s638" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="246-263" id="s638.e0" ontology_id="GO_0007420" text="brain development" type="GO"/>
    <entity charOffset="473-485" id="s638.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s638.e0" e2="s638.e1" id="s638.p0" relation="true"/>
  </sentence>
  <sentence id="s639" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="265-287" id="s639.e0" ontology_id="GO_0016574" text="histone ubiquitination" type="GO"/>
    <entity charOffset="473-485" id="s639.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s639.e0" e2="s639.e1" id="s639.p0" relation="true"/>
  </sentence>
  <sentence id="s640" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="289-332" id="s640.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="473-485" id="s640.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s640.e0" e2="s640.e1" id="s640.p0" relation="true"/>
  </sentence>
  <sentence id="s641" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="341-362" id="s641.e0" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <entity charOffset="473-485" id="s641.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s641.e0" e2="s641.e1" id="s641.p0" relation="true"/>
  </sentence>
  <sentence id="s642" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="364-390" id="s642.e0" ontology_id="GO_0051977" text="lysophospholipid transport" type="GO"/>
    <entity charOffset="473-485" id="s642.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s642.e0" e2="s642.e1" id="s642.p0" relation="true"/>
  </sentence>
  <sentence id="s643" text="There are several genetic mutations that lead to signal transduction development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (response to superoxide) and fused in sarcoma (FUS).">
    <entity charOffset="214-236" id="s643.e0" ontology_id="GO_0000303" text="response to superoxide" type="GO"/>
    <entity charOffset="251-258" id="s643.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s643.e0" e2="s643.e1" id="s643.p0" relation="false"/>
  </sentence>
  <sentence id="s644" text="Targeted resequencing was used to screen 460 unselected epilepsy patients for variants in chemical synaptic transmission.">
    <entity charOffset="56-64" id="s644.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="90-120" id="s644.e1" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <pair e1="s644.e0" e2="s644.e1" id="s644.p0" relation="true"/>
  </sentence>
  <sentence id="s645" text="Previous reports have identified chemical synaptic transmission variants in patients with generalized epilepsies, such as myoclonic-atonic epilepsy and childhood absence epilepsy.">
    <entity charOffset="33-63" id="s645.e0" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <entity charOffset="102-112" id="s645.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s645.e0" e2="s645.e1" id="s645.p0" relation="false"/>
  </sentence>
  <sentence id="s646" text="These findings demonstrate that SLC6A1 is an important contributor to childhood epilepsy and that reduced glycine metabolic process-1 function is a common consequence of epilepsy-causing SLC6A1 variants">
    <entity charOffset="80-88" id="s646.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="106-131" id="s646.e1" ontology_id="GO_0006544" text="glycine metabolic process" type="GO"/>
    <pair e1="s646.e0" e2="s646.e1" id="s646.p0" relation="true"/>
  </sentence>
  <sentence id="s647" text="To better understand the biology of this molecularly distinct tumor submuscle organ development, we analyze the microRNA (protein polyubiquitinationNA) expression profiles of Xp11 response to hydroperoxide compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.">
    <entity charOffset="62-67" id="s647.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="180-205" id="s647.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s647.e0" e2="s647.e1" id="s647.p0" relation="false"/>
  </sentence>
  <sentence id="s648" text="To better understand the biology of this molecularly distinct tumor submuscle organ development, we analyze the microRNA (protein polyubiquitinationNA) expression profiles of Xp11 response to hydroperoxide compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.">
    <entity charOffset="62-67" id="s648.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="122-148" id="s648.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s648.e0" e2="s648.e1" id="s648.p0" relation="false"/>
  </sentence>
  <sentence id="s649" text="The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (cell-substrate junction assembly) on electrochemical transduction format.">
    <entity charOffset="254-259" id="s649.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="305-337" id="s649.e1" ontology_id="GO_0007044" text="cell-substrate junction assembly" type="GO"/>
    <pair e1="s649.e0" e2="s649.e1" id="s649.p0" relation="false"/>
  </sentence>
  <sentence id="s650" text="Mutations in Vps33 isoforms cause pigment dilution in epidermis development (vesicle-mediated transport, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, vesicle-mediated transport).">
    <entity charOffset="54-75" id="s650.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="151-165" id="s650.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s650.e0" e2="s650.e1" id="s650.p0" relation="false"/>
  </sentence>
  <sentence id="s651" text="Mutations in Vps33 isoforms cause pigment dilution in epidermis development (vesicle-mediated transport, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, vesicle-mediated transport).">
    <entity charOffset="77-103" id="s651.e0" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <entity charOffset="151-165" id="s651.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s651.e0" e2="s651.e1" id="s651.p0" relation="false"/>
  </sentence>
  <sentence id="s652" text="Mutations in Vps33 isoforms cause pigment dilution in epidermis development (vesicle-mediated transport, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, vesicle-mediated transport).">
    <entity charOffset="151-165" id="s652.e0" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <entity charOffset="227-253" id="s652.e1" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <pair e1="s652.e0" e2="s652.e1" id="s652.p0" relation="true"/>
  </sentence>
  <sentence id="s653" text="The in vivo impact of regulation of cytokinesis loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.">
    <entity charOffset="22-47" id="s653.e0" ontology_id="GO_0032465" text="regulation of cytokinesis" type="GO"/>
    <entity charOffset="62-67" id="s653.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s653.e0" e2="s653.e1" id="s653.p0" relation="false"/>
  </sentence>
  <sentence id="s654" text="Three submuscle organ developments, &lt;i&gt;PTPN11- , Ras protein signal transduction-&lt;/i&gt;, and &lt;i&gt;positive regulation of protein phosphorylation&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="49-80" id="s654.e0" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <entity charOffset="283-300" id="s654.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s654.e0" e2="s654.e1" id="s654.p0" relation="false"/>
  </sentence>
  <sentence id="s655" text="Three submuscle organ developments, &lt;i&gt;PTPN11- , Ras protein signal transduction-&lt;/i&gt;, and &lt;i&gt;positive regulation of protein phosphorylation&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="94-140" id="s655.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="283-300" id="s655.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s655.e0" e2="s655.e1" id="s655.p0" relation="false"/>
  </sentence>
  <sentence id="s656" text="We show that mice lacking protein phosphorylation develop a slowly progressive cerebellar ataxia linked to Purkinje cell dysfunction and mild exercise intolerance, recapitulating ARCA2.">
    <entity charOffset="26-49" id="s656.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="90-96" id="s656.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s656.e0" e2="s656.e1" id="s656.p0" relation="true"/>
  </sentence>
  <sentence id="s657" text="In this study, we identified prolyl-tRNA aminoacylation as upregulated in estrogen receptor positive (ER+) human breast tumors in the TCGA and METABRIC cohorts, with copy number gains in nearly 50% of samples in both datasets.">
    <entity charOffset="29-55" id="s657.e0" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="120-126" id="s657.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s657.e0" e2="s657.e1" id="s657.p0" relation="false"/>
  </sentence>
  <sentence id="s658" text="prolyl-tRNA aminoacylation expression is associated with reduced overall survival in patients with ER+ tumors in TCGA and METABRIC datasets.">
    <entity charOffset="0-26" id="s658.e0" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="103-109" id="s658.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s658.e0" e2="s658.e1" id="s658.p0" relation="false"/>
  </sentence>
  <sentence id="s659" text="We demonstrated the necessity of prolyl-tRNA aminoacylation for proliferation of tamoxifen-resistant ER+ breast cancer, but not ER- breast cancer cells.">
    <entity charOffset="33-59" id="s659.e0" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="112-118" id="s659.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s659.e0" e2="s659.e1" id="s659.p0" relation="true"/>
  </sentence>
  <sentence id="s660" text="In recent years, genetically determined forms of microangiopathy (e.g. transcription initiation from RNA polymerase II promoter, CARASIL, Trex1-related microangiopathies, CARASAL, familial forms of cerebral amyloid angiopathy or CAA) have provided interesting cellular and molecular clues to the pathogenesis of sporadic microvascular disease such as arteriolosclerosis and AD-related CAA">
    <entity charOffset="71-127" id="s660.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="312-320" id="s660.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s660.e0" e2="s660.e1" id="s660.p0" relation="false"/>
  </sentence>
  <sentence id="s661" text="Furthermore, we detected association of rs58978565 near extracellular matrix organization (P = 2.3  10-8), rs28368872 near ATF7IP2 (P = 2.9  10-8) and rs142450006 near proteolysis (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.">
    <entity charOffset="56-89" id="s661.e0" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <entity charOffset="215-243" id="s661.e1" ontology_id="HP_0011506" text="choroidal neovascularization" type="HP"/>
    <pair e1="s661.e0" e2="s661.e1" id="s661.p0" relation="false"/>
  </sentence>
  <sentence id="s662" text="Furthermore, we detected association of rs58978565 near extracellular matrix organization (P = 2.3  10-8), rs28368872 near ATF7IP2 (P = 2.9  10-8) and rs142450006 near proteolysis (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.">
    <entity charOffset="170-181" id="s662.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="215-243" id="s662.e1" ontology_id="HP_0011506" text="choroidal neovascularization" type="HP"/>
    <pair e1="s662.e0" e2="s662.e1" id="s662.p0" relation="true"/>
  </sentence>
  <sentence id="s663" text="The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-receptor-mediated endocytosis) has been demonstrated for several conditions, including cancer, obesity, diabetes, and ocular disease.">
    <entity charOffset="75-104" id="s663.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="162-168" id="s663.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s663.e0" e2="s663.e1" id="s663.p0" relation="false"/>
  </sentence>
  <sentence id="s664" text="Biological relationships among these mutated genes were mined using Ingenuity Pathway Analysis, and the results demonstrated that top two networks with highest scores were highly associated with cancer and hematological diseases, indicating that the mutated genes identified by our method were highly relevant to microtubule-based process.">
    <entity charOffset="195-201" id="s664.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="313-338" id="s664.e1" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <pair e1="s664.e0" e2="s664.e1" id="s664.p0" relation="false"/>
  </sentence>
  <sentence id="s665" text="Over 140 disease-causing mutations have been described so far in GUCY2D, 88% of which cause autosomal recessive Leber congenital amaurosis (LCA) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (adpositive regulation of transcription by RNA polymerase II).">
    <entity charOffset="92-111" id="s665.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="233-290" id="s665.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s665.e0" e2="s665.e1" id="s665.p0" relation="false"/>
  </sentence>
  <sentence id="s666" text="Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human biological_process as the gene affected at DFNB6, a non-syndromic hearing loss locus.">
    <entity charOffset="117-135" id="s666.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="183-195" id="s666.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s666.e0" e2="s666.e1" id="s666.p0" relation="true"/>
  </sentence>
  <sentence id="s667" text="Here, we present a familial case of a lethal early-onset epileptic encephalopathy, associated with two novel compound heterozygous missense variants on the neuron projection development gene, which were detected by exome sequencing.">
    <entity charOffset="67-81" id="s667.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="156-185" id="s667.e1" ontology_id="GO_0031175" text="neuron projection development" type="GO"/>
    <pair e1="s667.e0" e2="s667.e1" id="s667.p0" relation="true"/>
  </sentence>
  <sentence id="s668" text="Three predicted driver genes (G1/S transition of mitotic cell cycle, AKT1, RNF139) were found common in these three cancers by comparative analysis.">
    <entity charOffset="30-67" id="s668.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="116-122" id="s668.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s668.e0" e2="s668.e1" id="s668.p0" relation="true"/>
  </sentence>
  <sentence id="s669" text="Mutations in the human tRNA 3'-terminal CCA addition gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the camera-type eye development (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.">
    <entity charOffset="23-52" id="s669.e0" ontology_id="GO_0001680" text="tRNA 3'-terminal CCA addition" type="GO"/>
    <entity charOffset="452-464" id="s669.e1" ontology_id="HP_0025066" text="microcytosis" type="HP"/>
    <pair e1="s669.e0" e2="s669.e1" id="s669.p0" relation="true"/>
  </sentence>
  <sentence id="s670" text="Mutations in the human tRNA 3'-terminal CCA addition gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the camera-type eye development (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.">
    <entity charOffset="158-185" id="s670.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="452-464" id="s670.e1" ontology_id="HP_0025066" text="microcytosis" type="HP"/>
    <pair e1="s670.e0" e2="s670.e1" id="s670.p0" relation="false"/>
  </sentence>
  <sentence id="s671" text="Numerous studies have recently demonstrated that protein deacetylation expression and activity are increased in kidney disease, such as autosomal dominant polycystic kidney disease (ADPKD), renal fibrosis, and acute kidney injury (AKI), among others.">
    <entity charOffset="49-70" id="s671.e0" ontology_id="GO_0006476" text="protein deacetylation" type="GO"/>
    <entity charOffset="112-126" id="s671.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s671.e0" e2="s671.e1" id="s671.p0" relation="true"/>
  </sentence>
  <sentence id="s672" text="In fact, protein deacetylation inhibitors effectively limit the progression of kidney diseases, suggesting that targeting HDAC6 may provide a novel treatment approach.">
    <entity charOffset="9-30" id="s672.e0" ontology_id="GO_0006476" text="protein deacetylation" type="GO"/>
    <entity charOffset="79-93" id="s672.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s672.e0" e2="s672.e1" id="s672.p0" relation="true"/>
  </sentence>
  <sentence id="s673" text="protein glycosylation-positive cells were significantly lesser in organ-confined disease than in that with extra-capsular extensions, and GCNT2-negative tumors were associated with significantly better prostate-specific antigen-free survival compared with GCNT2-positive tumors.">
    <entity charOffset="0-21" id="s673.e0" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <entity charOffset="153-159" id="s673.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s673.e0" e2="s673.e1" id="s673.p0" relation="false"/>
  </sentence>
  <sentence id="s674" text="Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmentalmalformations caused by mutations in regulation of cell growth pathway genes.">
    <entity charOffset="35-53" id="s674.e0" ontology_id="HP_0007206" text="hemimegalencephaly" type="HP"/>
    <entity charOffset="134-159" id="s674.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s674.e0" e2="s674.e1" id="s674.p0" relation="true"/>
  </sentence>
  <sentence id="s675" text="In conclusion, truncating variants in TEX15 and response to gamma radiation are potential breast cancer risk factors, warranting further investigations in other populations.">
    <entity charOffset="48-75" id="s675.e0" ontology_id="GO_0010332" text="response to gamma radiation" type="GO"/>
    <entity charOffset="97-103" id="s675.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s675.e0" e2="s675.e1" id="s675.p0" relation="true"/>
  </sentence>
  <sentence id="s676" text="Mutations in the coumarin metabolic process gene have been identified in patients with temporal lobe epilepsy and febrile seizures.">
    <entity charOffset="17-43" id="s676.e0" ontology_id="GO_0009804" text="coumarin metabolic process" type="GO"/>
    <entity charOffset="122-130" id="s676.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s676.e0" e2="s676.e1" id="s676.p0" relation="false"/>
  </sentence>
  <sentence id="s677" text="Our experiments demonstrate that these mutations in coumarin metabolic process are deleterious and provide further evidence for the involvement of CPA6 mutations in the predisposition for several types of epilepsy.">
    <entity charOffset="52-78" id="s677.e0" ontology_id="GO_0009804" text="coumarin metabolic process" type="GO"/>
    <entity charOffset="205-213" id="s677.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s677.e0" e2="s677.e1" id="s677.p0" relation="true"/>
  </sentence>
  <sentence id="s678" text="activation of innate immune response(Gt-ex13) homozygotes are early embryo lethal, but Matr3(Gt-ex13) heterozygotes exhibit incompletely penetrant BAV, CoA and PDA phenotypes similar to those in the human proband, as well as ventricular septal defect (VSD) and double-outlet right ventricle (DORV).">
    <entity charOffset="0-36" id="s678.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="225-250" id="s678.e1" ontology_id="HP_0001629" text="ventricular septal defect" type="HP"/>
    <pair e1="s678.e0" e2="s678.e1" id="s678.p0" relation="false"/>
  </sentence>
  <sentence id="s679" text="The 1p breakpoint disrupts the 5' UTR of biological_process, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.">
    <entity charOffset="41-59" id="s679.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="211-230" id="s679.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s679.e0" e2="s679.e1" id="s679.p0" relation="true"/>
  </sentence>
  <sentence id="s680" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, regulation of translation, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s680.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="117-142" id="s680.e1" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <pair e1="s680.e0" e2="s680.e1" id="s680.p0" relation="true"/>
  </sentence>
  <sentence id="s681" text="In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, nuclear pore complex assembly, NUP107 and regulation of glycolytic process) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) epidermis development and sporadic signal transduction patients.">
    <entity charOffset="124-153" id="s681.e0" ontology_id="GO_0051292" text="nuclear pore complex assembly" type="GO"/>
    <entity charOffset="302-310" id="s681.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s681.e0" e2="s681.e1" id="s681.p0" relation="false"/>
  </sentence>
  <sentence id="s682" text="In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, nuclear pore complex assembly, NUP107 and regulation of glycolytic process) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) epidermis development and sporadic signal transduction patients.">
    <entity charOffset="166-198" id="s682.e0" ontology_id="GO_0006110" text="regulation of glycolytic process" type="GO"/>
    <entity charOffset="302-310" id="s682.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s682.e0" e2="s682.e1" id="s682.p0" relation="true"/>
  </sentence>
  <sentence id="s683" text="The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-thyroid gland development epidermis development and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in cell killing-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention">
    <entity charOffset="187-195" id="s683.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="299-311" id="s683.e1" ontology_id="GO_0001906" text="cell killing" type="GO"/>
    <pair e1="s683.e0" e2="s683.e1" id="s683.p0" relation="false"/>
  </sentence>
  <sentence id="s684" text="Evidence for association with endometriosis was also found for the AC genotype of the rs10859871 of cell-cell adhesion.">
    <entity charOffset="30-43" id="s684.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="100-118" id="s684.e1" ontology_id="GO_0098609" text="cell-cell adhesion" type="GO"/>
    <pair e1="s684.e0" e2="s684.e1" id="s684.p0" relation="false"/>
  </sentence>
  <sentence id="s685" text="In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to negative regulation of gene expression, VEZT and FSHB genetic loci, respectively, are associated with risk for endometriosis in a Greek population.">
    <entity charOffset="127-165" id="s685.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="238-251" id="s685.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s685.e0" e2="s685.e1" id="s685.p0" relation="false"/>
  </sentence>
  <sentence id="s686" text="Primary hyperoxaluria muscle organ development 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene glyoxylate catabolic process.">
    <entity charOffset="8-21" id="s686.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="147-175" id="s686.e1" ontology_id="GO_0009436" text="glyoxylate catabolic process" type="GO"/>
    <pair e1="s686.e0" e2="s686.e1" id="s686.p0" relation="true"/>
  </sentence>
  <sentence id="s687" text="Primary hyperoxaluria muscle organ development 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene glyoxylate catabolic process.">
    <entity charOffset="81-100" id="s687.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="147-175" id="s687.e1" ontology_id="GO_0009436" text="glyoxylate catabolic process" type="GO"/>
    <pair e1="s687.e0" e2="s687.e1" id="s687.p0" relation="true"/>
  </sentence>
  <sentence id="s688" text="The A Desintegrin And Metalloproteinase 23 (spermatogenesis) gene is epigenetically silenced in different types of tumors, and silencing is often associated with advanced disease and metastasis.">
    <entity charOffset="44-59" id="s688.e0" ontology_id="GO_0007283" text="spermatogenesis" type="GO"/>
    <entity charOffset="115-121" id="s688.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s688.e0" e2="s688.e1" id="s688.p0" relation="false"/>
  </sentence>
  <sentence id="s689" text="Rather, we observed that, in spermatogenesis-heterotypic environments, ADAM23-negative cells promote tumor growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production ofLGI4 (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).">
    <entity charOffset="29-44" id="s689.e0" ontology_id="GO_0007283" text="spermatogenesis" type="GO"/>
    <entity charOffset="101-106" id="s689.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s689.e0" e2="s689.e1" id="s689.p0" relation="true"/>
  </sentence>
  <sentence id="s690" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and autophagy mutations, respectively.">
    <entity charOffset="176-196" id="s690.e0" ontology_id="GO_0006862" text="nucleotide transport" type="GO"/>
    <entity charOffset="355-372" id="s690.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s690.e0" e2="s690.e1" id="s690.p0" relation="false"/>
  </sentence>
  <sentence id="s691" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and autophagy mutations, respectively.">
    <entity charOffset="299-323" id="s691.e0" ontology_id="GO_0097352" text="autophagosome maturation" type="GO"/>
    <entity charOffset="377-400" id="s691.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s691.e0" e2="s691.e1" id="s691.p0" relation="true"/>
  </sentence>
  <sentence id="s692" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and autophagy mutations, respectively.">
    <entity charOffset="355-372" id="s692.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="538-547" id="s692.e1" ontology_id="GO_0006914" text="autophagy" type="GO"/>
    <pair e1="s692.e0" e2="s692.e1" id="s692.p0" relation="false"/>
  </sentence>
  <sentence id="s693" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and autophagy mutations, respectively.">
    <entity charOffset="441-459" id="s693.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="478-508" id="s693.e1" ontology_id="GO_0097267" text="omega-hydroxylase P450 pathway" type="GO"/>
    <pair e1="s693.e0" e2="s693.e1" id="s693.p0" relation="false"/>
  </sentence>
  <sentence id="s694" text="Here, we found that the levels of regulation of phosphorylation in phosphatidylinositol phosphorylation tissues were notably overexpressed compared to non-cancerous specimens.">
    <entity charOffset="34-63" id="s694.e0" ontology_id="GO_0042325" text="regulation of phosphorylation" type="GO"/>
    <entity charOffset="155-161" id="s694.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s694.e0" e2="s694.e1" id="s694.p0" relation="true"/>
  </sentence>
  <sentence id="s695" text="Recent studies have reported that regulation of phosphorylation overexpression is observed in gastrointestinal cancer, and promotes migration and invasion of cancer cells.">
    <entity charOffset="34-63" id="s695.e0" ontology_id="GO_0042325" text="regulation of phosphorylation" type="GO"/>
    <entity charOffset="111-117" id="s695.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s695.e0" e2="s695.e1" id="s695.p0" relation="true"/>
  </sentence>
  <sentence id="s696" text="By exome sequencing, we identified three different bi-allelic truncating mutations in biological_process in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.">
    <entity charOffset="86-104" id="s696.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="198-212" id="s696.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s696.e0" e2="s696.e1" id="s696.p0" relation="false"/>
  </sentence>
  <sentence id="s697" text="She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included osteoblast differentiation3, GCK, and CCM2.">
    <entity charOffset="66-85" id="s697.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="200-226" id="s697.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s697.e0" e2="s697.e1" id="s697.p0" relation="true"/>
  </sentence>
  <sentence id="s698" text="The present study aimed to explore regulation of small GTPase mediated signal transduction expression in cervical cancer and the possible function in tumor progression.">
    <entity charOffset="35-90" id="s698.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="150-155" id="s698.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s698.e0" e2="s698.e1" id="s698.p0" relation="true"/>
  </sentence>
  <sentence id="s699" text="These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/positive regulation of protein phosphorylation signaling and up-regulation of P21 and P27 expression">
    <entity charOffset="79-85" id="s699.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="160-206" id="s699.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s699.e0" e2="s699.e1" id="s699.p0" relation="true"/>
  </sentence>
  <sentence id="s700" text="Manipulation of regulation of small GTPase mediated signal transduction affected cell proliferation in vitro and tumor growth in vivo.">
    <entity charOffset="16-71" id="s700.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="113-118" id="s700.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s700.e0" e2="s700.e1" id="s700.p0" relation="true"/>
  </sentence>
  <sentence id="s701" text="Recently, a few G protein-coupled receptor signaling pathway GTPase activating proteins (RhoGAPs) have been identified as tumor suppressors in some human cancers.">
    <entity charOffset="16-60" id="s701.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="122-127" id="s701.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s701.e0" e2="s701.e1" id="s701.p0" relation="false"/>
  </sentence>
  <sentence id="s702" text="Recently, a few G protein-coupled receptor signaling pathway GTPase activating proteins (RhoGAPs) have been identified as tumor suppressors in some human cancers.">
    <entity charOffset="16-60" id="s702.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="154-160" id="s702.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s702.e0" e2="s702.e1" id="s702.p0" relation="true"/>
  </sentence>
  <sentence id="s703" text="Stepwise investigations demonstrated that regulation of small GTPase mediated signal transduction suppressed malignant phenotype of cervical cancer cells via inhibiting PI3K/positive regulation of protein phosphorylation signaling pathway.">
    <entity charOffset="42-97" id="s703.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="141-147" id="s703.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s703.e0" e2="s703.e1" id="s703.p0" relation="true"/>
  </sentence>
  <sentence id="s704" text="Stepwise investigations demonstrated that regulation of small GTPase mediated signal transduction suppressed malignant phenotype of cervical cancer cells via inhibiting PI3K/positive regulation of protein phosphorylation signaling pathway.">
    <entity charOffset="141-147" id="s704.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="174-220" id="s704.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s704.e0" e2="s704.e1" id="s704.p0" relation="true"/>
  </sentence>
  <sentence id="s705" text="Although humans with X-linked hypophosphatemia (proteolysis) and the Hyp mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.">
    <entity charOffset="30-46" id="s705.e0" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <entity charOffset="48-59" id="s705.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s705.e0" e2="s705.e1" id="s705.p0" relation="false"/>
  </sentence>
  <sentence id="s706" text="However, the function and mechanism underlying the action of UCA1 in papillary thyroid cancer (biological_process) remains unclear.">
    <entity charOffset="87-93" id="s706.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="95-113" id="s706.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s706.e0" e2="s706.e1" id="s706.p0" relation="false"/>
  </sentence>
  <sentence id="s707" text="However, correlation between positive regulation of cytosolic calcium ion concentration-1 and prostate cancer (PCa) remains still unclear.">
    <entity charOffset="29-87" id="s707.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="103-109" id="s707.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s707.e0" e2="s707.e1" id="s707.p0" relation="false"/>
  </sentence>
  <sentence id="s708" text="The Cripto-1 (CR-1) derived angiogenesis-post-chaperonin tubulin folding pathway family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (cytokine production) and migration of tumor cells.">
    <entity charOffset="28-40" id="s708.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="109-114" id="s708.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s708.e0" e2="s708.e1" id="s708.p0" relation="true"/>
  </sentence>
  <sentence id="s709" text="The Cripto-1 (CR-1) derived angiogenesis-post-chaperonin tubulin folding pathway family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (cytokine production) and migration of tumor cells.">
    <entity charOffset="41-80" id="s709.e0" ontology_id="GO_0007023" text="post-chaperonin tubulin folding pathway" type="GO"/>
    <entity charOffset="109-114" id="s709.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s709.e0" e2="s709.e1" id="s709.p0" relation="true"/>
  </sentence>
  <sentence id="s710" text="Immunohistochemistry was used to observe the mitotic spindle organization expression and its correlation with clinicopathologic factors in oral tongue cancer.">
    <entity charOffset="45-73" id="s710.e0" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <entity charOffset="151-157" id="s710.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s710.e0" e2="s710.e1" id="s710.p0" relation="true"/>
  </sentence>
  <sentence id="s711" text="In recent years, it has been demonstrated that dolichyl diphosphate biosynthetic process plays an important role in human pathophysiological processes, including lipid metabolism, angiogenesis, N-glycosylation, cell apoptosis, chemoresistance in human hepatocellular carcinoma, and epithelial-mesenchymal transition.">
    <entity charOffset="47-88" id="s711.e0" ontology_id="GO_0006489" text="dolichyl diphosphate biosynthetic process" type="GO"/>
    <entity charOffset="252-276" id="s711.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s711.e0" e2="s711.e1" id="s711.p0" relation="true"/>
  </sentence>
  <sentence id="s712" text="Downregulation of osteoblast differentiation, Gli2, Gli3 and negative regulation of smoothened signaling pathway was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.">
    <entity charOffset="18-44" id="s712.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="153-168" id="s712.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s712.e0" e2="s712.e1" id="s712.p0" relation="true"/>
  </sentence>
  <sentence id="s713" text="Downregulation of osteoblast differentiation, Gli2, Gli3 and negative regulation of smoothened signaling pathway was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.">
    <entity charOffset="61-112" id="s713.e0" ontology_id="GO_0045879" text="negative regulation of smoothened signaling pathway" type="GO"/>
    <entity charOffset="153-168" id="s713.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s713.e0" e2="s713.e1" id="s713.p0" relation="true"/>
  </sentence>
  <sentence id="s714" text="Global smoothened signaling pathway deletion recapitulates learning impairment, hyper-aggression, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the protein import into nucleus-restricted deletion mouse.">
    <entity charOffset="7-35" id="s714.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="86-96" id="s714.e1" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <pair e1="s714.e0" e2="s714.e1" id="s714.p0" relation="true"/>
  </sentence>
  <sentence id="s715" text="Global smoothened signaling pathway deletion recapitulates learning impairment, hyper-aggression, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the protein import into nucleus-restricted deletion mouse.">
    <entity charOffset="86-96" id="s715.e0" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <entity charOffset="199-226" id="s715.e1" ontology_id="GO_0006606" text="protein import into nucleus" type="GO"/>
    <pair e1="s715.e0" e2="s715.e1" id="s715.p0" relation="false"/>
  </sentence>
  <sentence id="s716" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit MAPK cascade of COPI.">
    <entity charOffset="171-179" id="s716.e0" ontology_id="HP_0003510" text="dwarfism" type="HP"/>
    <entity charOffset="260-291" id="s716.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s716.e0" e2="s716.e1" id="s716.p0" relation="true"/>
  </sentence>
  <sentence id="s717" text="As a potential target for cancer treatment, the negative regulation of transcription by RNA polymerase II high expresses abnormally in a variety of solid tumors and hematological malignancies in humans.">
    <entity charOffset="26-32" id="s717.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="48-105" id="s717.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s717.e0" e2="s717.e1" id="s717.p0" relation="true"/>
  </sentence>
  <sentence id="s718" text="Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein histone H3-K4 methylation is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells">
    <entity charOffset="129-154" id="s718.e0" ontology_id="GO_0051568" text="histone H3-K4 methylation" type="GO"/>
    <entity charOffset="234-240" id="s718.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s718.e0" e2="s718.e1" id="s718.p0" relation="true"/>
  </sentence>
  <sentence id="s719" text="Furthermore, we identified the activity of nitric oxide synthase 2 (negative regulation of translation, also known as iNOS) originating from the glioma cells as a driving stimulus in the control of microglial caspase-3 activity.">
    <entity charOffset="68-102" id="s719.e0" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <entity charOffset="145-151" id="s719.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s719.e0" e2="s719.e1" id="s719.p0" relation="true"/>
  </sentence>
  <sentence id="s720" text="However, the negative association between 25(OH)D and negative regulation of apoptotic process was modified by obesity and sun exposure.">
    <entity charOffset="54-94" id="s720.e0" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <entity charOffset="111-118" id="s720.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s720.e0" e2="s720.e1" id="s720.p0" relation="true"/>
  </sentence>
  <sentence id="s721" text="Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ nucleotide-excision repair]) and subsequent CNS tumors in survivors of childhood cancer.">
    <entity charOffset="213-239" id="s721.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="261-267" id="s721.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s721.e0" e2="s721.e1" id="s721.p0" relation="true"/>
  </sentence>
  <sentence id="s722" text="The human protein acetylation and histone acetylation genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying intellectual disability and various other abnormalities.">
    <entity charOffset="10-29" id="s722.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="175-198" id="s722.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s722.e0" e2="s722.e1" id="s722.p0" relation="true"/>
  </sentence>
  <sentence id="s723" text="The human protein acetylation and histone acetylation genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying intellectual disability and various other abnormalities.">
    <entity charOffset="34-53" id="s723.e0" ontology_id="GO_0016573" text="histone acetylation" type="GO"/>
    <entity charOffset="175-198" id="s723.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s723.e0" e2="s723.e1" id="s723.p0" relation="true"/>
  </sentence>
  <sentence id="s724" text="In addition, the histone H3 acetylation gene is mutated in childhood leukemia and adult medulloblastoma.">
    <entity charOffset="17-39" id="s724.e0" ontology_id="GO_0043966" text="histone H3 acetylation" type="GO"/>
    <entity charOffset="88-103" id="s724.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s724.e0" e2="s724.e1" id="s724.p0" relation="true"/>
  </sentence>
  <sentence id="s725" text="regulation of translation has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, mandibular hypoplasia and microtia.">
    <entity charOffset="0-25" id="s725.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="180-188" id="s725.e1" ontology_id="HP_0008551" text="microtia" type="HP"/>
    <pair e1="s725.e0" e2="s725.e1" id="s725.p0" relation="true"/>
  </sentence>
  <sentence id="s726" text="We report a pair of siblings carrying a homozygous missense mutation p.P333L in cellular response to epidermal growth factor stimulus2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.">
    <entity charOffset="80-133" id="s726.e0" ontology_id="GO_0071364" text="cellular response to epidermal growth factor stimulus" type="GO"/>
    <entity charOffset="156-175" id="s726.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s726.e0" e2="s726.e1" id="s726.p0" relation="false"/>
  </sentence>
  <sentence id="s727" text="Here, we sought to cellular response to interleukin-4 lncRNAs differentially regulated in cancer cells resistant to either negative regulation of transcription by RNA polymerase II-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that coenzyme A biosynthetic process through the extrinsic and intrinsic apoptotic pathways, respectively.">
    <entity charOffset="90-96" id="s727.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="123-180" id="s727.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s727.e0" e2="s727.e1" id="s727.p0" relation="false"/>
  </sentence>
  <sentence id="s728" text="This review focuses on the molecular basis of the pathogenesis of cardiac abnormality due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by lipid biosynthetic process.">
    <entity charOffset="66-85" id="s728.e0" ontology_id="HP_0001627" text="cardiac abnormality" type="HP"/>
    <entity charOffset="187-213" id="s728.e1" ontology_id="GO_0008610" text="lipid biosynthetic process" type="GO"/>
    <pair e1="s728.e0" e2="s728.e1" id="s728.p0" relation="true"/>
  </sentence>
  <sentence id="s729" text="Mutations in the gene encoding CCT (&lt;i&gt;positive regulation of cell migrationYT1A&lt;/i&gt;) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy.">
    <entity charOffset="40-77" id="s729.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="224-241" id="s729.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s729.e0" e2="s729.e1" id="s729.p0" relation="false"/>
  </sentence>
  <sentence id="s730" text="Ex vivo data showed that Golgi organization expression in GBM tissue samples was associated with tumor recurrence after TMZ chemotherapy.">
    <entity charOffset="25-43" id="s730.e0" ontology_id="GO_0007030" text="Golgi organization" type="GO"/>
    <entity charOffset="97-102" id="s730.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s730.e0" e2="s730.e1" id="s730.p0" relation="true"/>
  </sentence>
  <sentence id="s731" text="De novo heterozygous mutations in protein localization to plasma membrane/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.">
    <entity charOffset="34-73" id="s731.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="181-189" id="s731.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s731.e0" e2="s731.e1" id="s731.p0" relation="true"/>
  </sentence>
  <sentence id="s732" text="De novo heterozygous mutations in protein localization to plasma membrane/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.">
    <entity charOffset="34-73" id="s732.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="191-210" id="s732.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s732.e0" e2="s732.e1" id="s732.p0" relation="true"/>
  </sentence>
  <sentence id="s733" text="LMO1 is a high-risk neuroblastoma susceptibility gene, but how LMO1 cooperates with positive regulation of gene expression in neuroblastoma tumorigenesis is unclear.">
    <entity charOffset="20-33" id="s733.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="84-122" id="s733.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s733.e0" e2="s733.e1" id="s733.p0" relation="true"/>
  </sentence>
  <sentence id="s734" text="Homozygous recessive mutations in either elastic fiber assembly (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively.">
    <entity charOffset="41-63" id="s734.e0" ontology_id="GO_0048251" text="elastic fiber assembly" type="GO"/>
    <entity charOffset="158-177" id="s734.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s734.e0" e2="s734.e1" id="s734.p0" relation="true"/>
  </sentence>
  <sentence id="s735" text="Loss-of-function mutations of GNA11, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia muscle organ development 2 (FHH2).">
    <entity charOffset="175-188" id="s735.e0" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <entity charOffset="189-213" id="s735.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s735.e0" e2="s735.e1" id="s735.p0" relation="false"/>
  </sentence>
  <sentence id="s736" text="With alignment to T2DM susceptibility genes and deafness genes published, response to ATP was found to be the only overlapped gene.">
    <entity charOffset="48-56" id="s736.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="74-89" id="s736.e1" ontology_id="GO_0033198" text="response to ATP" type="GO"/>
    <pair e1="s736.e0" e2="s736.e1" id="s736.p0" relation="true"/>
  </sentence>
  <sentence id="s737" text="The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and cellular response to mechanical stimulus) and glaucoma-related phenotypes (FNDC3B, LMX1B and protein deamination).">
    <entity charOffset="101-141" id="s737.e0" ontology_id="GO_0071260" text="cellular response to mechanical stimulus" type="GO"/>
    <entity charOffset="147-155" id="s737.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s737.e0" e2="s737.e1" id="s737.p0" relation="false"/>
  </sentence>
  <sentence id="s738" text="The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and cellular response to mechanical stimulus) and glaucoma-related phenotypes (FNDC3B, LMX1B and protein deamination).">
    <entity charOffset="147-155" id="s738.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="194-213" id="s738.e1" ontology_id="GO_0018277" text="protein deamination" type="GO"/>
    <pair e1="s738.e0" e2="s738.e1" id="s738.p0" relation="false"/>
  </sentence>
  <sentence id="s739" text="In proximal renal tubules, regulation of phosphate transport suppresses the membrane expression of the sodium-phosphate cotransporters Npt2a and Npt2c which mediate urinary reabsorption of filtered phosphate.">
    <entity charOffset="3-11" id="s739.e0" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <entity charOffset="27-60" id="s739.e1" ontology_id="GO_0010966" text="regulation of phosphate transport" type="GO"/>
    <pair e1="s739.e0" e2="s739.e1" id="s739.p0" relation="false"/>
  </sentence>
  <sentence id="s740" text="In distal renal tubules, regulation of phosphate transport signaling activates with-no-lysine kinase 4, leading to increased renal tubular reabsorption of calcium and sodium.">
    <entity charOffset="3-9" id="s740.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="25-58" id="s740.e1" ontology_id="GO_0010966" text="regulation of phosphate transport" type="GO"/>
    <pair e1="s740.e0" e2="s740.e1" id="s740.p0" relation="false"/>
  </sentence>
  <sentence id="s741" text="Mutant mice lacking cilium movement show typical PCD defects such as hydrocephalus and laterality defects.">
    <entity charOffset="20-35" id="s741.e0" ontology_id="GO_0003341" text="cilium movement" type="GO"/>
    <entity charOffset="69-82" id="s741.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s741.e0" e2="s741.e1" id="s741.p0" relation="true"/>
  </sentence>
  <sentence id="s742" text="Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (biological_process) gene, mapping in the minimal critical deleted region.">
    <entity charOffset="82-93" id="s742.e0" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <entity charOffset="299-317" id="s742.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s742.e0" e2="s742.e1" id="s742.p0" relation="true"/>
  </sentence>
  <sentence id="s743" text="Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (biological_process) gene, mapping in the minimal critical deleted region.">
    <entity charOffset="215-223" id="s743.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="299-317" id="s743.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s743.e0" e2="s743.e1" id="s743.p0" relation="true"/>
  </sentence>
  <sentence id="s744" text="Silencing of biological_process in the developing rat neocortex produced periventricular nodular heterotopia that was rescued by concomitant expression of wild-type human C6orf70 protein.">
    <entity charOffset="13-31" id="s744.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="97-108" id="s744.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s744.e0" e2="s744.e1" id="s744.p0" relation="true"/>
  </sentence>
  <sentence id="s745" text="The suppression of cellular response to starvation expression in TAM was induced by the hypoxic condition in the tumor microenviroment.">
    <entity charOffset="19-50" id="s745.e0" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <entity charOffset="113-118" id="s745.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s745.e0" e2="s745.e1" id="s745.p0" relation="true"/>
  </sentence>
  <sentence id="s746" text="First, we showed that TAMs expressed reduced levels of cellular response to starvation, which was associated with their protumoral M2 polarization state.">
    <entity charOffset="55-86" id="s746.e0" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <entity charOffset="123-128" id="s746.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s746.e0" e2="s746.e1" id="s746.p0" relation="true"/>
  </sentence>
  <sentence id="s747" text="Furthermore, we used cellular response to starvation conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates tumor growth.">
    <entity charOffset="21-52" id="s747.e0" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <entity charOffset="138-143" id="s747.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s747.e0" e2="s747.e1" id="s747.p0" relation="true"/>
  </sentence>
  <sentence id="s748" text="Further functional studies show that forced expression of positive regulation of transcription by RNA polymerase II in lung cancer cells obviously promotes cell proliferation and invasion, whereas inhibits cell apoptosis.">
    <entity charOffset="58-115" id="s748.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="124-130" id="s748.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s748.e0" e2="s748.e1" id="s748.p0" relation="true"/>
  </sentence>
  <sentence id="s749" text="Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).">
    <entity charOffset="13-70" id="s749.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="206-225" id="s749.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s749.e0" e2="s749.e1" id="s749.p0" relation="true"/>
  </sentence>
  <sentence id="s750" text="Pathogenic variant in COCH are a known cause of regulation of cell shape autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="48-72" id="s750.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="104-116" id="s750.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s750.e0" e2="s750.e1" id="s750.p0" relation="false"/>
  </sentence>
  <sentence id="s751" text="An earlier onset of hearing impairment and vestibular dysfunction compared to the dominant hearing loss causing regulation of cell shape variants is observed">
    <entity charOffset="43-65" id="s751.e0" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <entity charOffset="112-136" id="s751.e1" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <pair e1="s751.e0" e2="s751.e1" id="s751.p0" relation="true"/>
  </sentence>
  <sentence id="s752" text="The K&lt;sup&gt;+&lt;/sup&gt; channel cellular response to drug has been proposed as a tumor suppressor in colorectal cancer (CRC).">
    <entity charOffset="26-51" id="s752.e0" ontology_id="GO_0035690" text="cellular response to drug" type="GO"/>
    <entity charOffset="75-80" id="s752.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s752.e0" e2="s752.e1" id="s752.p0" relation="true"/>
  </sentence>
  <sentence id="s753" text="Hence, we focus on the relationship between YAP/TAZ and serine metabolism to control methylation of DNA or histone in breast cancer with protein phosphorylation deficiency.">
    <entity charOffset="125-131" id="s753.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-160" id="s753.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s753.e0" e2="s753.e1" id="s753.p0" relation="true"/>
  </sentence>
  <sentence id="s754" text="telomere maintenance via telomerase is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote cancer metastasis.">
    <entity charOffset="0-35" id="s754.e0" ontology_id="GO_0007004" text="telomere maintenance via telomerase" type="GO"/>
    <entity charOffset="69-75" id="s754.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s754.e0" e2="s754.e1" id="s754.p0" relation="true"/>
  </sentence>
  <sentence id="s755" text="telomere maintenance via telomerase is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote cancer metastasis.">
    <entity charOffset="0-35" id="s755.e0" ontology_id="GO_0007004" text="telomere maintenance via telomerase" type="GO"/>
    <entity charOffset="133-139" id="s755.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s755.e0" e2="s755.e1" id="s755.p0" relation="true"/>
  </sentence>
  <sentence id="s756" text="The gonadoblastoma gene, testis-specific protein Y-encoded (sex differentiation), on the Y chromosome and its X-homologue, negative regulation of DNA replication, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.">
    <entity charOffset="4-18" id="s756.e0" ontology_id="HP_0000150" text="gonadoblastoma" type="HP"/>
    <entity charOffset="60-79" id="s756.e1" ontology_id="GO_0007548" text="sex differentiation" type="GO"/>
    <pair e1="s756.e0" e2="s756.e1" id="s756.p0" relation="false"/>
  </sentence>
  <sentence id="s757" text="The gonadoblastoma gene, testis-specific protein Y-encoded (sex differentiation), on the Y chromosome and its X-homologue, negative regulation of DNA replication, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.">
    <entity charOffset="123-161" id="s757.e0" ontology_id="GO_0008156" text="negative regulation of DNA replication" type="GO"/>
    <entity charOffset="228-233" id="s757.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s757.e0" e2="s757.e1" id="s757.p0" relation="true"/>
  </sentence>
  <sentence id="s758" text="Hence, sex differentiation and negative regulation of DNA replication exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man">
    <entity charOffset="7-26" id="s758.e0" ontology_id="GO_0007548" text="sex differentiation" type="GO"/>
    <entity charOffset="309-315" id="s758.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s758.e0" e2="s758.e1" id="s758.p0" relation="false"/>
  </sentence>
  <sentence id="s759" text="Hence, sex differentiation and negative regulation of DNA replication exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man">
    <entity charOffset="31-69" id="s759.e0" ontology_id="GO_0008156" text="negative regulation of DNA replication" type="GO"/>
    <entity charOffset="309-315" id="s759.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s759.e0" e2="s759.e1" id="s759.p0" relation="false"/>
  </sentence>
  <sentence id="s760" text="The canonical Hippo tumor suppressor pathway in mammalian cells is primarily composed of the MST1/2-SAV1-LATS1/2-MOB1-regulation of cell cycle/TAZ cascade.">
    <entity charOffset="20-25" id="s760.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="118-142" id="s760.e1" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <pair e1="s760.e0" e2="s760.e1" id="s760.p0" relation="false"/>
  </sentence>
  <sentence id="s761" text="Our results provide evidence that sequence variants in human epithelial cell morphogenesis cause autosomal recessive isolated CC and give new insight into the molecular pathogenesis underlying human cataracts.">
    <entity charOffset="61-90" id="s761.e0" ontology_id="GO_0003382" text="epithelial cell morphogenesis" type="GO"/>
    <entity charOffset="199-207" id="s761.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s761.e0" e2="s761.e1" id="s761.p0" relation="true"/>
  </sentence>
  <sentence id="s762" text="Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/negative regulation of kinase activity) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.">
    <entity charOffset="91-129" id="s762.e0" ontology_id="GO_0033673" text="negative regulation of kinase activity" type="GO"/>
    <entity charOffset="222-235" id="s762.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s762.e0" e2="s762.e1" id="s762.p0" relation="false"/>
  </sentence>
  <sentence id="s763" text="One presently identified eQTL for the protein targeting to peroxisome gene was rs10948059, which had been associated with prostate cancer from previous association studies.">
    <entity charOffset="38-69" id="s763.e0" ontology_id="GO_0006625" text="protein targeting to peroxisome" type="GO"/>
    <entity charOffset="131-137" id="s763.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s763.e0" e2="s763.e1" id="s763.p0" relation="false"/>
  </sentence>
  <sentence id="s764" text="Study of RetGC1 regulation in vitro and its association with fluorescently tagged positive regulation of guanylate cyclase activity in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photoreceptor-specific protein, retinal degeneration 3 (RD3).">
    <entity charOffset="82-131" id="s764.e0" ontology_id="GO_0031284" text="positive regulation of guanylate cyclase activity" type="GO"/>
    <entity charOffset="250-259" id="s764.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s764.e0" e2="s764.e1" id="s764.p0" relation="true"/>
  </sentence>
  <sentence id="s765" text="Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (tricarboxylic acid cycle) has been recently described as a neurodegenerative disease of autosomal recessive inheritance.">
    <entity charOffset="107-131" id="s765.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="195-226" id="s765.e1" ontology_id="HP_0000007" text="autosomal recessive inheritance" type="HP"/>
    <pair e1="s765.e0" e2="s765.e1" id="s765.p0" relation="true"/>
  </sentence>
  <sentence id="s766" text="-Ureidopropionase deficiency is a rare autosomal recessive disease affecting the last protein dephosphorylation of pyrimidine degradation, and it is caused by a mutation in the beta-alanine biosynthetic process via 3-ureidopropionate gene.">
    <entity charOffset="40-59" id="s766.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="178-234" id="s766.e1" ontology_id="GO_0033396" text="beta-alanine biosynthetic process via 3-ureidopropionate" type="GO"/>
    <pair e1="s766.e0" e2="s766.e1" id="s766.p0" relation="true"/>
  </sentence>
  <sentence id="s767" text="Here, we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in retrograde transport, endosome to Golgi.">
    <entity charOffset="38-52" id="s767.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="177-216" id="s767.e1" ontology_id="GO_0042147" text="retrograde transport, endosome to Golgi" type="GO"/>
    <pair e1="s767.e0" e2="s767.e1" id="s767.p0" relation="true"/>
  </sentence>
  <sentence id="s768" text="Here, we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in retrograde transport, endosome to Golgi.">
    <entity charOffset="76-99" id="s768.e0" ontology_id="HP_0002514" text="cerebral calcifications" type="HP"/>
    <entity charOffset="177-216" id="s768.e1" ontology_id="GO_0042147" text="retrograde transport, endosome to Golgi" type="GO"/>
    <pair e1="s768.e0" e2="s768.e1" id="s768.p0" relation="true"/>
  </sentence>
  <sentence id="s769" text="Despite this multisystemic involvement and contrasting with a cachectic appearance, the anthropometric parameters showed marked overgrowth (+4 DS), leading to diagnosis of congenital lipodystrophy, which was confirmed by the presence of the new homozygous c.259C&amp;gt;T (p.Gln87*) mutation in the positive regulation of cytokine production gene.">
    <entity charOffset="183-196" id="s769.e0" ontology_id="HP_0009125" text="lipodystrophy" type="HP"/>
    <entity charOffset="295-337" id="s769.e1" ontology_id="GO_0001819" text="positive regulation of cytokine production" type="GO"/>
    <pair e1="s769.e0" e2="s769.e1" id="s769.p0" relation="true"/>
  </sentence>
  <sentence id="s770" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, endoplasmic reticulum organization, ureteric bud development, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s770.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="201-235" id="s770.e1" ontology_id="GO_0007029" text="endoplasmic reticulum organization" type="GO"/>
    <pair e1="s770.e0" e2="s770.e1" id="s770.p0" relation="true"/>
  </sentence>
  <sentence id="s771" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, endoplasmic reticulum organization, ureteric bud development, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s771.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="237-261" id="s771.e1" ontology_id="GO_0001657" text="ureteric bud development" type="GO"/>
    <pair e1="s771.e0" e2="s771.e1" id="s771.p0" relation="true"/>
  </sentence>
  <sentence id="s772" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in peptidyl-serine phosphorylation, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="56-79" id="s772.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="412-443" id="s772.e1" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <pair e1="s772.e0" e2="s772.e1" id="s772.p0" relation="false"/>
  </sentence>
  <sentence id="s773" text="Recently, we identified disease-linked mutations in the &lt;i&gt;CCNF&lt;/i&gt; gene, which encodes the cyclin F protein, in cohorts of patients with familial and sporadic signal transduction and frontotemporal dementia (FTD) (Williams KL &lt;i&gt;et al&lt;/i&gt; 2016 &lt;i&gt;Nat.">
    <entity charOffset="160-179" id="s773.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="184-207" id="s773.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s773.e0" e2="s773.e1" id="s773.p0" relation="false"/>
  </sentence>
  <sentence id="s774" text="A high proportion of tumors harbors multiple mutations, especially phosphorylation plus phosphatidylinositol 3-kinase signaling mutations (9.0%).">
    <entity charOffset="21-27" id="s774.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="88-127" id="s774.e1" ontology_id="GO_0014065" text="phosphatidylinositol 3-kinase signaling" type="GO"/>
    <pair e1="s774.e0" e2="s774.e1" id="s774.p0" relation="true"/>
  </sentence>
  <sentence id="s775" text="A high proportion of tumors harbors multiple mutations, especially phosphorylation plus phosphatidylinositol 3-kinase signaling mutations (9.0%).">
    <entity charOffset="21-27" id="s775.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="67-82" id="s775.e1" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <pair e1="s775.e0" e2="s775.e1" id="s775.p0" relation="true"/>
  </sentence>
  <sentence id="s776" text="Our study reports the first mutations in the tRNA aminoacylation for protein translation and mitochondrial threonyl-tRNA aminoacylation genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.">
    <entity charOffset="45-88" id="s776.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="160-173" id="s776.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s776.e0" e2="s776.e1" id="s776.p0" relation="false"/>
  </sentence>
  <sentence id="s777" text="Our study reports the first mutations in the tRNA aminoacylation for protein translation and mitochondrial threonyl-tRNA aminoacylation genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.">
    <entity charOffset="93-135" id="s777.e0" ontology_id="GO_0070159" text="mitochondrial threonyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="160-173" id="s777.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s777.e0" e2="s777.e1" id="s777.p0" relation="true"/>
  </sentence>
  <sentence id="s778" text="This result suggests that activation of cysteine-type endopeptidase activity involved in apoptotic process and glomerular basement membrane development digenic mutations in cis mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown">
    <entity charOffset="26-106" id="s778.e0" ontology_id="GO_0006919" text="activation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="209-220" id="s778.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s778.e0" e2="s778.e1" id="s778.p0" relation="true"/>
  </sentence>
  <sentence id="s779" text="This result suggests that activation of cysteine-type endopeptidase activity involved in apoptotic process and glomerular basement membrane development digenic mutations in cis mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown">
    <entity charOffset="111-151" id="s779.e0" ontology_id="GO_0032836" text="glomerular basement membrane development" type="GO"/>
    <entity charOffset="209-220" id="s779.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s779.e0" e2="s779.e1" id="s779.p0" relation="false"/>
  </sentence>
  <sentence id="s780" text="Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in activation of cysteine-type endopeptidase activity involved in apoptotic process or COL4A4 are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.">
    <entity charOffset="114-194" id="s780.e0" ontology_id="GO_0006919" text="activation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="225-244" id="s780.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s780.e0" e2="s780.e1" id="s780.p0" relation="true"/>
  </sentence>
  <sentence id="s781" text="Surprisingly, either silencing protein polyubiquitination-126-3p by LNA-antimiR or overexpressing miR-126-3p by miRNA mimic repressed laser-induced choroidal neovascularization.">
    <entity charOffset="31-57" id="s781.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="148-176" id="s781.e1" ontology_id="HP_0011506" text="choroidal neovascularization" type="HP"/>
    <pair e1="s781.e0" e2="s781.e1" id="s781.p0" relation="false"/>
  </sentence>
  <sentence id="s782" text="The schizophrenia-associated gene response to ethanol (glutamate ionotropic receptor NMDA type subunit 2a) codes for a protein subunit of the NMDA (N-methyl-D-aspartate) receptor that underlies central aspects of human cognition.">
    <entity charOffset="4-17" id="s782.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="34-53" id="s782.e1" ontology_id="GO_0045471" text="response to ethanol" type="GO"/>
    <pair e1="s782.e0" e2="s782.e1" id="s782.p0" relation="true"/>
  </sentence>
  <sentence id="s783" text="The most significant association with childhood brain tumor risk was for IVS1-401G&amp;gt;C in the AICDA gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&amp;gt;C of epidermis development was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).">
    <entity charOffset="54-59" id="s783.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="208-229" id="s783.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s783.e0" e2="s783.e1" id="s783.p0" relation="true"/>
  </sentence>
  <sentence id="s784" text="We concluded that genetic polymorphisms in AICDA and epidermis development are associated with risk for brain tumor in Korean children.">
    <entity charOffset="53-74" id="s784.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="110-115" id="s784.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s784.e0" e2="s784.e1" id="s784.p0" relation="false"/>
  </sentence>
  <sentence id="s785" text="The results revealed that the dual use of the positive regulation of cell proliferation inhibitor and the HDAC inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver cancer cells.">
    <entity charOffset="46-87" id="s785.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="201-207" id="s785.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s785.e0" e2="s785.e1" id="s785.p0" relation="true"/>
  </sentence>
  <sentence id="s786" text="Clinical trials have revealed that inhibition of sonic Hedgehog (positive regulation of cell proliferation) signaling or histone deacetylase (HDAC) holds promise as a treatment for liver cancer.">
    <entity charOffset="65-106" id="s786.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="187-193" id="s786.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s786.e0" e2="s786.e1" id="s786.p0" relation="false"/>
  </sentence>
  <sentence id="s787" text="In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for protein export from nucleus (p-value: 9.3x10-05).">
    <entity charOffset="107-113" id="s787.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="263-290" id="s787.e1" ontology_id="GO_0006611" text="protein export from nucleus" type="GO"/>
    <pair e1="s787.e0" e2="s787.e1" id="s787.p0" relation="true"/>
  </sentence>
  <sentence id="s788" text="Five haplotypes (GTTAT, ATTGT, GCTAC, ACTAC, and ACCAC) were found significantly associated with low &lt;i&gt;G protein-coupled acetylcholine receptor signaling pathway&lt;/i&gt; mRNA level and contributed to increased susceptibility of bladder cancer in Kaohsiung city after rigid 10000 consecutive permutation tests.">
    <entity charOffset="104-162" id="s788.e0" ontology_id="GO_0007213" text="G protein-coupled acetylcholine receptor signaling pathway" type="GO"/>
    <entity charOffset="233-239" id="s788.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s788.e0" e2="s788.e1" id="s788.p0" relation="true"/>
  </sentence>
  <sentence id="s789" text="However, the mechanism causing quaternary ammonium group transport as a result of exercise remains unknown, but exercise-induced ventricular arrhythmias are thought to be responsible for this fatal consequence.">
    <entity charOffset="31-66" id="s789.e0" ontology_id="GO_0015697" text="quaternary ammonium group transport" type="GO"/>
    <entity charOffset="129-152" id="s789.e1" ontology_id="HP_0004308" text="ventricular arrhythmias" type="HP"/>
    <pair e1="s789.e0" e2="s789.e1" id="s789.p0" relation="false"/>
  </sentence>
  <sentence id="s790" text="The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, positive regulation of sodium ion transport, inhibitory synapse assembly, and GABRA1.">
    <entity charOffset="141-151" id="s790.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="368-411" id="s790.e1" ontology_id="GO_0010765" text="positive regulation of sodium ion transport" type="GO"/>
    <pair e1="s790.e0" e2="s790.e1" id="s790.p0" relation="true"/>
  </sentence>
  <sentence id="s791" text="The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, positive regulation of sodium ion transport, inhibitory synapse assembly, and GABRA1.">
    <entity charOffset="206-214" id="s791.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="306-366" id="s791.e1" ontology_id="GO_0086002" text="cardiac muscle cell action potential involved in contraction" type="GO"/>
    <pair e1="s791.e0" e2="s791.e1" id="s791.p0" relation="true"/>
  </sentence>
  <sentence id="s792" text="The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, positive regulation of sodium ion transport, inhibitory synapse assembly, and GABRA1.">
    <entity charOffset="206-214" id="s792.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="368-411" id="s792.e1" ontology_id="GO_0010765" text="positive regulation of sodium ion transport" type="GO"/>
    <pair e1="s792.e0" e2="s792.e1" id="s792.p0" relation="true"/>
  </sentence>
  <sentence id="s793" text="The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, positive regulation of sodium ion transport, inhibitory synapse assembly, and GABRA1.">
    <entity charOffset="206-214" id="s793.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="413-440" id="s793.e1" ontology_id="GO_1904862" text="inhibitory synapse assembly" type="GO"/>
    <pair e1="s793.e0" e2="s793.e1" id="s793.p0" relation="true"/>
  </sentence>
  <sentence id="s794" text="Genome-wide studies examining common genetic risk factors identified common variants in cardiac muscle cell action potential involved in contraction, indicating a convergence of shared pathophysiological pathways in various types of epilepsies.">
    <entity charOffset="88-148" id="s794.e0" ontology_id="GO_0086002" text="cardiac muscle cell action potential involved in contraction" type="GO"/>
    <entity charOffset="233-243" id="s794.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s794.e0" e2="s794.e1" id="s794.p0" relation="true"/>
  </sentence>
  <sentence id="s795" text="Characteristic findings among all forms of muscle contraction include short horizontal ribs, short limbs and polydactyly.">
    <entity charOffset="43-61" id="s795.e0" ontology_id="GO_0006936" text="muscle contraction" type="GO"/>
    <entity charOffset="109-120" id="s795.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s795.e0" e2="s795.e1" id="s795.p0" relation="false"/>
  </sentence>
  <sentence id="s796" text="Specifically, glutamate catabolic process via 2-oxoglutarate, HAND2, and GNAO1 were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.">
    <entity charOffset="14-60" id="s796.e0" ontology_id="GO_0006539" text="glutamate catabolic process via 2-oxoglutarate" type="GO"/>
    <entity charOffset="127-133" id="s796.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s796.e0" e2="s796.e1" id="s796.p0" relation="true"/>
  </sentence>
  <sentence id="s797" text="Using exome sequencing, we identified three unrelated patients with bi-allelic mutations in mRNA export from nucleus associated with intellectual disability and additional clinical features.">
    <entity charOffset="92-116" id="s797.e0" ontology_id="GO_0006406" text="mRNA export from nucleus" type="GO"/>
    <entity charOffset="133-156" id="s797.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s797.e0" e2="s797.e1" id="s797.p0" relation="true"/>
  </sentence>
  <sentence id="s798" text="Our study demonstrated that protein phosphorylation rs1047972 TT and (CC+CT) genotypes were significantly associated with an increased risk of gastric cancer.">
    <entity charOffset="28-51" id="s798.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="153-159" id="s798.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s798.e0" e2="s798.e1" id="s798.p0" relation="true"/>
  </sentence>
  <sentence id="s799" text="Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of cellular calcium ion homeostasis and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2">
    <entity charOffset="11-30" id="s799.e0" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <entity charOffset="117-149" id="s799.e1" ontology_id="GO_0006874" text="cellular calcium ion homeostasis" type="GO"/>
    <pair e1="s799.e0" e2="s799.e1" id="s799.p0" relation="true"/>
  </sentence>
  <sentence id="s800" text="Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of cellular calcium ion homeostasis and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2">
    <entity charOffset="42-60" id="s800.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="117-149" id="s800.e1" ontology_id="GO_0006874" text="cellular calcium ion homeostasis" type="GO"/>
    <pair e1="s800.e0" e2="s800.e1" id="s800.p0" relation="true"/>
  </sentence>
  <sentence id="s801" text="epithelial to mesenchymal transition-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.">
    <entity charOffset="0-36" id="s801.e0" ontology_id="GO_0001837" text="epithelial to mesenchymal transition" type="GO"/>
    <entity charOffset="128-134" id="s801.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s801.e0" e2="s801.e1" id="s801.p0" relation="false"/>
  </sentence>
  <sentence id="s802" text="Brain somatic mutations in the gene encoding mTOR (regulation of cell growth) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.">
    <entity charOffset="51-76" id="s802.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="181-199" id="s802.e1" ontology_id="HP_0007206" text="hemimegalencephaly" type="HP"/>
    <pair e1="s802.e0" e2="s802.e1" id="s802.p0" relation="true"/>
  </sentence>
  <sentence id="s803" text="There is emerging evidence that double-strand break repair via homologous recombination gene product (BRCA1) also plays a role in cancer cell migration.">
    <entity charOffset="32-87" id="s803.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="130-136" id="s803.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s803.e0" e2="s803.e1" id="s803.p0" relation="true"/>
  </sentence>
  <sentence id="s804" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (proteolysis, 14-3-3, CAPG, negative regulation of actin filament polymerization, SPTBN1, CFN1) associated with loss of BRCA1 function.">
    <entity charOffset="60-65" id="s804.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="193-204" id="s804.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s804.e0" e2="s804.e1" id="s804.p0" relation="true"/>
  </sentence>
  <sentence id="s805" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (proteolysis, 14-3-3, CAPG, negative regulation of actin filament polymerization, SPTBN1, CFN1) associated with loss of BRCA1 function.">
    <entity charOffset="60-65" id="s805.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="220-272" id="s805.e1" ontology_id="GO_0030837" text="negative regulation of actin filament polymerization" type="GO"/>
    <pair e1="s805.e0" e2="s805.e1" id="s805.p0" relation="true"/>
  </sentence>
  <sentence id="s806" text="Functional loss of expression of breast cancer susceptibility gene 1(double-strand break repair via homologous recombination) has been implicated in genomic instability and cancer progression.">
    <entity charOffset="40-46" id="s806.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="69-124" id="s806.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s806.e0" e2="s806.e1" id="s806.p0" relation="true"/>
  </sentence>
  <sentence id="s807" text="Taken together, our results illustrated that LINC00963-miR-608-protein homooligomerization pathway might be a potential target for melanoma therapy">
    <entity charOffset="63-90" id="s807.e0" ontology_id="GO_0051260" text="protein homooligomerization" type="GO"/>
    <entity charOffset="131-139" id="s807.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s807.e0" e2="s807.e1" id="s807.p0" relation="true"/>
  </sentence>
  <sentence id="s808" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-140" id="s808.e0" ontology_id="GO_0030166" text="proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="410-419" id="s808.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s808.e0" e2="s808.e1" id="s808.p0" relation="true"/>
  </sentence>
  <sentence id="s809" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-140" id="s809.e0" ontology_id="GO_0030166" text="proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="468-486" id="s809.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s809.e0" e2="s809.e1" id="s809.p0" relation="false"/>
  </sentence>
  <sentence id="s810" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="142-191" id="s810.e0" ontology_id="GO_0015012" text="heparan sulfate proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="369-385" id="s810.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s810.e0" e2="s810.e1" id="s810.p0" relation="true"/>
  </sentence>
  <sentence id="s811" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="142-191" id="s811.e0" ontology_id="GO_0015012" text="heparan sulfate proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="387-397" id="s811.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s811.e0" e2="s811.e1" id="s811.p0" relation="false"/>
  </sentence>
  <sentence id="s812" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="202-240" id="s812.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="387-397" id="s812.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s812.e0" e2="s812.e1" id="s812.p0" relation="true"/>
  </sentence>
  <sentence id="s813" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="246-284" id="s813.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="369-385" id="s813.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s813.e0" e2="s813.e1" id="s813.p0" relation="false"/>
  </sentence>
  <sentence id="s814" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="246-284" id="s814.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="468-486" id="s814.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s814.e0" e2="s814.e1" id="s814.p0" relation="true"/>
  </sentence>
  <sentence id="s815" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="246-284" id="s815.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="421-429" id="s815.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s815.e0" e2="s815.e1" id="s815.p0" relation="true"/>
  </sentence>
  <sentence id="s816" text="Mechanistically, TUFM knockdown activated lipid biosynthetic process and phosphorylated GSK3 and increased the nuclear accumulation of -catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung cancer cells.">
    <entity charOffset="42-68" id="s816.e0" ontology_id="GO_0008610" text="lipid biosynthetic process" type="GO"/>
    <entity charOffset="231-237" id="s816.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s816.e0" e2="s816.e1" id="s816.p0" relation="true"/>
  </sentence>
  <sentence id="s817" text="Here, we show that translational elongation is downregulated in human cancer tissues.">
    <entity charOffset="19-43" id="s817.e0" ontology_id="GO_0006414" text="translational elongation" type="GO"/>
    <entity charOffset="70-76" id="s817.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s817.e0" e2="s817.e1" id="s817.p0" relation="true"/>
  </sentence>
  <sentence id="s818" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, synaptonemal complex assembly, mitotic cytokinesis, PRC1, TOP2A, LAMP3, KIF20A, cellular response to DNA damage stimulus, and APOBEC3B.">
    <entity charOffset="81-87" id="s818.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="141-160" id="s818.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s818.e0" e2="s818.e1" id="s818.p0" relation="true"/>
  </sentence>
  <sentence id="s819" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, synaptonemal complex assembly, mitotic cytokinesis, PRC1, TOP2A, LAMP3, KIF20A, cellular response to DNA damage stimulus, and APOBEC3B.">
    <entity charOffset="81-87" id="s819.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="110-139" id="s819.e1" ontology_id="GO_0007130" text="synaptonemal complex assembly" type="GO"/>
    <pair e1="s819.e0" e2="s819.e1" id="s819.p0" relation="true"/>
  </sentence>
  <sentence id="s820" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, synaptonemal complex assembly, mitotic cytokinesis, PRC1, TOP2A, LAMP3, KIF20A, cellular response to DNA damage stimulus, and APOBEC3B.">
    <entity charOffset="81-87" id="s820.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="190-230" id="s820.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s820.e0" e2="s820.e1" id="s820.p0" relation="true"/>
  </sentence>
  <sentence id="s821" text="Further, we analyzed the expression of these nine genes during the progression of cervical cancer, and found that post-translational protein modification is also related to precancerous lesions and migration processes during cervical cancer pathogenesis.">
    <entity charOffset="91-97" id="s821.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-153" id="s821.e1" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <pair e1="s821.e0" e2="s821.e1" id="s821.p0" relation="true"/>
  </sentence>
  <sentence id="s822" text="Here, we causally link a previously unreported missense mutation in biological_process (c.1249G&amp;gt;A, p.D417N), encoding one of the neuron-specific -tubulin isotype II, to a disorder characterized by progressive spastic paraplegia, peripheral sensory-motor polyneuropathy and ataxia.">
    <entity charOffset="68-86" id="s822.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="213-231" id="s822.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s822.e0" e2="s822.e1" id="s822.p0" relation="true"/>
  </sentence>
  <sentence id="s823" text="We also evaluated negative regulation of transcription by RNA polymerase II expression in various kidney diseases including membranous nephropathy, minimal change nephrotic syndrome with or without acute kidney injury, immunoglobulin A nephropathy, diabetic nephropathy, acute tubular necrosis, and antineutrophil cytoplasmic antibody-related glomerulonephritis.">
    <entity charOffset="18-75" id="s823.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="124-146" id="s823.e1" ontology_id="HP_0012578" text="membranous nephropathy" type="HP"/>
    <pair e1="s823.e0" e2="s823.e1" id="s823.p0" relation="true"/>
  </sentence>
  <sentence id="s824" text="Overall, our findings establish small GTPase mediated signal transduction as a tumor-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.&lt;b&gt;Significance:&lt;/b&gt; These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.">
    <entity charOffset="32-73" id="s824.e0" ontology_id="GO_0007264" text="small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="79-84" id="s824.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s824.e0" e2="s824.e1" id="s824.p0" relation="true"/>
  </sentence>
  <sentence id="s825" text="Biallelic biological_process mutations have recently been reported to cause autosomal recessive nonsyndromic sensorineural hearing loss.">
    <entity charOffset="10-28" id="s825.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="123-135" id="s825.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s825.e0" e2="s825.e1" id="s825.p0" relation="true"/>
  </sentence>
  <sentence id="s826" text="While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial protein maturation by [2Fe-2S] cluster transfer protein has only recently been recognized in cancer.">
    <entity charOffset="152-199" id="s826.e0" ontology_id="GO_0106034" text="protein maturation by [2Fe-2S] cluster transfer" type="GO"/>
    <entity charOffset="245-251" id="s826.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s826.e0" e2="s826.e1" id="s826.p0" relation="true"/>
  </sentence>
  <sentence id="s827" text="Here we show in a child with microthrombocytopenia, eosinophilia and inflammatory disease, a homozygous frameshift mutation in Arp2/3 complex-mediated actin nucleation (p.Val91Trpfs*30).">
    <entity charOffset="52-64" id="s827.e0" ontology_id="HP_0001880" text="eosinophilia" type="HP"/>
    <entity charOffset="127-167" id="s827.e1" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <pair e1="s827.e0" e2="s827.e1" id="s827.p0" relation="true"/>
  </sentence>
  <sentence id="s828" text="DNA repair and RAD51D have been defined as susceptibility genes for hereditary breast and ovarian cancer syndrome in several studies.">
    <entity charOffset="0-10" id="s828.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="98-104" id="s828.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s828.e0" e2="s828.e1" id="s828.p0" relation="true"/>
  </sentence>
  <sentence id="s829" text="Additionally, inhibition of mitotic chromosome condensation expression by shRNA induced tumor formation in normal renal cells.">
    <entity charOffset="28-59" id="s829.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="88-93" id="s829.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s829.e0" e2="s829.e1" id="s829.p0" relation="true"/>
  </sentence>
  <sentence id="s830" text="However, inhibition of mitotic chromosome condensation did not significantly affect tumor cell proliferation in vitro and tumor progression in vivo.">
    <entity charOffset="23-54" id="s830.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="84-89" id="s830.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s830.e0" e2="s830.e1" id="s830.p0" relation="true"/>
  </sentence>
  <sentence id="s831" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, superoxide metabolic process, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="118-146" id="s831.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="251-256" id="s831.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s831.e0" e2="s831.e1" id="s831.p0" relation="true"/>
  </sentence>
  <sentence id="s832" text="These findings, together with the role of superoxide metabolic process in maintaining self-tolerance, imply that NOX2 is a targetable immune checkpoint in cancer.">
    <entity charOffset="42-70" id="s832.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="155-161" id="s832.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s832.e0" e2="s832.e1" id="s832.p0" relation="true"/>
  </sentence>
  <sentence id="s833" text="The impact of superoxide metabolic process and regulation of cell growth on cancer development is only partly explored.">
    <entity charOffset="14-42" id="s833.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="76-82" id="s833.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s833.e0" e2="s833.e1" id="s833.p0" relation="true"/>
  </sentence>
  <sentence id="s834" text="The impact of superoxide metabolic process and regulation of cell growth on cancer development is only partly explored.">
    <entity charOffset="47-72" id="s834.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="76-82" id="s834.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s834.e0" e2="s834.e1" id="s834.p0" relation="true"/>
  </sentence>
  <sentence id="s835" text="As previously observed in the mutant mouse carrying a disrupted protein tetramerization gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present intellectual disability without seizure and epilepsy">
    <entity charOffset="64-87" id="s835.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="215-222" id="s835.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s835.e0" e2="s835.e1" id="s835.p0" relation="false"/>
  </sentence>
  <sentence id="s836" text="p.(Arg320His) mutation in the protein tetramerization gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.">
    <entity charOffset="30-53" id="s836.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="144-154" id="s836.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s836.e0" e2="s836.e1" id="s836.p0" relation="true"/>
  </sentence>
  <sentence id="s837" text="p.(Arg320His) mutation in the protein tetramerization gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.">
    <entity charOffset="30-53" id="s837.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="251-257" id="s837.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s837.e0" e2="s837.e1" id="s837.p0" relation="true"/>
  </sentence>
  <sentence id="s838" text="We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, dTMP biosynthetic process, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.">
    <entity charOffset="79-104" id="s838.e0" ontology_id="GO_0006231" text="dTMP biosynthetic process" type="GO"/>
    <entity charOffset="253-259" id="s838.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s838.e0" e2="s838.e1" id="s838.p0" relation="true"/>
  </sentence>
  <sentence id="s839" text="We aimed to identify the genetic cause of the devastating neurodegenerative disease amyotrophic lateral sclerosis (signal transduction) in a German family with two affected individuals, and to assess the prevalence of variants in the identified risk gene, FIG4, in a central European ALS cohort.">
    <entity charOffset="58-83" id="s839.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="115-134" id="s839.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s839.e0" e2="s839.e1" id="s839.p0" relation="false"/>
  </sentence>
  <sentence id="s840" text="Recessive mutations in the secreted metalloprotease proteolysis cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.">
    <entity charOffset="52-63" id="s840.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="89-102" id="s840.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s840.e0" e2="s840.e1" id="s840.p0" relation="true"/>
  </sentence>
  <sentence id="s841" text="Inductions of negative regulation of transcription by RNA polymerase II and phospho-acetylated histone 3 (molecular correlates of dyskinesia) were potentiated in the lesioned striatum of TG epidermis development compared with their WT littermates.">
    <entity charOffset="14-71" id="s841.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="130-140" id="s841.e1" ontology_id="HP_0100660" text="dyskinesia" type="HP"/>
    <pair e1="s841.e0" e2="s841.e1" id="s841.p0" relation="false"/>
  </sentence>
  <sentence id="s842" text="We show that the protein polyubiquitination-106b-25 cluster upregulates cell cycle arrest in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.">
    <entity charOffset="17-43" id="s842.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="109-115" id="s842.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s842.e0" e2="s842.e1" id="s842.p0" relation="false"/>
  </sentence>
  <sentence id="s843" text="We show that the protein polyubiquitination-106b-25 cluster upregulates cell cycle arrest in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.">
    <entity charOffset="72-89" id="s843.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="109-115" id="s843.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s843.e0" e2="s843.e1" id="s843.p0" relation="true"/>
  </sentence>
  <sentence id="s844" text="We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of regulation of membrane depolarization is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
    <entity charOffset="130-136" id="s844.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="170-207" id="s844.e1" ontology_id="GO_0003254" text="regulation of membrane depolarization" type="GO"/>
    <pair e1="s844.e0" e2="s844.e1" id="s844.p0" relation="false"/>
  </sentence>
  <sentence id="s845" text="Further, we show for the first time that regulation of membrane depolarization expression alone is significantly associated with a better relapse-free prognosis for breast cancer patients.">
    <entity charOffset="41-78" id="s845.e0" ontology_id="GO_0003254" text="regulation of membrane depolarization" type="GO"/>
    <entity charOffset="172-178" id="s845.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s845.e0" e2="s845.e1" id="s845.p0" relation="true"/>
  </sentence>
  <sentence id="s846" text="Here we identify a novel mechanism of NOTCH regulation and TIC induction in breast cancer via the protein polyubiquitination-106b-25 miRNA cluster.">
    <entity charOffset="83-89" id="s846.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="98-124" id="s846.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s846.e0" e2="s846.e1" id="s846.p0" relation="true"/>
  </sentence>
  <sentence id="s847" text="Tumor-initiating cells (regulation of ARF protein signal transduction) represent a subset of tumor cells with increased self-renewal capability.">
    <entity charOffset="24-69" id="s847.e0" ontology_id="GO_0032012" text="regulation of ARF protein signal transduction" type="GO"/>
    <entity charOffset="93-98" id="s847.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s847.e0" e2="s847.e1" id="s847.p0" relation="true"/>
  </sentence>
  <sentence id="s848" text="NOTCH signaling has been identified as an important driver of the regulation of ARF protein signal transduction population, yet mechanisms governing regulation of this pathway in cancer remain to be fully elucidated.">
    <entity charOffset="66-111" id="s848.e0" ontology_id="GO_0032012" text="regulation of ARF protein signal transduction" type="GO"/>
    <entity charOffset="179-185" id="s848.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s848.e0" e2="s848.e1" id="s848.p0" relation="false"/>
  </sentence>
  <sentence id="s849" text="Importantly, we demonstrate a significant positive correlation between protein polyubiquitination-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and regulation of membrane depolarization mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.">
    <entity charOffset="71-97" id="s849.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="247-253" id="s849.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s849.e0" e2="s849.e1" id="s849.p0" relation="true"/>
  </sentence>
  <sentence id="s850" text="Importantly, we demonstrate a significant positive correlation between protein polyubiquitination-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and regulation of membrane depolarization mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.">
    <entity charOffset="188-225" id="s850.e0" ontology_id="GO_0003254" text="regulation of membrane depolarization" type="GO"/>
    <entity charOffset="247-253" id="s850.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s850.e0" e2="s850.e1" id="s850.p0" relation="true"/>
  </sentence>
  <sentence id="s851" text="These data expand our knowledge of the mechanisms underlying NOTCH activation and regulation of ARF protein signal transduction induction in breast cancer, and may provide new avenues for the development of therapies targeting this resistant subset of tumor cells">
    <entity charOffset="82-127" id="s851.e0" ontology_id="GO_0032012" text="regulation of ARF protein signal transduction" type="GO"/>
    <entity charOffset="252-257" id="s851.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s851.e0" e2="s851.e1" id="s851.p0" relation="false"/>
  </sentence>
  <sentence id="s852" text="We found that hypertonia-associated mutation impairs endosome to lysosome transport mitochondrial localization and its ability to facilitate mitochondrial tethering and fusion.">
    <entity charOffset="14-24" id="s852.e0" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <entity charOffset="53-83" id="s852.e1" ontology_id="GO_0008333" text="endosome to lysosome transport" type="GO"/>
    <pair e1="s852.e0" e2="s852.e1" id="s852.p0" relation="true"/>
  </sentence>
  <sentence id="s853" text="Our findings uncover a novel function of endosome to lysosome transport as a regulator of mitochondrial fusion and provide evidence linking dysregulated mitochondrial dynamics to hypertonia pathogenesis">
    <entity charOffset="41-71" id="s853.e0" ontology_id="GO_0008333" text="endosome to lysosome transport" type="GO"/>
    <entity charOffset="179-189" id="s853.e1" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <pair e1="s853.e0" e2="s853.e1" id="s853.p0" relation="true"/>
  </sentence>
  <sentence id="s854" text="Biological activities of compounds 3-7 towards human cancer cells, COX-2, leukocyte cell-cell adhesion, and JAK3 were evaluated">
    <entity charOffset="53-59" id="s854.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="74-102" id="s854.e1" ontology_id="GO_0007159" text="leukocyte cell-cell adhesion" type="GO"/>
    <pair e1="s854.e0" e2="s854.e1" id="s854.p0" relation="true"/>
  </sentence>
  <sentence id="s855" text="Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and biological_process gene expression modulation in two different human breast cancer cell lines to suggest potential molecular mechanisms to unveil their role in the disease.">
    <entity charOffset="120-138" id="s855.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="196-202" id="s855.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s855.e0" e2="s855.e1" id="s855.p0" relation="true"/>
  </sentence>
  <sentence id="s856" text="Our findings establish lesions in asparaginyl-tRNA aminoacylation as a new cause for nonsyndromic hearing loss and Leigh syndrome.">
    <entity charOffset="34-65" id="s856.e0" ontology_id="GO_0006421" text="asparaginyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="98-110" id="s856.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s856.e0" e2="s856.e1" id="s856.p0" relation="false"/>
  </sentence>
  <sentence id="s857" text="We also demonstrate that ATP-binding cassette subfamily C member 2 (transmembrane transport) gene, responsible for hyperbilirubinemia, is linked to ERLIN1">
    <entity charOffset="68-91" id="s857.e0" ontology_id="GO_0055085" text="transmembrane transport" type="GO"/>
    <entity charOffset="115-133" id="s857.e1" ontology_id="HP_0002904" text="hyperbilirubinemia" type="HP"/>
    <pair e1="s857.e0" e2="s857.e1" id="s857.p0" relation="true"/>
  </sentence>
  <sentence id="s858" text="Fasting serum tumor necrosis factor (negative regulation of transcription by RNA polymerase II)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), negative regulation of axon extension-B (reticulon 4B) and its receptor dolichyl diphosphate biosynthetic process, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.">
    <entity charOffset="14-19" id="s858.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="37-94" id="s858.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s858.e0" e2="s858.e1" id="s858.p0" relation="false"/>
  </sentence>
  <sentence id="s859" text="Fasting serum tumor necrosis factor (negative regulation of transcription by RNA polymerase II)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), negative regulation of axon extension-B (reticulon 4B) and its receptor dolichyl diphosphate biosynthetic process, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.">
    <entity charOffset="14-19" id="s859.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="160-197" id="s859.e1" ontology_id="GO_0030517" text="negative regulation of axon extension" type="GO"/>
    <pair e1="s859.e0" e2="s859.e1" id="s859.p0" relation="true"/>
  </sentence>
  <sentence id="s860" text="Fasting serum tumor necrosis factor (negative regulation of transcription by RNA polymerase II)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), negative regulation of axon extension-B (reticulon 4B) and its receptor dolichyl diphosphate biosynthetic process, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.">
    <entity charOffset="14-19" id="s860.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="232-273" id="s860.e1" ontology_id="GO_0006489" text="dolichyl diphosphate biosynthetic process" type="GO"/>
    <pair e1="s860.e0" e2="s860.e1" id="s860.p0" relation="true"/>
  </sentence>
  <sentence id="s861" text="The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in L-serine biosynthetic process gene.">
    <entity charOffset="56-68" id="s861.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="221-250" id="s861.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="s861.e0" e2="s861.e1" id="s861.p0" relation="true"/>
  </sentence>
  <sentence id="s862" text="The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in L-serine biosynthetic process gene.">
    <entity charOffset="95-101" id="s862.e0" ontology_id="HP_0001903" text="anemia" type="HP"/>
    <entity charOffset="221-250" id="s862.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="s862.e0" e2="s862.e1" id="s862.p0" relation="true"/>
  </sentence>
  <sentence id="s863" text="The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in L-serine biosynthetic process gene.">
    <entity charOffset="103-113" id="s863.e0" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <entity charOffset="221-250" id="s863.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="s863.e0" e2="s863.e1" id="s863.p0" relation="false"/>
  </sentence>
  <sentence id="s864" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in L-serine biosynthetic process.">
    <entity charOffset="98-110" id="s864.e0" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <entity charOffset="182-211" id="s864.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="s864.e0" e2="s864.e1" id="s864.p0" relation="false"/>
  </sentence>
  <sentence id="s865" text="protein homooligomerization is a paralogue of ATL1, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory neuropathy.">
    <entity charOffset="0-27" id="s865.e0" ontology_id="GO_0051260" text="protein homooligomerization" type="GO"/>
    <entity charOffset="155-165" id="s865.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s865.e0" e2="s865.e1" id="s865.p0" relation="true"/>
  </sentence>
  <sentence id="s866" text="Succinate dehydrogenase subunit B and D (SDHB and tricarboxylic acid cycle) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (PPGL).">
    <entity charOffset="50-74" id="s866.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="155-168" id="s866.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s866.e0" e2="s866.e1" id="s866.p0" relation="true"/>
  </sentence>
  <sentence id="s867" text="By contrast, the higher number of genetic abnormalities required for tumor initiation and maintenance in SDHB Ptricarboxylic acid cycle result in a lower penetrance of PGL, but when cells give rise to metastases they are assumed to be better adapted to sustain survival.">
    <entity charOffset="69-74" id="s867.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="111-135" id="s867.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s867.e0" e2="s867.e1" id="s867.p0" relation="false"/>
  </sentence>
  <sentence id="s868" text="These findings align with data suggesting that SDHD-related Ptricarboxylic acid cycle require less genetic events for tumor initiation and maintenance compared to those related to SDHB, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.">
    <entity charOffset="61-85" id="s868.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="118-123" id="s868.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s868.e0" e2="s868.e1" id="s868.p0" relation="false"/>
  </sentence>
  <sentence id="s869" text="In tricarboxylic acid cycle-related syndrome, PPGL maintenance seems to be reduced compared to tricarboxylic acid cycle (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).">
    <entity charOffset="3-27" id="s869.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="168-173" id="s869.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s869.e0" e2="s869.e1" id="s869.p0" relation="true"/>
  </sentence>
  <sentence id="s870" text="In tricarboxylic acid cycle-related syndrome, PPGL maintenance seems to be reduced compared to tricarboxylic acid cycle (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).">
    <entity charOffset="95-119" id="s870.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="168-173" id="s870.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s870.e0" e2="s870.e1" id="s870.p0" relation="true"/>
  </sentence>
  <sentence id="s871" text="Until now, the role of VGSCs and the relationships between calmodulin (negative regulation of endothelial cell proliferation)/CaM-dependent protein kinase II (CaMKII) and VGSCs in low-grade astrocytoma have not been demonstrated.">
    <entity charOffset="71-124" id="s871.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="190-201" id="s871.e1" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <pair e1="s871.e0" e2="s871.e1" id="s871.p0" relation="false"/>
  </sentence>
  <sentence id="s872" text="Membrane transporters (such as ABCs, establishment of T cell polaritys and ATPases) act in carcinogenesis and chemoresistance development, but their relevance for prognosis of epithelial ovarian cancer (EOC) remains poorly understood.">
    <entity charOffset="37-69" id="s872.e0" ontology_id="GO_0001768" text="establishment of T cell polarity" type="GO"/>
    <entity charOffset="195-201" id="s872.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s872.e0" e2="s872.e1" id="s872.p0" relation="false"/>
  </sentence>
  <sentence id="s873" text="Here we report a novel missense mutation in regulation of epithelial cell migration gene that is inherited as an autosomal recessive mode and probably explain the clinical status of the proband.">
    <entity charOffset="44-83" id="s873.e0" ontology_id="GO_0010632" text="regulation of epithelial cell migration" type="GO"/>
    <entity charOffset="113-132" id="s873.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s873.e0" e2="s873.e1" id="s873.p0" relation="true"/>
  </sentence>
  <sentence id="s874" text="Mucopolysaccharidosis VI (MPS-VI) is an infrequent autosomal recessive disorder caused by mutations in regulation of epithelial cell migration gene and deficiency in lysosomal enzyyme ARSB activities subsequently.">
    <entity charOffset="51-70" id="s874.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="103-142" id="s874.e1" ontology_id="GO_0010632" text="regulation of epithelial cell migration" type="GO"/>
    <pair e1="s874.e0" e2="s874.e1" id="s874.p0" relation="true"/>
  </sentence>
  <sentence id="s875" text="We found that proteolysis was significantly overexpressed in tissues of pancreatic intraepithelial neoplasia (PanIN) and PDAC from Pdx1-Cre; LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt; mice (KC) and Pdx1-Cre; LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt;; LSL-Trp53&lt;sup&gt;R172H/+&lt;/sup&gt; mice (KPC) by immunohistochemical analysis.">
    <entity charOffset="14-25" id="s875.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="99-108" id="s875.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s875.e0" e2="s875.e1" id="s875.p0" relation="true"/>
  </sentence>
  <sentence id="s876" text="Mutations in the membrane frizzled-related protein (MFRP/embryo development ending in birth or egg hatching) gene, specifically expressed in the retinal pigment epithelium (carbohydrate metabolic process) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in epidermis development.">
    <entity charOffset="57-107" id="s876.e0" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <entity charOffset="256-270" id="s876.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s876.e0" e2="s876.e1" id="s876.p0" relation="true"/>
  </sentence>
  <sentence id="s877" text="Mutations in the membrane frizzled-related protein (MFRP/embryo development ending in birth or egg hatching) gene, specifically expressed in the retinal pigment epithelium (carbohydrate metabolic process) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in epidermis development.">
    <entity charOffset="173-203" id="s877.e0" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <entity charOffset="256-270" id="s877.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s877.e0" e2="s877.e1" id="s877.p0" relation="false"/>
  </sentence>
  <sentence id="s878" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, retinol metabolic process, visual perception), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (visual perception and Fscn2).">
    <entity charOffset="107-127" id="s878.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="342-359" id="s878.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s878.e0" e2="s878.e1" id="s878.p0" relation="false"/>
  </sentence>
  <sentence id="s879" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, retinol metabolic process, visual perception), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (visual perception and Fscn2).">
    <entity charOffset="107-127" id="s879.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="178-203" id="s879.e1" ontology_id="GO_0042572" text="retinol metabolic process" type="GO"/>
    <pair e1="s879.e0" e2="s879.e1" id="s879.p0" relation="true"/>
  </sentence>
  <sentence id="s880" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, retinol metabolic process, visual perception), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (visual perception and Fscn2).">
    <entity charOffset="107-127" id="s880.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="205-222" id="s880.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s880.e0" e2="s880.e1" id="s880.p0" relation="true"/>
  </sentence>
  <sentence id="s881" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, retinol metabolic process, visual perception), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (visual perception and Fscn2).">
    <entity charOffset="107-127" id="s881.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="259-301" id="s881.e1" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <pair e1="s881.e0" e2="s881.e1" id="s881.p0" relation="true"/>
  </sentence>
  <sentence id="s882" text="Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in embryo development ending in birth or egg hatchingrd6 eyes by 17-fold.">
    <entity charOffset="80-94" id="s882.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="125-175" id="s882.e1" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <pair e1="s882.e0" e2="s882.e1" id="s882.p0" relation="true"/>
  </sentence>
  <sentence id="s883" text="Gorlin syndrome is a rare multisystem inherited disorder which can predispose to basal cell carcinomas (BCCs), childhood medulloblastomas in addition to various developmental abnormalities; the majority of cases are due to mutations in the positive regulation of cholesterol efflux gene.">
    <entity charOffset="81-102" id="s883.e0" ontology_id="HP_0002671" text="basal cell carcinomas" type="HP"/>
    <entity charOffset="240-281" id="s883.e1" ontology_id="GO_0010875" text="positive regulation of cholesterol efflux" type="GO"/>
    <pair e1="s883.e0" e2="s883.e1" id="s883.p0" relation="true"/>
  </sentence>
  <sentence id="s884" text="Both carbohydrate metabolic process65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced retinal degeneration.">
    <entity charOffset="5-35" id="s884.e0" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <entity charOffset="178-198" id="s884.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s884.e0" e2="s884.e1" id="s884.p0" relation="true"/>
  </sentence>
  <sentence id="s885" text="The genes with the highest number of hypermethylated CpG sites in INRG M tumors are TERT, PCDHGA4, DLX5, and DLX6-antigen processing and presentation of peptide antigen via MHC class I1.">
    <entity charOffset="73-78" id="s885.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="114-184" id="s885.e1" ontology_id="GO_0002474" text="antigen processing and presentation of peptide antigen via MHC class I" type="GO"/>
    <pair e1="s885.e0" e2="s885.e1" id="s885.p0" relation="false"/>
  </sentence>
  <sentence id="s886" text="Here, we identified, by next generation sequencing, sequence variants affecting function in the phosphatidylcholine biosynthetic process gene in three young patients with isolated retinal dystrophy from two different Italian families.">
    <entity charOffset="96-136" id="s886.e0" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <entity charOffset="180-197" id="s886.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s886.e0" e2="s886.e1" id="s886.p0" relation="true"/>
  </sentence>
  <sentence id="s887" text="Based on our and published data we propose that the mRNA splicing, via spliceosome gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenomuscle organ development characterised by microcephaly and IUGR">
    <entity charOffset="52-82" id="s887.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="154-160" id="s887.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s887.e0" e2="s887.e1" id="s887.p0" relation="false"/>
  </sentence>
  <sentence id="s888" text="Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (mRNA splicing, via spliceosome) gene (NG_021310.2:g.6126G&amp;gt;A, NM_015698.4:c.331+5G&amp;gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).">
    <entity charOffset="88-118" id="s888.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="319-325" id="s888.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s888.e0" e2="s888.e1" id="s888.p0" relation="false"/>
  </sentence>
  <sentence id="s889" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-158" id="s889.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="180-196" id="s889.e1" ontology_id="HP_0000121" text="nephrocalcinosis" type="HP"/>
    <pair e1="s889.e0" e2="s889.e1" id="s889.p0" relation="true"/>
  </sentence>
  <sentence id="s890" text="Moreover, CpG island methylation status of ubiquitin-dependent protein catabolic process, a candidate tumor-suppressor gene, was determined in ANKL samples.">
    <entity charOffset="43-88" id="s890.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="102-107" id="s890.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s890.e0" e2="s890.e1" id="s890.p0" relation="true"/>
  </sentence>
  <sentence id="s891" text="Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, mitochondrial translational elongation, double-strand break repair via homologous recombination, and DNA repair, are associated with high or moderate risk of developing breast cancer.">
    <entity charOffset="68-87" id="s891.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="265-271" id="s891.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s891.e0" e2="s891.e1" id="s891.p0" relation="true"/>
  </sentence>
  <sentence id="s892" text="Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, mitochondrial translational elongation, double-strand break repair via homologous recombination, and DNA repair, are associated with high or moderate risk of developing breast cancer.">
    <entity charOffset="89-127" id="s892.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="265-271" id="s892.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s892.e0" e2="s892.e1" id="s892.p0" relation="true"/>
  </sentence>
  <sentence id="s893" text="Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, mitochondrial translational elongation, double-strand break repair via homologous recombination, and DNA repair, are associated with high or moderate risk of developing breast cancer.">
    <entity charOffset="129-184" id="s893.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="265-271" id="s893.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s893.e0" e2="s893.e1" id="s893.p0" relation="true"/>
  </sentence>
  <sentence id="s894" text="Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, mitochondrial translational elongation, double-strand break repair via homologous recombination, and DNA repair, are associated with high or moderate risk of developing breast cancer.">
    <entity charOffset="190-200" id="s894.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="265-271" id="s894.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s894.e0" e2="s894.e1" id="s894.p0" relation="true"/>
  </sentence>
  <sentence id="s895" text="Here we show, using whole-exome and cancer gene panel sequencing of 79 aGCTs from two independent cohorts, that truncating mutation of the histone lysine methyltransferase gene response to estrogen (also known as MLL2) is a recurrent somatic event in aGCT.">
    <entity charOffset="36-42" id="s895.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="177-197" id="s895.e1" ontology_id="GO_0043627" text="response to estrogen" type="GO"/>
    <pair e1="s895.e0" e2="s895.e1" id="s895.p0" relation="true"/>
  </sentence>
  <sentence id="s896" text="IHC detects additional non-response to estrogen-mutated aGCTs with loss of nuclear KMT2D expression, suggesting that non-genetic KMT2D inactivation may occur in this tumor type.">
    <entity charOffset="27-47" id="s896.e0" ontology_id="GO_0043627" text="response to estrogen" type="GO"/>
    <entity charOffset="166-171" id="s896.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s896.e0" e2="s896.e1" id="s896.p0" relation="true"/>
  </sentence>
  <sentence id="s897" text="Adult-type granulosa cell tumors of the ovary (aGCTs) are rare gynecologic malignancies that exhibit a high frequency of somatic negative regulation of transcription, DNA-templated c.C402G (p.Cys134Trp) mutation.">
    <entity charOffset="26-32" id="s897.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="129-180" id="s897.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s897.e0" e2="s897.e1" id="s897.p0" relation="true"/>
  </sentence>
  <sentence id="s898" text="Moreover, Adenomatous polyposis coli 2 (protein K11-linked ubiquitination), a tumor suppressor and a negative regulator of Wnt signaling, was found to be the direct target of miR-3648.">
    <entity charOffset="40-73" id="s898.e0" ontology_id="GO_0070979" text="protein K11-linked ubiquitination" type="GO"/>
    <entity charOffset="78-83" id="s898.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s898.e0" e2="s898.e1" id="s898.p0" relation="true"/>
  </sentence>
  <sentence id="s899" text="We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as ptosis and blepharophimosis, are mostly driven by histone H3 acetylation haploinsufficiency">
    <entity charOffset="133-139" id="s899.e0" ontology_id="HP_0000508" text="ptosis" type="HP"/>
    <entity charOffset="183-205" id="s899.e1" ontology_id="GO_0043966" text="histone H3 acetylation" type="GO"/>
    <pair e1="s899.e0" e2="s899.e1" id="s899.p0" relation="true"/>
  </sentence>
  <sentence id="s900" text="Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and cellular response to unfolded protein (four index patients/510; 0.8%) genes.">
    <entity charOffset="34-40" id="s900.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="126-163" id="s900.e1" ontology_id="GO_0034620" text="cellular response to unfolded protein" type="GO"/>
    <pair e1="s900.e0" e2="s900.e1" id="s900.p0" relation="false"/>
  </sentence>
  <sentence id="s901" text="Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and cellular response to unfolded protein (four index patients/510; 0.8%) genes.">
    <entity charOffset="47-57" id="s901.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="126-163" id="s901.e1" ontology_id="GO_0034620" text="cellular response to unfolded protein" type="GO"/>
    <pair e1="s901.e0" e2="s901.e1" id="s901.p0" relation="true"/>
  </sentence>
  <sentence id="s902" text="In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and cellular response to unfolded protein and investigate the functional consequences of newly discovered variants.">
    <entity charOffset="54-60" id="s902.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="152-189" id="s902.e1" ontology_id="GO_0034620" text="cellular response to unfolded protein" type="GO"/>
    <pair e1="s902.e0" e2="s902.e1" id="s902.p0" relation="true"/>
  </sentence>
  <sentence id="s903" text="We demonstrate that HSPB1 and cellular response to unfolded protein mutations are a major cause of inherited motor axonal neuropathy.">
    <entity charOffset="30-67" id="s903.e0" ontology_id="GO_0034620" text="cellular response to unfolded protein" type="GO"/>
    <entity charOffset="122-132" id="s903.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s903.e0" e2="s903.e1" id="s903.p0" relation="false"/>
  </sentence>
  <sentence id="s904" text="Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of NUP214 and NUP98 in hematological neoplasms and overexpression of regulation of glycolytic process in a variety of human cancers.">
    <entity charOffset="126-135" id="s904.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="158-190" id="s904.e1" ontology_id="GO_0006110" text="regulation of glycolytic process" type="GO"/>
    <pair e1="s904.e0" e2="s904.e1" id="s904.p0" relation="true"/>
  </sentence>
  <sentence id="s905" text="The core phenotype of X-linked protein acetylation-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-50" id="s905.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="254-271" id="s905.e1" ontology_id="HP_0001627" text="cardiac anomalies" type="HP"/>
    <pair e1="s905.e0" e2="s905.e1" id="s905.p0" relation="false"/>
  </sentence>
  <sentence id="s906" text="The core phenotype of X-linked protein acetylation-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-50" id="s906.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="134-153" id="s906.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s906.e0" e2="s906.e1" id="s906.p0" relation="true"/>
  </sentence>
  <sentence id="s907" text="By whole exome sequencing we identified a de novo splicing mutation in negative regulation of B cell apoptotic process in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with trigonocephaly.">
    <entity charOffset="71-118" id="s907.e0" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <entity charOffset="195-218" id="s907.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s907.e0" e2="s907.e1" id="s907.p0" relation="false"/>
  </sentence>
  <sentence id="s908" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in sex steroid hormone pathways (FN1, biological_process, ESR1, SYNE1 and FSHB).">
    <entity charOffset="111-124" id="s908.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="223-241" id="s908.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s908.e0" e2="s908.e1" id="s908.p0" relation="false"/>
  </sentence>
  <sentence id="s909" text="It is well known that protein polyubiquitination-145-5p (the guide strand) functions as a tumor suppressor in several types of cancer.">
    <entity charOffset="22-48" id="s909.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="90-95" id="s909.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s909.e0" e2="s909.e1" id="s909.p0" relation="true"/>
  </sentence>
  <sentence id="s910" text="It is well known that protein polyubiquitination-145-5p (the guide strand) functions as a tumor suppressor in several types of cancer.">
    <entity charOffset="22-48" id="s910.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="127-133" id="s910.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s910.e0" e2="s910.e1" id="s910.p0" relation="true"/>
  </sentence>
  <sentence id="s911" text="Expression levels of protein polyubiquitination-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.">
    <entity charOffset="21-47" id="s911.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="172-186" id="s911.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s911.e0" e2="s911.e1" id="s911.p0" relation="false"/>
  </sentence>
  <sentence id="s912" text="On comparing Nesprin-2 and double-strand break repair via homologous recombination localization in the ovarian cancer cell lines SKOV-3 and Caov-3, Nesprin-2 and BRCA1 were localized to the NE envelope and the nucleus in SKOV-3, respectively, and to the cytoplasm in Caov-3 cells.">
    <entity charOffset="27-82" id="s912.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="111-117" id="s912.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s912.e0" e2="s912.e1" id="s912.p0" relation="true"/>
  </sentence>
  <sentence id="s913" text="The negative regulation of transcription by RNA polymerase II gene FokI CT/TT genotype was associated with an increased papillary thyroid cancer risk (CT vs CC: odds ratio=1.71, 95% confidence interval=1.15-2.76, p=0.028; TT vs CC: odds ratio=2.44, 95% confidence interval=1.29-4.62, p=0.005; CT/TT vs CC: odds ratio=1.88, 95% confidence interval=1.20-2.96, p=0.006; CT/CC vs TT: odds ratio=1.80, 95% confidence interval=1.05-3.20, p=0.041).">
    <entity charOffset="4-61" id="s913.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="138-144" id="s913.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s913.e0" e2="s913.e1" id="s913.p0" relation="true"/>
  </sentence>
  <sentence id="s914" text="We also provide an example of using the platform to screen compounds for their ability to lower Apolipoprotein B (positive regulation of macrophage derived foam cell differentiation) produced from iPSC-derived hepatocytes generated from a familial hypercholesterolemia patient.">
    <entity charOffset="114-181" id="s914.e0" ontology_id="GO_0010744" text="positive regulation of macrophage derived foam cell differentiation" type="GO"/>
    <entity charOffset="248-268" id="s914.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s914.e0" e2="s914.e1" id="s914.p0" relation="false"/>
  </sentence>
  <sentence id="s915" text="Overall, 40 of the 73 ICA patients (55%) and 23 of the 56 kindreds (41%) carry mutations located in translated or untranslated exons of &lt;i&gt;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.&lt;/i&gt; Eleven of the 43 kindreds affected by sporadic disease (26%) carry &lt;i&gt;RPSA&lt;/i&gt; mutations, whereas 12 of the 13 multiplex kindreds (92%) carry &lt;i&gt;RPSA&lt;/i&gt; mutations.">
    <entity charOffset="139-206" id="s915.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="250-258" id="s915.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s915.e0" e2="s915.e1" id="s915.p0" relation="false"/>
  </sentence>
  <sentence id="s916" text="Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (asparagine catabolic process via L-aspartate), severe developmental delay, intellectual disability, and seizures.">
    <entity charOffset="170-214" id="s916.e0" ontology_id="GO_0033345" text="asparagine catabolic process via L-aspartate" type="GO"/>
    <entity charOffset="224-243" id="s916.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s916.e0" e2="s916.e1" id="s916.p0" relation="false"/>
  </sentence>
  <sentence id="s917" text="Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (asparagine catabolic process via L-aspartate), severe developmental delay, intellectual disability, and seizures.">
    <entity charOffset="170-214" id="s917.e0" ontology_id="GO_0033345" text="asparagine catabolic process via L-aspartate" type="GO"/>
    <entity charOffset="274-282" id="s917.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s917.e0" e2="s917.e1" id="s917.p0" relation="false"/>
  </sentence>
  <sentence id="s918" text="The tumor suppressor characteristics of cyclindependent kinase 10 (peptidyl-threonine phosphorylation) in nasopharyngeal carcinoma and breast cancer have been previously demonstrated.">
    <entity charOffset="68-102" id="s918.e0" ontology_id="GO_0018107" text="peptidyl-threonine phosphorylation" type="GO"/>
    <entity charOffset="143-149" id="s918.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s918.e0" e2="s918.e1" id="s918.p0" relation="true"/>
  </sentence>
  <sentence id="s919" text="Multivariate analysis suggested that peptidyl-threonine phosphorylation expression may serve as an independent prognostic predictor (P=0.001) for the progression of gastric cancer.">
    <entity charOffset="37-71" id="s919.e0" ontology_id="GO_0018107" text="peptidyl-threonine phosphorylation" type="GO"/>
    <entity charOffset="173-179" id="s919.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s919.e0" e2="s919.e1" id="s919.p0" relation="true"/>
  </sentence>
  <sentence id="s920" text="In addition, ectopic peptidyl-threonine phosphorylation expression inhibited gastric cancer cell proliferation, migration and invasion, while knockdown of CDK10 promoted these phenotypes.">
    <entity charOffset="21-55" id="s920.e0" ontology_id="GO_0018107" text="peptidyl-threonine phosphorylation" type="GO"/>
    <entity charOffset="85-91" id="s920.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s920.e0" e2="s920.e1" id="s920.p0" relation="false"/>
  </sentence>
  <sentence id="s921" text="Immunohistochemistry demonstrated that the loss of peptidyl-threonine phosphorylation expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced tumor stage (P&amp;lt;0.001), frequent lymph node metastasis (P&amp;lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&amp;lt;0.001).">
    <entity charOffset="51-85" id="s921.e0" ontology_id="GO_0018107" text="peptidyl-threonine phosphorylation" type="GO"/>
    <entity charOffset="208-213" id="s921.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s921.e0" e2="s921.e1" id="s921.p0" relation="true"/>
  </sentence>
  <sentence id="s922" text="In order to provide an additional insight into its functional role we compared target gene expression levels between human neuroblastoma cells (SH-SY5Y) stably overexpressing &lt;i&gt;negative regulation of transcription, DNA-templated&lt;/i&gt; cDNA of either humans or the common chimpanzee, Rhesus monkey, and marmoset, respectively.">
    <entity charOffset="123-136" id="s922.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="178-229" id="s922.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s922.e0" e2="s922.e1" id="s922.p0" relation="true"/>
  </sentence>
  <sentence id="s923" text="We performed a retrospective review of electronic patient records to identify patients with macular dystrophy due to bi-allelic variants in establishment or maintenance of cell polarity.">
    <entity charOffset="92-109" id="s923.e0" ontology_id="HP_0007754" text="macular dystrophy" type="HP"/>
    <entity charOffset="140-185" id="s923.e1" ontology_id="GO_0007163" text="establishment or maintenance of cell polarity" type="GO"/>
    <pair e1="s923.e0" e2="s923.e1" id="s923.p0" relation="false"/>
  </sentence>
  <sentence id="s924" text="The expression of melanosome transport in primary prostate tumors was significantly lower in those with the G compared with the T allele and correlated significantly with AR protein.">
    <entity charOffset="18-38" id="s924.e0" ontology_id="GO_0032402" text="melanosome transport" type="GO"/>
    <entity charOffset="59-65" id="s924.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s924.e0" e2="s924.e1" id="s924.p0" relation="true"/>
  </sentence>
  <sentence id="s925" text="The autosomal recessive disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either PCCA or biotin metabolic process genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.">
    <entity charOffset="4-23" id="s925.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="236-260" id="s925.e1" ontology_id="GO_0006768" text="biotin metabolic process" type="GO"/>
    <pair e1="s925.e0" e2="s925.e1" id="s925.p0" relation="true"/>
  </sentence>
  <sentence id="s926" text="Mutations in regulation of membrane potential lead to various neuromuscular phenomuscle organ developments with partial overlap, including limb girdle muscular dystrophy type 1C (regulation of membrane potential), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="13-45" id="s926.e0" ontology_id="GO_0042391" text="regulation of membrane potential" type="GO"/>
    <entity charOffset="246-254" id="s926.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s926.e0" e2="s926.e1" id="s926.p0" relation="true"/>
  </sentence>
  <sentence id="s927" text="Mutations in regulation of membrane potential lead to various neuromuscular phenomuscle organ developments with partial overlap, including limb girdle muscular dystrophy type 1C (regulation of membrane potential), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="179-211" id="s927.e0" ontology_id="GO_0042391" text="regulation of membrane potential" type="GO"/>
    <entity charOffset="246-254" id="s927.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s927.e0" e2="s927.e1" id="s927.p0" relation="false"/>
  </sentence>
  <sentence id="s928" text="Here we present a series of eight patients from seven families presenting with exercise intolerance and rhabdomyolysis caused by mutations in regulation of membrane potential diagnosed by next generation sequencing (NGS) (n=6).">
    <entity charOffset="104-118" id="s928.e0" ontology_id="HP_0003201" text="rhabdomyolysis" type="HP"/>
    <entity charOffset="142-174" id="s928.e1" ontology_id="GO_0042391" text="regulation of membrane potential" type="GO"/>
    <pair e1="s928.e0" e2="s928.e1" id="s928.p0" relation="true"/>
  </sentence>
  <sentence id="s929" text="The ID2 gene expression was increased in the most advanced stage of endometriosis and in ovarian endometriomas, the skeletal system development was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.">
    <entity charOffset="68-81" id="s929.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="116-143" id="s929.e1" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="s929.e0" e2="s929.e1" id="s929.p0" relation="true"/>
  </sentence>
  <sentence id="s930" text="With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation mice and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="119-124" id="s930.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="206-252" id="s930.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s930.e0" e2="s930.e1" id="s930.p0" relation="false"/>
  </sentence>
  <sentence id="s931" text="positive regulation of protein phosphorylation tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs.">
    <entity charOffset="0-46" id="s931.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="161-180" id="s931.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s931.e0" e2="s931.e1" id="s931.p0" relation="false"/>
  </sentence>
  <sentence id="s932" text="While control subjects with high PGC-1 expression exhibited high PV and neurofilament bundle assembly expression, schizophrenia subjects with high PGC-1 expression did not, suggesting dissociation between PGC-1 expression and these targets in schizophrenia.">
    <entity charOffset="73-102" id="s932.e0" ontology_id="GO_0033693" text="neurofilament bundle assembly" type="GO"/>
    <entity charOffset="115-128" id="s932.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s932.e0" e2="s932.e1" id="s932.p0" relation="false"/>
  </sentence>
  <sentence id="s933" text="Interestingly, the positive correlation between PGC-1 and PV, positive regulation of dendrite extension, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.">
    <entity charOffset="63-104" id="s933.e0" ontology_id="GO_1903861" text="positive regulation of dendrite extension" type="GO"/>
    <entity charOffset="138-151" id="s933.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s933.e0" e2="s933.e1" id="s933.p0" relation="false"/>
  </sentence>
  <sentence id="s934" text="The newly reported myoclonus-dystonia gene, cell morphogenesis involved in differentiation, plays also a role in the formation of brain structures.">
    <entity charOffset="29-37" id="s934.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="44-90" id="s934.e1" ontology_id="GO_0000904" text="cell morphogenesis involved in differentiation" type="GO"/>
    <pair e1="s934.e0" e2="s934.e1" id="s934.p0" relation="true"/>
  </sentence>
  <sentence id="s935" text="Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in tetrahydrobiopterin biosynthetic process, TH, SPR, or to heterozygous TUBB4A mutations.">
    <entity charOffset="95-103" id="s935.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="163-203" id="s935.e1" ontology_id="GO_0006729" text="tetrahydrobiopterin biosynthetic process" type="GO"/>
    <pair e1="s935.e0" e2="s935.e1" id="s935.p0" relation="false"/>
  </sentence>
  <sentence id="s936" text="The novel myoclonus-dystonia genes endoplasmic reticulum calcium ion homeostasis and CACNA1B also implicate abnormal calcium signaling in dystonia.">
    <entity charOffset="20-28" id="s936.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="35-80" id="s936.e1" ontology_id="GO_0032469" text="endoplasmic reticulum calcium ion homeostasis" type="GO"/>
    <pair e1="s936.e0" e2="s936.e1" id="s936.p0" relation="false"/>
  </sentence>
  <sentence id="s937" text="This includes the first two genes linked to recessively inherited isolated dystonia, that is, HPCA (hippocalcin) and muscle organ development (collagen VI alpha 3).">
    <entity charOffset="75-83" id="s937.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="117-141" id="s937.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s937.e0" e2="s937.e1" id="s937.p0" relation="false"/>
  </sentence>
  <sentence id="s938" text="regulation of transcription by RNA polymerase II, HES7 and DUSP6 genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.">
    <entity charOffset="0-48" id="s938.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="141-150" id="s938.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s938.e0" e2="s938.e1" id="s938.p0" relation="true"/>
  </sentence>
  <sentence id="s939" text="MESP2, mesoderm development and DUSP6 genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population">
    <entity charOffset="7-27" id="s939.e0" ontology_id="GO_0007498" text="mesoderm development" type="GO"/>
    <entity charOffset="91-99" id="s939.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s939.e0" e2="s939.e1" id="s939.p0" relation="false"/>
  </sentence>
  <sentence id="s940" text="No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="41-92" id="s940.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="248-261" id="s940.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s940.e0" e2="s940.e1" id="s940.p0" relation="false"/>
  </sentence>
  <sentence id="s941" text="No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="41-92" id="s941.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="183-191" id="s941.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s941.e0" e2="s941.e1" id="s941.p0" relation="true"/>
  </sentence>
  <sentence id="s942" text="No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="94-109" id="s942.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="183-191" id="s942.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s942.e0" e2="s942.e1" id="s942.p0" relation="true"/>
  </sentence>
  <sentence id="s943" text="No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="94-109" id="s943.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="248-261" id="s943.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s943.e0" e2="s943.e1" id="s943.p0" relation="true"/>
  </sentence>
  <sentence id="s944" text="No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="113-155" id="s944.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="183-191" id="s944.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s944.e0" e2="s944.e1" id="s944.p0" relation="false"/>
  </sentence>
  <sentence id="s945" text="No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="113-155" id="s945.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="248-261" id="s945.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s945.e0" e2="s945.e1" id="s945.p0" relation="true"/>
  </sentence>
  <sentence id="s946" text="We identified mutations of positive regulation of protein ubiquitination in 32%, CTNNB1 in 15%, WT1 in 12% and TP53 in 5% of tumors.">
    <entity charOffset="27-72" id="s946.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="125-130" id="s946.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s946.e0" e2="s946.e1" id="s946.p0" relation="true"/>
  </sentence>
  <sentence id="s947" text="Here, we determine that non-canonical IKK-RelB pathway activation of positive regulation of protein phosphorylation-mutant tumor cells mediates MPE development and this is fueled by host-provided interleukin IL-1.">
    <entity charOffset="70-116" id="s947.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="124-129" id="s947.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s947.e0" e2="s947.e1" id="s947.p0" relation="true"/>
  </sentence>
  <sentence id="s948" text="Hence we show that mutant positive regulation of protein phosphorylation facilitates IKK-mediated responsiveness of tumor cells to host IL-1, thereby establishing a host-to-tumor signaling circuit that culminates in inflammatory MPE development and drug resistance">
    <entity charOffset="26-72" id="s948.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="117-122" id="s948.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s948.e0" e2="s948.e1" id="s948.p0" relation="true"/>
  </sentence>
  <sentence id="s949" text="We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (G protein-coupled receptor signaling pathway, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (GLI1).">
    <entity charOffset="171-215" id="s949.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="315-321" id="s949.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s949.e0" e2="s949.e1" id="s949.p0" relation="true"/>
  </sentence>
  <sentence id="s950" text="Pompe disease, also called type II glycogen storage disease, is a rare autosomal recessive inherited disease caused by the storage of glycogen in lysosome due to acid -glucosidase (glycogen catabolic process) deficiency, with the most severe conditions in the skeletal muscle, the myocardium, and the smooth muscle.">
    <entity charOffset="71-90" id="s950.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="182-208" id="s950.e1" ontology_id="GO_0005980" text="glycogen catabolic process" type="GO"/>
    <pair e1="s950.e0" e2="s950.e1" id="s950.p0" relation="false"/>
  </sentence>
  <sentence id="s951" text="Unlike previously reported patients with keratan sulfate biosynthetic process mutations, our four patients with ACAN variants manifested non-specific short stature with age-appropriate or mildly delayed bone ages, and had parents of normal stature.">
    <entity charOffset="41-77" id="s951.e0" ontology_id="GO_0018146" text="keratan sulfate biosynthetic process" type="GO"/>
    <entity charOffset="150-163" id="s951.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s951.e0" e2="s951.e1" id="s951.p0" relation="true"/>
  </sentence>
  <sentence id="s952" text="Although mutations in ACAN, FGFR3, negative regulation of kinase activity, and SHOX typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, GH1, GHR, response to estradiol, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="35-73" id="s952.e0" ontology_id="GO_0033673" text="negative regulation of kinase activity" type="GO"/>
    <entity charOffset="443-456" id="s952.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s952.e0" e2="s952.e1" id="s952.p0" relation="false"/>
  </sentence>
  <sentence id="s953" text="Although mutations in ACAN, FGFR3, negative regulation of kinase activity, and SHOX typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, GH1, GHR, response to estradiol, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="102-120" id="s953.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="224-245" id="s953.e1" ontology_id="GO_0032355" text="response to estradiol" type="GO"/>
    <pair e1="s953.e0" e2="s953.e1" id="s953.p0" relation="true"/>
  </sentence>
  <sentence id="s954" text="Although mutations in ACAN, FGFR3, negative regulation of kinase activity, and SHOX typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, GH1, GHR, response to estradiol, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="139-212" id="s954.e0" ontology_id="GO_0007189" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="443-456" id="s954.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s954.e0" e2="s954.e1" id="s954.p0" relation="false"/>
  </sentence>
  <sentence id="s955" text="Several studies have investigated single nucleotide polymorphisms (SNPs) in a number of genes associated with the susceptibility to or severity and outcome of community-acquired pneumonia (CAP), but no research has yet been conducted on the role of response to peptidoglycan gene polymorphisms in CAP.">
    <entity charOffset="178-187" id="s955.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="249-274" id="s955.e1" ontology_id="GO_0032494" text="response to peptidoglycan" type="GO"/>
    <pair e1="s955.e0" e2="s955.e1" id="s955.p0" relation="true"/>
  </sentence>
  <sentence id="s956" text="The expression levels of Ras protein signal transduction in human clinical specimens were higher in breast cancer tissues when compared to normal tissues.">
    <entity charOffset="25-56" id="s956.e0" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <entity charOffset="107-113" id="s956.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s956.e0" e2="s956.e1" id="s956.p0" relation="true"/>
  </sentence>
  <sentence id="s957" text="Heparanase (&lt;i&gt;cell-matrix adhesion&lt;/i&gt;) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.">
    <entity charOffset="15-35" id="s957.e0" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <entity charOffset="154-167" id="s957.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s957.e0" e2="s957.e1" id="s957.p0" relation="true"/>
  </sentence>
  <sentence id="s958" text="Heparanase (&lt;i&gt;cell-matrix adhesion&lt;/i&gt;) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.">
    <entity charOffset="15-35" id="s958.e0" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <entity charOffset="81-88" id="s958.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s958.e0" e2="s958.e1" id="s958.p0" relation="false"/>
  </sentence>
  <sentence id="s959" text="RT-PCR analysis showed that the overall transcriptional activity of the main HS biosynthesis-involved genes (&lt;i&gt;EXT1&lt;/i&gt;, &lt;i&gt;EXT2&lt;/i&gt;, &lt;i&gt;NDST1&lt;/i&gt;, &lt;i&gt;NDST2&lt;/i&gt;, &lt;i&gt;GLCE&lt;/i&gt;, &lt;i&gt;HS2ST1&lt;/i&gt;, &lt;i&gt;HS3ST1&lt;/i&gt;, &lt;i&gt;HS3ST2&lt;/i&gt;, &lt;i&gt;HS6ST1&lt;/i&gt;, &lt;i&gt;HS6ST2&lt;/i&gt;, &lt;i&gt;SULF1&lt;/i&gt;, &lt;i&gt;SULF2&lt;/i&gt;, &lt;i&gt;cell-matrix adhesion&lt;/i&gt;) was decreased by 1.5-2-fold in Grade II-III glioma (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01) and by 3-fold in Grade IV glioma (glioblastoma multiforme, GBM) (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05), as compared with the para-tumourous tissue.">
    <entity charOffset="282-302" id="s959.e0" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <entity charOffset="352-358" id="s959.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s959.e0" e2="s959.e1" id="s959.p0" relation="false"/>
  </sentence>
  <sentence id="s960" text="Mutations in the activation of MAPK activity gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.">
    <entity charOffset="17-44" id="s960.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="236-250" id="s960.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s960.e0" e2="s960.e1" id="s960.p0" relation="false"/>
  </sentence>
  <sentence id="s961" text="We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; positive regulation of cell migration, n=1; cellular response to starvation, n=1).">
    <entity charOffset="47-93" id="s961.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="138-144" id="s961.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s961.e0" e2="s961.e1" id="s961.p0" relation="true"/>
  </sentence>
  <sentence id="s962" text="We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; positive regulation of cell migration, n=1; cellular response to starvation, n=1).">
    <entity charOffset="138-144" id="s962.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="305-336" id="s962.e1" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <pair e1="s962.e0" e2="s962.e1" id="s962.p0" relation="true"/>
  </sentence>
  <sentence id="s963" text="We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; positive regulation of cell migration, n=1; cellular response to starvation, n=1).">
    <entity charOffset="138-144" id="s963.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="215-254" id="s963.e1" ontology_id="GO_0014065" text="phosphatidylinositol 3-kinase signaling" type="GO"/>
    <pair e1="s963.e0" e2="s963.e1" id="s963.p0" relation="true"/>
  </sentence>
  <sentence id="s964" text="We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; positive regulation of cell migration, n=1; cellular response to starvation, n=1).">
    <entity charOffset="138-144" id="s964.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="261-298" id="s964.e1" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <pair e1="s964.e0" e2="s964.e1" id="s964.p0" relation="false"/>
  </sentence>
  <sentence id="s965" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s965.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="312-323" id="s965.e1" ontology_id="GO_0030097" text="hemopoiesis" type="GO"/>
    <pair e1="s965.e0" e2="s965.e1" id="s965.p0" relation="false"/>
  </sentence>
  <sentence id="s966" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s966.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="405-427" id="s966.e1" ontology_id="GO_0007059" text="chromosome segregation" type="GO"/>
    <pair e1="s966.e0" e2="s966.e1" id="s966.p0" relation="false"/>
  </sentence>
  <sentence id="s967" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s967.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="108-133" id="s967.e1" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <pair e1="s967.e0" e2="s967.e1" id="s967.p0" relation="true"/>
  </sentence>
  <sentence id="s968" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s968.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="180-252" id="s968.e1" ontology_id="GO_0017015" text="regulation of transforming growth factor beta receptor signaling pathway" type="GO"/>
    <pair e1="s968.e0" e2="s968.e1" id="s968.p0" relation="false"/>
  </sentence>
  <sentence id="s969" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s969.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="59-69" id="s969.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s969.e0" e2="s969.e1" id="s969.p0" relation="true"/>
  </sentence>
  <sentence id="s970" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s970.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="269-310" id="s970.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s970.e0" e2="s970.e1" id="s970.p0" relation="true"/>
  </sentence>
  <sentence id="s971" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s971.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="325-360" id="s971.e1" ontology_id="GO_0001779" text="natural killer cell differentiation" type="GO"/>
    <pair e1="s971.e0" e2="s971.e1" id="s971.p0" relation="false"/>
  </sentence>
  <sentence id="s972" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s972.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="163-178" id="s972.e1" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <pair e1="s972.e0" e2="s972.e1" id="s972.p0" relation="true"/>
  </sentence>
  <sentence id="s973" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s973.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="362-389" id="s973.e1" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <pair e1="s973.e0" e2="s973.e1" id="s973.p0" relation="false"/>
  </sentence>
  <sentence id="s974" text="To dissect the genetic architecture of sporadic signal transduction, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, negative regulation of protein phosphorylation, TARDBP, FUS, angiogenesis, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s974.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="253-265" id="s974.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s974.e0" e2="s974.e1" id="s974.p0" relation="false"/>
  </sentence>
  <sentence id="s975" text="To dissect the genetic architecture of sporadic signal transduction, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, negative regulation of protein phosphorylation, TARDBP, FUS, angiogenesis, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s975.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="192-238" id="s975.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s975.e0" e2="s975.e1" id="s975.p0" relation="false"/>
  </sentence>
  <sentence id="s976" text="Crisponi syndrome (CS)/cold-induced sweating syndrome muscle organ development 1 (positive regulation of cell proliferation) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.">
    <entity charOffset="54-78" id="s976.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="290-302" id="s976.e1" ontology_id="HP_0001945" text="hyperthermia" type="HP"/>
    <pair e1="s976.e0" e2="s976.e1" id="s976.p0" relation="false"/>
  </sentence>
  <sentence id="s977" text="Although these data further support the pathogenic role of KLHL7 mutations in a CS/positive regulation of cell proliferation-like phenotype, they do not explain all their clinical manifestations and highlight the high phenotypic heterogeneity associated with mutations in KLHL7.">
    <entity charOffset="83-124" id="s977.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="229-242" id="s977.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s977.e0" e2="s977.e1" id="s977.p0" relation="false"/>
  </sentence>
  <sentence id="s978" text="In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(PAX9) and Msh homeobox1(cell morphogenesis) genes in 9subjects.">
    <entity charOffset="82-92" id="s978.e0" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <entity charOffset="181-199" id="s978.e1" ontology_id="GO_0000902" text="cell morphogenesis" type="GO"/>
    <pair e1="s978.e0" e2="s978.e1" id="s978.p0" relation="true"/>
  </sentence>
  <sentence id="s979" text="Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) mice.">
    <entity charOffset="48-78" id="s979.e0" ontology_id="GO_0002009" text="morphogenesis of an epithelium" type="GO"/>
    <entity charOffset="129-138" id="s979.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s979.e0" e2="s979.e1" id="s979.p0" relation="false"/>
  </sentence>
  <sentence id="s980" text="Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) mice.">
    <entity charOffset="139-153" id="s980.e0" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <entity charOffset="198-228" id="s980.e1" ontology_id="GO_0002009" text="morphogenesis of an epithelium" type="GO"/>
    <pair e1="s980.e0" e2="s980.e1" id="s980.p0" relation="false"/>
  </sentence>
  <sentence id="s981" text="The Nodal co-receptor activation of MAPK activity is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.">
    <entity charOffset="22-49" id="s981.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="183-192" id="s981.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s981.e0" e2="s981.e1" id="s981.p0" relation="false"/>
  </sentence>
  <sentence id="s982" text="Finally, the proteasome inhibitor bortezomib is a potent enhancer of global developmental delay in our fly model, evidence of a defective proteasome &amp;quot;bounce-back&amp;quot; response that is also observed in nematode and cellular models of glycoprotein catabolic process Deficiency.">
    <entity charOffset="76-95" id="s982.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="239-269" id="s982.e1" ontology_id="GO_0006516" text="glycoprotein catabolic process" type="GO"/>
    <pair e1="s982.e0" e2="s982.e1" id="s982.p0" relation="false"/>
  </sentence>
  <sentence id="s983" text="In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the ion transmembrane transport gene of a newborn girl with acute clinical symptoms including early-onset chronic renal failure.">
    <entity charOffset="97-124" id="s983.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="207-220" id="s983.e1" ontology_id="HP_0000083" text="renal failure" type="HP"/>
    <pair e1="s983.e0" e2="s983.e1" id="s983.p0" relation="true"/>
  </sentence>
  <sentence id="s984" text="In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the ion transmembrane transport gene of a newborn girl with acute clinical symptoms including early-onset chronic renal failure.">
    <entity charOffset="97-124" id="s984.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="199-206" id="s984.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s984.e0" e2="s984.e1" id="s984.p0" relation="true"/>
  </sentence>
  <sentence id="s985" text="DNA damage checkpoint, both at the mRNA and protein level, is highly expressed in medulloblastoma and elevated CHK1 expression in Group3 medulloblastoma is an adverse prognostic marker.">
    <entity charOffset="0-21" id="s985.e0" ontology_id="GO_0000077" text="DNA damage checkpoint" type="GO"/>
    <entity charOffset="82-97" id="s985.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s985.e0" e2="s985.e1" id="s985.p0" relation="true"/>
  </sentence>
  <sentence id="s986" text="We evaluated whether methylation of tumor-suppressor genes (negative regulation of cytokine productions) would classify non-muscle-invasive (inflammatory response) bladder cancer subgroups and predict outcome.">
    <entity charOffset="36-41" id="s986.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="141-162" id="s986.e1" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <pair e1="s986.e0" e2="s986.e1" id="s986.p0" relation="false"/>
  </sentence>
  <sentence id="s987" text="We evaluated whether methylation of tumor-suppressor genes (negative regulation of cytokine productions) would classify non-muscle-invasive (inflammatory response) bladder cancer subgroups and predict outcome.">
    <entity charOffset="36-41" id="s987.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="60-102" id="s987.e1" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <pair e1="s987.e0" e2="s987.e1" id="s987.p0" relation="false"/>
  </sentence>
  <sentence id="s988" text="We evaluated whether methylation of tumor-suppressor genes (negative regulation of cytokine productions) would classify non-muscle-invasive (inflammatory response) bladder cancer subgroups and predict outcome.">
    <entity charOffset="60-102" id="s988.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="172-178" id="s988.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s988.e0" e2="s988.e1" id="s988.p0" relation="false"/>
  </sentence>
  <sentence id="s989" text="Methylation of embryonic digestive tract development, CD44, PAX5A, negative regulation of protein kinase activity, IGSF4 (T cell mediated cytotoxicity), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="15-52" id="s989.e0" ontology_id="GO_0048566" text="embryonic digestive tract development" type="GO"/>
    <entity charOffset="210-215" id="s989.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s989.e0" e2="s989.e1" id="s989.p0" relation="false"/>
  </sentence>
  <sentence id="s990" text="Methylation of embryonic digestive tract development, CD44, PAX5A, negative regulation of protein kinase activity, IGSF4 (T cell mediated cytotoxicity), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="67-113" id="s990.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="210-215" id="s990.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s990.e0" e2="s990.e1" id="s990.p0" relation="true"/>
  </sentence>
  <sentence id="s991" text="Methylation of embryonic digestive tract development, CD44, PAX5A, negative regulation of protein kinase activity, IGSF4 (T cell mediated cytotoxicity), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="122-150" id="s991.e0" ontology_id="GO_0001913" text="T cell mediated cytotoxicity" type="GO"/>
    <entity charOffset="210-215" id="s991.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s991.e0" e2="s991.e1" id="s991.p0" relation="true"/>
  </sentence>
  <sentence id="s992" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="149-157" id="s992.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="231-272" id="s992.e1" ontology_id="GO_0050884" text="neuromuscular process controlling posture" type="GO"/>
    <pair e1="s992.e0" e2="s992.e1" id="s992.p0" relation="false"/>
  </sentence>
  <sentence id="s993" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="315-373" id="s993.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="460-466" id="s993.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s993.e0" e2="s993.e1" id="s993.p0" relation="false"/>
  </sentence>
  <sentence id="s994" text="Herein, we report biallelic pathogenic variants in cell proliferation in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features.">
    <entity charOffset="51-69" id="s994.e0" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <entity charOffset="173-181" id="s994.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s994.e0" e2="s994.e1" id="s994.p0" relation="true"/>
  </sentence>
  <sentence id="s995" text="Homozygous cell proliferation knockout epidermis development were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans.">
    <entity charOffset="11-29" id="s995.e0" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <entity charOffset="102-126" id="s995.e1" ontology_id="HP_0001627" text="congenital heart defects" type="HP"/>
    <pair e1="s995.e0" e2="s995.e1" id="s995.p0" relation="false"/>
  </sentence>
  <sentence id="s996" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="94-102" id="s996.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="157-224" id="s996.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s996.e0" e2="s996.e1" id="s996.p0" relation="false"/>
  </sentence>
  <sentence id="s997" text="The combination of sensorineural hearing loss and partial agenesis of the corpus callosum is a highly recognizable clinico-radiological entity that should prompt mutational analysis of the establishment of mitotic spindle orientation gene.">
    <entity charOffset="58-89" id="s997.e0" ontology_id="HP_0001274" text="agenesis of the corpus callosum" type="HP"/>
    <entity charOffset="189-233" id="s997.e1" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <pair e1="s997.e0" e2="s997.e1" id="s997.p0" relation="true"/>
  </sentence>
  <sentence id="s998" text="Here, we report the potential clinical implication and biological functions of morphogenesis of an epithelium in cervical squamous cell carcinoma (CSCC).">
    <entity charOffset="79-109" id="s998.e0" ontology_id="GO_0002009" text="morphogenesis of an epithelium" type="GO"/>
    <entity charOffset="122-145" id="s998.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s998.e0" e2="s998.e1" id="s998.p0" relation="true"/>
  </sentence>
  <sentence id="s999" text="Knockdown of RIPK4 reduced cell migration and invasion via inhibition of Vimentin, proteolysis and Fibronectin expression in cervical cancer cells.">
    <entity charOffset="83-94" id="s999.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="134-140" id="s999.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s999.e0" e2="s999.e1" id="s999.p0" relation="true"/>
  </sentence>
  <sentence id="s1000" text="We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (biological_process; P=0.090) and abdominal aortic aneurysms (nucleocytoplasmic transport; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).">
    <entity charOffset="50-56" id="s1000.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="229-256" id="s1000.e1" ontology_id="GO_0006913" text="nucleocytoplasmic transport" type="GO"/>
    <pair e1="s1000.e0" e2="s1000.e1" id="s1000.p0" relation="false"/>
  </sentence>
  <sentence id="s1001" text="Here, we identify tumor-associated calcium signal transducer 2 (negative regulation of epithelial cell migration), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with cell-cell junction organization and OCLN and regulates their cellular localization.">
    <entity charOffset="18-23" id="s1001.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="211-242" id="s1001.e1" ontology_id="GO_0045216" text="cell-cell junction organization" type="GO"/>
    <pair e1="s1001.e0" e2="s1001.e1" id="s1001.p0" relation="true"/>
  </sentence>
  <sentence id="s1002" text="Here, we identify tumor-associated calcium signal transducer 2 (negative regulation of epithelial cell migration), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with cell-cell junction organization and OCLN and regulates their cellular localization.">
    <entity charOffset="18-23" id="s1002.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="64-112" id="s1002.e1" ontology_id="GO_0010633" text="negative regulation of epithelial cell migration" type="GO"/>
    <pair e1="s1002.e0" e2="s1002.e1" id="s1002.p0" relation="true"/>
  </sentence>
  <sentence id="s1003" text="Patients with the combination of dystonia and ataxia and a family history of a neurodegenerative disorder should be tested for biological_process.">
    <entity charOffset="46-52" id="s1003.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="127-145" id="s1003.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1003.e0" e2="s1003.e1" id="s1003.p0" relation="false"/>
  </sentence>
  <sentence id="s1004" text="Previously there have been no reports of biological_process associated with dystonia.">
    <entity charOffset="41-59" id="s1004.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="76-84" id="s1004.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s1004.e0" e2="s1004.e1" id="s1004.p0" relation="true"/>
  </sentence>
  <sentence id="s1005" text="We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (biological_process) who had dystonia.">
    <entity charOffset="100-118" id="s1005.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="128-136" id="s1005.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s1005.e0" e2="s1005.e1" id="s1005.p0" relation="true"/>
  </sentence>
  <sentence id="s1006" text="Mutations in CHCHD2 and oxidative phosphorylation were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="24-49" id="s1006.e0" ontology_id="GO_0006119" text="oxidative phosphorylation" type="GO"/>
    <entity charOffset="96-122" id="s1006.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1006.e0" e2="s1006.e1" id="s1006.p0" relation="true"/>
  </sentence>
  <sentence id="s1007" text="Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="42-65" id="s1007.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="369-374" id="s1007.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1007.e0" e2="s1007.e1" id="s1007.p0" relation="false"/>
  </sentence>
  <sentence id="s1008" text="Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="73-106" id="s1008.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="369-374" id="s1008.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1008.e0" e2="s1008.e1" id="s1008.p0" relation="false"/>
  </sentence>
  <sentence id="s1009" text="Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="115-156" id="s1009.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="369-374" id="s1009.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1009.e0" e2="s1009.e1" id="s1009.p0" relation="false"/>
  </sentence>
  <sentence id="s1010" text="Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="246-269" id="s1010.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="369-374" id="s1010.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1010.e0" e2="s1010.e1" id="s1010.p0" relation="false"/>
  </sentence>
  <sentence id="s1011" text="Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="271-331" id="s1011.e0" ontology_id="GO_0031547" text="brain-derived neurotrophic factor receptor signaling pathway" type="GO"/>
    <entity charOffset="369-374" id="s1011.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1011.e0" e2="s1011.e1" id="s1011.p0" relation="true"/>
  </sentence>
  <sentence id="s1012" text="TRIO and regulation of protein kinase B signaling co-amplification was seen in 8 (44%) G3 and 1 (10%) G1 myxofibrosarcomas and RICTOR amplification alone in 4 (40%) G1 myxofibrosarcomas.">
    <entity charOffset="9-49" id="s1012.e0" ontology_id="GO_0051896" text="regulation of protein kinase B signaling" type="GO"/>
    <entity charOffset="114-122" id="s1012.e1" ontology_id="HP_0100242" text="sarcomas" type="HP"/>
    <pair e1="s1012.e0" e2="s1012.e1" id="s1012.p0" relation="false"/>
  </sentence>
  <sentence id="s1013" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="185-203" id="s1013.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="234-260" id="s1013.e1" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <pair e1="s1013.e0" e2="s1013.e1" id="s1013.p0" relation="true"/>
  </sentence>
  <sentence id="s1014" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="185-203" id="s1014.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="266-278" id="s1014.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1014.e0" e2="s1014.e1" id="s1014.p0" relation="true"/>
  </sentence>
  <sentence id="s1015" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="234-260" id="s1015.e0" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <entity charOffset="280-310" id="s1015.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s1015.e0" e2="s1015.e1" id="s1015.p0" relation="true"/>
  </sentence>
  <sentence id="s1016" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="266-278" id="s1016.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="280-310" id="s1016.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s1016.e0" e2="s1016.e1" id="s1016.p0" relation="true"/>
  </sentence>
  <sentence id="s1017" text="Despite the identification of several oncogenic driver mutations leading to constitutive JAK-cholesterol metabolic process activation, the cellular and molecular biology of myeloproliferative neoplasms (MPN) remains incompletely understood.">
    <entity charOffset="93-122" id="s1017.e0" ontology_id="GO_0008203" text="cholesterol metabolic process" type="GO"/>
    <entity charOffset="192-201" id="s1017.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s1017.e0" e2="s1017.e1" id="s1017.p0" relation="true"/>
  </sentence>
  <sentence id="s1018" text="Mutations of the steroid biosynthetic process gene encoding adrenal 21-hydroxylase cause congenital adrenal hyperplasia (CAH).">
    <entity charOffset="17-45" id="s1018.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="100-119" id="s1018.e1" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <pair e1="s1018.e0" e2="s1018.e1" id="s1018.p0" relation="true"/>
  </sentence>
  <sentence id="s1019" text="Mutations affecting both alleles of collagen metabolic process cause a severe, autosomal recessive form of Ehlers-Danlos syndrome (EDS).">
    <entity charOffset="36-62" id="s1019.e0" ontology_id="GO_0032963" text="collagen metabolic process" type="GO"/>
    <entity charOffset="79-98" id="s1019.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1019.e0" e2="s1019.e1" id="s1019.p0" relation="true"/>
  </sentence>
  <sentence id="s1020" text="In humans, &lt;i&gt;negative regulation of cell proliferation&lt;/i&gt; is the gene responsible for the disease neurofibromatosis muscle organ development II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="14-55" id="s1020.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="100-117" id="s1020.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s1020.e0" e2="s1020.e1" id="s1020.p0" relation="true"/>
  </sentence>
  <sentence id="s1021" text="We have been investigating the pancreas specific transcription factor, 1a cre-recombinase; blood vessel morphogenesis-stop-lox- Kristen rat sarcoma, glycine to aspartic acid at the 12 codon (Ptf1a&lt;sup&gt;cre/+&lt;/sup&gt;;LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt;) mouse strain as a model of human pancreatic cancer.">
    <entity charOffset="91-117" id="s1021.e0" ontology_id="GO_0048514" text="blood vessel morphogenesis" type="GO"/>
    <entity charOffset="140-147" id="s1021.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1021.e0" e2="s1021.e1" id="s1021.p0" relation="false"/>
  </sentence>
  <sentence id="s1022" text="Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the intermediate filament cytoskeleton organization or KRT12 genes, which encode the cytoskeletal protein keratins K3 and visual perception, respectively.">
    <entity charOffset="20-37" id="s1022.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="132-179" id="s1022.e1" ontology_id="GO_0045104" text="intermediate filament cytoskeleton organization" type="GO"/>
    <pair e1="s1022.e0" e2="s1022.e1" id="s1022.p0" relation="false"/>
  </sentence>
  <sentence id="s1023" text="Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the intermediate filament cytoskeleton organization or KRT12 genes, which encode the cytoskeletal protein keratins K3 and visual perception, respectively.">
    <entity charOffset="20-37" id="s1023.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="250-267" id="s1023.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s1023.e0" e2="s1023.e1" id="s1023.p0" relation="true"/>
  </sentence>
  <sentence id="s1024" text="Using whole-exome sequencing in four probands with undiagnosed skin hyperkeratosis/ichthyosis, we identified compound heterozygosity for mutations in 3-keto-sphinganine metabolic process, encoding an enzyme in the de novo synthesis pathway of ceramides.">
    <entity charOffset="68-82" id="s1024.e0" ontology_id="HP_0000962" text="hyperkeratosis" type="HP"/>
    <entity charOffset="150-186" id="s1024.e1" ontology_id="GO_0006666" text="3-keto-sphinganine metabolic process" type="GO"/>
    <pair e1="s1024.e0" e2="s1024.e1" id="s1024.p0" relation="true"/>
  </sentence>
  <sentence id="s1025" text="Biallelic mutations in IRE1-mediated unfolded protein response cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.">
    <entity charOffset="23-62" id="s1025.e0" ontology_id="GO_0036498" text="IRE1-mediated unfolded protein response" type="GO"/>
    <entity charOffset="135-146" id="s1025.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s1025.e0" e2="s1025.e1" id="s1025.p0" relation="false"/>
  </sentence>
  <sentence id="s1026" text="Importantly, depletion of regulation of cell proliferation strongly reduced the tumorigenicity and distant colonization capacities of TNBC cells in vivo.">
    <entity charOffset="26-58" id="s1026.e0" ontology_id="GO_0042127" text="regulation of cell proliferation" type="GO"/>
    <entity charOffset="80-85" id="s1026.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1026.e0" e2="s1026.e1" id="s1026.p0" relation="true"/>
  </sentence>
  <sentence id="s1027" text="Furthermore, CDCA7 increased the expression of negative regulation of transcription by RNA polymerase II, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.">
    <entity charOffset="47-104" id="s1027.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="163-168" id="s1027.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1027.e0" e2="s1027.e1" id="s1027.p0" relation="true"/>
  </sentence>
  <sentence id="s1028" text="Signicant associations between activation of MAPKK activity expression and invasion and metastasis capability in lung cancer A549 and H1299 cell lines were identied.">
    <entity charOffset="32-60" id="s1028.e0" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <entity charOffset="119-125" id="s1028.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1028.e0" e2="s1028.e1" id="s1028.p0" relation="true"/>
  </sentence>
  <sentence id="s1029" text="However, few studies are available on the expression and clinical significance of activation of MAPKK activity in nonsmall cell lung cancer (NSCLC).">
    <entity charOffset="82-110" id="s1029.e0" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <entity charOffset="134-140" id="s1029.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1029.e0" e2="s1029.e1" id="s1029.p0" relation="true"/>
  </sentence>
  <sentence id="s1030" text="Conclusions: The current meta-analysis shows the associations between five SNPs of double-strand break repair via homologous recombination and breast cancer risk">
    <entity charOffset="83-138" id="s1030.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="150-156" id="s1030.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1030.e0" e2="s1030.e1" id="s1030.p0" relation="true"/>
  </sentence>
  <sentence id="s1031" text="the Partner and localizer of mitotic cytokinesis (PALB2) gene and risk of breast cancer.">
    <entity charOffset="29-48" id="s1031.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="81-87" id="s1031.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1031.e0" e2="s1031.e1" id="s1031.p0" relation="true"/>
  </sentence>
  <sentence id="s1032" text="Clinical features of affected individuals with LGD variants in N-terminal protein amino acid acetylation include variable levels of intellectual disability, delayed speech and motor milestones, and autism spectrum disorder.">
    <entity charOffset="63-104" id="s1032.e0" ontology_id="GO_0006474" text="N-terminal protein amino acid acetylation" type="GO"/>
    <entity charOffset="132-155" id="s1032.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1032.e0" e2="s1032.e1" id="s1032.p0" relation="true"/>
  </sentence>
  <sentence id="s1033" text="Twenty-one genes showed single or cross-cancer associations, including novel associations of succinate metabolic process in melanoma and PALB2 in stomach adenocarcinoma.">
    <entity charOffset="93-120" id="s1033.e0" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <entity charOffset="124-132" id="s1033.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1033.e0" e2="s1033.e1" id="s1033.p0" relation="true"/>
  </sentence>
  <sentence id="s1034" text="Recently, we reported that a series of nonHodgkin's lymphoma occurs in children with outflow tract morphogenesis and thus hypothesized that a predisposition to cancer may be associated with this genetic disorder.">
    <entity charOffset="86-113" id="s1034.e0" ontology_id="GO_0003151" text="outflow tract morphogenesis" type="GO"/>
    <entity charOffset="161-167" id="s1034.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1034.e0" e2="s1034.e1" id="s1034.p0" relation="false"/>
  </sentence>
  <sentence id="s1035" text="Truncating mutations in the last and penultimate exons of the peptidyl-threonine dephosphorylation gene were recently described as a cause for mild to severe intellectual disability in fourteen patients.">
    <entity charOffset="62-98" id="s1035.e0" ontology_id="GO_0035970" text="peptidyl-threonine dephosphorylation" type="GO"/>
    <entity charOffset="158-181" id="s1035.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1035.e0" e2="s1035.e1" id="s1035.p0" relation="true"/>
  </sentence>
  <sentence id="s1036" text="Considering that visual perception associates with CRYBB2 and that the latter protein has been implicated in microphthalmia, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).">
    <entity charOffset="17-34" id="s1036.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="109-123" id="s1036.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s1036.e0" e2="s1036.e1" id="s1036.p0" relation="true"/>
  </sentence>
  <sentence id="s1037" text="To date, visual perception was the only gene in this cluster not associated with either human or murine cataracts.">
    <entity charOffset="9-26" id="s1037.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="104-112" id="s1037.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s1037.e0" e2="s1037.e1" id="s1037.p0" relation="false"/>
  </sentence>
  <sentence id="s1038" text="natural killer cell differentiation variants can cause diabetes and might be involved in the development of primary liver neoplasm.">
    <entity charOffset="0-35" id="s1038.e0" ontology_id="GO_0001779" text="natural killer cell differentiation" type="GO"/>
    <entity charOffset="122-130" id="s1038.e1" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="s1038.e0" e2="s1038.e1" id="s1038.p0" relation="true"/>
  </sentence>
  <sentence id="s1039" text="Blocking the expression of PAK1, DIAPH2, and regulation of cell shape significantly inhibits breast cancer cell migration induced by let-7b repression.">
    <entity charOffset="45-69" id="s1039.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="100-106" id="s1039.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1039.e0" e2="s1039.e1" id="s1039.p0" relation="true"/>
  </sentence>
  <sentence id="s1040" text="The aim of the study was to understand the role of SLIT2-ROBO1/2-actin cytoskeleton organization signalling pathways in development of breast cancer (BC).">
    <entity charOffset="65-96" id="s1040.e0" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <entity charOffset="142-148" id="s1040.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1040.e0" e2="s1040.e1" id="s1040.p0" relation="true"/>
  </sentence>
  <sentence id="s1041" text="The strongly positive rate of mitochondrial calcium ion transmembrane transport in TNBC was 69.2% (74/107), which was significantly higher than in both DCIS 35.7% (15/42) and adjacent non-tumor tissues 12.3% (8/65).">
    <entity charOffset="30-79" id="s1041.e0" ontology_id="GO_0006851" text="mitochondrial calcium ion transmembrane transport" type="GO"/>
    <entity charOffset="188-193" id="s1041.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1041.e0" e2="s1041.e1" id="s1041.p0" relation="true"/>
  </sentence>
  <sentence id="s1042" text="In humans and epidermis development hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="36-61" id="s1042.e0" ontology_id="GO_0001942" text="hair follicle development" type="GO"/>
    <entity charOffset="368-380" id="s1042.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s1042.e0" e2="s1042.e1" id="s1042.p0" relation="true"/>
  </sentence>
  <sentence id="s1043" text="By using exome and capillary sequencing, we here identify biallelic biological_process mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.">
    <entity charOffset="68-86" id="s1043.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="178-194" id="s1043.e1" ontology_id="HP_0000581" text="blepharophimosis" type="HP"/>
    <pair e1="s1043.e0" e2="s1043.e1" id="s1043.p0" relation="true"/>
  </sentence>
  <sentence id="s1044" text="By using exome and capillary sequencing, we here identify biallelic biological_process mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.">
    <entity charOffset="68-86" id="s1044.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="252-271" id="s1044.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1044.e0" e2="s1044.e1" id="s1044.p0" relation="false"/>
  </sentence>
  <sentence id="s1045" text="Induction of DNA strand renaturation by 5-Aza-dC was tested in vitro using cancer cells.">
    <entity charOffset="13-36" id="s1045.e0" ontology_id="GO_0000733" text="DNA strand renaturation" type="GO"/>
    <entity charOffset="75-81" id="s1045.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1045.e0" e2="s1045.e1" id="s1045.p0" relation="false"/>
  </sentence>
  <sentence id="s1046" text="5'-Aza-2'-deoxycytidine (5-Aza-neuron migration) is a demethylating drug that causes genome-wide hypomethylation resulting in the expression of several tumor suppressor genes causing growth arrest of cancer cells.">
    <entity charOffset="31-47" id="s1046.e0" ontology_id="GO_0001764" text="neuron migration" type="GO"/>
    <entity charOffset="200-206" id="s1046.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1046.e0" e2="s1046.e1" id="s1046.p0" relation="false"/>
  </sentence>
  <sentence id="s1047" text="Fragile X syndrome (FXS), caused by the loss of functional regulation of alternative mRNA splicing, via spliceosome, is a leading cause of autism.">
    <entity charOffset="59-115" id="s1047.e0" ontology_id="GO_0000381" text="regulation of alternative mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="139-145" id="s1047.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1047.e0" e2="s1047.e1" id="s1047.p0" relation="true"/>
  </sentence>
  <sentence id="s1048" text="Genetic reduction of cAMP biosynthetic process also ameliorates autism-related symptoms including repetitive behaviour, defective social interaction and audiogenic seizures.">
    <entity charOffset="21-46" id="s1048.e0" ontology_id="GO_0006171" text="cAMP biosynthetic process" type="GO"/>
    <entity charOffset="164-172" id="s1048.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1048.e0" e2="s1048.e1" id="s1048.p0" relation="false"/>
  </sentence>
  <sentence id="s1049" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s1049.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="488-520" id="s1049.e1" ontology_id="GO_0009298" text="GDP-mannose biosynthetic process" type="GO"/>
    <pair e1="s1049.e0" e2="s1049.e1" id="s1049.p0" relation="true"/>
  </sentence>
  <sentence id="s1050" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s1050.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="446-477" id="s1050.e1" ontology_id="GO_0051259" text="protein complex oligomerization" type="GO"/>
    <pair e1="s1050.e0" e2="s1050.e1" id="s1050.p0" relation="true"/>
  </sentence>
  <sentence id="s1051" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s1051.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="241-271" id="s1051.e1" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <pair e1="s1051.e0" e2="s1051.e1" id="s1051.p0" relation="true"/>
  </sentence>
  <sentence id="s1052" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s1052.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="531-561" id="s1052.e1" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <pair e1="s1052.e0" e2="s1052.e1" id="s1052.p0" relation="true"/>
  </sentence>
  <sentence id="s1053" text="In vitro test on colon cancer resistant/susceptible to chemoradioterapy cells, finally prove that telomere maintenance via recombination deregulation is extensively involved in the chemoresistance mechanisms.">
    <entity charOffset="23-29" id="s1053.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="98-136" id="s1053.e1" ontology_id="GO_0000722" text="telomere maintenance via recombination" type="GO"/>
    <pair e1="s1053.e0" e2="s1053.e1" id="s1053.p0" relation="true"/>
  </sentence>
  <sentence id="s1054" text="osteoblast differentiation expression is absent in normal urothelial cells, but it begins to be expressed in pre-neoplastic bladder tumors and continues to be expressed in invasive mouse BCa.">
    <entity charOffset="0-26" id="s1054.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="132-138" id="s1054.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1054.e0" e2="s1054.e1" id="s1054.p0" relation="true"/>
  </sentence>
  <sentence id="s1055" text="Ablation of osteoblast differentiation-expressing cells within primary invasive intracellular signal transduction led to enhanced tumor regression, supporting the essential role of SOX2-positive cells in regulating BCa maintenance and progression.">
    <entity charOffset="12-38" id="s1055.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="130-135" id="s1055.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1055.e0" e2="s1055.e1" id="s1055.p0" relation="true"/>
  </sentence>
  <sentence id="s1056" text="Ablation of osteoblast differentiation-expressing cells within primary invasive intracellular signal transduction led to enhanced tumor regression, supporting the essential role of SOX2-positive cells in regulating BCa maintenance and progression.">
    <entity charOffset="80-113" id="s1056.e0" ontology_id="GO_0035556" text="intracellular signal transduction" type="GO"/>
    <entity charOffset="130-135" id="s1056.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1056.e0" e2="s1056.e1" id="s1056.p0" relation="true"/>
  </sentence>
  <sentence id="s1057" text="epidermis development but not KRT6C mRNA expression was increased in chemotherapy resistant primary serous ovarian cancer cells compared to chemotherapy sensitive cells.">
    <entity charOffset="0-21" id="s1057.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="115-121" id="s1057.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1057.e0" e2="s1057.e1" id="s1057.p0" relation="true"/>
  </sentence>
  <sentence id="s1058" text="KRT5 and keratinization (KRT6A, KRT6B &amp;amp; KRT6C) gene expression was assessed in publically available serous ovarian cancer data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.">
    <entity charOffset="9-23" id="s1058.e0" ontology_id="GO_0031424" text="keratinization" type="GO"/>
    <entity charOffset="119-125" id="s1058.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1058.e0" e2="s1058.e1" id="s1058.p0" relation="false"/>
  </sentence>
  <sentence id="s1059" text="Our findings suggest that DEGs encoding subunits of NADH, G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, MAPK1, STAT3, activation of MAPKK activity, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="58-95" id="s1059.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="233-252" id="s1059.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1059.e0" e2="s1059.e1" id="s1059.p0" relation="true"/>
  </sentence>
  <sentence id="s1060" text="Our findings suggest that DEGs encoding subunits of NADH, G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, MAPK1, STAT3, activation of MAPKK activity, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="97-134" id="s1060.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="233-252" id="s1060.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1060.e0" e2="s1060.e1" id="s1060.p0" relation="false"/>
  </sentence>
  <sentence id="s1061" text="Our findings suggest that DEGs encoding subunits of NADH, G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, MAPK1, STAT3, activation of MAPKK activity, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="150-178" id="s1061.e0" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <entity charOffset="233-252" id="s1061.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1061.e0" e2="s1061.e1" id="s1061.p0" relation="false"/>
  </sentence>
  <sentence id="s1062" text="Oral squamous cell carcinoma studies have correlated regulation of cell shape expression with metastatic disease and poor prognosis.">
    <entity charOffset="5-28" id="s1062.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="53-77" id="s1062.e1" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <pair e1="s1062.e0" e2="s1062.e1" id="s1062.p0" relation="false"/>
  </sentence>
  <sentence id="s1063" text="The association between low regulation of cell shape expression and p16&lt;sup&gt;+&lt;/sup&gt; HNSCCs suggests that alternative signaling pathways may be used for their tumorigenesis">
    <entity charOffset="28-52" id="s1063.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="158-163" id="s1063.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1063.e0" e2="s1063.e1" id="s1063.p0" relation="true"/>
  </sentence>
  <sentence id="s1064" text="A case with protein sumoylation (C.700G&amp;gt;A) had seizure controlled for 6 mouths.">
    <entity charOffset="12-31" id="s1064.e0" ontology_id="GO_0016925" text="protein sumoylation" type="GO"/>
    <entity charOffset="50-57" id="s1064.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s1064.e0" e2="s1064.e1" id="s1064.p0" relation="false"/>
  </sentence>
  <sentence id="s1065" text="Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous SCC and melanomas, is explained by mutations in protein polyubiquitination.">
    <entity charOffset="153-162" id="s1065.e0" ontology_id="HP_0002861" text="melanomas" type="HP"/>
    <entity charOffset="193-219" id="s1065.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s1065.e0" e2="s1065.e1" id="s1065.p0" relation="true"/>
  </sentence>
  <sentence id="s1066" text="We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a negative regulation of transcription, DNA-templated-like presentation.">
    <entity charOffset="74-94" id="s1066.e0" ontology_id="HP_0002310" text="orofacial dyskinesia" type="HP"/>
    <entity charOffset="187-238" id="s1066.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1066.e0" e2="s1066.e1" id="s1066.p0" relation="true"/>
  </sentence>
  <sentence id="s1067" text="We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a negative regulation of transcription, DNA-templated-like presentation.">
    <entity charOffset="96-116" id="s1067.e0" ontology_id="HP_0002510" text="spastic quadriplegia" type="HP"/>
    <entity charOffset="187-238" id="s1067.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1067.e0" e2="s1067.e1" id="s1067.p0" relation="false"/>
  </sentence>
  <sentence id="s1068" text="The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with negative regulation of transcription, DNA-templated, a gene shown to be involved in a postnatal microcephaly syndrome.">
    <entity charOffset="110-161" id="s1068.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="206-218" id="s1068.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1068.e0" e2="s1068.e1" id="s1068.p0" relation="true"/>
  </sentence>
  <sentence id="s1069" text="Additionally, skeletal system development can be a potential tumor suppressor">
    <entity charOffset="14-41" id="s1069.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="61-66" id="s1069.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1069.e0" e2="s1069.e1" id="s1069.p0" relation="true"/>
  </sentence>
  <sentence id="s1070" text="In conclusion, the hypermethylation of skeletal system development is an independent prognostic biomarker in breast cancer.">
    <entity charOffset="39-66" id="s1070.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="116-122" id="s1070.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1070.e0" e2="s1070.e1" id="s1070.p0" relation="true"/>
  </sentence>
  <sentence id="s1071" text="Interestingly, protein insertion into membrane mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).">
    <entity charOffset="15-46" id="s1071.e0" ontology_id="GO_0051205" text="protein insertion into membrane" type="GO"/>
    <entity charOffset="203-213" id="s1071.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1071.e0" e2="s1071.e1" id="s1071.p0" relation="false"/>
  </sentence>
  <sentence id="s1072" text="Altogether these data demonstrate that mutations in negative regulation of protein kinase activity cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability">
    <entity charOffset="52-98" id="s1072.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="166-175" id="s1072.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s1072.e0" e2="s1072.e1" id="s1072.p0" relation="true"/>
  </sentence>
  <sentence id="s1073" text="Altogether these data demonstrate that mutations in negative regulation of protein kinase activity cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability">
    <entity charOffset="52-98" id="s1073.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="118-136" id="s1073.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1073.e0" e2="s1073.e1" id="s1073.p0" relation="true"/>
  </sentence>
  <sentence id="s1074" text="This result represents another indication for the genetic heterogeneity of visual perception and extends the mutational spectrum of the disease by introducing nine novel mutations in five BBS genes.">
    <entity charOffset="58-71" id="s1074.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="75-92" id="s1074.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s1074.e0" e2="s1074.e1" id="s1074.p0" relation="false"/>
  </sentence>
  <sentence id="s1075" text="Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) negative regulation by host of viral transcription (POU class 2 homeobox 3; also known as smoothened signaling pathway-1a/regulation of cell migration-11) as a powerful dependency in a subset of SCLC lines.">
    <entity charOffset="58-64" id="s1075.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="208-236" id="s1075.e1" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <pair e1="s1075.e0" e2="s1075.e1" id="s1075.p0" relation="true"/>
  </sentence>
  <sentence id="s1076" text="Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) negative regulation by host of viral transcription (POU class 2 homeobox 3; also known as smoothened signaling pathway-1a/regulation of cell migration-11) as a powerful dependency in a subset of SCLC lines.">
    <entity charOffset="58-64" id="s1076.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="118-168" id="s1076.e1" ontology_id="GO_0043922" text="negative regulation by host of viral transcription" type="GO"/>
    <pair e1="s1076.e0" e2="s1076.e1" id="s1076.p0" relation="true"/>
  </sentence>
  <sentence id="s1077" text="Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) negative regulation by host of viral transcription (POU class 2 homeobox 3; also known as smoothened signaling pathway-1a/regulation of cell migration-11) as a powerful dependency in a subset of SCLC lines.">
    <entity charOffset="58-64" id="s1077.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="240-268" id="s1077.e1" ontology_id="GO_0030334" text="regulation of cell migration" type="GO"/>
    <pair e1="s1077.e0" e2="s1077.e1" id="s1077.p0" relation="false"/>
  </sentence>
  <sentence id="s1078" text="Moreover, we show that most SCLC tumors can be classified into one of three lineages based on the expression of POU2F3, negative regulation of transcription by RNA polymerase II, or NEUROD1.">
    <entity charOffset="33-38" id="s1078.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="120-177" id="s1078.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1078.e0" e2="s1078.e1" id="s1078.p0" relation="true"/>
  </sentence>
  <sentence id="s1079" text="Prior studies that explored the hypothesis that cytokine production gene variants contribute to epithelial ovarian carcinoma (EOC) risk have been based on small sample sizes and none have sought replication in an independent population.">
    <entity charOffset="48-67" id="s1079.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="107-124" id="s1079.e1" ontology_id="HP_0025318" text="ovarian carcinoma" type="HP"/>
    <pair e1="s1079.e0" e2="s1079.e1" id="s1079.p0" relation="true"/>
  </sentence>
  <sentence id="s1080" text="Perturbation of muscle organ development function has previously been suggested in Alzheimer's disease (AD) as shown in fibroblasts from AD patients and a neuroblastoma cell line containing familial presenilin-2 AD mutation.">
    <entity charOffset="16-40" id="s1080.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="155-168" id="s1080.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1080.e0" e2="s1080.e1" id="s1080.p0" relation="true"/>
  </sentence>
  <sentence id="s1081" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), protein targeting to membrane (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="21-34" id="s1081.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="111-139" id="s1081.e1" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <pair e1="s1081.e0" e2="s1081.e1" id="s1081.p0" relation="true"/>
  </sentence>
  <sentence id="s1082" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), protein targeting to membrane (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="21-34" id="s1082.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="305-334" id="s1082.e1" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <pair e1="s1082.e0" e2="s1082.e1" id="s1082.p0" relation="false"/>
  </sentence>
  <sentence id="s1083" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), protein targeting to membrane (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="200-219" id="s1083.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="261-288" id="s1083.e1" ontology_id="GO_0017004" text="cytochrome complex assembly" type="GO"/>
    <pair e1="s1083.e0" e2="s1083.e1" id="s1083.p0" relation="true"/>
  </sentence>
  <sentence id="s1084" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), protein targeting to membrane (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="200-219" id="s1084.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="305-334" id="s1084.e1" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <pair e1="s1084.e0" e2="s1084.e1" id="s1084.p0" relation="true"/>
  </sentence>
  <sentence id="s1085" text="Taken together, these results suggest the implication of platelet aggregation in a new autosomal recessive MCA.">
    <entity charOffset="57-77" id="s1085.e0" ontology_id="GO_0070527" text="platelet aggregation" type="GO"/>
    <entity charOffset="87-106" id="s1085.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1085.e0" e2="s1085.e1" id="s1085.p0" relation="true"/>
  </sentence>
  <sentence id="s1086" text="One clue to this relationship has come from the elucidation of the hereditary kidney cancer gene, negative regulation of cell proliferation, which functions partly to degrade key regulators of endogenous cholesterol and lipid biosynthesis.">
    <entity charOffset="85-91" id="s1086.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="98-139" id="s1086.e1" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <pair e1="s1086.e0" e2="s1086.e1" id="s1086.p0" relation="true"/>
  </sentence>
  <sentence id="s1087" text="Mutation in the hippo signalingVS gene causes nephronophthisis type II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="16-31" id="s1087.e0" ontology_id="GO_0035329" text="hippo signaling" type="GO"/>
    <entity charOffset="179-190" id="s1087.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s1087.e0" e2="s1087.e1" id="s1087.p0" relation="false"/>
  </sentence>
  <sentence id="s1088" text="Mutation in the hippo signalingVS gene causes nephronophthisis type II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="72-126" id="s1088.e0" ontology_id="GO_0090090" text="negative regulation of canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="179-190" id="s1088.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s1088.e0" e2="s1088.e1" id="s1088.p0" relation="true"/>
  </sentence>
  <sentence id="s1089" text="Here, integrated analysis of gene expression in non-small cell lung cancer revealed that cellular response to zinc ion starvation expression is significantly correlated with increased tumour size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).">
    <entity charOffset="89-129" id="s1089.e0" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <entity charOffset="184-190" id="s1089.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1089.e0" e2="s1089.e1" id="s1089.p0" relation="true"/>
  </sentence>
  <sentence id="s1090" text="&lt;i&gt;negative regulation of cell proliferation&lt;/i&gt; methylation was frequently detected in ESCC tumors and correlated with lymph node metastasis, tumor recurrence and progression, with &lt;i&gt;DLEC1&lt;/i&gt; as the most frequently methylated among the established 3p22.2 tumor suppressors (&lt;i&gt;RASSF1A, PLCD1&lt;/i&gt; and &lt;i&gt;ZMYND10/BLU&lt;/i&gt;).">
    <entity charOffset="3-44" id="s1090.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="143-148" id="s1090.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1090.e0" e2="s1090.e1" id="s1090.p0" relation="true"/>
  </sentence>
  <sentence id="s1091" text="Mutations in the Pejvakin (biological_process) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.">
    <entity charOffset="27-45" id="s1091.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="78-90" id="s1091.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1091.e0" e2="s1091.e1" id="s1091.p0" relation="true"/>
  </sentence>
  <sentence id="s1092" text="Mutations in the Pejvakin (biological_process) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.">
    <entity charOffset="27-45" id="s1092.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="58-77" id="s1092.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1092.e0" e2="s1092.e1" id="s1092.p0" relation="true"/>
  </sentence>
  <sentence id="s1093" text="By contrast, loss of biological_process in adult OHCs causes a slowly progressive hearing loss associated with OHC degeneration and delayed loss of inner hair cells (IHCs), indicating a primary role for pejvakin in regulating OHC function and survival.">
    <entity charOffset="21-39" id="s1093.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="82-94" id="s1093.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1093.e0" e2="s1093.e1" id="s1093.p0" relation="true"/>
  </sentence>
  <sentence id="s1094" text="Here, we demonstrate that mice with conditional ablation of the biological_process gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.">
    <entity charOffset="64-82" id="s1094.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="208-220" id="s1094.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1094.e0" e2="s1094.e1" id="s1094.p0" relation="true"/>
  </sentence>
  <sentence id="s1095" text="Here, we demonstrate that mice with conditional ablation of the biological_process gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.">
    <entity charOffset="64-82" id="s1095.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="199-207" id="s1095.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s1095.e0" e2="s1095.e1" id="s1095.p0" relation="false"/>
  </sentence>
  <sentence id="s1096" text="Moreover, we confirmed that knockdown of pyruvate metabolic process could inhibit tumor growth in vivo.">
    <entity charOffset="41-67" id="s1096.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="82-87" id="s1096.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1096.e0" e2="s1096.e1" id="s1096.p0" relation="true"/>
  </sentence>
  <sentence id="s1097" text="The SNPs rs2124437 (MAPK cascade), rs1335022 (GRIK2), rs4512367 (G protein-coupled receptor signaling pathway), rs4748011 (negative regulation of tumor necrosis factor-mediated signaling pathway), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="20-32" id="s1097.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="274-280" id="s1097.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1097.e0" e2="s1097.e1" id="s1097.p0" relation="true"/>
  </sentence>
  <sentence id="s1098" text="The SNPs rs2124437 (MAPK cascade), rs1335022 (GRIK2), rs4512367 (G protein-coupled receptor signaling pathway), rs4748011 (negative regulation of tumor necrosis factor-mediated signaling pathway), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="65-109" id="s1098.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="274-280" id="s1098.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1098.e0" e2="s1098.e1" id="s1098.p0" relation="true"/>
  </sentence>
  <sentence id="s1099" text="The SNPs rs2124437 (MAPK cascade), rs1335022 (GRIK2), rs4512367 (G protein-coupled receptor signaling pathway), rs4748011 (negative regulation of tumor necrosis factor-mediated signaling pathway), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="123-194" id="s1099.e0" ontology_id="GO_0010804" text="negative regulation of tumor necrosis factor-mediated signaling pathway" type="GO"/>
    <entity charOffset="274-280" id="s1099.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1099.e0" e2="s1099.e1" id="s1099.p0" relation="true"/>
  </sentence>
  <sentence id="s1100" text="DLX3 mutations have been found to be responsible for Tricho-Dento-Osseous (tryptophan catabolic process to kynurenine) syndrome, charcoenzyme A biosynthetic processerized by kinky hair, thin-pitted enamel and increased bone density.">
    <entity charOffset="75-117" id="s1100.e0" ontology_id="GO_0019441" text="tryptophan catabolic process to kynurenine" type="GO"/>
    <entity charOffset="209-231" id="s1100.e1" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <pair e1="s1100.e0" e2="s1100.e1" id="s1100.p0" relation="false"/>
  </sentence>
  <sentence id="s1101" text="In contrast, patients with the non-hereditary Carney triad, including paraganglioma, GIST, and pulmonary chondroma, usually lack germline choline catabolic process mutations and instead show epigenetic SDH complex inactivation through SDHC promoter methylation.">
    <entity charOffset="95-114" id="s1101.e0" ontology_id="HP_0031474" text="pulmonary chondroma" type="HP"/>
    <entity charOffset="138-163" id="s1101.e1" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <pair e1="s1101.e0" e2="s1101.e1" id="s1101.p0" relation="false"/>
  </sentence>
  <sentence id="s1102" text="&lt;b&gt;Conclusions:&lt;/b&gt; The expression of negative regulation of osteoblast differentiation in human glioma is positively correlated with the malignant grade of glioma, which may be involved in the malignant progression of glioma by EMT">
    <entity charOffset="38-87" id="s1102.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="97-103" id="s1102.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1102.e0" e2="s1102.e1" id="s1102.p0" relation="true"/>
  </sentence>
  <sentence id="s1103" text="Real-time fluorescence quantitative PCR and Western blot were used to detect the expression level of negative regulation of osteoblast differentiation mRNA and protein in 61 cases of fresh glioma tissue (WHO grade  16 cases,  21 cases,  24 cases) and 12 cases of adjacent tissues, and the expression levels of E-cadherin, N-cadherin and vimentin were also investigated in fresh glioma tissue.">
    <entity charOffset="101-150" id="s1103.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="189-195" id="s1103.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1103.e0" e2="s1103.e1" id="s1103.p0" relation="true"/>
  </sentence>
  <sentence id="s1104" text="&lt;b&gt;Methods:&lt;/b&gt; Using immunohistochemical method detected the expression level of negative regulation of osteoblast differentiation in 60 cases of gliomas (including WHO grades ,  and , each for 20 cases) and 20 cases of non-tumor brain tissues.">
    <entity charOffset="82-131" id="s1104.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="228-233" id="s1104.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1104.e0" e2="s1104.e1" id="s1104.p0" relation="false"/>
  </sentence>
  <sentence id="s1105" text="&lt;b&gt;Objective:&lt;/b&gt; To investigate the significance of Twist2 in glioma and whether it is involved in the malignant transformation of glioma by epithelial-mesenchymal transition (cytokine production).">
    <entity charOffset="63-69" id="s1105.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="177-196" id="s1105.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s1105.e0" e2="s1105.e1" id="s1105.p0" relation="false"/>
  </sentence>
  <sentence id="s1106" text="The percentages of negative regulation of osteoblast differentiation expression were 75% (15/20), 95% (19/20), and 100% (20/20) in the WHO grades,  and  gliomas, respectively.">
    <entity charOffset="19-68" id="s1106.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="156-162" id="s1106.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1106.e0" e2="s1106.e1" id="s1106.p0" relation="false"/>
  </sentence>
  <sentence id="s1107" text="Detection of key protein expression in cytokine production by Western blot displayed that the expression of E-cadherin was negatively associated with negative regulation of osteoblast differentiation in glioma (&lt;i&gt;r&lt;/i&gt;=-0.972, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="39-58" id="s1107.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="203-209" id="s1107.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1107.e0" e2="s1107.e1" id="s1107.p0" relation="false"/>
  </sentence>
  <sentence id="s1108" text="Detection of key protein expression in cytokine production by Western blot displayed that the expression of E-cadherin was negatively associated with negative regulation of osteoblast differentiation in glioma (&lt;i&gt;r&lt;/i&gt;=-0.972, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="150-199" id="s1108.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="203-209" id="s1108.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1108.e0" e2="s1108.e1" id="s1108.p0" relation="true"/>
  </sentence>
  <sentence id="s1109" text="Global-genome nucleotide excision repair (GG-positive regulation of cholesterol transport) prevents ultraviolet (UV) light-induced skin cancer by removing mutagenic cyclobutane pyrimidine dimers (CPDs).">
    <entity charOffset="45-89" id="s1109.e0" ontology_id="GO_0032376" text="positive regulation of cholesterol transport" type="GO"/>
    <entity charOffset="136-142" id="s1109.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1109.e0" e2="s1109.e1" id="s1109.p0" relation="false"/>
  </sentence>
  <sentence id="s1110" text="MIB1/regulation of proteasomal protein catabolic process-67 was low and highlighted 4%-5% tumor nuclei.">
    <entity charOffset="5-56" id="s1110.e0" ontology_id="GO_0061136" text="regulation of proteasomal protein catabolic process" type="GO"/>
    <entity charOffset="90-95" id="s1110.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1110.e0" e2="s1110.e1" id="s1110.p0" relation="false"/>
  </sentence>
  <sentence id="s1111" text="In this study superoxide metabolic process exhibited sensitivity and specificity in diagnosis of acral melanoma which allows its application as an auxiliary diagnostic test in acral melanocytic tumours">
    <entity charOffset="14-42" id="s1111.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="97-102" id="s1111.e1" ontology_id="HP_0025292" text="acral" type="HP"/>
    <pair e1="s1111.e0" e2="s1111.e1" id="s1111.p0" relation="false"/>
  </sentence>
  <sentence id="s1112" text="This phenotypic variability should be taken into account when treating patients with positive regulation of protein phosphorylation-associated neurodegenerative disease.">
    <entity charOffset="85-131" id="s1112.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="143-168" id="s1112.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s1112.e0" e2="s1112.e1" id="s1112.p0" relation="true"/>
  </sentence>
  <sentence id="s1113" text="Recessive mutations in positive regulation of protein phosphorylation cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-69" id="s1113.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="213-221" id="s1113.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1113.e0" e2="s1113.e1" id="s1113.p0" relation="true"/>
  </sentence>
  <sentence id="s1114" text="Here, we report two affected siblings with compound heterozygous truncating mutations in positive regulation of protein phosphorylation and intra-familial phenotypic heterogeneity, with a less severe disease course in the female sibling.">
    <entity charOffset="89-135" id="s1114.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="166-179" id="s1114.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1114.e0" e2="s1114.e1" id="s1114.p0" relation="false"/>
  </sentence>
  <sentence id="s1115" text="Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced xenobiotic metabolic process expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras&lt;sup&gt;LSL-G12D/+&lt;/sup&gt;; Ptf1a&lt;sup&gt;Cre/+&lt;/sup&gt; (KC) epidermis development.">
    <entity charOffset="78-106" id="s1115.e0" ontology_id="GO_0006805" text="xenobiotic metabolic process" type="GO"/>
    <entity charOffset="246-251" id="s1115.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1115.e0" e2="s1115.e1" id="s1115.p0" relation="true"/>
  </sentence>
  <sentence id="s1116" text="Here, we found that 15-L-serine biosynthetic process expression was inversely correlated with oxidation-reduction process, an important cancer stem cell-associated marker indicative of poor prognosis in humans.">
    <entity charOffset="23-52" id="s1116.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="136-142" id="s1116.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1116.e0" e2="s1116.e1" id="s1116.p0" relation="true"/>
  </sentence>
  <sentence id="s1117" text="Here, we found that 15-L-serine biosynthetic process expression was inversely correlated with oxidation-reduction process, an important cancer stem cell-associated marker indicative of poor prognosis in humans.">
    <entity charOffset="94-121" id="s1117.e0" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <entity charOffset="136-142" id="s1117.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1117.e0" e2="s1117.e1" id="s1117.p0" relation="true"/>
  </sentence>
  <sentence id="s1118" text="Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; folate import across plasma membrane 80G&amp;gt;A, DHFR 829C&amp;gt;T, MTHFR 677C&amp;gt;T, MTHFR 1298A&amp;gt;C, and ATIC 347C&amp;gt;G.">
    <entity charOffset="33-45" id="s1118.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="117-153" id="s1118.e1" ontology_id="GO_1904447" text="folate import across plasma membrane" type="GO"/>
    <pair e1="s1118.e0" e2="s1118.e1" id="s1118.p0" relation="false"/>
  </sentence>
  <sentence id="s1119" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, regulation of transcription by RNA polymerase II, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="87-108" id="s1119.e0" ontology_id="GO_0051216" text="cartilage development" type="GO"/>
    <entity charOffset="410-426" id="s1119.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s1119.e0" e2="s1119.e1" id="s1119.p0" relation="false"/>
  </sentence>
  <sentence id="s1120" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, regulation of transcription by RNA polymerase II, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="130-187" id="s1120.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="410-426" id="s1120.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s1120.e0" e2="s1120.e1" id="s1120.p0" relation="true"/>
  </sentence>
  <sentence id="s1121" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, regulation of transcription by RNA polymerase II, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="189-237" id="s1121.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="410-426" id="s1121.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s1121.e0" e2="s1121.e1" id="s1121.p0" relation="false"/>
  </sentence>
  <sentence id="s1122" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, regulation of transcription by RNA polymerase II, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="243-284" id="s1122.e0" ontology_id="GO_0045646" text="regulation of erythrocyte differentiation" type="GO"/>
    <entity charOffset="410-426" id="s1122.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s1122.e0" e2="s1122.e1" id="s1122.p0" relation="true"/>
  </sentence>
  <sentence id="s1123" text="cation transport mutations are one cause of autosomal recessive RP making the CNGB1 mutant dog a valuable large animal model of the condition">
    <entity charOffset="0-16" id="s1123.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="44-63" id="s1123.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1123.e0" e2="s1123.e1" id="s1123.p0" relation="true"/>
  </sentence>
  <sentence id="s1124" text="Uterine carcinosarcoma (UCS) has been proposed as a model for epithelial-mesenchymal transition (cytokine production), a process characterized by a functional change facilitating migration and metastasis in many types of cancer.">
    <entity charOffset="97-116" id="s1124.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="221-227" id="s1124.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1124.e0" e2="s1124.e1" id="s1124.p0" relation="false"/>
  </sentence>
  <sentence id="s1125" text="This study demonstrates that peptidyl-serine phosphorylation and regulation of double-strand break repair via homologous recombination are indicators of poor prognosis for breast carcinomas and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma">
    <entity charOffset="29-60" id="s1125.e0" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <entity charOffset="172-188" id="s1125.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1125.e0" e2="s1125.e1" id="s1125.p0" relation="true"/>
  </sentence>
  <sentence id="s1126" text="This study demonstrates that peptidyl-serine phosphorylation and regulation of double-strand break repair via homologous recombination are indicators of poor prognosis for breast carcinomas and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma">
    <entity charOffset="65-134" id="s1126.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="172-188" id="s1126.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1126.e0" e2="s1126.e1" id="s1126.p0" relation="true"/>
  </sentence>
  <sentence id="s1127" text="Though using the term gray platelets for negative regulation of transcription by RNA polymerase II deficiency has been debated, a reduced number of -granules has been described for macrothrombocytopenia due to &lt;i&gt;GATA1&lt;/i&gt; mutations.">
    <entity charOffset="41-98" id="s1127.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="182-203" id="s1127.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1127.e0" e2="s1127.e1" id="s1127.p0" relation="true"/>
  </sentence>
  <sentence id="s1128" text="Biallelic mutations in mitochondrial respiratory chain complex I assembly have been identified as responsible for cases of autosomal recessive Leigh syndrome associated with mitochondrial complex I deficiency.">
    <entity charOffset="23-73" id="s1128.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="123-142" id="s1128.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1128.e0" e2="s1128.e1" id="s1128.p0" relation="true"/>
  </sentence>
  <sentence id="s1129" text="Next, we show that biological_process functions as a tumor suppressor in GBM.">
    <entity charOffset="19-37" id="s1129.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="53-58" id="s1129.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1129.e0" e2="s1129.e1" id="s1129.p0" relation="true"/>
  </sentence>
  <sentence id="s1130" text="The fetus inherited an additional likely pathogenic novel missense change to a second MKS gene, positive regulation of transcription, DNA-templated; p.R2210C, suggesting oligogenic inheritance in this disorder">
    <entity charOffset="96-147" id="s1130.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="170-192" id="s1130.e1" ontology_id="HP_0010983" text="oligogenic inheritance" type="HP"/>
    <pair e1="s1130.e0" e2="s1130.e1" id="s1130.p0" relation="true"/>
  </sentence>
  <sentence id="s1131" text="&lt;b&gt;Objective:&lt;/b&gt; To investigate the genotype-phenotype correlation in Chinese familial hypertrophic cardiomyopathy (HCM )focusing on the cardiac troponin C gene negative regulation of ATPase activity c.">
    <entity charOffset="101-115" id="s1131.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="162-200" id="s1131.e1" ontology_id="GO_0032780" text="negative regulation of ATPase activity" type="GO"/>
    <pair e1="s1131.e0" e2="s1131.e1" id="s1131.p0" relation="true"/>
  </sentence>
  <sentence id="s1132" text="As it is currently unclear whether localized production of either H&lt;sub&gt;2&lt;/sub&gt;S or GSH contributes to retinal homeostasis, we undertook a comparative analysis of L-serine metabolic process and CSE expression in canine, non-human primate (NHP) and human retinas to determine if these antioxidants could play a regulatory role in age-related or disease-associated retinal degeneration.">
    <entity charOffset="163-189" id="s1132.e0" ontology_id="GO_0006563" text="L-serine metabolic process" type="GO"/>
    <entity charOffset="363-383" id="s1132.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1132.e0" e2="s1132.e1" id="s1132.p0" relation="false"/>
  </sentence>
  <sentence id="s1133" text="However, only recently have genetic studies demonstrated sequence variation in protein homotetramerization and HCN2 genes associated with human epilepsy.">
    <entity charOffset="79-106" id="s1133.e0" ontology_id="GO_0051289" text="protein homotetramerization" type="GO"/>
    <entity charOffset="144-152" id="s1133.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1133.e0" e2="s1133.e1" id="s1133.p0" relation="true"/>
  </sentence>
  <sentence id="s1134" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive muscle organ development 4 in SLC26A4 (~500 mutations, 203 point mutations).">
    <entity charOffset="160-191" id="s1134.e0" ontology_id="GO_1902358" text="sulfate transmembrane transport" type="GO"/>
    <entity charOffset="336-344" id="s1134.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1134.e0" e2="s1134.e1" id="s1134.p0" relation="false"/>
  </sentence>
  <sentence id="s1135" text="Of the genes detected out, gap junction-mediated intercellular transport gene mutation was with significant difference (&lt;sup&gt;2&lt;/sup&gt;=75.132, p=0.000) between audio-no-pass group (417/1315, 31.711%) and random-selected cohort (159/1000, 15.900%); c.109G&amp;gt;A was the most common allele, as well as the only one with significantly different allele frequency (&lt;sup&gt;2&lt;/sup&gt;=79.327, p=0.000) between audio-no-pass group (392/1315, 16.84%) and random-selected cohort (140/1000, 7.55%), which suggested c.109G&amp;gt;A mutation was critical for newborns' hearing loss.">
    <entity charOffset="27-72" id="s1135.e0" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <entity charOffset="558-570" id="s1135.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1135.e0" e2="s1135.e1" id="s1135.p0" relation="true"/>
  </sentence>
  <sentence id="s1136" text="In order to investigate essential molecular causes for hearing loss and mutation frequency of deafness-related genes, 1315 newborns who did not pass the Newborn Hearing Screening (biological_process) (audio-no-pass) and 1000 random-selected infants were subjected to detection for 101 hotspot mutations in 18 common deafness-related genes.">
    <entity charOffset="55-67" id="s1136.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="180-198" id="s1136.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1136.e0" e2="s1136.e1" id="s1136.p0" relation="false"/>
  </sentence>
  <sentence id="s1137" text="Because of the distinct ear anomalies and the hearing loss a cell fate determination mutation was taken into account.">
    <entity charOffset="24-37" id="s1137.e0" ontology_id="HP_0000598" text="ear anomalies" type="HP"/>
    <entity charOffset="61-84" id="s1137.e1" ontology_id="GO_0001709" text="cell fate determination" type="GO"/>
    <pair e1="s1137.e0" e2="s1137.e1" id="s1137.p0" relation="true"/>
  </sentence>
  <sentence id="s1138" text="Treacher Collins syndrome (regulation of translation, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-52" id="s1138.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="139-155" id="s1138.e1" ontology_id="HP_0000271" text="facial anomalies" type="HP"/>
    <pair e1="s1138.e0" e2="s1138.e1" id="s1138.p0" relation="false"/>
  </sentence>
  <sentence id="s1139" text="Treacher Collins syndrome (regulation of translation, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-52" id="s1139.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="235-247" id="s1139.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s1139.e0" e2="s1139.e1" id="s1139.p0" relation="false"/>
  </sentence>
  <sentence id="s1140" text="Treacher Collins syndrome (regulation of translation, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-52" id="s1140.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="249-261" id="s1140.e1" ontology_id="HP_0000175" text="cleft palate" type="HP"/>
    <pair e1="s1140.e0" e2="s1140.e1" id="s1140.p0" relation="false"/>
  </sentence>
  <sentence id="s1141" text="Here we describe three unrelated patients showing clinical features overlapping with regulation of translation, but who in addition have developmental delay, microcephaly and a distinct facial gestalt.">
    <entity charOffset="85-110" id="s1141.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="137-156" id="s1141.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1141.e0" e2="s1141.e1" id="s1141.p0" relation="false"/>
  </sentence>
  <sentence id="s1142" text="We have generated four thyroid cancer cell lines with a greater than 30-fold increase in acquired resistance to the peptidyl-tyrosine phosphorylation inhibitor dasatinib.">
    <entity charOffset="31-37" id="s1142.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="116-149" id="s1142.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s1142.e0" e2="s1142.e1" id="s1142.p0" relation="false"/>
  </sentence>
  <sentence id="s1143" text="We specifically discuss the role of eye development in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 tumor suppressor and MYC oncogene.">
    <entity charOffset="36-51" id="s1143.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="228-233" id="s1143.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1143.e0" e2="s1143.e1" id="s1143.p0" relation="true"/>
  </sentence>
  <sentence id="s1144" text="Special attention is given to p53-independent SALL2 regulation of pro-apoptotic genes B cell apoptotic process and PMAIP1, and the implication of these findings on the apoptotic response of cancer cells to therapy.">
    <entity charOffset="86-110" id="s1144.e0" ontology_id="GO_0001783" text="B cell apoptotic process" type="GO"/>
    <entity charOffset="190-196" id="s1144.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1144.e0" e2="s1144.e1" id="s1144.p0" relation="true"/>
  </sentence>
  <sentence id="s1145" text="Hence, this previously unknown protein ubiquitination/Brg1 signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric cancers">
    <entity charOffset="31-53" id="s1145.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="170-176" id="s1145.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1145.e0" e2="s1145.e1" id="s1145.p0" relation="true"/>
  </sentence>
  <sentence id="s1146" text="In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and nucleosome disassembly expression in human gastric cancer clinical samples.">
    <entity charOffset="18-23" id="s1146.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="122-144" id="s1146.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s1146.e0" e2="s1146.e1" id="s1146.p0" relation="true"/>
  </sentence>
  <sentence id="s1147" text="In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and nucleosome disassembly expression in human gastric cancer clinical samples.">
    <entity charOffset="66-72" id="s1147.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="122-144" id="s1147.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s1147.e0" e2="s1147.e1" id="s1147.p0" relation="true"/>
  </sentence>
  <sentence id="s1148" text="A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="55-73" id="s1148.e0" ontology_id="GO_0048666" text="neuron development" type="GO"/>
    <entity charOffset="284-290" id="s1148.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1148.e0" e2="s1148.e1" id="s1148.p0" relation="true"/>
  </sentence>
  <sentence id="s1149" text="A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="75-92" id="s1149.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="284-290" id="s1149.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1149.e0" e2="s1149.e1" id="s1149.p0" relation="true"/>
  </sentence>
  <sentence id="s1150" text="A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="101-127" id="s1150.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="284-290" id="s1150.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1150.e0" e2="s1150.e1" id="s1150.p0" relation="true"/>
  </sentence>
  <sentence id="s1151" text="A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="129-160" id="s1151.e0" ontology_id="GO_0060913" text="cardiac cell fate determination" type="GO"/>
    <entity charOffset="284-290" id="s1151.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1151.e0" e2="s1151.e1" id="s1151.p0" relation="true"/>
  </sentence>
  <sentence id="s1152" text="A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="168-210" id="s1152.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="284-290" id="s1152.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1152.e0" e2="s1152.e1" id="s1152.p0" relation="true"/>
  </sentence>
  <sentence id="s1153" text="A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="222-273" id="s1153.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="284-290" id="s1153.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1153.e0" e2="s1153.e1" id="s1153.p0" relation="true"/>
  </sentence>
  <sentence id="s1154" text="Further experiments demonstrated that the MYEOV ceRNA sequestered protein polyubiquitination-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.">
    <entity charOffset="66-92" id="s1154.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="223-228" id="s1154.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1154.e0" e2="s1154.e1" id="s1154.p0" relation="false"/>
  </sentence>
  <sentence id="s1155" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, ventricular trabecula myocardium morphogenesis, signal transduction, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s1155.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="288-307" id="s1155.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s1155.e0" e2="s1155.e1" id="s1155.p0" relation="false"/>
  </sentence>
  <sentence id="s1156" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, ventricular trabecula myocardium morphogenesis, signal transduction, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s1156.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="240-286" id="s1156.e1" ontology_id="GO_0003222" text="ventricular trabecula myocardium morphogenesis" type="GO"/>
    <pair e1="s1156.e0" e2="s1156.e1" id="s1156.p0" relation="false"/>
  </sentence>
  <sentence id="s1157" text="Empty spiracles homeobox 2 (regulation of transcription by RNA polymerase II) is a homeodomain-containing transcription factor that plays an essential role in tumorigenesis.">
    <entity charOffset="28-76" id="s1157.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="159-164" id="s1157.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1157.e0" e2="s1157.e1" id="s1157.p0" relation="true"/>
  </sentence>
  <sentence id="s1158" text="Global &lt;i&gt;ubiquitin-dependent protein catabolic process&lt;/i&gt; gene deletion or conditional inactivation in Nestin-positive cells led to formation of supratentorial hydrocephalus in the early postnatal period.">
    <entity charOffset="10-55" id="s1158.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="162-175" id="s1158.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s1158.e0" e2="s1158.e1" id="s1158.p0" relation="false"/>
  </sentence>
  <sentence id="s1159" text="&lt;i&gt;LCAM1&lt;/i&gt; and &lt;i&gt;ubiquitin-dependent protein catabolic process&lt;/i&gt; (&lt;i&gt;MUPP1&lt;/i&gt;) are the only known human gene loci associated with non-syndromic hydrocephalus.">
    <entity charOffset="20-65" id="s1159.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="150-163" id="s1159.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s1159.e0" e2="s1159.e1" id="s1159.p0" relation="true"/>
  </sentence>
  <sentence id="s1160" text="Expression of miR-17-92a miRNAs improved sensitivity of androgen dependent LNCaP 104-S prostate cancer cells to anti-androgen drug Casodex, positive regulation of protein phosphorylation inhibitor MK-2206 2HCl, and docetaxel.">
    <entity charOffset="96-102" id="s1160.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="140-186" id="s1160.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1160.e0" e2="s1160.e1" id="s1160.p0" relation="true"/>
  </sentence>
  <sentence id="s1161" text="Our study identifies WDR4 as an oncoprotein that negatively regulates response to hypoxia via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="70-89" id="s1161.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="196-201" id="s1161.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1161.e0" e2="s1161.e1" id="s1161.p0" relation="true"/>
  </sentence>
  <sentence id="s1162" text="The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (acute-phase response), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="161-181" id="s1162.e0" ontology_id="GO_0006953" text="acute-phase response" type="GO"/>
    <entity charOffset="281-287" id="s1162.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1162.e0" e2="s1162.e1" id="s1162.p0" relation="true"/>
  </sentence>
  <sentence id="s1163" text="protein phosphorylation overexpression promotes tumorigenesis and is associated with poor prognosis in several cancers.">
    <entity charOffset="0-23" id="s1163.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="111-117" id="s1163.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1163.e0" e2="s1163.e1" id="s1163.p0" relation="true"/>
  </sentence>
  <sentence id="s1164" text="The high levels of response to wounding expression in gastric GISTs was significantly associated with tumor size (P&amp;lt;.001), multivisceral resection (P=.006), metastasis at initial diagnosis (P=.006), mitotic count (P=.002) and NIH risk classification (P=.015).">
    <entity charOffset="19-39" id="s1164.e0" ontology_id="GO_0009611" text="response to wounding" type="GO"/>
    <entity charOffset="102-107" id="s1164.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1164.e0" e2="s1164.e1" id="s1164.p0" relation="true"/>
  </sentence>
  <sentence id="s1165" text="In particular, the negative regulation of phosphatase activity, SPTA1 and VPS13B genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.">
    <entity charOffset="19-62" id="s1165.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="138-144" id="s1165.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1165.e0" e2="s1165.e1" id="s1165.p0" relation="true"/>
  </sentence>
  <sentence id="s1166" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1166.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="399-456" id="s1166.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1166.e0" e2="s1166.e1" id="s1166.p0" relation="true"/>
  </sentence>
  <sentence id="s1167" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1167.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="357-397" id="s1167.e1" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <pair e1="s1167.e0" e2="s1167.e1" id="s1167.p0" relation="false"/>
  </sentence>
  <sentence id="s1168" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1168.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="162-198" id="s1168.e1" ontology_id="GO_0001837" text="epithelial to mesenchymal transition" type="GO"/>
    <pair e1="s1168.e0" e2="s1168.e1" id="s1168.p0" relation="false"/>
  </sentence>
  <sentence id="s1169" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1169.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="254-271" id="s1169.e1" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <pair e1="s1169.e0" e2="s1169.e1" id="s1169.p0" relation="false"/>
  </sentence>
  <sentence id="s1170" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1170.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="287-309" id="s1170.e1" ontology_id="GO_0045454" text="cell redox homeostasis" type="GO"/>
    <pair e1="s1170.e0" e2="s1170.e1" id="s1170.p0" relation="false"/>
  </sentence>
  <sentence id="s1171" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1171.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="208-252" id="s1171.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s1171.e0" e2="s1171.e1" id="s1171.p0" relation="true"/>
  </sentence>
  <sentence id="s1172" text="Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by MYOC, positive regulation of autophagy and TBK1 mutations.">
    <entity charOffset="94-102" id="s1172.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="162-194" id="s1172.e1" ontology_id="GO_0010508" text="positive regulation of autophagy" type="GO"/>
    <pair e1="s1172.e0" e2="s1172.e1" id="s1172.p0" relation="true"/>
  </sentence>
  <sentence id="s1173" text="Currently the only established high penetrance familial melanoma genes are G1/S transition of mitotic cell cycle and CDK4.">
    <entity charOffset="56-64" id="s1173.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="75-112" id="s1173.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s1173.e0" e2="s1173.e1" id="s1173.p0" relation="true"/>
  </sentence>
  <sentence id="s1174" text="The classical mammalian isoforms of PLD are PLD1 and phosphatidic acid biosynthetic process, and the levels of both mRNA were higher at the primary tumor sites than in normal kidney tissues.">
    <entity charOffset="53-91" id="s1174.e0" ontology_id="GO_0006654" text="phosphatidic acid biosynthetic process" type="GO"/>
    <entity charOffset="148-153" id="s1174.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1174.e0" e2="s1174.e1" id="s1174.p0" relation="true"/>
  </sentence>
  <sentence id="s1175" text="Notably, shRNA-mediated knockdown of phosphatidic acid biosynthetic process suppressed the growth and invasion of tumors in nude mouse xenograft models.">
    <entity charOffset="37-75" id="s1175.e0" ontology_id="GO_0006654" text="phosphatidic acid biosynthetic process" type="GO"/>
    <entity charOffset="114-119" id="s1175.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1175.e0" e2="s1175.e1" id="s1175.p0" relation="true"/>
  </sentence>
  <sentence id="s1176" text="As for genes relating to the tumor invasion of PLD2, we found that angiogenin (angiogenesis) was positively regulated by PLD2.">
    <entity charOffset="29-34" id="s1176.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="79-91" id="s1176.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s1176.e0" e2="s1176.e1" id="s1176.p0" relation="false"/>
  </sentence>
  <sentence id="s1177" text="We will systematically examine seven genes (CHN1, MDH1, PCP4, biological_process, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="62-80" id="s1177.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="139-165" id="s1177.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1177.e0" e2="s1177.e1" id="s1177.p0" relation="true"/>
  </sentence>
  <sentence id="s1178" text="Ectodysplasin-A2 (positive regulation of NF-kappaB transcription factor activity) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (XEDAR).">
    <entity charOffset="18-80" id="s1178.e0" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <entity charOffset="176-196" id="s1178.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s1178.e0" e2="s1178.e1" id="s1178.p0" relation="false"/>
  </sentence>
  <sentence id="s1179" text="The therapeutic strategy to recover immune function through the restoration of impaired Tregs function with the mounting evidences regarding positive regulation of protein phosphorylation in autoimmune mediated disorder (MS, SLE, RA, T1D) suggest as working hypothesis the direct targeting KRAS activation using cancer-derived small molecules may be clinically relevant">
    <entity charOffset="141-187" id="s1179.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="312-318" id="s1179.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1179.e0" e2="s1179.e1" id="s1179.p0" relation="true"/>
  </sentence>
  <sentence id="s1180" text="In order to investigate whether somatic positive regulation of cell proliferation gene mutations play a role in sporadic pediatric myeloproliferative diseases, we performed a mutation screening of a large representative cohort of pediatric acute myeloid leukemia, myeloid leukemia of Down syndrome, and juvenile myelomonocytic leukemia samples and show that gain-of-function THPO mutations are extremely rare in sporadic pediatric myeloproliferative diseases">
    <entity charOffset="40-81" id="s1180.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="112-120" id="s1180.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1180.e0" e2="s1180.e1" id="s1180.p0" relation="true"/>
  </sentence>
  <sentence id="s1181" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (regulation of postsynapse organization), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (positive regulation of receptor internalization), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (homophilic cell adhesion via plasma membrane adhesion molecules), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s1181.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="613-676" id="s1181.e1" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <pair e1="s1181.e0" e2="s1181.e1" id="s1181.p0" relation="false"/>
  </sentence>
  <sentence id="s1182" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (regulation of postsynapse organization), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (positive regulation of receptor internalization), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (homophilic cell adhesion via plasma membrane adhesion molecules), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s1182.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="211-249" id="s1182.e1" ontology_id="GO_0099175" text="regulation of postsynapse organization" type="GO"/>
    <pair e1="s1182.e0" e2="s1182.e1" id="s1182.p0" relation="true"/>
  </sentence>
  <sentence id="s1183" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (regulation of postsynapse organization), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (positive regulation of receptor internalization), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (homophilic cell adhesion via plasma membrane adhesion molecules), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s1183.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="451-498" id="s1183.e1" ontology_id="GO_0002092" text="positive regulation of receptor internalization" type="GO"/>
    <pair e1="s1183.e0" e2="s1183.e1" id="s1183.p0" relation="false"/>
  </sentence>
  <sentence id="s1184" text="Overall, our results define an oncogenic role of &lt;i&gt;pancEts-1&lt;/i&gt; in neuroblastoma progression through regulation of low-density lipoprotein particle clearance-mediated -catenin stabilization, with potential implications for the clinical therapeutics of neuroblastoma.&lt;b&gt;Significance:&lt;/b&gt; These findings reveal the oncogenic functions of a long noncoding RNA in neuroblastoma progression, offering a potential target for clinical therapeutics.">
    <entity charOffset="69-82" id="s1184.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="103-159" id="s1184.e1" ontology_id="GO_0010988" text="regulation of low-density lipoprotein particle clearance" type="GO"/>
    <pair e1="s1184.e0" e2="s1184.e1" id="s1184.p0" relation="false"/>
  </sentence>
  <sentence id="s1185" text="Both &lt;i&gt;pancEts-1&lt;/i&gt; and &lt;i&gt;regulation of low-density lipoprotein particle clearance&lt;/i&gt; were upregulated in clinical neuroblastoma tissues, and were associated with unfavorable outcome of patients.">
    <entity charOffset="29-85" id="s1185.e0" ontology_id="GO_0010988" text="regulation of low-density lipoprotein particle clearance" type="GO"/>
    <entity charOffset="119-132" id="s1185.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1185.e0" e2="s1185.e1" id="s1185.p0" relation="true"/>
  </sentence>
  <sentence id="s1186" text="Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, DNA replication initiation, negative regulation of cell division, CDT1, and CDC6.">
    <entity charOffset="45-58" id="s1186.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="245-281" id="s1186.e1" ontology_id="GO_0051782" text="negative regulation of cell division" type="GO"/>
    <pair e1="s1186.e0" e2="s1186.e1" id="s1186.p0" relation="true"/>
  </sentence>
  <sentence id="s1187" text="Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, DNA replication initiation, negative regulation of cell division, CDT1, and CDC6.">
    <entity charOffset="45-58" id="s1187.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="217-243" id="s1187.e1" ontology_id="GO_0006270" text="DNA replication initiation" type="GO"/>
    <pair e1="s1187.e0" e2="s1187.e1" id="s1187.p0" relation="false"/>
  </sentence>
  <sentence id="s1188" text="Multiple mitochondrial dysfunction syndrome 1 (MMDS1) arises as a result of the missense mutation in iron-sulfur cluster assembly, an Fe/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).">
    <entity charOffset="9-34" id="s1188.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="101-129" id="s1188.e1" ontology_id="GO_0016226" text="iron-sulfur cluster assembly" type="GO"/>
    <pair e1="s1188.e0" e2="s1188.e1" id="s1188.p0" relation="true"/>
  </sentence>
  <sentence id="s1189" text="Retrospectively study revealed that protein polyubiquitination-34a expression was downregulated in human primary GC tissues compared with non-tumor tissues and low miR-34a expression was associated with a significantly shorter overall survival and disease-free survival.">
    <entity charOffset="36-62" id="s1189.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="142-147" id="s1189.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1189.e0" e2="s1189.e1" id="s1189.p0" relation="true"/>
  </sentence>
  <sentence id="s1190" text="However, the relationship between protein polyubiquitination-34a and luteolin's susceptibility to cancer cells still remains unclear.">
    <entity charOffset="34-60" id="s1190.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="98-104" id="s1190.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1190.e0" e2="s1190.e1" id="s1190.p0" relation="false"/>
  </sentence>
  <sentence id="s1191" text="This case unravels a previously unrecognized phenotype of camptodactyly due to a significant skeletal deformity of PRS with a heterogeneous negative regulation of apoptotic process mutation of hexanucleotide duplication.">
    <entity charOffset="126-139" id="s1191.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="140-180" id="s1191.e1" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <pair e1="s1191.e0" e2="s1191.e1" id="s1191.p0" relation="true"/>
  </sentence>
  <sentence id="s1192" text="The regulation of cell growth pathway was significantly associated with overall and estrogen receptor-negative (ER-) breast cancer risk (P = 0.003 and 0.03, respectively).">
    <entity charOffset="4-29" id="s1192.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="124-130" id="s1192.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1192.e0" e2="s1192.e1" id="s1192.p0" relation="true"/>
  </sentence>
  <sentence id="s1193" text="cell cycle arrest (Padj = 0.0018) and RPS6KA3 (Padj = 0.061) were the leading genes for the associations with overall breast cancer risk and ER- breast cancer risk, respectively.">
    <entity charOffset="0-17" id="s1193.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="125-131" id="s1193.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1193.e0" e2="s1193.e1" id="s1193.p0" relation="true"/>
  </sentence>
  <sentence id="s1194" text="detection of calcium ion expression is lost in colonic malignancies, indicating that the CaSR is a biomarker for colonic cancer progression.">
    <entity charOffset="0-24" id="s1194.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="121-127" id="s1194.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1194.e0" e2="s1194.e1" id="s1194.p0" relation="true"/>
  </sentence>
  <sentence id="s1195" text="More important, negative regulation of endodermal cell differentiation haploinsufficiency markedly increased the incidence and severity of abdominal aortic aneurysms, and caused aortic arch ruptures and dissections, indicating that 2(V) chain deficits may play roles in these pathologies in humans">
    <entity charOffset="16-70" id="s1195.e0" ontology_id="GO_1903225" text="negative regulation of endodermal cell differentiation" type="GO"/>
    <entity charOffset="149-165" id="s1195.e1" ontology_id="HP_0004942" text="aortic aneurysms" type="HP"/>
    <pair e1="s1195.e0" e2="s1195.e1" id="s1195.p0" relation="true"/>
  </sentence>
  <sentence id="s1196" text="We aimed to investigate the effect of the AS to negative regulation of transcription by RNA polymerase II gene on non-small cell lung cancer (NSCLC) development.">
    <entity charOffset="48-105" id="s1196.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="134-140" id="s1196.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1196.e0" e2="s1196.e1" id="s1196.p0" relation="true"/>
  </sentence>
  <sentence id="s1197" text="By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and negative regulation of transcription by RNA polymerase II were significantly higher in tumour tissues than those of the adjacent non-cancerous tissues in 969 NSCLC patients (P&amp;lt;0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r=0.90, P&amp;lt;0.001).">
    <entity charOffset="85-142" id="s1197.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="172-178" id="s1197.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1197.e0" e2="s1197.e1" id="s1197.p0" relation="true"/>
  </sentence>
  <sentence id="s1198" text="In the framework of this heterogeneity, we report the clinical description of a neonate, first child of consanguineous parents, who had osteoclast-rich osteopetrosis and bone marrow failure in early life, but no other usual classical features of infantile malignant positive regulation of collagen biosynthetic process, such as visual or hearing impairments.">
    <entity charOffset="25-38" id="s1198.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="266-318" id="s1198.e1" ontology_id="GO_0032967" text="positive regulation of collagen biosynthetic process" type="GO"/>
    <pair e1="s1198.e0" e2="s1198.e1" id="s1198.p0" relation="false"/>
  </sentence>
  <sentence id="s1199" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="86-102" id="s1199.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="353-384" id="s1199.e1" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <pair e1="s1199.e0" e2="s1199.e1" id="s1199.p0" relation="true"/>
  </sentence>
  <sentence id="s1200" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="86-102" id="s1200.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="239-273" id="s1200.e1" ontology_id="GO_0006211" text="5-methylcytosine catabolic process" type="GO"/>
    <pair e1="s1200.e0" e2="s1200.e1" id="s1200.p0" relation="true"/>
  </sentence>
  <sentence id="s1201" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="86-102" id="s1201.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="340-351" id="s1201.e1" ontology_id="GO_0030097" text="hemopoiesis" type="GO"/>
    <pair e1="s1201.e0" e2="s1201.e1" id="s1201.p0" relation="false"/>
  </sentence>
  <sentence id="s1202" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="121-130" id="s1202.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="141-166" id="s1202.e1" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <pair e1="s1202.e0" e2="s1202.e1" id="s1202.p0" relation="true"/>
  </sentence>
  <sentence id="s1203" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="121-130" id="s1203.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="275-332" id="s1203.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1203.e0" e2="s1203.e1" id="s1203.p0" relation="false"/>
  </sentence>
  <sentence id="s1204" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and cellular response to reactive oxygen species rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="19-24" id="s1204.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="101-145" id="s1204.e1" ontology_id="GO_0034614" text="cellular response to reactive oxygen species" type="GO"/>
    <pair e1="s1204.e0" e2="s1204.e1" id="s1204.p0" relation="false"/>
  </sentence>
  <sentence id="s1205" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and cellular response to reactive oxygen species rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="19-24" id="s1205.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="255-275" id="s1205.e1" ontology_id="GO_0061621" text="canonical glycolysis" type="GO"/>
    <pair e1="s1205.e0" e2="s1205.e1" id="s1205.p0" relation="true"/>
  </sentence>
  <sentence id="s1206" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and cellular response to reactive oxygen species rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="101-145" id="s1206.e0" ontology_id="GO_0034614" text="cellular response to reactive oxygen species" type="GO"/>
    <entity charOffset="222-245" id="s1206.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1206.e0" e2="s1206.e1" id="s1206.p0" relation="true"/>
  </sentence>
  <sentence id="s1207" text="Hypermethylated in cancer 1 (negative regulation of transcription by RNA polymerase II) is frequently deleted or epigenetically silenced in various human cancers.">
    <entity charOffset="19-25" id="s1207.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="29-86" id="s1207.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1207.e0" e2="s1207.e1" id="s1207.p0" relation="true"/>
  </sentence>
  <sentence id="s1208" text="The results provide evidence that lncRNA-numb is a newly proposed tumor suppressor that is involved in negative regulation of transcription by RNA polymerase II-induced phenotypes.">
    <entity charOffset="66-71" id="s1208.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="103-160" id="s1208.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1208.e0" e2="s1208.e1" id="s1208.p0" relation="true"/>
  </sentence>
  <sentence id="s1209" text="In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in protein sumoylation previously associated with SMS.">
    <entity charOffset="81-91" id="s1209.e0" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <entity charOffset="210-229" id="s1209.e1" ontology_id="GO_0016925" text="protein sumoylation" type="GO"/>
    <pair e1="s1209.e0" e2="s1209.e1" id="s1209.p0" relation="true"/>
  </sentence>
  <sentence id="s1210" text="De novo missense and frameshift mutations and deletions involving negative regulation of transcription by RNA polymerase II have been described in patients with intellectual disability and autism, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.">
    <entity charOffset="66-123" id="s1210.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="189-195" id="s1210.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1210.e0" e2="s1210.e1" id="s1210.p0" relation="false"/>
  </sentence>
  <sentence id="s1211" text="Here, we report mutations in proline biosynthetic process, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, hypomyelination, and reduced cerebral white-matter volume.">
    <entity charOffset="29-57" id="s1211.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="181-193" id="s1211.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1211.e0" e2="s1211.e1" id="s1211.p0" relation="true"/>
  </sentence>
  <sentence id="s1212" text="negative regulation of mammary gland epithelial cell proliferation, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary tumorigenesis by regulating transcription in coordination with two essential DNA repair factors, PARP1 and BRCA1.">
    <entity charOffset="0-66" id="s1212.e0" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <entity charOffset="188-193" id="s1212.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1212.e0" e2="s1212.e1" id="s1212.p0" relation="true"/>
  </sentence>
  <sentence id="s1213" text="In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and double-strand break repair via homologous recombination in paratumors, but the correlation turned insignificant in mammary tumors.">
    <entity charOffset="130-185" id="s1213.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="193-199" id="s1213.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1213.e0" e2="s1213.e1" id="s1213.p0" relation="true"/>
  </sentence>
  <sentence id="s1214" text="Using vectors encoding negative regulation of mammary gland epithelial cell proliferation with mutations frequently occurring in mammary tumors, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair.">
    <entity charOffset="23-89" id="s1214.e0" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <entity charOffset="137-143" id="s1214.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1214.e0" e2="s1214.e1" id="s1214.p0" relation="true"/>
  </sentence>
  <sentence id="s1215" text="Multivariate analysis data revealed that nucleotide-excision repair and protein phosphorylation protein expression were independent predictors of overall survival of ESCC patients after chemotherapy and/or radiotherapy (P&amp;lt;.05).ERCC1 overexpression is an important phenotype that is associated with ESCC lymph node metastasis and advanced tumor clinical stages.">
    <entity charOffset="41-67" id="s1215.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="343-348" id="s1215.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1215.e0" e2="s1215.e1" id="s1215.p0" relation="true"/>
  </sentence>
  <sentence id="s1216" text="nucleotide-excision repair overexpression associated with advanced tumor clinical stage and lymph node metastasis (P&amp;lt;.05), but not with tumor size, depth of invasion, or differentiation (P&amp;gt;.05).">
    <entity charOffset="0-26" id="s1216.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="67-72" id="s1216.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1216.e0" e2="s1216.e1" id="s1216.p0" relation="true"/>
  </sentence>
  <sentence id="s1217" text="Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the blood coagulation gene in infants from consanguineous families who suffered from life-threatening neutropenia, which was refractory to granulocyte CSF, from defective platelet aggregation and myelofibrosis.">
    <entity charOffset="99-116" id="s1217.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="256-286" id="s1217.e1" ontology_id="HP_0003540" text="defective platelet aggregation" type="HP"/>
    <pair e1="s1217.e0" e2="s1217.e1" id="s1217.p0" relation="true"/>
  </sentence>
  <sentence id="s1218" text="Importantly, cell line and animal experiments both confirmed that E2F6 promotes ovarian cancer stemness, whereas E2F6 or negative regulation of transcription by RNA polymerase II depletion derepressed miR-193a, which opposes cancer stemness, by alleviating DNA methylation and repressive chromatin.">
    <entity charOffset="88-94" id="s1218.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="121-178" id="s1218.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1218.e0" e2="s1218.e1" id="s1218.p0" relation="true"/>
  </sentence>
  <sentence id="s1219" text="To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, activation of MAPK activity, by epigenetic silencing the tumor suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.">
    <entity charOffset="212-239" id="s1219.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="269-274" id="s1219.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1219.e0" e2="s1219.e1" id="s1219.p0" relation="true"/>
  </sentence>
  <sentence id="s1220" text="positive regulation of cytosolic calcium ion concentration showed the highest enrichment of gene signatures for interleukin-13/T-helper cell type 2 (Th2) and innate lymphoid cell type 2.TAC1 had the highest sputum eosinophilia and exhaled nitric oxide fraction, and was restricted to severe asthma with oral corticosteroid dependency, frequent exacerbations and severe airflow obstruction.">
    <entity charOffset="0-58" id="s1220.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="215-227" id="s1220.e1" ontology_id="HP_0001880" text="eosinophilia" type="HP"/>
    <pair e1="s1220.e0" e2="s1220.e1" id="s1220.p0" relation="false"/>
  </sentence>
  <sentence id="s1221" text="We found that protein acetylation was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast cancers.">
    <entity charOffset="14-33" id="s1221.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="203-209" id="s1221.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1221.e0" e2="s1221.e1" id="s1221.p0" relation="true"/>
  </sentence>
  <sentence id="s1222" text="Our study shows that in neuroblastomas, negative regulation of transcription by RNA polymerase II- or negative regulation of DNA replication-based PI provides valuable prognostic information and high PI indicates aggressive disease">
    <entity charOffset="24-38" id="s1222.e0" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <entity charOffset="102-140" id="s1222.e1" ontology_id="GO_0008156" text="negative regulation of DNA replication" type="GO"/>
    <pair e1="s1222.e0" e2="s1222.e1" id="s1222.p0" relation="false"/>
  </sentence>
  <sentence id="s1223" text="Our study shows that in neuroblastomas, negative regulation of transcription by RNA polymerase II- or negative regulation of DNA replication-based PI provides valuable prognostic information and high PI indicates aggressive disease">
    <entity charOffset="24-38" id="s1223.e0" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <entity charOffset="40-97" id="s1223.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1223.e0" e2="s1223.e1" id="s1223.p0" relation="false"/>
  </sentence>
  <sentence id="s1224" text="By whole-exome sequencing, recessive protein-truncating mutations in mRNA splicing, via spliceosome were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.">
    <entity charOffset="69-99" id="s1224.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="256-269" id="s1224.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s1224.e0" e2="s1224.e1" id="s1224.p0" relation="false"/>
  </sentence>
  <sentence id="s1225" text="By whole-exome sequencing, recessive protein-truncating mutations in mRNA splicing, via spliceosome were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.">
    <entity charOffset="69-99" id="s1225.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="191-211" id="s1225.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1225.e0" e2="s1225.e1" id="s1225.p0" relation="true"/>
  </sentence>
  <sentence id="s1226" text="Remarkably, variable expressivity of the human phenotype can be recapitulated in mRNA splicing, via spliceosome mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.">
    <entity charOffset="81-111" id="s1226.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="291-311" id="s1226.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1226.e0" e2="s1226.e1" id="s1226.p0" relation="true"/>
  </sentence>
  <sentence id="s1227" text="The abnormal regulation of protein polyubiquitination-483 may play an important role in tumorigenesis, and G protein-coupled receptor signaling pathway is known to regulate cell polarity, cell migration, and cell division.">
    <entity charOffset="27-53" id="s1227.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="88-93" id="s1227.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1227.e0" e2="s1227.e1" id="s1227.p0" relation="false"/>
  </sentence>
  <sentence id="s1228" text="The abnormal regulation of protein polyubiquitination-483 may play an important role in tumorigenesis, and G protein-coupled receptor signaling pathway is known to regulate cell polarity, cell migration, and cell division.">
    <entity charOffset="88-93" id="s1228.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="107-151" id="s1228.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s1228.e0" e2="s1228.e1" id="s1228.p0" relation="true"/>
  </sentence>
  <sentence id="s1229" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of positive regulation of cell proliferation and regulation of cell cycle in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="48-89" id="s1229.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="141-146" id="s1229.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1229.e0" e2="s1229.e1" id="s1229.p0" relation="true"/>
  </sentence>
  <sentence id="s1230" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of positive regulation of cell proliferation and regulation of cell cycle in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="94-118" id="s1230.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="141-146" id="s1230.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1230.e0" e2="s1230.e1" id="s1230.p0" relation="true"/>
  </sentence>
  <sentence id="s1231" text="Few studies have examined the roles of endocardial cushion development and GATA4 in cardiac abnormalities or their association with pulmonary artery histopathology.">
    <entity charOffset="39-70" id="s1231.e0" ontology_id="GO_0003197" text="endocardial cushion development" type="GO"/>
    <entity charOffset="84-105" id="s1231.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s1231.e0" e2="s1231.e1" id="s1231.p0" relation="true"/>
  </sentence>
  <sentence id="s1232" text="Addition of exogenous negative regulation of cell proliferation (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor- (negative regulation of transcription by RNA polymerase II-)-stimulated human umbilical cord vascular endothelial cell (HUVEC) tube formation.">
    <entity charOffset="22-63" id="s1232.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="171-176" id="s1232.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1232.e0" e2="s1232.e1" id="s1232.p0" relation="false"/>
  </sentence>
  <sentence id="s1233" text="Addition of exogenous negative regulation of cell proliferation (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor- (negative regulation of transcription by RNA polymerase II-)-stimulated human umbilical cord vascular endothelial cell (HUVEC) tube formation.">
    <entity charOffset="171-176" id="s1233.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="196-253" id="s1233.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1233.e0" e2="s1233.e1" id="s1233.p0" relation="false"/>
  </sentence>
  <sentence id="s1234" text="The melanogenic activity of 6-benzylaminopurine, the compound identified as the most potent, was further verified by measuring green fluorescent protein concentration in positive regulation of melanin biosynthetic process a: eGFP (tyrosinase-related protein 1) zebrafish and mitfa: eGFP (microphthalmia associated transcription factor) zebrafish and antioxidative activity.">
    <entity charOffset="170-221" id="s1234.e0" ontology_id="GO_0048023" text="positive regulation of melanin biosynthetic process" type="GO"/>
    <entity charOffset="288-302" id="s1234.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s1234.e0" e2="s1234.e1" id="s1234.p0" relation="false"/>
  </sentence>
  <sentence id="s1235" text="Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and ossification genes and the clinical phenotype.">
    <entity charOffset="88-117" id="s1235.e0" ontology_id="HP_0008341" text="distal renal tubular acidosis" type="HP"/>
    <entity charOffset="188-200" id="s1235.e1" ontology_id="GO_0001503" text="ossification" type="GO"/>
    <pair e1="s1235.e0" e2="s1235.e1" id="s1235.p0" relation="false"/>
  </sentence>
  <sentence id="s1236" text="Cerebellar involvement is an important feature of protein glycosylation-CDG, the congenital muscular dystrophies due to dystroglycanopathy, and polyprenol catabolic process-CDG.">
    <entity charOffset="50-71" id="s1236.e0" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <entity charOffset="92-112" id="s1236.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s1236.e0" e2="s1236.e1" id="s1236.p0" relation="true"/>
  </sentence>
  <sentence id="s1237" text="Cerebellar involvement is an important feature of protein glycosylation-CDG, the congenital muscular dystrophies due to dystroglycanopathy, and polyprenol catabolic process-CDG.">
    <entity charOffset="92-112" id="s1237.e0" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <entity charOffset="144-172" id="s1237.e1" ontology_id="GO_0016095" text="polyprenol catabolic process" type="GO"/>
    <pair e1="s1237.e0" e2="s1237.e1" id="s1237.p0" relation="true"/>
  </sentence>
  <sentence id="s1238" text="Double-labeling immunohistochemistry for Pit-1/GH, Pit-1/NFP, Pit-1/MAP2, and mRNA processing/GH was performed in 9/10 tumors.">
    <entity charOffset="78-93" id="s1238.e0" ontology_id="GO_0006397" text="mRNA processing" type="GO"/>
    <entity charOffset="119-125" id="s1238.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1238.e0" e2="s1238.e1" id="s1238.p0" relation="true"/>
  </sentence>
  <sentence id="s1239" text="We investigate the association of DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest with castration-resistant prostate cancer (CRPC), bone metastasis, and PC recurrence.">
    <entity charOffset="34-127" id="s1239.e0" ontology_id="GO_0006977" text="DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" type="GO"/>
    <entity charOffset="163-169" id="s1239.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1239.e0" e2="s1239.e1" id="s1239.p0" relation="true"/>
  </sentence>
  <sentence id="s1240" text="Logistic regression analysis adjusted for age and gender reported a moderate association between rectal cancer risk and two negative regulation of NF-kappaB transcription factor activity SNPs, rs1684575 T&amp;gt;G (OR: 1.60, 95% CI: 1.13-2.27, recessive model) and rs3751710 (OR: 0.70, 95% CI: 0.51-0.96, dominant model).">
    <entity charOffset="104-110" id="s1240.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="124-186" id="s1240.e1" ontology_id="GO_0032088" text="negative regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s1240.e0" e2="s1240.e1" id="s1240.p0" relation="true"/>
  </sentence>
  <sentence id="s1241" text="Constitutive activation of interferon signaling pathways has been reported in colorectal cancer (CRC), leading to a strong CD8+ T cell response through stimulation of negative regulation of NF-kappaB transcription factor activity expression.">
    <entity charOffset="89-95" id="s1241.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="167-229" id="s1241.e1" ontology_id="GO_0032088" text="negative regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s1241.e0" e2="s1241.e1" id="s1241.p0" relation="true"/>
  </sentence>
  <sentence id="s1242" text="Additionally, chemotaxis increases the metastatic ability of a cancer by enhancing cell migration, matrix metalloproteinase-7 expression and EMT.">
    <entity charOffset="14-24" id="s1242.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="63-69" id="s1242.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1242.e0" e2="s1242.e1" id="s1242.p0" relation="true"/>
  </sentence>
  <sentence id="s1243" text="Inflammatory chemokine chemotaxis, present in large amounts in DCs isolated from colon cancer patients, and SW620-conditioned TADCs, enhance CSC characteristics in cancer, supported by enhanced anchorage-independent growth, CD133 expression and aldehyde dehydrogenase activity.">
    <entity charOffset="23-33" id="s1243.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="87-93" id="s1243.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1243.e0" e2="s1243.e1" id="s1243.p0" relation="true"/>
  </sentence>
  <sentence id="s1244" text="Transcriptome analysis of chemotaxis-treated SW620 cells indicates that CXCL1 increases potential oncogene expression in colon cancer, including &lt;i&gt;PTHLH&lt;/i&gt;, &lt;i&gt;TYRP1&lt;/i&gt;, &lt;i&gt;FOXO1&lt;/i&gt;, &lt;i&gt;TCF4&lt;/i&gt; and &lt;i&gt;ZNF880&lt;/i&gt;.">
    <entity charOffset="26-36" id="s1244.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="127-133" id="s1244.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1244.e0" e2="s1244.e1" id="s1244.p0" relation="true"/>
  </sentence>
  <sentence id="s1245" text="WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (bile acid biosynthetic process).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.">
    <entity charOffset="204-234" id="s1245.e0" ontology_id="GO_0006699" text="bile acid biosynthetic process" type="GO"/>
    <entity charOffset="352-360" id="s1245.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1245.e0" e2="s1245.e1" id="s1245.p0" relation="true"/>
  </sentence>
  <sentence id="s1246" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, negative regulation of Wnt signaling pathway and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="103-147" id="s1246.e0" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="298-317" id="s1246.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1246.e0" e2="s1246.e1" id="s1246.p0" relation="false"/>
  </sentence>
  <sentence id="s1247" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, negative regulation of Wnt signaling pathway and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="245-289" id="s1247.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="298-317" id="s1247.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1247.e0" e2="s1247.e1" id="s1247.p0" relation="true"/>
  </sentence>
  <sentence id="s1248" text="Familial microscopic hematuria (FMH) is associated with a genetically heterogeneous group of conditions including the collagen-IV nephropathies, the heritable C3/negative regulation of protein binding nephropathy and the glomerulopathy with fibronectin deposits.">
    <entity charOffset="70-83" id="s1248.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="162-200" id="s1248.e1" ontology_id="GO_0032091" text="negative regulation of protein binding" type="GO"/>
    <pair e1="s1248.e0" e2="s1248.e1" id="s1248.p0" relation="true"/>
  </sentence>
  <sentence id="s1249" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and protein phosphorylation, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="s1249.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="308-331" id="s1249.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1249.e0" e2="s1249.e1" id="s1249.p0" relation="true"/>
  </sentence>
  <sentence id="s1250" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of biological_process transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and positive regulation of protein phosphorylation activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="s1250.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="327-373" id="s1250.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1250.e0" e2="s1250.e1" id="s1250.p0" relation="true"/>
  </sentence>
  <sentence id="s1251" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of biological_process transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and positive regulation of protein phosphorylation activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="s1251.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="182-200" id="s1251.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1251.e0" e2="s1251.e1" id="s1251.p0" relation="true"/>
  </sentence>
  <sentence id="s1252" text="YY1 expression is associated with that of cancer stem cell markers SOX2, BMI1 and negative regulation of transcription by RNA polymerase II across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.">
    <entity charOffset="42-48" id="s1252.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="82-139" id="s1252.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1252.e0" e2="s1252.e1" id="s1252.p0" relation="true"/>
  </sentence>
  <sentence id="s1253" text="In the present case, a sporadic FGP with LGD did not develop into invasive carcinoma, but contained foci of L-phenylalanine catabolic process 14 years after diagnosis.">
    <entity charOffset="75-84" id="s1253.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="108-141" id="s1253.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s1253.e0" e2="s1253.e1" id="s1253.p0" relation="false"/>
  </sentence>
  <sentence id="s1254" text="Hepatocyte growth factor (HGF)/c-apoptotic process signaling plays an important role in cell proliferation, survival, migration and motility of cancer cells.">
    <entity charOffset="33-50" id="s1254.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="144-150" id="s1254.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1254.e0" e2="s1254.e1" id="s1254.p0" relation="true"/>
  </sentence>
  <sentence id="s1255" text="Functional assays indicate that negative regulation of cell-cell adhesion reactivation ameliorates the malignant phenotype, specifically reducing cell viability, migration and invasion in diverse cancer cell lines.">
    <entity charOffset="32-73" id="s1255.e0" ontology_id="GO_0022408" text="negative regulation of cell-cell adhesion" type="GO"/>
    <entity charOffset="196-202" id="s1255.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1255.e0" e2="s1255.e1" id="s1255.p0" relation="true"/>
  </sentence>
  <sentence id="s1256" text="Further, mice heterozygous for either nuclear-transcribed mRNA catabolic process, nonsense-mediated decay or mRNA splicing, via spliceosome exhibit aberrant neurogenesis and microcephaly.">
    <entity charOffset="38-105" id="s1256.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="174-186" id="s1256.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1256.e0" e2="s1256.e1" id="s1256.p0" relation="false"/>
  </sentence>
  <sentence id="s1257" text="Further, mice heterozygous for either nuclear-transcribed mRNA catabolic process, nonsense-mediated decay or mRNA splicing, via spliceosome exhibit aberrant neurogenesis and microcephaly.">
    <entity charOffset="109-139" id="s1257.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="174-186" id="s1257.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1257.e0" e2="s1257.e1" id="s1257.p0" relation="true"/>
  </sentence>
  <sentence id="s1258" text="Using a new conditional allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of Magoh and mRNA splicing, via spliceosome mutant epidermis development.">
    <entity charOffset="115-127" id="s1258.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="141-171" id="s1258.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s1258.e0" e2="s1258.e1" id="s1258.p0" relation="true"/>
  </sentence>
  <sentence id="s1259" text="In MCDS epidermis development expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as cellular response to glucose starvation and response to endoplasmic reticulum stress, increased bone growth, and reduced skeletal dysplasia.">
    <entity charOffset="211-250" id="s1259.e0" ontology_id="GO_0042149" text="cellular response to glucose starvation" type="GO"/>
    <entity charOffset="332-350" id="s1259.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s1259.e0" e2="s1259.e1" id="s1259.p0" relation="false"/>
  </sentence>
  <sentence id="s1260" text="In MCDS epidermis development expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as cellular response to glucose starvation and response to endoplasmic reticulum stress, increased bone growth, and reduced skeletal dysplasia.">
    <entity charOffset="255-295" id="s1260.e0" ontology_id="GO_0034976" text="response to endoplasmic reticulum stress" type="GO"/>
    <entity charOffset="332-350" id="s1260.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s1260.e0" e2="s1260.e1" id="s1260.p0" relation="true"/>
  </sentence>
  <sentence id="s1261" text="Overall, our findings show how the tumor suppressor regulation of double-strand break repair via homologous recombination is regulated in hepatocellular carcinoma and establish the mechanism underlying positive regulation of protein ubiquitination-mediated tumorigenesis in this disease.&lt;b&gt;Significance:&lt;/b&gt; These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.">
    <entity charOffset="35-40" id="s1261.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="52-121" id="s1261.e1" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s1261.e0" e2="s1261.e1" id="s1261.p0" relation="false"/>
  </sentence>
  <sentence id="s1262" text="Overall, our findings show how the tumor suppressor regulation of double-strand break repair via homologous recombination is regulated in hepatocellular carcinoma and establish the mechanism underlying positive regulation of protein ubiquitination-mediated tumorigenesis in this disease.&lt;b&gt;Significance:&lt;/b&gt; These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.">
    <entity charOffset="138-162" id="s1262.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="202-247" id="s1262.e1" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <pair e1="s1262.e0" e2="s1262.e1" id="s1262.p0" relation="false"/>
  </sentence>
  <sentence id="s1263" text="In mouse models of hepatocellular carcinoma, regulation of double-strand break repair via homologous recombination downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.">
    <entity charOffset="19-43" id="s1263.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="45-114" id="s1263.e1" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s1263.e0" e2="s1263.e1" id="s1263.p0" relation="false"/>
  </sentence>
  <sentence id="s1264" text="In mouse models of hepatocellular carcinoma, regulation of double-strand break repair via homologous recombination downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.">
    <entity charOffset="45-114" id="s1264.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="197-202" id="s1264.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1264.e0" e2="s1264.e1" id="s1264.p0" relation="true"/>
  </sentence>
  <sentence id="s1265" text="Corresponding implicated genes, such as TNNI3K, negative regulation of cell adhesion, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.">
    <entity charOffset="48-84" id="s1265.e0" ontology_id="GO_0007162" text="negative regulation of cell adhesion" type="GO"/>
    <entity charOffset="172-185" id="s1265.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s1265.e0" e2="s1265.e1" id="s1265.p0" relation="true"/>
  </sentence>
  <sentence id="s1266" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor regulation of transcription by RNA polymerase II that interacts with activation of innate immune response/p54NRB, a survival factor.">
    <entity charOffset="48-54" id="s1266.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="276-312" id="s1266.e1" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <pair e1="s1266.e0" e2="s1266.e1" id="s1266.p0" relation="true"/>
  </sentence>
  <sentence id="s1267" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor regulation of transcription by RNA polymerase II that interacts with activation of innate immune response/p54NRB, a survival factor.">
    <entity charOffset="56-67" id="s1267.e0" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <entity charOffset="276-312" id="s1267.e1" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <pair e1="s1267.e0" e2="s1267.e1" id="s1267.p0" relation="true"/>
  </sentence>
  <sentence id="s1268" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor regulation of transcription by RNA polymerase II that interacts with activation of innate immune response/p54NRB, a survival factor.">
    <entity charOffset="56-67" id="s1268.e0" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <entity charOffset="207-255" id="s1268.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1268.e0" e2="s1268.e1" id="s1268.p0" relation="true"/>
  </sentence>
  <sentence id="s1269" text="Also, two somatic heterozygous activation of innate immune response mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).">
    <entity charOffset="31-67" id="s1269.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="184-189" id="s1269.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1269.e0" e2="s1269.e1" id="s1269.p0" relation="true"/>
  </sentence>
  <sentence id="s1270" text="Overall, our results highlight the importance of regulation of transcription by RNA polymerase II in conditions of -cell excess (insulinomas) and in conditions of -cell loss or dysfunction (diabetes).">
    <entity charOffset="49-97" id="s1270.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="130-141" id="s1270.e1" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <pair e1="s1270.e0" e2="s1270.e1" id="s1270.p0" relation="true"/>
  </sentence>
  <sentence id="s1271" text="Smith-Magenis syndrome (positive regulation of transcription, DNA-templated), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the positive regulation of transcription, DNA-templated gene.">
    <entity charOffset="146-169" id="s1271.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="258-309" id="s1271.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1271.e0" e2="s1271.e1" id="s1271.p0" relation="true"/>
  </sentence>
  <sentence id="s1272" text="Smith-Magenis syndrome (positive regulation of transcription, DNA-templated), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the positive regulation of transcription, DNA-templated gene.">
    <entity charOffset="180-198" id="s1272.e0" ontology_id="HP_0002360" text="sleep disturbances" type="HP"/>
    <entity charOffset="258-309" id="s1272.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1272.e0" e2="s1272.e1" id="s1272.p0" relation="true"/>
  </sentence>
  <sentence id="s1273" text="The Gene Expression Profiling Interactive Analyses application (GEPIA) was used to analysis the expression of regulation of ion transport in breast cancer tissues and normal samples.The polymorphism of rs1325774 was significantly associated with an increased risk of breast cancer (T/G vs T/T: OR=2.073, 95% CI=1.095-3.927, P=.025).">
    <entity charOffset="110-137" id="s1273.e0" ontology_id="GO_0043269" text="regulation of ion transport" type="GO"/>
    <entity charOffset="148-154" id="s1273.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1273.e0" e2="s1273.e1" id="s1273.p0" relation="true"/>
  </sentence>
  <sentence id="s1274" text="Among these genes, mutations in double-strand break repair gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).">
    <entity charOffset="32-58" id="s1274.e0" ontology_id="GO_0006302" text="double-strand break repair" type="GO"/>
    <entity charOffset="130-153" id="s1274.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s1274.e0" e2="s1274.e1" id="s1274.p0" relation="false"/>
  </sentence>
  <sentence id="s1275" text="We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with signal peptide processing like pro-protein convertases activates signal transduction mediated by the signal transduction receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="268-287" id="s1275.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="313-318" id="s1275.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1275.e0" e2="s1275.e1" id="s1275.p0" relation="true"/>
  </sentence>
  <sentence id="s1276" text="This contributes to the intrinsic aggressiveness of these cells by upregulating Rab27-dependent recycling of the transmembrane matrix metalloprotease, proteolysis to promote invasive behaviour leading to basement membrane disruption.">
    <entity charOffset="34-48" id="s1276.e0" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <entity charOffset="151-162" id="s1276.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s1276.e0" e2="s1276.e1" id="s1276.p0" relation="false"/>
  </sentence>
  <sentence id="s1277" text="However, the relationship between homotypic cell-cell adhesion and autism remains poorly understood.">
    <entity charOffset="34-62" id="s1277.e0" ontology_id="GO_0034109" text="homotypic cell-cell adhesion" type="GO"/>
    <entity charOffset="67-73" id="s1277.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1277.e0" e2="s1277.e1" id="s1277.p0" relation="true"/>
  </sentence>
  <sentence id="s1278" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, protein K63-linked deubiquitination, histone deubiquitination, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s1278.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="197-255" id="s1278.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s1278.e0" e2="s1278.e1" id="s1278.p0" relation="true"/>
  </sentence>
  <sentence id="s1279" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, protein K63-linked deubiquitination, histone deubiquitination, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s1279.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="171-195" id="s1279.e1" ontology_id="GO_0016578" text="histone deubiquitination" type="GO"/>
    <pair e1="s1279.e0" e2="s1279.e1" id="s1279.p0" relation="true"/>
  </sentence>
  <sentence id="s1280" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, protein K63-linked deubiquitination, histone deubiquitination, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s1280.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="85-132" id="s1280.e1" ontology_id="GO_0002091" text="negative regulation of receptor internalization" type="GO"/>
    <pair e1="s1280.e0" e2="s1280.e1" id="s1280.p0" relation="true"/>
  </sentence>
  <sentence id="s1281" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, protein K63-linked deubiquitination, histone deubiquitination, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s1281.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="134-169" id="s1281.e1" ontology_id="GO_0070536" text="protein K63-linked deubiquitination" type="GO"/>
    <pair e1="s1281.e0" e2="s1281.e1" id="s1281.p0" relation="true"/>
  </sentence>
  <sentence id="s1282" text="In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and regulation of mitochondrial membrane permeability as major ataxia genes.">
    <entity charOffset="173-222" id="s1282.e0" ontology_id="GO_0046902" text="regulation of mitochondrial membrane permeability" type="GO"/>
    <entity charOffset="232-238" id="s1282.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1282.e0" e2="s1282.e1" id="s1282.p0" relation="true"/>
  </sentence>
  <sentence id="s1283" text="However, little is known regarding regulation of synapse assemblyK/cofilin and SSH in human colorectal cancer (CRC).">
    <entity charOffset="35-65" id="s1283.e0" ontology_id="GO_0051963" text="regulation of synapse assembly" type="GO"/>
    <entity charOffset="103-109" id="s1283.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1283.e0" e2="s1283.e1" id="s1283.p0" relation="true"/>
  </sentence>
  <sentence id="s1284" text="We show that active cofilin, LIMK1, LIMK2, and regulation of cellular protein metabolic process are overexpressed in human CRC and are associated with tumor progression parameters.">
    <entity charOffset="47-95" id="s1284.e0" ontology_id="GO_0032268" text="regulation of cellular protein metabolic process" type="GO"/>
    <entity charOffset="151-156" id="s1284.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1284.e0" e2="s1284.e1" id="s1284.p0" relation="false"/>
  </sentence>
  <sentence id="s1285" text="Our results suggest that F-actin regulators regulation of synapse assemblyK/cofilin pathway and SSH1 are associated with CRC progression and chemoresistance representing promising tumor biomarkers and therapeutic targets in CRC">
    <entity charOffset="44-74" id="s1285.e0" ontology_id="GO_0051963" text="regulation of synapse assembly" type="GO"/>
    <entity charOffset="180-185" id="s1285.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1285.e0" e2="s1285.e1" id="s1285.p0" relation="true"/>
  </sentence>
  <sentence id="s1286" text="We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the signal transduction gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.">
    <entity charOffset="108-127" id="s1286.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="221-240" id="s1286.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1286.e0" e2="s1286.e1" id="s1286.p0" relation="true"/>
  </sentence>
  <sentence id="s1287" text="We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the signal transduction gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.">
    <entity charOffset="108-127" id="s1287.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="197-202" id="s1287.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s1287.e0" e2="s1287.e1" id="s1287.p0" relation="false"/>
  </sentence>
  <sentence id="s1288" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="224-258" id="s1288.e0" ontology_id="GO_0016441" text="posttranscriptional gene silencing" type="GO"/>
    <entity charOffset="327-346" id="s1288.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1288.e0" e2="s1288.e1" id="s1288.p0" relation="false"/>
  </sentence>
  <sentence id="s1289" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="281-305" id="s1289.e0" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <entity charOffset="327-346" id="s1289.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1289.e0" e2="s1289.e1" id="s1289.p0" relation="false"/>
  </sentence>
  <sentence id="s1290" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="327-346" id="s1290.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="446-476" id="s1290.e1" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <pair e1="s1290.e0" e2="s1290.e1" id="s1290.p0" relation="false"/>
  </sentence>
  <sentence id="s1291" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="327-346" id="s1291.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="392-422" id="s1291.e1" ontology_id="GO_0019731" text="antibacterial humoral response" type="GO"/>
    <pair e1="s1291.e0" e2="s1291.e1" id="s1291.p0" relation="true"/>
  </sentence>
  <sentence id="s1292" text="Murine double minute 2 (negative regulation of transcription by RNA polymerase II) is the E3 ubiquitin ligase of the tumor suppressor gene, p53, and inhibition of MDM2 can suppress tumor cell growth.">
    <entity charOffset="24-81" id="s1292.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="117-122" id="s1292.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1292.e0" e2="s1292.e1" id="s1292.p0" relation="true"/>
  </sentence>
  <sentence id="s1293" text="The cytolysis G1 polymorphism, an identified risk factor for non-diabetic renal disease, was associated with albuminuria.">
    <entity charOffset="4-13" id="s1293.e0" ontology_id="GO_0019835" text="cytolysis" type="GO"/>
    <entity charOffset="109-120" id="s1293.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s1293.e0" e2="s1293.e1" id="s1293.p0" relation="true"/>
  </sentence>
  <sentence id="s1294" text="Growing evidence suggests that MAPK cascade may represent an important genetic modifier locus for sporadic signal transduction.">
    <entity charOffset="31-43" id="s1294.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="98-106" id="s1294.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1294.e0" e2="s1294.e1" id="s1294.p0" relation="false"/>
  </sentence>
  <sentence id="s1295" text="Hemizygosity of the distal region, designated negative regulation of mammary gland epithelial cell proliferation1, can cause hypoparathyroidism and in addition sensorineuronal deafness and renal dysplasia/insufficiency or a subset of this triad">
    <entity charOffset="46-112" id="s1295.e0" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <entity charOffset="176-184" id="s1295.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1295.e0" e2="s1295.e1" id="s1295.p0" relation="true"/>
  </sentence>
  <sentence id="s1296" text="Hemizygosity of the distal region, designated negative regulation of mammary gland epithelial cell proliferation1, can cause hypoparathyroidism and in addition sensorineuronal deafness and renal dysplasia/insufficiency or a subset of this triad">
    <entity charOffset="46-112" id="s1296.e0" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <entity charOffset="125-143" id="s1296.e1" ontology_id="HP_0000829" text="hypoparathyroidism" type="HP"/>
    <pair e1="s1296.e0" e2="s1296.e1" id="s1296.p0" relation="true"/>
  </sentence>
  <sentence id="s1297" text="Compared to normal tissues, decorin expression was reduced in CRC patients' tumors, while there were increased endothelial cell morphogenesis and VEGFA levels.">
    <entity charOffset="76-82" id="s1297.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="111-141" id="s1297.e1" ontology_id="GO_0001886" text="endothelial cell morphogenesis" type="GO"/>
    <pair e1="s1297.e0" e2="s1297.e1" id="s1297.p0" relation="false"/>
  </sentence>
  <sentence id="s1298" text="Several therapeutic strategies expressing positive regulation of cell proliferation have been employed in clinical trials for treating metastatic colorectal cancer.">
    <entity charOffset="42-83" id="s1298.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="157-163" id="s1298.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1298.e0" e2="s1298.e1" id="s1298.p0" relation="true"/>
  </sentence>
  <sentence id="s1299" text="The authors report a patient with a novel positive regulation of GTPase activity mutation, who presented with intellectual disability, severe automutilation, and epilepsy.">
    <entity charOffset="42-80" id="s1299.e0" ontology_id="GO_0043547" text="positive regulation of GTPase activity" type="GO"/>
    <entity charOffset="110-133" id="s1299.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1299.e0" e2="s1299.e1" id="s1299.p0" relation="false"/>
  </sentence>
  <sentence id="s1300" text="PAK3-related intellectual disability is caused by mutations in the gene encoding the negative regulation of transcription by RNA polymerase II-activated kinase (PAK) protein.">
    <entity charOffset="13-36" id="s1300.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="85-142" id="s1300.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1300.e0" e2="s1300.e1" id="s1300.p0" relation="true"/>
  </sentence>
  <sentence id="s1301" text="We observed a higher rate of individuals with a history of high blood pressure among affected versus healthy individuals carrying angiogenesis variants, suggesting that ANGPTL6 could trigger cerebrovascular lesions when combined with other risk factors such as hypertension.">
    <entity charOffset="130-142" id="s1301.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="261-273" id="s1301.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s1301.e0" e2="s1301.e1" id="s1301.p0" relation="true"/>
  </sentence>
  <sentence id="s1302" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, resolution of meiotic recombination intermediates, FAN1, TP53, regulation of sister chromatid cohesion, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s1302.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="157-206" id="s1302.e1" ontology_id="GO_0000712" text="resolution of meiotic recombination intermediates" type="GO"/>
    <pair e1="s1302.e0" e2="s1302.e1" id="s1302.p0" relation="true"/>
  </sentence>
  <sentence id="s1303" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, resolution of meiotic recombination intermediates, FAN1, TP53, regulation of sister chromatid cohesion, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s1303.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="220-259" id="s1303.e1" ontology_id="GO_0007063" text="regulation of sister chromatid cohesion" type="GO"/>
    <pair e1="s1303.e0" e2="s1303.e1" id="s1303.p0" relation="true"/>
  </sentence>
  <sentence id="s1304" text="We found sufficient evidence for base-excision repair, AP site formation to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G&amp;gt;A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls.">
    <entity charOffset="33-72" id="s1304.e0" ontology_id="GO_0006285" text="base-excision repair, AP site formation" type="GO"/>
    <entity charOffset="260-266" id="s1304.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1304.e0" e2="s1304.e1" id="s1304.p0" relation="true"/>
  </sentence>
  <sentence id="s1305" text="Over 60 years after the initial description of cellular aldehyde metabolic process, we report the first animal model for this disease: an cellular aldehyde metabolic process-null zebrafish (&lt;i&gt;Danio rerio&lt;/i&gt;) displaying deficient lysine metabolism and spontaneous and recurrent seizures in the larval stage (10 days postfertilization).">
    <entity charOffset="138-173" id="s1305.e0" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <entity charOffset="279-287" id="s1305.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1305.e0" e2="s1305.e1" id="s1305.p0" relation="true"/>
  </sentence>
  <sentence id="s1306" text="This novel model provides valuable insights into cellular aldehyde metabolic process pathophysiology; further research may offer new opportunities for drug discovery to control seizure activity and improve neurodevelopmental outcomes for PDE">
    <entity charOffset="49-84" id="s1306.e0" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <entity charOffset="177-184" id="s1306.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s1306.e0" e2="s1306.e1" id="s1306.p0" relation="false"/>
  </sentence>
  <sentence id="s1307" text="Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and protein phosphorylation, and enrichment of our signal transduction proteome.">
    <entity charOffset="99-112" id="s1307.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="256-275" id="s1307.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s1307.e0" e2="s1307.e1" id="s1307.p0" relation="false"/>
  </sentence>
  <sentence id="s1308" text="Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and protein phosphorylation, and enrichment of our signal transduction proteome.">
    <entity charOffset="99-112" id="s1308.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="209-232" id="s1308.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1308.e0" e2="s1308.e1" id="s1308.p0" relation="false"/>
  </sentence>
  <sentence id="s1309" text="Taken together, our data provide robust evidence implicating signal transduction-associated proteins and genes in schizophrenia, and suggest that within the PSD, NMDA-interacting and endocytosis-related proteins contribute to disease pathophysiology">
    <entity charOffset="61-80" id="s1309.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="114-127" id="s1309.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1309.e0" e2="s1309.e1" id="s1309.p0" relation="true"/>
  </sentence>
  <sentence id="s1310" text="However, the clinical significance and precise role of regulation of transcription by RNA polymerase II in cancer progression are largely unknown.">
    <entity charOffset="55-103" id="s1310.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="107-113" id="s1310.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1310.e0" e2="s1310.e1" id="s1310.p0" relation="true"/>
  </sentence>
  <sentence id="s1311" text="Zinc finger protein 687 (regulation of transcription by RNA polymerase II), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell tumor of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in cancer.">
    <entity charOffset="25-73" id="s1311.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="262-268" id="s1311.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1311.e0" e2="s1311.e1" id="s1311.p0" relation="true"/>
  </sentence>
  <sentence id="s1312" text="Herein, we report that ZNF687 was markedly upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) cell lines and HCC tissues, and was significantly correlated with relapse-free survival in HCC.">
    <entity charOffset="58-82" id="s1312.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="84-120" id="s1312.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1312.e0" e2="s1312.e1" id="s1312.p0" relation="false"/>
  </sentence>
  <sentence id="s1313" text="Moreover, regulation of cell shape predicted poor prognosis of pancreatic cancer, partially due to its role in E-cadherin expression regulation, and the results were further validated by analysis of the correlation between ALDOA and E-cadherin expression in pancreatic cancer tissue samples.">
    <entity charOffset="10-34" id="s1313.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="74-80" id="s1313.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1313.e0" e2="s1313.e1" id="s1313.p0" relation="true"/>
  </sentence>
  <sentence id="s1314" text="Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of negative regulation of transcription by RNA polymerase II, HIF1 and positive regulation of transcription by RNA polymerase II (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.">
    <entity charOffset="49-55" id="s1314.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="93-150" id="s1314.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1314.e0" e2="s1314.e1" id="s1314.p0" relation="true"/>
  </sentence>
  <sentence id="s1315" text="Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of negative regulation of transcription by RNA polymerase II, HIF1 and positive regulation of transcription by RNA polymerase II (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.">
    <entity charOffset="49-55" id="s1315.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="162-219" id="s1315.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1315.e0" e2="s1315.e1" id="s1315.p0" relation="true"/>
  </sentence>
  <sentence id="s1316" text="Genetic or small-molecule inhibitor-based ablation of HIF-1/TGF-2-mediated smoothened signaling pathway signaling effectively reversed the chemoresistance caused by the tumor microenvironment.">
    <entity charOffset="77-105" id="s1316.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="171-176" id="s1316.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1316.e0" e2="s1316.e1" id="s1316.p0" relation="true"/>
  </sentence>
  <sentence id="s1317" text="However, the ectopic expression of G protein-coupled receptor signaling pathway was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).">
    <entity charOffset="35-79" id="s1317.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="198-204" id="s1317.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1317.e0" e2="s1317.e1" id="s1317.p0" relation="true"/>
  </sentence>
  <sentence id="s1318" text="The paper reviews the data concerning the appearance of ectopic G protein-coupled receptor signaling pathway in particular human neoplasms.">
    <entity charOffset="64-108" id="s1318.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="129-138" id="s1318.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s1318.e0" e2="s1318.e1" id="s1318.p0" relation="false"/>
  </sentence>
  <sentence id="s1319" text="Patients exhibit a variety of symptoms predominantly linked to the function of regulation of alternative mRNA splicing, via spliceosome protein in the nervous system like autistic behavior and mild-to-severe intellectual disability.">
    <entity charOffset="79-135" id="s1319.e0" ontology_id="GO_0000381" text="regulation of alternative mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="208-231" id="s1319.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1319.e0" e2="s1319.e1" id="s1319.p0" relation="true"/>
  </sentence>
  <sentence id="s1320" text="The findings in this study expand our understanding of SRPS locus heterogeneity and demonstrate the importance of intraciliary transport involved in cilium assembly in dynein-2 complex stability, cilium function, Hedgehog regulation and skeletogenesis.">
    <entity charOffset="66-79" id="s1320.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="114-164" id="s1320.e1" ontology_id="GO_0035735" text="intraciliary transport involved in cilium assembly" type="GO"/>
    <pair e1="s1320.e0" e2="s1320.e1" id="s1320.p0" relation="true"/>
  </sentence>
  <sentence id="s1321" text="Megaconial congenital muscular dystrophy is a disease caused by pathogenic mutations in the gene encoding choline kinase beta (phosphatidylethanolamine biosynthetic process).">
    <entity charOffset="22-40" id="s1321.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="127-172" id="s1321.e1" ontology_id="GO_0006646" text="phosphatidylethanolamine biosynthetic process" type="GO"/>
    <pair e1="s1321.e0" e2="s1321.e1" id="s1321.p0" relation="true"/>
  </sentence>
  <sentence id="s1322" text="Similarly, positive regulation of protein ubiquitination has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.">
    <entity charOffset="11-56" id="s1322.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="117-124" id="s1322.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s1322.e0" e2="s1322.e1" id="s1322.p0" relation="false"/>
  </sentence>
  <sentence id="s1323" text="Downregulation of miR-29a caused overexpression of LOXL2 and response to unfolded protein in lung cancer and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases">
    <entity charOffset="61-89" id="s1323.e0" ontology_id="GO_0006986" text="response to unfolded protein" type="GO"/>
    <entity charOffset="98-104" id="s1323.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1323.e0" e2="s1323.e1" id="s1323.p0" relation="true"/>
  </sentence>
  <sentence id="s1324" text="Overexpression of LOXL2 and response to unfolded protein was observed in clinical specimens of lung cancer and fibrotic lesions.">
    <entity charOffset="28-56" id="s1324.e0" ontology_id="GO_0006986" text="response to unfolded protein" type="GO"/>
    <entity charOffset="100-106" id="s1324.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1324.e0" e2="s1324.e1" id="s1324.p0" relation="true"/>
  </sentence>
  <sentence id="s1325" text="While examining pedigrees of JEB patients with negative regulation of cold-induced thermogenesis mutations, we observed that heterozygous carriers of functional null mutations displayed subtle enamel pitting in the absence of skin fragility or other JEB symptoms.">
    <entity charOffset="47-96" id="s1325.e0" ontology_id="GO_0120163" text="negative regulation of cold-induced thermogenesis" type="GO"/>
    <entity charOffset="226-240" id="s1325.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s1325.e0" e2="s1325.e1" id="s1325.p0" relation="false"/>
  </sentence>
  <sentence id="s1326" text="Most often, hypogonadotropic hypogonadism is caused by disorder in secretion of gonadoliberin, the product of gene signal transduction.">
    <entity charOffset="29-41" id="s1326.e0" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <entity charOffset="115-134" id="s1326.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s1326.e0" e2="s1326.e1" id="s1326.p0" relation="true"/>
  </sentence>
  <sentence id="s1327" text="Thus, increased expression of gene signal transduction in blood cells appears to be associated with the isolated form of hypogonadotropic hypogonadism and, in prospect, may be used as one of the disease markers">
    <entity charOffset="35-54" id="s1327.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="138-150" id="s1327.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s1327.e0" e2="s1327.e1" id="s1327.p0" relation="true"/>
  </sentence>
  <sentence id="s1328" text="positive regulation of protein ubiquitination is also known as a tumor suppressor gene, and somatic mutations in that gene have been identified in Wilms tumors.">
    <entity charOffset="0-45" id="s1328.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="65-70" id="s1328.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1328.e0" e2="s1328.e1" id="s1328.p0" relation="true"/>
  </sentence>
  <sentence id="s1329" text="RESULTS There was an increased expression of dolichol-linked oligosaccharide biosynthetic process in breast cancer tissues compared to normal breast tissues (p&amp;lt;0.05).">
    <entity charOffset="45-97" id="s1329.e0" ontology_id="GO_0006488" text="dolichol-linked oligosaccharide biosynthetic process" type="GO"/>
    <entity charOffset="108-114" id="s1329.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1329.e0" e2="s1329.e1" id="s1329.p0" relation="true"/>
  </sentence>
  <sentence id="s1330" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="85-128" id="s1330.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="578-592" id="s1330.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s1330.e0" e2="s1330.e1" id="s1330.p0" relation="true"/>
  </sentence>
  <sentence id="s1331" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="166-220" id="s1331.e0" ontology_id="GO_0033539" text="fatty acid beta-oxidation using acyl-CoA dehydrogenase" type="GO"/>
    <entity charOffset="578-592" id="s1331.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s1331.e0" e2="s1331.e1" id="s1331.p0" relation="false"/>
  </sentence>
  <sentence id="s1332" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="235-278" id="s1332.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="594-602" id="s1332.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1332.e0" e2="s1332.e1" id="s1332.p0" relation="false"/>
  </sentence>
  <sentence id="s1333" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="355-392" id="s1333.e0" ontology_id="GO_0019216" text="regulation of lipid metabolic process" type="GO"/>
    <entity charOffset="578-592" id="s1333.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s1333.e0" e2="s1333.e1" id="s1333.p0" relation="false"/>
  </sentence>
  <sentence id="s1334" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="449-476" id="s1334.e0" ontology_id="GO_0051289" text="protein homotetramerization" type="GO"/>
    <entity charOffset="594-602" id="s1334.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1334.e0" e2="s1334.e1" id="s1334.p0" relation="false"/>
  </sentence>
  <sentence id="s1335" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="449-476" id="s1335.e0" ontology_id="GO_0051289" text="protein homotetramerization" type="GO"/>
    <entity charOffset="608-620" id="s1335.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1335.e0" e2="s1335.e1" id="s1335.p0" relation="false"/>
  </sentence>
  <sentence id="s1336" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="578-592" id="s1336.e0" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <entity charOffset="634-651" id="s1336.e1" ontology_id="GO_0007420" text="brain development" type="GO"/>
    <pair e1="s1336.e0" e2="s1336.e1" id="s1336.p0" relation="false"/>
  </sentence>
  <sentence id="s1337" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="608-620" id="s1337.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="634-651" id="s1337.e1" ontology_id="GO_0007420" text="brain development" type="GO"/>
    <pair e1="s1337.e0" e2="s1337.e1" id="s1337.p0" relation="false"/>
  </sentence>
  <sentence id="s1338" text="Homozygous null mutation of tumor suppressor &lt;i&gt;negative regulation of Wnt signaling pathway/Wwox&lt;/i&gt; gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats.">
    <entity charOffset="28-33" id="s1338.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="48-92" id="s1338.e1" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <pair e1="s1338.e0" e2="s1338.e1" id="s1338.p0" relation="true"/>
  </sentence>
  <sentence id="s1339" text="There has been virtually no tissue study on the expression of negative regulation of transcription by RNA polymerase II in prostate cancer (PCa).">
    <entity charOffset="62-119" id="s1339.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="132-138" id="s1339.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1339.e0" e2="s1339.e1" id="s1339.p0" relation="true"/>
  </sentence>
  <sentence id="s1340" text="This study aimed to investigate the expression of PLZF by immunohistochemistry in different grade as well as metastatic mitochondrial transport and to correlate the alteration of PLZF expression with PCa aggressiveness.">
    <entity charOffset="120-143" id="s1340.e0" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <entity charOffset="204-218" id="s1340.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s1340.e0" e2="s1340.e1" id="s1340.p0" relation="false"/>
  </sentence>
  <sentence id="s1341" text="Our findings offer a foundation for understanding activation of innate immune response-related neurodegeneration and how nucleic acid binding functions, localization, and pathogenic mutations drive sporadic and familial disease">
    <entity charOffset="50-86" id="s1341.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="198-206" id="s1341.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1341.e0" e2="s1341.e1" id="s1341.p0" relation="true"/>
  </sentence>
  <sentence id="s1342" text="Taken together, these data provide novel information for comprehending the tumor-suppressive role of miR-200a in HCC pathogenesis through inhibition of GPI anchor biosynthetic process translation">
    <entity charOffset="75-80" id="s1342.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="152-183" id="s1342.e1" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <pair e1="s1342.e0" e2="s1342.e1" id="s1342.p0" relation="false"/>
  </sentence>
  <sentence id="s1343" text="positive regulation of B cell proliferation and its ligand are members of the TNF/TNF receptor superfamily, which includes various molecules influencing cellular signaling and function of both tumor and immune cells.">
    <entity charOffset="0-43" id="s1343.e0" ontology_id="GO_0030890" text="positive regulation of B cell proliferation" type="GO"/>
    <entity charOffset="193-198" id="s1343.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1343.e0" e2="s1343.e1" id="s1343.p0" relation="true"/>
  </sentence>
  <sentence id="s1344" text="Thus, our results suggest that aberrantly expressed Aurora-C in somatic cancer cells may impair cAMP biosynthetic process by displacing the centromeric localization of CPCs.">
    <entity charOffset="72-78" id="s1344.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="96-121" id="s1344.e1" ontology_id="GO_0006171" text="cAMP biosynthetic process" type="GO"/>
    <pair e1="s1344.e0" e2="s1344.e1" id="s1344.p0" relation="false"/>
  </sentence>
  <sentence id="s1345" text="CHIME syndrome is a rare autosomal recessive neuroectodermal disorder associated with biallelic mutations in preassembly of GPI anchor in ER membrane.">
    <entity charOffset="25-44" id="s1345.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="109-149" id="s1345.e1" ontology_id="GO_0016254" text="preassembly of GPI anchor in ER membrane" type="GO"/>
    <pair e1="s1345.e0" e2="s1345.e1" id="s1345.p0" relation="true"/>
  </sentence>
  <sentence id="s1346" text="Noonan syndrome (NS), the commonest RASopathy, is genetically heterogeneous and caused by functional dysregulation of signal transducers and regulatory proteins with roles in the RAS/extracellular signal-regulated kinase (angiogenesis) signal transduction pathway.">
    <entity charOffset="62-75" id="s1346.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="222-234" id="s1346.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s1346.e0" e2="s1346.e1" id="s1346.p0" relation="false"/>
  </sentence>
  <sentence id="s1347" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="152-198" id="s1347.e0" ontology_id="GO_0030200" text="heparan sulfate proteoglycan catabolic process" type="GO"/>
    <entity charOffset="354-360" id="s1347.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1347.e0" e2="s1347.e1" id="s1347.p0" relation="true"/>
  </sentence>
  <sentence id="s1348" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="220-261" id="s1348.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="354-360" id="s1348.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1348.e0" e2="s1348.e1" id="s1348.p0" relation="true"/>
  </sentence>
  <sentence id="s1349" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="264-287" id="s1349.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="421-439" id="s1349.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1349.e0" e2="s1349.e1" id="s1349.p0" relation="false"/>
  </sentence>
  <sentence id="s1350" text="Mice carrying kinase-dead tRNA splicing, via endonucleolytic cleavage and ligation also displayed microcephaly and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons.">
    <entity charOffset="26-82" id="s1350.e0" ontology_id="GO_0006388" text="tRNA splicing, via endonucleolytic cleavage and ligation" type="GO"/>
    <entity charOffset="98-110" id="s1350.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1350.e0" e2="s1350.e1" id="s1350.p0" relation="true"/>
  </sentence>
  <sentence id="s1351" text="Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, positive regulation of transcription, DNA-templated, and regulation of transcription, DNA-templated) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="69-120" id="s1351.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="283-291" id="s1351.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1351.e0" e2="s1351.e1" id="s1351.p0" relation="false"/>
  </sentence>
  <sentence id="s1352" text="Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, positive regulation of transcription, DNA-templated, and regulation of transcription, DNA-templated) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="126-168" id="s1352.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="283-291" id="s1352.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1352.e0" e2="s1352.e1" id="s1352.p0" relation="true"/>
  </sentence>
  <sentence id="s1353" text="Our findings indicate that ether lipid biosynthetic process, SUMO1, SPINT2, positive regulation of transcription, DNA-templated, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="27-59" id="s1353.e0" ontology_id="GO_0008611" text="ether lipid biosynthetic process" type="GO"/>
    <entity charOffset="210-218" id="s1353.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1353.e0" e2="s1353.e1" id="s1353.p0" relation="true"/>
  </sentence>
  <sentence id="s1354" text="Our findings indicate that ether lipid biosynthetic process, SUMO1, SPINT2, positive regulation of transcription, DNA-templated, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="76-127" id="s1354.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="210-218" id="s1354.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1354.e0" e2="s1354.e1" id="s1354.p0" relation="true"/>
  </sentence>
  <sentence id="s1355" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that telomere maintenance, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="52-58" id="s1355.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="102-122" id="s1355.e1" ontology_id="GO_0000723" text="telomere maintenance" type="GO"/>
    <pair e1="s1355.e0" e2="s1355.e1" id="s1355.p0" relation="false"/>
  </sentence>
  <sentence id="s1356" text="PDSS2 is a putative tumor suppressor, and promoter hypermethylation is a key regulatory mechanism in phosphatidylinositol phosphorylation.">
    <entity charOffset="20-25" id="s1356.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="101-137" id="s1356.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1356.e0" e2="s1356.e1" id="s1356.p0" relation="false"/>
  </sentence>
  <sentence id="s1357" text="Here, we report 1 known (c.1489C&amp;gt;T, p.Pro497Ser, P497S) and 3 novel (c.1481C&amp;gt;T, p.Pro494Leu, P494L; c.1498C&amp;gt;T, p.Pro500Ser, P500S; and c.1516C&amp;gt;G, p.Pro506Ala, P506A) missense mutations in the PXX domain of regulation of macroautophagy in familial motor neuron diseases including ALS and spastic paraplegia (SP).">
    <entity charOffset="218-246" id="s1357.e0" ontology_id="GO_0016241" text="regulation of macroautophagy" type="GO"/>
    <entity charOffset="299-317" id="s1357.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s1357.e0" e2="s1357.e1" id="s1357.p0" relation="true"/>
  </sentence>
  <sentence id="s1358" text="Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), autosomal recessive (PYGM), and X-linked (carbohydrate metabolic process, acetyl-CoA biosynthetic process from pyruvate, urea cycle, and SLC6A8) disorders.">
    <entity charOffset="55-75" id="s1358.e0" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <entity charOffset="78-97" id="s1358.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1358.e0" e2="s1358.e1" id="s1358.p0" relation="false"/>
  </sentence>
  <sentence id="s1359" text="Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), autosomal recessive (PYGM), and X-linked (carbohydrate metabolic process, acetyl-CoA biosynthetic process from pyruvate, urea cycle, and SLC6A8) disorders.">
    <entity charOffset="78-97" id="s1359.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="199-209" id="s1359.e1" ontology_id="GO_0000050" text="urea cycle" type="GO"/>
    <pair e1="s1359.e0" e2="s1359.e1" id="s1359.p0" relation="false"/>
  </sentence>
  <sentence id="s1360" text="Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), autosomal recessive (PYGM), and X-linked (carbohydrate metabolic process, acetyl-CoA biosynthetic process from pyruvate, urea cycle, and SLC6A8) disorders.">
    <entity charOffset="78-97" id="s1360.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="152-197" id="s1360.e1" ontology_id="GO_0006086" text="acetyl-CoA biosynthetic process from pyruvate" type="GO"/>
    <pair e1="s1360.e0" e2="s1360.e1" id="s1360.p0" relation="false"/>
  </sentence>
  <sentence id="s1361" text="Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), autosomal recessive (PYGM), and X-linked (carbohydrate metabolic process, acetyl-CoA biosynthetic process from pyruvate, urea cycle, and SLC6A8) disorders.">
    <entity charOffset="78-97" id="s1361.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="120-150" id="s1361.e1" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <pair e1="s1361.e0" e2="s1361.e1" id="s1361.p0" relation="false"/>
  </sentence>
  <sentence id="s1362" text="Some individuals with heterozygous negative regulation of transcription by RNA polymerase II mutations demonstrate a carrier ocular phenotype, which includes a mildly reduced corneal thickness, keratoconus and blue sclera.">
    <entity charOffset="35-92" id="s1362.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="194-205" id="s1362.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s1362.e0" e2="s1362.e1" id="s1362.p0" relation="true"/>
  </sentence>
  <sentence id="s1363" text="Hyperphosphatasia with mental retardation syndrome (HPMRS) is caused by mutations in GPI anchor biosynthetic process and includes hyperphosphatasia as a diagnostic hallmark.">
    <entity charOffset="85-116" id="s1363.e0" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <entity charOffset="130-147" id="s1363.e1" ontology_id="HP_0003155" text="hyperphosphatasia" type="HP"/>
    <pair e1="s1363.e0" e2="s1363.e1" id="s1363.p0" relation="true"/>
  </sentence>
  <sentence id="s1364" text="Glutaric acidemia I (GAI) is an autosomal recessive metabolic disease caused by a deficiency of glutaryl-CoA dehydrogenase enzyme (fatty acid beta-oxidation using acyl-CoA dehydrogenase).">
    <entity charOffset="32-51" id="s1364.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="131-185" id="s1364.e1" ontology_id="GO_0033539" text="fatty acid beta-oxidation using acyl-CoA dehydrogenase" type="GO"/>
    <pair e1="s1364.e0" e2="s1364.e1" id="s1364.p0" relation="false"/>
  </sentence>
  <sentence id="s1365" text="Extensive glycosaminoglycan catabolic process gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire AFF2 gene, and epilepsy developed in only one of them.">
    <entity charOffset="10-45" id="s1365.e0" ontology_id="GO_0006027" text="glycosaminoglycan catabolic process" type="GO"/>
    <entity charOffset="183-191" id="s1365.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1365.e0" e2="s1365.e1" id="s1365.p0" relation="true"/>
  </sentence>
  <sentence id="s1366" text="In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-chemical synaptic transmission-coexpressing tumors had longer &lt;sup&gt;131&lt;/sup&gt;I-MIBG retention time than NET-expressing tumors.">
    <entity charOffset="68-74" id="s1366.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="102-132" id="s1366.e1" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <pair e1="s1366.e0" e2="s1366.e1" id="s1366.p0" relation="true"/>
  </sentence>
  <sentence id="s1367" text="The reported hypertrophic cardiomyopathy relevant genes MYPN, regulation of the force of heart contraction and MYBP3 had also been found in case 1 and 2.">
    <entity charOffset="26-40" id="s1367.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="62-106" id="s1367.e1" ontology_id="GO_0002026" text="regulation of the force of heart contraction" type="GO"/>
    <pair e1="s1367.e0" e2="s1367.e1" id="s1367.p0" relation="true"/>
  </sentence>
  <sentence id="s1368" text="Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, G protein-coupled receptor signaling pathway and DDIT3).">
    <entity charOffset="79-85" id="s1368.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="322-366" id="s1368.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s1368.e0" e2="s1368.e1" id="s1368.p0" relation="true"/>
  </sentence>
  <sentence id="s1369" text="Carriers of CT or TT genotype of monocyte chemotaxis rs13900 had increased risk of hearing loss at birth and at 6months of age (aOR=3.59; p=0.028 and aOR=4.10; p=0.039, respectively).">
    <entity charOffset="33-52" id="s1369.e0" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <entity charOffset="83-95" id="s1369.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1369.e0" e2="s1369.e1" id="s1369.p0" relation="true"/>
  </sentence>
  <sentence id="s1370" text="Moreover, Reg-1 colocalizes with exostosin tumor-like 3 (heparan sulfate proteoglycan biosynthetic process), its putative receptor, at the membrane of these cells.">
    <entity charOffset="44-49" id="s1370.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="58-107" id="s1370.e1" ontology_id="GO_0015012" text="heparan sulfate proteoglycan biosynthetic process" type="GO"/>
    <pair e1="s1370.e0" e2="s1370.e1" id="s1370.p0" relation="true"/>
  </sentence>
  <sentence id="s1371" text="Microfibrillar-associated protein 5 (definitive hemopoiesis) is a component of extracellular elastic microfibril which has been confirmed to function in tissue development and cancer progression.">
    <entity charOffset="37-59" id="s1371.e0" ontology_id="GO_0060216" text="definitive hemopoiesis" type="GO"/>
    <entity charOffset="176-182" id="s1371.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1371.e0" e2="s1371.e1" id="s1371.p0" relation="true"/>
  </sentence>
  <sentence id="s1372" text="The present study demonstrated that definitive hemopoiesis was up-regulated in breast cancers compared with that in normal breast tissues, and further increased in breast cancer bone metastasis.">
    <entity charOffset="36-58" id="s1372.e0" ontology_id="GO_0060216" text="definitive hemopoiesis" type="GO"/>
    <entity charOffset="86-92" id="s1372.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1372.e0" e2="s1372.e1" id="s1372.p0" relation="true"/>
  </sentence>
  <sentence id="s1373" text="In terms of prognostic features, a survival analysis revealed that the high glycogen biosynthetic process and HK2 expression group exhibited poorer survival in lung adenocarcinoma patients.">
    <entity charOffset="76-105" id="s1373.e0" ontology_id="GO_0005978" text="glycogen biosynthetic process" type="GO"/>
    <entity charOffset="160-179" id="s1373.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1373.e0" e2="s1373.e1" id="s1373.p0" relation="false"/>
  </sentence>
  <sentence id="s1374" text="The key clinical features of the patient with receptor-mediated endocytosis included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="46-75" id="s1374.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="249-257" id="s1374.e1" ontology_id="HP_0002808" text="kyphosis" type="HP"/>
    <pair e1="s1374.e0" e2="s1374.e1" id="s1374.p0" relation="true"/>
  </sentence>
  <sentence id="s1375" text="Schwartz-Jampel syndrome muscle organ development 1 (SJS1) is a rare autosomal recessive disease caused by mutations in the gene heparan sulfate proteoglycan 2 (HSPG2; also known as basement membranespecific heparin sulfate).">
    <entity charOffset="25-49" id="s1375.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="69-88" id="s1375.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1375.e0" e2="s1375.e1" id="s1375.p0" relation="false"/>
  </sentence>
  <sentence id="s1376" text="The family members harboring 1 heterozygous mutation in receptor-mediated endocytosis did not exhibit any skeletal abnormalities.">
    <entity charOffset="56-85" id="s1376.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="106-128" id="s1376.e1" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <pair e1="s1376.e0" e2="s1376.e1" id="s1376.p0" relation="true"/>
  </sentence>
  <sentence id="s1377" text="In ALDH&lt;sup&gt;+&lt;/sup&gt;CD24&lt;sup&gt;-&lt;/sup&gt;CD44&lt;sup&gt;+&lt;/sup&gt; BCSCs, we identified P4HA2, PTGR1 and multi-organism toxin transport as potential prognostic markers, which were virtually related to the status of BCSCs and tumor growth in TNBC cells">
    <entity charOffset="90-120" id="s1377.e0" ontology_id="GO_1990967" text="multi-organism toxin transport" type="GO"/>
    <entity charOffset="210-215" id="s1377.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1377.e0" e2="s1377.e1" id="s1377.p0" relation="true"/>
  </sentence>
  <sentence id="s1378" text="Missense mutations in SCN2A (p.Leu1342Pro) and potassium ion transmembrane transport (p.Ala306Thr) were found in two patients with no history of epilepsy before the onset of ISs.">
    <entity charOffset="47-84" id="s1378.e0" ontology_id="GO_0071805" text="potassium ion transmembrane transport" type="GO"/>
    <entity charOffset="145-153" id="s1378.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1378.e0" e2="s1378.e1" id="s1378.p0" relation="false"/>
  </sentence>
  <sentence id="s1379" text="Other rRNA processing mutations and rRNA processing cases are intermediate - spliceosomal snRNP assembly muscle organ development 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.">
    <entity charOffset="6-21" id="s1379.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="151-161" id="s1379.e1" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <pair e1="s1379.e0" e2="s1379.e1" id="s1379.p0" relation="true"/>
  </sentence>
  <sentence id="s1380" text="Other rRNA processing mutations and rRNA processing cases are intermediate - spliceosomal snRNP assembly muscle organ development 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.">
    <entity charOffset="36-51" id="s1380.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="151-161" id="s1380.e1" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <pair e1="s1380.e0" e2="s1380.e1" id="s1380.p0" relation="true"/>
  </sentence>
  <sentence id="s1381" text="Other rRNA processing mutations and rRNA processing cases are intermediate - spliceosomal snRNP assembly muscle organ development 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.">
    <entity charOffset="77-104" id="s1381.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="151-161" id="s1381.e1" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <pair e1="s1381.e0" e2="s1381.e1" id="s1381.p0" relation="false"/>
  </sentence>
  <sentence id="s1382" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="120-135" id="s1382.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="333-345" id="s1382.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1382.e0" e2="s1382.e1" id="s1382.p0" relation="true"/>
  </sentence>
  <sentence id="s1383" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="120-135" id="s1383.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="361-374" id="s1383.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s1383.e0" e2="s1383.e1" id="s1383.p0" relation="false"/>
  </sentence>
  <sentence id="s1384" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="139-169" id="s1384.e0" ontology_id="GO_0090149" text="mitochondrial membrane fission" type="GO"/>
    <entity charOffset="333-345" id="s1384.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1384.e0" e2="s1384.e1" id="s1384.p0" relation="true"/>
  </sentence>
  <sentence id="s1385" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="187-214" id="s1385.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="297-315" id="s1385.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s1385.e0" e2="s1385.e1" id="s1385.p0" relation="false"/>
  </sentence>
  <sentence id="s1386" text="Mutations with milder presentation (homozygous p.D132A/EXOSC3 or protein phosphorylation) may display additionally signs of upper motor neuron impairment, dystonia or ataxia and die at age between 5 and 18 years.">
    <entity charOffset="65-88" id="s1386.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="167-173" id="s1386.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1386.e0" e2="s1386.e1" id="s1386.p0" relation="true"/>
  </sentence>
  <sentence id="s1387" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), positive regulation of transcription by RNA polymerase II (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, protein polyubiquitination, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-integrin-mediated signaling pathway, GFAP.">
    <entity charOffset="23-28" id="s1387.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="241-267" id="s1387.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s1387.e0" e2="s1387.e1" id="s1387.p0" relation="true"/>
  </sentence>
  <sentence id="s1388" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), positive regulation of transcription by RNA polymerase II (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, protein polyubiquitination, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-integrin-mediated signaling pathway, GFAP.">
    <entity charOffset="23-28" id="s1388.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="92-149" id="s1388.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1388.e0" e2="s1388.e1" id="s1388.p0" relation="true"/>
  </sentence>
  <sentence id="s1389" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), positive regulation of transcription by RNA polymerase II (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, protein polyubiquitination, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-integrin-mediated signaling pathway, GFAP.">
    <entity charOffset="23-28" id="s1389.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="328-363" id="s1389.e1" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <pair e1="s1389.e0" e2="s1389.e1" id="s1389.p0" relation="false"/>
  </sentence>
  <sentence id="s1390" text="To explore the underlying mechanism of tumor suppression by outer dynein arm assembly, its potential to promote apoptosis induced by TRAIL, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.">
    <entity charOffset="39-44" id="s1390.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="60-85" id="s1390.e1" ontology_id="GO_0036158" text="outer dynein arm assembly" type="GO"/>
    <pair e1="s1390.e0" e2="s1390.e1" id="s1390.p0" relation="true"/>
  </sentence>
  <sentence id="s1391" text="Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (positive regulation of blood vessel endothelial cell migration) to be associated with unfavourable outcome in patients with pneumococcal meningitis.">
    <entity charOffset="262-324" id="s1391.e0" ontology_id="GO_0043536" text="positive regulation of blood vessel endothelial cell migration" type="GO"/>
    <entity charOffset="399-409" id="s1391.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s1391.e0" e2="s1391.e1" id="s1391.p0" relation="true"/>
  </sentence>
  <sentence id="s1392" text="These findings suggest that negative regulation of transcription by RNA polymerase II is not only driving EMT, but also contributes to the formation of osteolytic bone metastases in breast cancer.">
    <entity charOffset="28-85" id="s1392.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="189-195" id="s1392.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1392.e0" e2="s1392.e1" id="s1392.p0" relation="true"/>
  </sentence>
  <sentence id="s1393" text="Placental mRNA abundance for the folate receptor alpha (&lt;i&gt;FOLR1&lt;/i&gt;) was reduced with obesity, whilst &lt;i&gt;maintenance of DNA methylation1&lt;/i&gt; was increased with raised BMI, responses that were unaffected by GD.">
    <entity charOffset="87-94" id="s1393.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="106-136" id="s1393.e1" ontology_id="GO_0010216" text="maintenance of DNA methylation" type="GO"/>
    <pair e1="s1393.e0" e2="s1393.e1" id="s1393.p0" relation="true"/>
  </sentence>
  <sentence id="s1394" text="In a few (non-Swedish) melanoma families, mutations in other genes have been found, including protein phosphorylation, transcription, RNA-templated, POT1, ACD and TERF2IP.">
    <entity charOffset="23-31" id="s1394.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="94-117" id="s1394.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1394.e0" e2="s1394.e1" id="s1394.p0" relation="true"/>
  </sentence>
  <sentence id="s1395" text="In a few (non-Swedish) melanoma families, mutations in other genes have been found, including protein phosphorylation, transcription, RNA-templated, POT1, ACD and TERF2IP.">
    <entity charOffset="23-31" id="s1395.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="119-147" id="s1395.e1" ontology_id="GO_0001172" text="transcription, RNA-templated" type="GO"/>
    <pair e1="s1395.e0" e2="s1395.e1" id="s1395.p0" relation="true"/>
  </sentence>
  <sentence id="s1396" text="In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, melanin biosynthetic process, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.">
    <entity charOffset="83-111" id="s1396.e0" ontology_id="GO_0042438" text="melanin biosynthetic process" type="GO"/>
    <entity charOffset="261-269" id="s1396.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1396.e0" e2="s1396.e1" id="s1396.p0" relation="true"/>
  </sentence>
  <sentence id="s1397" text="Individuals with known mutations in tumor suppressor genes such as G1/S transition of mitotic cell cycle and BAP1 require, in addition, follow up for other cancers">
    <entity charOffset="36-41" id="s1397.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="67-104" id="s1397.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s1397.e0" e2="s1397.e1" id="s1397.p0" relation="true"/>
  </sentence>
  <sentence id="s1398" text="Swedish G1/S transition of mitotic cell cycle mutation carriers have a young median age of onset of melanoma, increased risks of multiple primary melanoma and of tobacco-associated cancers in respiratory and upper digestive tissues, and also worse survival compared to non-carriers.">
    <entity charOffset="8-45" id="s1398.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="100-108" id="s1398.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1398.e0" e2="s1398.e1" id="s1398.p0" relation="true"/>
  </sentence>
  <sentence id="s1399" text="Congenital myasthenic syndromes (actin filament organization) are a heterogeneous group of genetic disorders.">
    <entity charOffset="33-60" id="s1399.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="68-81" id="s1399.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1399.e0" e2="s1399.e1" id="s1399.p0" relation="false"/>
  </sentence>
  <sentence id="s1400" text="In case of DLEC1 and cell adhesion, expression levels were decreased in 71-78% of tumor samples and significantly different between tumor and normal tissues (P=0.0001).">
    <entity charOffset="21-34" id="s1400.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="83-88" id="s1400.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1400.e0" e2="s1400.e1" id="s1400.p0" relation="true"/>
  </sentence>
  <sentence id="s1401" text="The presented workflow employed three different peptide microarray formats to discover and resolve the epitopes of human autoantibodies and revealed two potentially new autoantigens: MAP3K7 in multiple sclerosis and learning in narcolepsy.">
    <entity charOffset="216-224" id="s1401.e0" ontology_id="GO_0007612" text="learning" type="GO"/>
    <entity charOffset="228-238" id="s1401.e1" ontology_id="HP_0030050" text="narcolepsy" type="HP"/>
    <pair e1="s1401.e0" e2="s1401.e1" id="s1401.p0" relation="true"/>
  </sentence>
  <sentence id="s1402" text="Recently, autosomal recessive loss-of-function mutations in keratinocyte development (encoding exophilin-5, also known as Slac2-b, a protein involved in intracellular vesicle transport) were identified in a new mechanobullous disease resembling a form of epidermolysis bullosa simplex (EBS).">
    <entity charOffset="10-29" id="s1402.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="60-84" id="s1402.e1" ontology_id="GO_0003334" text="keratinocyte development" type="GO"/>
    <pair e1="s1402.e0" e2="s1402.e1" id="s1402.p0" relation="true"/>
  </sentence>
  <sentence id="s1403" text="Here, we searched for mutations in keratinocyte development in a 4-year-old white boy with EBS in whom initial Sanger sequencing of known genes implicated in intraepidermal skin fragility failed to identify pathogenic mutations.">
    <entity charOffset="35-59" id="s1403.e0" ontology_id="GO_0003334" text="keratinocyte development" type="GO"/>
    <entity charOffset="173-187" id="s1403.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s1403.e0" e2="s1403.e1" id="s1403.p0" relation="true"/>
  </sentence>
  <sentence id="s1404" text="Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo homophilic cell adhesion via plasma membrane adhesion molecules gene mutations were found in their epilepsy gene protein polyubiquitination sequencing.">
    <entity charOffset="189-252" id="s1404.e0" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <entity charOffset="288-296" id="s1404.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1404.e0" e2="s1404.e1" id="s1404.p0" relation="true"/>
  </sentence>
  <sentence id="s1405" text="Epilepsy with mental retardation limited to females (EFMR) is a syndrome characterized by early onset heat-sensitive epilepsy of infancy or early childhood and generally limited to females, which previously reported that the cadherin gene superfamily subtype protocadherin 19 (homophilic cell adhesion via plasma membrane adhesion molecules) gene is its pathogenic gene.">
    <entity charOffset="117-125" id="s1405.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="277-340" id="s1405.e1" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <pair e1="s1405.e0" e2="s1405.e1" id="s1405.p0" relation="true"/>
  </sentence>
  <sentence id="s1406" text="Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the positive regulation of transforming growth factor beta1 production gene.">
    <entity charOffset="15-37" id="s1406.e0" ontology_id="HP_0000972" text="palmoplantar keratosis" type="HP"/>
    <entity charOffset="147-213" id="s1406.e1" ontology_id="GO_0032914" text="positive regulation of transforming growth factor beta1 production" type="GO"/>
    <pair e1="s1406.e0" e2="s1406.e1" id="s1406.p0" relation="true"/>
  </sentence>
  <sentence id="s1407" text="Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, negative regulation of transcription by RNA polymerase II DMR in 21%, mesoderm development ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="72-78" id="s1407.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="144-201" id="s1407.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1407.e0" e2="s1407.e1" id="s1407.p0" relation="false"/>
  </sentence>
  <sentence id="s1408" text="Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, negative regulation of transcription by RNA polymerase II DMR in 21%, mesoderm development ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="72-78" id="s1408.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="214-234" id="s1408.e1" ontology_id="GO_0007498" text="mesoderm development" type="GO"/>
    <pair e1="s1408.e0" e2="s1408.e1" id="s1408.p0" relation="true"/>
  </sentence>
  <sentence id="s1409" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="110-118" id="s1409.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="388-413" id="s1409.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s1409.e0" e2="s1409.e1" id="s1409.p0" relation="false"/>
  </sentence>
  <sentence id="s1410" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="144-171" id="s1410.e0" ontology_id="GO_0016079" text="synaptic vesicle exocytosis" type="GO"/>
    <entity charOffset="183-202" id="s1410.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1410.e0" e2="s1410.e1" id="s1410.p0" relation="false"/>
  </sentence>
  <sentence id="s1411" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="183-202" id="s1411.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="238-256" id="s1411.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1411.e0" e2="s1411.e1" id="s1411.p0" relation="true"/>
  </sentence>
  <sentence id="s1412" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="183-202" id="s1412.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="388-413" id="s1412.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s1412.e0" e2="s1412.e1" id="s1412.p0" relation="false"/>
  </sentence>
  <sentence id="s1413" text="Thus, the present study aimed to investigate molecular changes in the OTOF gene in patients with auditory neuropathy, and to develop a DNA protein polyubiquitination for the molecular diagnosis of auditory neuropathy using cell adhesion mediated by integrin spectrometry for genotyping.">
    <entity charOffset="106-116" id="s1413.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="139-165" id="s1413.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s1413.e0" e2="s1413.e1" id="s1413.p0" relation="false"/>
  </sentence>
  <sentence id="s1414" text="Several candidate genes for obesity and T2D (e.g., IRS1 and negative regulation of transcription by RNA polymerase II) were differentially expressed in discordant twins.">
    <entity charOffset="28-35" id="s1414.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="60-117" id="s1414.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1414.e0" e2="s1414.e1" id="s1414.p0" relation="false"/>
  </sentence>
  <sentence id="s1415" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="21-56" id="s1415.e0" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <entity charOffset="242-250" id="s1415.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1415.e0" e2="s1415.e1" id="s1415.p0" relation="true"/>
  </sentence>
  <sentence id="s1416" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="100-110" id="s1416.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="119-154" id="s1416.e1" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <pair e1="s1416.e0" e2="s1416.e1" id="s1416.p0" relation="true"/>
  </sentence>
  <sentence id="s1417" text="In this review article, we summarize the discovery of pyrimidine nucleoside metabolic process and the potential molecular mechanisms of TYMP involved in the development of various diseases, especially cardiovascular diseases.">
    <entity charOffset="54-93" id="s1417.e0" ontology_id="GO_0006213" text="pyrimidine nucleoside metabolic process" type="GO"/>
    <entity charOffset="201-224" id="s1417.e1" ontology_id="HP_0001626" text="cardiovascular diseases" type="HP"/>
    <pair e1="s1417.e0" e2="s1417.e1" id="s1417.p0" relation="false"/>
  </sentence>
  <sentence id="s1418" text="A total of nine non-coding variants on 11q13.5 predispose men to prostate cancer (PrCa). rs200331695 within the DNA repair intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.">
    <entity charOffset="74-80" id="s1418.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="112-122" id="s1418.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s1418.e0" e2="s1418.e1" id="s1418.p0" relation="true"/>
  </sentence>
  <sentence id="s1419" text="The high LD SNPs (rs143975731, rs12277366, rs2155225, and rs2155222) were associated with triglyceride biosynthetic process expression in both tumors negative regulation of transcription, DNA-templateds (screening P=0.035-0.043; validation P=0.005-0.018).">
    <entity charOffset="90-123" id="s1419.e0" ontology_id="GO_0019432" text="triglyceride biosynthetic process" type="GO"/>
    <entity charOffset="143-149" id="s1419.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1419.e0" e2="s1419.e1" id="s1419.p0" relation="true"/>
  </sentence>
  <sentence id="s1420" text="Altogether, our study provides direct evidence that endogenous positive regulation of Wnt signaling pathway and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers">
    <entity charOffset="63-107" id="s1420.e0" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="267-273" id="s1420.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1420.e0" e2="s1420.e1" id="s1420.p0" relation="true"/>
  </sentence>
  <sentence id="s1421" text="We show that both Rspo2 and positive regulation of Wnt signaling pathway fusion events are sufficient to initiate hyperplasia and tumour development in vivo, without additional cooperating genetic events.">
    <entity charOffset="28-72" id="s1421.e0" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="130-136" id="s1421.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1421.e0" e2="s1421.e1" id="s1421.p0" relation="true"/>
  </sentence>
  <sentence id="s1422" text="Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and protein dephosphorylation-RSPO3 chromosome rearrangements in vivo.">
    <entity charOffset="123-129" id="s1422.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="157-182" id="s1422.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s1422.e0" e2="s1422.e1" id="s1422.p0" relation="true"/>
  </sentence>
  <sentence id="s1423" text="Our results demonstrate that adenomyoepitheliomas are genetically heterogeneous, and qualify mutations in regulation of neurotransmitter receptor localization to postsynaptic specialization membrane, a gene whose mutations are vanishingly rare in common-type breast cancers, as likely drivers of ER-negative adenomyoepitheliomas">
    <entity charOffset="66-79" id="s1423.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="106-198" id="s1423.e1" ontology_id="GO_0098696" text="regulation of neurotransmitter receptor localization to postsynaptic specialization membrane" type="GO"/>
    <pair e1="s1423.e0" e2="s1423.e1" id="s1423.p0" relation="false"/>
  </sentence>
  <sentence id="s1424" text="Hennekam lymphangiectasia-lymphedema syndrome is an autosomal recessive disorder, with 25% of patients having mutations in positive regulation of vascular endothelial growth factor production.">
    <entity charOffset="52-71" id="s1424.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="123-191" id="s1424.e1" ontology_id="GO_0010575" text="positive regulation of vascular endothelial growth factor production" type="GO"/>
    <pair e1="s1424.e0" e2="s1424.e1" id="s1424.p0" relation="true"/>
  </sentence>
  <sentence id="s1425" text="While there were no significant correlations with both Se status markers, &lt;i&gt;SELENOF&lt;/i&gt;, &lt;i&gt;SELENOK&lt;/i&gt;, and &lt;i&gt;TXNRD1&lt;/i&gt; tumor tissue expression positively correlated with Se, while &lt;i&gt;TXNRD2&lt;/i&gt; and &lt;i&gt;TXNRD3&lt;/i&gt; negatively correlated with &lt;i&gt;platelet degranulation&lt;/i&gt;.">
    <entity charOffset="124-129" id="s1425.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="247-269" id="s1425.e1" ontology_id="GO_0002576" text="platelet degranulation" type="GO"/>
    <pair e1="s1425.e0" e2="s1425.e1" id="s1425.p0" relation="false"/>
  </sentence>
  <sentence id="s1426" text="Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-positive regulation of protein phosphorylation-regulation of cell growth signaling">
    <entity charOffset="46-52" id="s1426.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-133" id="s1426.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1426.e0" e2="s1426.e1" id="s1426.p0" relation="true"/>
  </sentence>
  <sentence id="s1427" text="Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-positive regulation of protein phosphorylation-regulation of cell growth signaling">
    <entity charOffset="46-52" id="s1427.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-159" id="s1427.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s1427.e0" e2="s1427.e1" id="s1427.p0" relation="true"/>
  </sentence>
  <sentence id="s1428" text="We find that STX3 promotes the proliferation of breast cancer cells by increasing the activation of the positive regulation of protein phosphorylation-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.">
    <entity charOffset="55-61" id="s1428.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-150" id="s1428.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1428.e0" e2="s1428.e1" id="s1428.p0" relation="false"/>
  </sentence>
  <sentence id="s1429" text="The up-regulation of positive regulation of cell proliferation is correlated with high disease stage and predicts overall and disease-free survival in patients with breast cancer.">
    <entity charOffset="21-62" id="s1429.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="172-178" id="s1429.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1429.e0" e2="s1429.e1" id="s1429.p0" relation="true"/>
  </sentence>
  <sentence id="s1430" text="Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-artery smooth muscle contraction in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis">
    <entity charOffset="107-139" id="s1430.e0" ontology_id="GO_0014824" text="artery smooth muscle contraction" type="GO"/>
    <entity charOffset="332-343" id="s1430.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s1430.e0" e2="s1430.e1" id="s1430.p0" relation="false"/>
  </sentence>
  <sentence id="s1431" text="Selective artery smooth muscle contraction blockade or mitochondrial-targeted reactive oxygen species scavenging prevented mitochondrial oxidative stress of endothelial cells and ameliorated diabetes-induced endothelial injury, podocyte loss, albuminuria, and glomerulosclerosis.">
    <entity charOffset="10-42" id="s1431.e0" ontology_id="GO_0014824" text="artery smooth muscle contraction" type="GO"/>
    <entity charOffset="243-254" id="s1431.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s1431.e0" e2="s1431.e1" id="s1431.p0" relation="false"/>
  </sentence>
  <sentence id="s1432" text="It is a genetic disorder caused by a mutation in the dysferlin gene (monocyte activation involved in immune response) with an autosomal recessive mode of inheritance.">
    <entity charOffset="69-116" id="s1432.e0" ontology_id="GO_0002280" text="monocyte activation involved in immune response" type="GO"/>
    <entity charOffset="126-145" id="s1432.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1432.e0" e2="s1432.e1" id="s1432.p0" relation="true"/>
  </sentence>
  <sentence id="s1433" text="In this article, we report a case of Limb-girdle muscular dystrophy muscle organ development 2B with a rare homozygous duplication c.164dupA, p.(Ile57Hisfs*8) (rs863225020) in DYSF in a Saudi patient.">
    <entity charOffset="49-67" id="s1433.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="68-92" id="s1433.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1433.e0" e2="s1433.e1" id="s1433.p0" relation="false"/>
  </sentence>
  <sentence id="s1434" text="Our results therefore confirm the KCNC3R423H allele as causative for protein tetramerization, through a dominant negative effect on KCNC3WT and links with positive regulation of protein phosphorylation that account for dominant inheritance, congenital onset, and disease pathology">
    <entity charOffset="69-92" id="s1434.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="228-239" id="s1434.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s1434.e0" e2="s1434.e1" id="s1434.p0" relation="false"/>
  </sentence>
  <sentence id="s1435" text="Our results therefore confirm the KCNC3R423H allele as causative for protein tetramerization, through a dominant negative effect on KCNC3WT and links with positive regulation of protein phosphorylation that account for dominant inheritance, congenital onset, and disease pathology">
    <entity charOffset="155-201" id="s1435.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="228-239" id="s1435.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s1435.e0" e2="s1435.e1" id="s1435.p0" relation="false"/>
  </sentence>
  <sentence id="s1436" text="In the present study, we first analyzed two expression quantitative trait loci (eQTL) datasets in healthy individuals and investigated the associations of eQTL of morphogenesis of a polarized epithelium with schizophrenia in independent European samples.">
    <entity charOffset="163-202" id="s1436.e0" ontology_id="GO_0001738" text="morphogenesis of a polarized epithelium" type="GO"/>
    <entity charOffset="208-221" id="s1436.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1436.e0" e2="s1436.e1" id="s1436.p0" relation="true"/>
  </sentence>
  <sentence id="s1437" text="Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (cytokine production) related transcription factor negative regulation of transcription by RNA polymerase II, while had no effect on negative regulation of transcription by RNA polymerase II, Slug or Twist.">
    <entity charOffset="112-118" id="s1437.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="330-387" id="s1437.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1437.e0" e2="s1437.e1" id="s1437.p0" relation="false"/>
  </sentence>
  <sentence id="s1438" text="Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (cytokine production) related transcription factor negative regulation of transcription by RNA polymerase II, while had no effect on negative regulation of transcription by RNA polymerase II, Slug or Twist.">
    <entity charOffset="112-118" id="s1438.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="248-305" id="s1438.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1438.e0" e2="s1438.e1" id="s1438.p0" relation="false"/>
  </sentence>
  <sentence id="s1439" text="In vivo imaging, ex vivo imaging and tumor tissue slides showed that PDT further contribute EGFP-mitochondrial translational elongation-nucleobase-containing compound metabolic process accumulation in tumor.">
    <entity charOffset="37-42" id="s1439.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="97-135" id="s1439.e1" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <pair e1="s1439.e0" e2="s1439.e1" id="s1439.p0" relation="true"/>
  </sentence>
  <sentence id="s1440" text="In vivo imaging, ex vivo imaging and tumor tissue slides showed that PDT further contribute EGFP-mitochondrial translational elongation-nucleobase-containing compound metabolic process accumulation in tumor.">
    <entity charOffset="37-42" id="s1440.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="136-184" id="s1440.e1" ontology_id="GO_0006139" text="nucleobase-containing compound metabolic process" type="GO"/>
    <pair e1="s1440.e0" e2="s1440.e1" id="s1440.p0" relation="true"/>
  </sentence>
  <sentence id="s1441" text="In this study, a positive regulation of receptor-mediated endocytosis-cascade-targeted strategy aiming to disrupt tumor blood vessels was developed by combination of TF-targeted HMME-loaded drug delivery system and PDT.">
    <entity charOffset="17-69" id="s1441.e0" ontology_id="GO_0048260" text="positive regulation of receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="114-119" id="s1441.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1441.e0" e2="s1441.e1" id="s1441.p0" relation="false"/>
  </sentence>
  <sentence id="s1442" text="By recruiting the methyltransferase positive regulation of cell proliferation, C/EBP can maintain an open chromatin state by H3K79 methylation of multiple drug-resistance genes, thereby augmenting the chemoresistance of tumor cells.">
    <entity charOffset="36-77" id="s1442.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="221-226" id="s1442.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1442.e0" e2="s1442.e1" id="s1442.p0" relation="true"/>
  </sentence>
  <sentence id="s1443" text="Analysis of clinical samples of oral cancer found a strong correlation of these genes with short survival, especially transforming growth factor beta receptor signaling pathway expression associated with metastasis.">
    <entity charOffset="37-43" id="s1443.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="118-176" id="s1443.e1" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <pair e1="s1443.e0" e2="s1443.e1" id="s1443.p0" relation="true"/>
  </sentence>
  <sentence id="s1444" text="Of these, Frem1, Foxo1, and cellular response to DNA damage stimulus have been implicated in the pathogenesis of nephropathy.">
    <entity charOffset="28-68" id="s1444.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="113-124" id="s1444.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s1444.e0" e2="s1444.e1" id="s1444.p0" relation="true"/>
  </sentence>
  <sentence id="s1445" text="Previous studies have reported the association of prodynorphin (G protein-coupled receptor signaling pathway) promoter polymorphism with temporal lobe epilepsy (TLE) susceptibility, but the results remain inconclusive.">
    <entity charOffset="64-108" id="s1445.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="151-159" id="s1445.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1445.e0" e2="s1445.e1" id="s1445.p0" relation="true"/>
  </sentence>
  <sentence id="s1446" text="In this research, we measured the expression of oxidative phosphorylation protein by immunohistochemistry assay in 89 paired paraffin-embedded tumor tissues and corresponding adjacent normal tissues from patients with colorectal adenocarcinoma and investigated possible correlations of UQCRC2 expression with clinicopathological parameters and prognosis.">
    <entity charOffset="48-73" id="s1446.e0" ontology_id="GO_0006119" text="oxidative phosphorylation" type="GO"/>
    <entity charOffset="143-148" id="s1446.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1446.e0" e2="s1446.e1" id="s1446.p0" relation="true"/>
  </sentence>
  <sentence id="s1447" text="These results provided novel insights into the potential role of oxidative phosphorylation in the tumorigenesis and progression of CRC, and revealed that UQCRC2 may serve as a new prognostic and therapeutic target in CRC">
    <entity charOffset="65-90" id="s1447.e0" ontology_id="GO_0006119" text="oxidative phosphorylation" type="GO"/>
    <entity charOffset="98-103" id="s1447.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1447.e0" e2="s1447.e1" id="s1447.p0" relation="true"/>
  </sentence>
  <sentence id="s1448" text="Examination of tumor-infiltrating immune cells from mice vaccinated with the positive regulation of cell proliferation-expressing exosomes showed robust tumor-reactive CD8&lt;sup&gt;+&lt;/sup&gt; T effector responses, Th1 cytokine responses, and higher CD8&lt;sup&gt;+&lt;/sup&gt; T effector/CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt;Foxp3&lt;sup&gt;+&lt;/sup&gt; T regulatory cell ratio in the tumors.">
    <entity charOffset="15-20" id="s1448.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="77-118" id="s1448.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1448.e0" e2="s1448.e1" id="s1448.p0" relation="true"/>
  </sentence>
  <sentence id="s1449" text="The homeodomain transcription factor eye development was recently reported to be a negative regulator of the Wnt pathway and has an emerging role in cancer.">
    <entity charOffset="37-52" id="s1449.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="149-155" id="s1449.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1449.e0" e2="s1449.e1" id="s1449.p0" relation="true"/>
  </sentence>
  <sentence id="s1450" text="To avoid this artifactual early priming of the host precluding the study of the interactions between the immune system and tumors at the steady state, we generated a cell line expressing the biological_process Ag in an inducible manner.">
    <entity charOffset="123-128" id="s1450.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="191-209" id="s1450.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1450.e0" e2="s1450.e1" id="s1450.p0" relation="true"/>
  </sentence>
  <sentence id="s1451" text="In this study, we show that the presentation of a MHC class II-restricted model Ag (male, biological_process) released by dying tumor cells may last more than 4 wk.">
    <entity charOffset="90-108" id="s1451.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="128-133" id="s1451.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1451.e0" e2="s1451.e1" id="s1451.p0" relation="false"/>
  </sentence>
  <sentence id="s1452" text="In the case-control analysis, the rs9607195 A&amp;gt;G on intergenic area 250kb away from the regulation of transcription by RNA polymerase II gene and the rs12738007 A&amp;gt;G on the intron of the MECR gene were the most strongly associated SNPs with the risk of schizophrenia (P=6.210(-8) , OR=0.50 and P=3.710(-7) , OR=2.39, respectively).">
    <entity charOffset="91-139" id="s1452.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="258-271" id="s1452.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1452.e0" e2="s1452.e1" id="s1452.p0" relation="true"/>
  </sentence>
  <sentence id="s1453" text="Clinical presentation of generation of precursor metabolites and energy deficiency is heterogeneous ranging from mild to severe neuromuscular diseases.">
    <entity charOffset="25-71" id="s1453.e0" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <entity charOffset="86-99" id="s1453.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1453.e0" e2="s1453.e1" id="s1453.p0" relation="false"/>
  </sentence>
  <sentence id="s1454" text="Furthermore, we identified some potential lung cancer driver genes, such as negative regulation of transcription by RNA polymerase II, G1/S transition of mitotic cell cycle, SLC2A1, protein phosphorylation, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s1454.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="135-172" id="s1454.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s1454.e0" e2="s1454.e1" id="s1454.p0" relation="true"/>
  </sentence>
  <sentence id="s1455" text="Furthermore, we identified some potential lung cancer driver genes, such as negative regulation of transcription by RNA polymerase II, G1/S transition of mitotic cell cycle, SLC2A1, protein phosphorylation, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s1455.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="182-205" id="s1455.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1455.e0" e2="s1455.e1" id="s1455.p0" relation="true"/>
  </sentence>
  <sentence id="s1456" text="Furthermore, we identified some potential lung cancer driver genes, such as negative regulation of transcription by RNA polymerase II, G1/S transition of mitotic cell cycle, SLC2A1, protein phosphorylation, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s1456.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="76-133" id="s1456.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1456.e0" e2="s1456.e1" id="s1456.p0" relation="true"/>
  </sentence>
  <sentence id="s1457" text="Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including positive regulation of protein phosphorylation and inactivation of tumor suppressors, such as TP53, transforming growth factor beta receptor signaling pathway and CDKN2A.">
    <entity charOffset="151-157" id="s1457.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="169-215" id="s1457.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1457.e0" e2="s1457.e1" id="s1457.p0" relation="true"/>
  </sentence>
  <sentence id="s1458" text="Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including positive regulation of protein phosphorylation and inactivation of tumor suppressors, such as TP53, transforming growth factor beta receptor signaling pathway and CDKN2A.">
    <entity charOffset="236-241" id="s1458.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="269-327" id="s1458.e1" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <pair e1="s1458.e0" e2="s1458.e1" id="s1458.p0" relation="true"/>
  </sentence>
  <sentence id="s1459" text="The most likely causal variant identified was a novel missense variant in the X-linked glutamate receptor signaling pathway gene, which has been implicated in intellectual disability.">
    <entity charOffset="87-123" id="s1459.e0" ontology_id="GO_0007215" text="glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="159-182" id="s1459.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1459.e0" e2="s1459.e1" id="s1459.p0" relation="true"/>
  </sentence>
  <sentence id="s1460" text="In co-culture experiments using positive regulation of protein kinase B signaling-OVA melanoma cells and tumor-specific CD3+ T cells, EGCG reduced &lt;i&gt;PD-L1&lt;/i&gt; mRNA expression about 30% in F10-OVA cells and restored &lt;i&gt;interleukin-2&lt;/i&gt; mRNA expression in tumor-specific CD3+ T cells.">
    <entity charOffset="32-81" id="s1460.e0" ontology_id="GO_0051897" text="positive regulation of protein kinase B signaling" type="GO"/>
    <entity charOffset="105-110" id="s1460.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1460.e0" e2="s1460.e1" id="s1460.p0" relation="false"/>
  </sentence>
  <sentence id="s1461" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (cellular response to DNA damage stimulus, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s1461.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="208-266" id="s1461.e1" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <pair e1="s1461.e0" e2="s1461.e1" id="s1461.p0" relation="false"/>
  </sentence>
  <sentence id="s1462" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (cellular response to DNA damage stimulus, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s1462.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="282-328" id="s1462.e1" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <pair e1="s1462.e0" e2="s1462.e1" id="s1462.p0" relation="false"/>
  </sentence>
  <sentence id="s1463" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (cellular response to DNA damage stimulus, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s1463.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="76-116" id="s1463.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s1463.e0" e2="s1463.e1" id="s1463.p0" relation="false"/>
  </sentence>
  <sentence id="s1464" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (cellular response to DNA damage stimulus, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s1464.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="124-155" id="s1464.e1" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <pair e1="s1464.e0" e2="s1464.e1" id="s1464.p0" relation="true"/>
  </sentence>
  <sentence id="s1465" text="We identified 22 genes including APC, positive regulation of protein phosphorylation, TP53, GNAS, Ras protein signal transduction, SMAD4, nucleosome disassembly, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="38-84" id="s1465.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="206-212" id="s1465.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1465.e0" e2="s1465.e1" id="s1465.p0" relation="true"/>
  </sentence>
  <sentence id="s1466" text="We identified 22 genes including APC, positive regulation of protein phosphorylation, TP53, GNAS, Ras protein signal transduction, SMAD4, nucleosome disassembly, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="98-129" id="s1466.e0" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <entity charOffset="206-212" id="s1466.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1466.e0" e2="s1466.e1" id="s1466.p0" relation="true"/>
  </sentence>
  <sentence id="s1467" text="We identified 22 genes including APC, positive regulation of protein phosphorylation, TP53, GNAS, Ras protein signal transduction, SMAD4, nucleosome disassembly, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="138-160" id="s1467.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="206-212" id="s1467.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1467.e0" e2="s1467.e1" id="s1467.p0" relation="true"/>
  </sentence>
  <sentence id="s1468" text="phosphatidylinositol biosynthetic process, known as a human homologue of the Drosophila retinal degeneration B (rdgB), lacks the N-terminal PIT domain needed for transport of phospholipids, renewal of photoreceptors membrane and providing the electroretinogram (positive regulation of transcription by RNA polymerase II) response to light.">
    <entity charOffset="0-41" id="s1468.e0" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <entity charOffset="88-108" id="s1468.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1468.e0" e2="s1468.e1" id="s1468.p0" relation="true"/>
  </sentence>
  <sentence id="s1469" text="phosphatidylinositol biosynthetic process, known as a human homologue of the Drosophila retinal degeneration B (rdgB), lacks the N-terminal PIT domain needed for transport of phospholipids, renewal of photoreceptors membrane and providing the electroretinogram (positive regulation of transcription by RNA polymerase II) response to light.">
    <entity charOffset="88-108" id="s1469.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="262-319" id="s1469.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1469.e0" e2="s1469.e1" id="s1469.p0" relation="false"/>
  </sentence>
  <sentence id="s1470" text="Factor VII (FVII) activating protease (cell adhesion) is a circulating serine protease that is likely to be involved in a number of disease conditions such as stroke, atherosclerosis, liver fibrosis, thrombosis and cancer.">
    <entity charOffset="39-52" id="s1470.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="215-221" id="s1470.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1470.e0" e2="s1470.e1" id="s1470.p0" relation="false"/>
  </sentence>
  <sentence id="s1471" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. endocytosis, RBMS1, biological_process), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, antigen processing and presentation of peptide antigen via MHC class I, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="94-105" id="s1471.e0" ontology_id="GO_0006897" text="endocytosis" type="GO"/>
    <entity charOffset="268-275" id="s1471.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1471.e0" e2="s1471.e1" id="s1471.p0" relation="false"/>
  </sentence>
  <sentence id="s1472" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. endocytosis, RBMS1, biological_process), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, antigen processing and presentation of peptide antigen via MHC class I, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="114-132" id="s1472.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="268-275" id="s1472.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1472.e0" e2="s1472.e1" id="s1472.p0" relation="false"/>
  </sentence>
  <sentence id="s1473" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. endocytosis, RBMS1, biological_process), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, antigen processing and presentation of peptide antigen via MHC class I, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="183-253" id="s1473.e0" ontology_id="GO_0002474" text="antigen processing and presentation of peptide antigen via MHC class I" type="GO"/>
    <entity charOffset="268-275" id="s1473.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1473.e0" e2="s1473.e1" id="s1473.p0" relation="false"/>
  </sentence>
  <sentence id="s1474" text="Although positive regulation of Ras protein signal transduction has been shown to be a scaffold protein of the Ras-ERK pathway, its interaction with other signaling pathways and its involvement in tumor malignancy has not been reported.">
    <entity charOffset="9-63" id="s1474.e0" ontology_id="GO_0046579" text="positive regulation of Ras protein signal transduction" type="GO"/>
    <entity charOffset="197-202" id="s1474.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1474.e0" e2="s1474.e1" id="s1474.p0" relation="false"/>
  </sentence>
  <sentence id="s1475" text="The tumor cells expressed maintenance of gastrointestinal epithelium, GLUT-1, and vimentin and were negative for S-100 protein, epithelial membrane antigen, smooth muscle actin, desmin, claudin-1, neurofilament and SOX10.">
    <entity charOffset="4-9" id="s1475.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="26-68" id="s1475.e1" ontology_id="GO_0030277" text="maintenance of gastrointestinal epithelium" type="GO"/>
    <pair e1="s1475.e0" e2="s1475.e1" id="s1475.p0" relation="true"/>
  </sentence>
  <sentence id="s1476" text="Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (PRPF3, spliceosomal tri-snRNP complex assembly, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited retinal degeneration.">
    <entity charOffset="89-128" id="s1476.e0" ontology_id="GO_0000244" text="spliceosomal tri-snRNP complex assembly" type="GO"/>
    <entity charOffset="215-235" id="s1476.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1476.e0" e2="s1476.e1" id="s1476.p0" relation="true"/>
  </sentence>
  <sentence id="s1477" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1477.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1205-1251" id="s1477.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1477.e0" e2="s1477.e1" id="s1477.p0" relation="false"/>
  </sentence>
  <sentence id="s1478" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1478.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1475-1503" id="s1478.e1" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <pair e1="s1478.e0" e2="s1478.e1" id="s1478.p0" relation="false"/>
  </sentence>
  <sentence id="s1479" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1479.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1171-1194" id="s1479.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1479.e0" e2="s1479.e1" id="s1479.p0" relation="false"/>
  </sentence>
  <sentence id="s1480" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1480.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="953-988" id="s1480.e1" ontology_id="GO_0035335" text="peptidyl-tyrosine dephosphorylation" type="GO"/>
    <pair e1="s1480.e0" e2="s1480.e1" id="s1480.p0" relation="false"/>
  </sentence>
  <sentence id="s1481" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1481.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1000-1092" id="s1481.e1" ontology_id="GO_0098696" text="regulation of neurotransmitter receptor localization to postsynaptic specialization membrane" type="GO"/>
    <pair e1="s1481.e0" e2="s1481.e1" id="s1481.p0" relation="false"/>
  </sentence>
  <sentence id="s1482" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s1482.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1378-1432" id="s1482.e1" ontology_id="GO_0046579" text="positive regulation of Ras protein signal transduction" type="GO"/>
    <pair e1="s1482.e0" e2="s1482.e1" id="s1482.p0" relation="false"/>
  </sentence>
  <sentence id="s1483" text="According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 spastic paraplegia 7 (regulation of mitochondrial membrane permeability) variant is associated with apoptotic DNA fragmentation as it bypasses the regulation of tyrosine phosphorylation of AFG3L2 and enhances the processing and maturation of SPG7 protein.">
    <entity charOffset="115-133" id="s1483.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="137-186" id="s1483.e1" ontology_id="GO_0046902" text="regulation of mitochondrial membrane permeability" type="GO"/>
    <pair e1="s1483.e0" e2="s1483.e1" id="s1483.p0" relation="false"/>
  </sentence>
  <sentence id="s1484" text="According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 spastic paraplegia 7 (regulation of mitochondrial membrane permeability) variant is associated with apoptotic DNA fragmentation as it bypasses the regulation of tyrosine phosphorylation of AFG3L2 and enhances the processing and maturation of SPG7 protein.">
    <entity charOffset="115-133" id="s1484.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="215-242" id="s1484.e1" ontology_id="GO_0006309" text="apoptotic DNA fragmentation" type="GO"/>
    <pair e1="s1484.e0" e2="s1484.e1" id="s1484.p0" relation="false"/>
  </sentence>
  <sentence id="s1485" text="The deafness genes GJB3, negative regulation of transcription by RNA polymerase II, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.">
    <entity charOffset="4-12" id="s1485.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="25-82" id="s1485.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1485.e0" e2="s1485.e1" id="s1485.p0" relation="true"/>
  </sentence>
  <sentence id="s1486" text="The other tested genes, including the deafness gene regulation of cell shape, in which mutation recapitulates deafness in epidermis development, were expressed in a similar manner in both species.">
    <entity charOffset="38-46" id="s1486.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="52-76" id="s1486.e1" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <pair e1="s1486.e0" e2="s1486.e1" id="s1486.p0" relation="true"/>
  </sentence>
  <sentence id="s1487" text="Ectopic expression of Cx31 in mouse skin results in skin abnormalities resembling human in utero embryonic development.">
    <entity charOffset="52-70" id="s1487.e0" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <entity charOffset="88-118" id="s1487.e1" ontology_id="GO_0001701" text="in utero embryonic development" type="GO"/>
    <pair e1="s1487.e0" e2="s1487.e1" id="s1487.p0" relation="false"/>
  </sentence>
  <sentence id="s1488" text="We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic RNA splicing protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from sporadic FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or C9orf72 repeat expansion mutations (FTLD-TDP-C9+).">
    <entity charOffset="85-97" id="s1488.e0" ontology_id="GO_0008380" text="RNA splicing" type="GO"/>
    <entity charOffset="238-246" id="s1488.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1488.e0" e2="s1488.e1" id="s1488.p0" relation="false"/>
  </sentence>
  <sentence id="s1489" text="To provide new ideas based on the use of peptide hormone processing for risk prediction, prognostic assessment, and clinical treatment of cardiovascular diseases and to promote the implementation of corin as a routine laboratory index, we summarize the latest studies of the association between corin and cardiovascular diseases in recent years and offer some prospective proposals for future research on corin in this review">
    <entity charOffset="41-67" id="s1489.e0" ontology_id="GO_0016486" text="peptide hormone processing" type="GO"/>
    <entity charOffset="138-161" id="s1489.e1" ontology_id="HP_0001626" text="cardiovascular diseases" type="HP"/>
    <pair e1="s1489.e0" e2="s1489.e1" id="s1489.p0" relation="false"/>
  </sentence>
  <sentence id="s1490" text="Mutation analysis of the mitochondrial respiratory chain complex I assembly is warranted in isolated complex I deficiency presenting with infantile lactic acidemia or encephalocardiomyopathy">
    <entity charOffset="25-75" id="s1490.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="148-163" id="s1490.e1" ontology_id="HP_0003128" text="lactic acidemia" type="HP"/>
    <pair e1="s1490.e0" e2="s1490.e1" id="s1490.p0" relation="true"/>
  </sentence>
  <sentence id="s1491" text="Although poly(A)+ mRNA export from nucleus plays a critical role in the regulation of RNA processing, mutation of the gene encoding this ubiquitously expressed RNA binding protein causes a specific form of muscular dystrophy termed oculopharyngeal muscular dystrophy (poly(A)+ mRNA export from nucleus).">
    <entity charOffset="9-42" id="s1491.e0" ontology_id="GO_0016973" text="poly(A)+ mRNA export from nucleus" type="GO"/>
    <entity charOffset="206-224" id="s1491.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1491.e0" e2="s1491.e1" id="s1491.p0" relation="true"/>
  </sentence>
  <sentence id="s1492" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="38-44" id="s1492.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="144-171" id="s1492.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s1492.e0" e2="s1492.e1" id="s1492.p0" relation="true"/>
  </sentence>
  <sentence id="s1493" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="38-44" id="s1493.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="173-195" id="s1493.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s1493.e0" e2="s1493.e1" id="s1493.p0" relation="true"/>
  </sentence>
  <sentence id="s1494" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="38-44" id="s1494.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="273-297" id="s1494.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s1494.e0" e2="s1494.e1" id="s1494.p0" relation="true"/>
  </sentence>
  <sentence id="s1495" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="38-44" id="s1495.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="299-323" id="s1495.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s1495.e0" e2="s1495.e1" id="s1495.p0" relation="true"/>
  </sentence>
  <sentence id="s1496" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="38-44" id="s1496.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="325-366" id="s1496.e1" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <pair e1="s1496.e0" e2="s1496.e1" id="s1496.p0" relation="true"/>
  </sentence>
  <sentence id="s1497" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="46-62" id="s1497.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="325-366" id="s1497.e1" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <pair e1="s1497.e0" e2="s1497.e1" id="s1497.p0" relation="true"/>
  </sentence>
  <sentence id="s1498" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="46-62" id="s1498.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="173-195" id="s1498.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s1498.e0" e2="s1498.e1" id="s1498.p0" relation="true"/>
  </sentence>
  <sentence id="s1499" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="68-81" id="s1499.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="299-323" id="s1499.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s1499.e0" e2="s1499.e1" id="s1499.p0" relation="true"/>
  </sentence>
  <sentence id="s1500" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="68-81" id="s1500.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="144-171" id="s1500.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s1500.e0" e2="s1500.e1" id="s1500.p0" relation="true"/>
  </sentence>
  <sentence id="s1501" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="68-81" id="s1501.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="173-195" id="s1501.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s1501.e0" e2="s1501.e1" id="s1501.p0" relation="true"/>
  </sentence>
  <sentence id="s1502" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="68-81" id="s1502.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="202-259" id="s1502.e1" ontology_id="GO_0006121" text="mitochondrial electron transport, succinate to ubiquinone" type="GO"/>
    <pair e1="s1502.e0" e2="s1502.e1" id="s1502.p0" relation="true"/>
  </sentence>
  <sentence id="s1503" text="A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, response to hypoxia, was in a focal (frontal lobe)-onset syndrome.">
    <entity charOffset="99-107" id="s1503.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="162-181" id="s1503.e1" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <pair e1="s1503.e0" e2="s1503.e1" id="s1503.p0" relation="true"/>
  </sentence>
  <sentence id="s1504" text="Mutations in the EFHC1 gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized epilepsies) and single nucleotide polymorphisms in the regulation of transcription by RNA polymerase II gene (unknown function) and the malic enzyme 2 (ME2) gene.">
    <entity charOffset="167-177" id="s1504.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="222-270" id="s1504.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1504.e0" e2="s1504.e1" id="s1504.p0" relation="false"/>
  </sentence>
  <sentence id="s1505" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or sodium ion transport).">
    <entity charOffset="133-141" id="s1505.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="447-485" id="s1505.e1" ontology_id="GO_0099175" text="regulation of postsynapse organization" type="GO"/>
    <pair e1="s1505.e0" e2="s1505.e1" id="s1505.p0" relation="true"/>
  </sentence>
  <sentence id="s1506" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or sodium ion transport).">
    <entity charOffset="133-141" id="s1506.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="624-644" id="s1506.e1" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <pair e1="s1506.e0" e2="s1506.e1" id="s1506.p0" relation="false"/>
  </sentence>
  <sentence id="s1507" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or sodium ion transport).">
    <entity charOffset="133-141" id="s1507.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="559-619" id="s1507.e1" ontology_id="GO_0086002" text="cardiac muscle cell action potential involved in contraction" type="GO"/>
    <pair e1="s1507.e0" e2="s1507.e1" id="s1507.p0" relation="true"/>
  </sentence>
  <sentence id="s1508" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or sodium ion transport).">
    <entity charOffset="133-141" id="s1508.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="487-519" id="s1508.e1" ontology_id="GO_1902476" text="chloride transmembrane transport" type="GO"/>
    <pair e1="s1508.e0" e2="s1508.e1" id="s1508.p0" relation="true"/>
  </sentence>
  <sentence id="s1509" text="A large proportion of cases (approximately 44%) remain unexplained, indicating that signal transduction in this breed is genetically heterogeneous and caused by at least three mutations.">
    <entity charOffset="84-103" id="s1509.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="133-146" id="s1509.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1509.e0" e2="s1509.e1" id="s1509.p0" relation="false"/>
  </sentence>
  <sentence id="s1510" text="bicarbonate transport is important for retinal function and has not previously been associated with spontaneously occurring retinal degenerations in any other species, including humans">
    <entity charOffset="0-21" id="s1510.e0" ontology_id="GO_0015701" text="bicarbonate transport" type="GO"/>
    <entity charOffset="124-145" id="s1510.e1" ontology_id="HP_0000546" text="retinal degenerations" type="HP"/>
    <pair e1="s1510.e0" e2="s1510.e1" id="s1510.p0" relation="false"/>
  </sentence>
  <sentence id="s1511" text="We report the association of many previously unreported variants with retinal disease, as well as new disease phenotypes associated with known genes, including the first association of the ion transport gene with retinitis pigmentosa.">
    <entity charOffset="70-85" id="s1511.e0" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <entity charOffset="189-202" id="s1511.e1" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <pair e1="s1511.e0" e2="s1511.e1" id="s1511.p0" relation="true"/>
  </sentence>
  <sentence id="s1512" text="Additionally, immunohistochemistry staining and Western blot showed that highly expressed miR-135b-5p accelerated cytokine production process of pancreatic cancer cells.">
    <entity charOffset="114-133" id="s1512.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="156-162" id="s1512.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1512.e0" e2="s1512.e1" id="s1512.p0" relation="false"/>
  </sentence>
  <sentence id="s1513" text="This study aimed to elucidate the potential functional mechanism of protein polyubiquitination-135b-5p in migration, invasion and epithelial-to-mesenchymal transition (EMT) of pancreatic cancer cells.">
    <entity charOffset="68-94" id="s1513.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="187-193" id="s1513.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1513.e0" e2="s1513.e1" id="s1513.p0" relation="true"/>
  </sentence>
  <sentence id="s1514" text="Haplotype glycine metabolic process for GRM6 markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high myopia.">
    <entity charOffset="10-35" id="s1514.e0" ontology_id="GO_0006544" text="glycine metabolic process" type="GO"/>
    <entity charOffset="282-288" id="s1514.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1514.e0" e2="s1514.e1" id="s1514.p0" relation="true"/>
  </sentence>
  <sentence id="s1515" text="The genetic model analysis found that G protein-coupled glutamate receptor signaling pathway-rs11746675 and GRM6-rs2067011 were suggestively associated with high myopia in the recessive model (OR=0.54, P=0.004; OR=0.52, P=0.003; respectively).">
    <entity charOffset="38-92" id="s1515.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="162-168" id="s1515.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1515.e0" e2="s1515.e1" id="s1515.p0" relation="true"/>
  </sentence>
  <sentence id="s1516" text="Fourteen single-nucleotide polymorphisms (SNPs) in three genes were genotyped by the TaqMan method using the real-time PCR system.ResultsThree SNPs G protein-coupled glutamate receptor signaling pathway-rs11746675, GRM6-rs2067011, and GRM6-rs2645339 were associated with high myopia (odds ratio (OR)=0.74, P=0.003; OR=0.78, P=0.018; and OR=0.78, P=0.023; respectively).">
    <entity charOffset="148-202" id="s1516.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="276-282" id="s1516.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1516.e0" e2="s1516.e1" id="s1516.p0" relation="true"/>
  </sentence>
  <sentence id="s1517" text="This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="64-121" id="s1517.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="329-347" id="s1517.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s1517.e0" e2="s1517.e1" id="s1517.p0" relation="true"/>
  </sentence>
  <sentence id="s1518" text="This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="122-160" id="s1518.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="301-324" id="s1518.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1518.e0" e2="s1518.e1" id="s1518.p0" relation="false"/>
  </sentence>
  <sentence id="s1519" text="Seborrhoeic Dermatitis (negative regulation of protein export from nucleus) is a common inflammatory skin disease that presents as itchy, flaking skin in the seborrhoeic areas.">
    <entity charOffset="24-74" id="s1519.e0" ontology_id="GO_0046826" text="negative regulation of protein export from nucleus" type="GO"/>
    <entity charOffset="138-150" id="s1519.e1" ontology_id="HP_0040189" text="flaking skin" type="HP"/>
    <pair e1="s1519.e0" e2="s1519.e1" id="s1519.p0" relation="false"/>
  </sentence>
  <sentence id="s1520" text="protein catabolic process in the vacuole knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, negative regulation of transcription by RNA polymerase II and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="0-40" id="s1520.e0" ontology_id="GO_0007039" text="protein catabolic process in the vacuole" type="GO"/>
    <entity charOffset="62-67" id="s1520.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1520.e0" e2="s1520.e1" id="s1520.p0" relation="true"/>
  </sentence>
  <sentence id="s1521" text="protein catabolic process in the vacuole knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, negative regulation of transcription by RNA polymerase II and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="62-67" id="s1521.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="403-460" id="s1521.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1521.e0" e2="s1521.e1" id="s1521.p0" relation="false"/>
  </sentence>
  <sentence id="s1522" text="Zebrafish with ryroxD1 knock-down recapitulate features of cellular response to oxidative stress myopathy with sarcomeric disorganization, myofibrillar aggregates, and marked swimming defect.">
    <entity charOffset="59-96" id="s1522.e0" ontology_id="GO_0034599" text="cellular response to oxidative stress" type="GO"/>
    <entity charOffset="97-105" id="s1522.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1522.e0" e2="s1522.e1" id="s1522.p0" relation="false"/>
  </sentence>
  <sentence id="s1523" text="We studied 46 cases of extramedullary plasmacytoma by immunostaining with anti-phosphorylation antibody and fluorescence in situ hybridization (superoxide metabolic process) analysis using an ALK break-apart probe and found one case to be ALK protein-positive and demonstrated the disruption of the ALK gene in this case.">
    <entity charOffset="38-50" id="s1523.e0" ontology_id="HP_0011857" text="plasmacytoma" type="HP"/>
    <entity charOffset="144-172" id="s1523.e1" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <pair e1="s1523.e0" e2="s1523.e1" id="s1523.p0" relation="false"/>
  </sentence>
  <sentence id="s1524" text="We studied 46 cases of extramedullary plasmacytoma by immunostaining with anti-phosphorylation antibody and fluorescence in situ hybridization (superoxide metabolic process) analysis using an ALK break-apart probe and found one case to be ALK protein-positive and demonstrated the disruption of the ALK gene in this case.">
    <entity charOffset="38-50" id="s1524.e0" ontology_id="HP_0011857" text="plasmacytoma" type="HP"/>
    <entity charOffset="79-94" id="s1524.e1" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <pair e1="s1524.e0" e2="s1524.e1" id="s1524.p0" relation="true"/>
  </sentence>
  <sentence id="s1525" text="This finding expands the lists of the phosphorylation-positive tumors, and ALK-positive extramedullary plasmacytoma may benefit from the treatment of ALK inhibitor in the future">
    <entity charOffset="38-53" id="s1525.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="63-69" id="s1525.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1525.e0" e2="s1525.e1" id="s1525.p0" relation="false"/>
  </sentence>
  <sentence id="s1526" text="This finding expands the lists of the phosphorylation-positive tumors, and ALK-positive extramedullary plasmacytoma may benefit from the treatment of ALK inhibitor in the future">
    <entity charOffset="38-53" id="s1526.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="103-115" id="s1526.e1" ontology_id="HP_0011857" text="plasmacytoma" type="HP"/>
    <pair e1="s1526.e0" e2="s1526.e1" id="s1526.p0" relation="false"/>
  </sentence>
  <sentence id="s1527" text="Biallelic loss-of-function mutations in TYROBP and positive regulation of antigen processing and presentation of peptide antigen via MHC class II cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (myeloid leukocyte activation).">
    <entity charOffset="51-145" id="s1527.e0" ontology_id="GO_0002588" text="positive regulation of antigen processing and presentation of peptide antigen via MHC class II" type="GO"/>
    <entity charOffset="194-217" id="s1527.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s1527.e0" e2="s1527.e1" id="s1527.p0" relation="true"/>
  </sentence>
  <sentence id="s1528" text="Biallelic loss-of-function mutations in TYROBP and positive regulation of antigen processing and presentation of peptide antigen via MHC class II cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (myeloid leukocyte activation).">
    <entity charOffset="51-145" id="s1528.e0" ontology_id="GO_0002588" text="positive regulation of antigen processing and presentation of peptide antigen via MHC class II" type="GO"/>
    <entity charOffset="300-319" id="s1528.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s1528.e0" e2="s1528.e1" id="s1528.p0" relation="false"/>
  </sentence>
  <sentence id="s1529" text="Dual-specificity tyrosine phosphorylation-regulated kinase 1A (peptidyl-tyrosine phosphorylation) is a potential target in Alzheimer's disease (AD) because of the established correlation between its over-expression and generation of neurofibrillary tangles (NFT) as well as the accumulation of amyloid plaques.">
    <entity charOffset="63-96" id="s1529.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="233-256" id="s1529.e1" ontology_id="HP_0002185" text="neurofibrillary tangles" type="HP"/>
    <pair e1="s1529.e0" e2="s1529.e1" id="s1529.p0" relation="true"/>
  </sentence>
  <sentence id="s1530" text="This result has clinical and genetic counseling implications for genetically unsolved male case subjects with a classic motile cilium assembly phenotype that lack additional phenotypes such as intellectual disability or retinitis pignegative regulation of phosphatase activitytosa">
    <entity charOffset="120-142" id="s1530.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="193-216" id="s1530.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1530.e0" e2="s1530.e1" id="s1530.p0" relation="false"/>
  </sentence>
  <sentence id="s1531" text="Bcl2-associated athanogene 3 (extrinsic apoptotic signaling pathway via death domain receptors) mutations have been reported to cause the myofibrillar myopathy (MFM) which shows progressive limb muscle weakness, respiratory failure, and cardiomyopathy.">
    <entity charOffset="30-94" id="s1531.e0" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <entity charOffset="212-231" id="s1531.e1" ontology_id="HP_0002878" text="respiratory failure" type="HP"/>
    <pair e1="s1531.e0" e2="s1531.e1" id="s1531.p0" relation="true"/>
  </sentence>
  <sentence id="s1532" text="A de novo heterozygous p.Pro209Leu (c.626C&amp;gt;T) mutation in extrinsic apoptotic signaling pathway via death domain receptors was identified in a female myopathy.">
    <entity charOffset="61-125" id="s1532.e0" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <entity charOffset="153-161" id="s1532.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1532.e0" e2="s1532.e1" id="s1532.p0" relation="true"/>
  </sentence>
  <sentence id="s1533" text="We found extrinsic apoptotic signaling pathway via death domain receptors mutation in one patient with neuropathy, myopathy and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.">
    <entity charOffset="9-73" id="s1533.e0" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <entity charOffset="103-113" id="s1533.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1533.e0" e2="s1533.e1" id="s1533.p0" relation="true"/>
  </sentence>
  <sentence id="s1534" text="She showed an axonal sensory-motor polyneuropathy like Charcot-Marie-Tooth disease (CMT), myopathy, rigid spine and respiratory dysfunction; however, she did not show any cardiomyopathy, which is a common symptom in extrinsic apoptotic signaling pathway via death domain receptors mutation.">
    <entity charOffset="90-98" id="s1534.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="216-280" id="s1534.e1" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <pair e1="s1534.e0" e2="s1534.e1" id="s1534.p0" relation="false"/>
  </sentence>
  <sentence id="s1535" text="Mutations in eight of them (PDSS1, ubiquinone biosynthetic process, COQ2, COQ4, COQ6, ADCK3, ADCK4, and ubiquinone biosynthetic process) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="35-66" id="s1535.e0" ontology_id="GO_0006744" text="ubiquinone biosynthetic process" type="GO"/>
    <entity charOffset="173-186" id="s1535.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1535.e0" e2="s1535.e1" id="s1535.p0" relation="true"/>
  </sentence>
  <sentence id="s1536" text="Mutations in eight of them (PDSS1, ubiquinone biosynthetic process, COQ2, COQ4, COQ6, ADCK3, ADCK4, and ubiquinone biosynthetic process) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="104-135" id="s1536.e0" ontology_id="GO_0006744" text="ubiquinone biosynthetic process" type="GO"/>
    <entity charOffset="173-186" id="s1536.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1536.e0" e2="s1536.e1" id="s1536.p0" relation="true"/>
  </sentence>
  <sentence id="s1537" text="Finally, we demonstrate that genetic incoenzyme A biosynthetic processivation of camera-type eye development rescues axial elongation in a mouse model of myopia caused by a null mutation in Egr1.">
    <entity charOffset="81-108" id="s1537.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="154-160" id="s1537.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1537.e0" e2="s1537.e1" id="s1537.p0" relation="true"/>
  </sentence>
  <sentence id="s1538" text="We have previously identified a role for the secreted serine protease camera-type eye development in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refrcoenzyme A biosynthetic processive development.">
    <entity charOffset="70-97" id="s1538.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="206-212" id="s1538.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1538.e0" e2="s1538.e1" id="s1538.p0" relation="true"/>
  </sentence>
  <sentence id="s1539" text="Here, we investigated associations between genetic variants of G protein-coupled receptor signaling pathway GTPases-related genes and cutaneous melanoma-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS.">
    <entity charOffset="63-107" id="s1539.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="134-152" id="s1539.e1" ontology_id="HP_0012056" text="cutaneous melanoma" type="HP"/>
    <pair e1="s1539.e0" e2="s1539.e1" id="s1539.p0" relation="true"/>
  </sentence>
  <sentence id="s1540" text="As ubiquitination is a versatile post-translational modification that can affect target turnover, sub-cellular localisation or activity, it is likely that diverse substrates may be differentially affected by protein polyubiquitination-mediated ubiquitination, reflecting its multi-faceted roles in muscle physiology, cancer and immunity.">
    <entity charOffset="208-234" id="s1540.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="317-323" id="s1540.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1540.e0" e2="s1540.e1" id="s1540.p0" relation="true"/>
  </sentence>
  <sentence id="s1541" text="In this review, we will focus on the ability of protein polyubiquitination to mark specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or tumour suppressive role for TRIM32 in the context of different types of cancer">
    <entity charOffset="48-74" id="s1541.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="304-310" id="s1541.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1541.e0" e2="s1541.e1" id="s1541.p0" relation="true"/>
  </sentence>
  <sentence id="s1542" text="Mice with a neuronal deletion of regulation of intracellular cholesterol transport recapitulated the human phenotype, exhibiting seizures and a severe survival defect in adulthood.">
    <entity charOffset="33-82" id="s1542.e0" ontology_id="GO_0032383" text="regulation of intracellular cholesterol transport" type="GO"/>
    <entity charOffset="129-136" id="s1542.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s1542.e0" e2="s1542.e1" id="s1542.p0" relation="true"/>
  </sentence>
  <sentence id="s1543" text="Is positive regulation of proteolysis due to the bilateral occurrence of APCCs, to germline variants, or perhaps due to unknown serum factors? Lastly, the etiology of unsolved cases of apparently familial hyperaldosteronism remains to be discovered.">
    <entity charOffset="3-37" id="s1543.e0" ontology_id="GO_0045862" text="positive regulation of proteolysis" type="GO"/>
    <entity charOffset="205-223" id="s1543.e1" ontology_id="HP_0000859" text="hyperaldosteronism" type="HP"/>
    <pair e1="s1543.e0" e2="s1543.e1" id="s1543.p0" relation="false"/>
  </sentence>
  <sentence id="s1544" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci collagen fibril organization (COL11A2), DFNB66, and DFNB67.">
    <entity charOffset="58-77" id="s1544.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="218-246" id="s1544.e1" ontology_id="GO_0030199" text="collagen fibril organization" type="GO"/>
    <pair e1="s1544.e0" e2="s1544.e1" id="s1544.p0" relation="true"/>
  </sentence>
  <sentence id="s1545" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci collagen fibril organization (COL11A2), DFNB66, and DFNB67.">
    <entity charOffset="91-103" id="s1545.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="218-246" id="s1545.e1" ontology_id="GO_0030199" text="collagen fibril organization" type="GO"/>
    <pair e1="s1545.e0" e2="s1545.e1" id="s1545.p0" relation="true"/>
  </sentence>
  <sentence id="s1546" text="Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (ion transport) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two DFNB67-linked families from Pakistan.">
    <entity charOffset="90-96" id="s1546.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="126-139" id="s1546.e1" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <pair e1="s1546.e0" e2="s1546.e1" id="s1546.p0" relation="true"/>
  </sentence>
  <sentence id="s1547" text="Beyond secretion, digestion is a tumor suppressor universally silenced by loss of expression of its paracrine hormone during carcinogenesis.">
    <entity charOffset="18-27" id="s1547.e0" ontology_id="GO_0007586" text="digestion" type="GO"/>
    <entity charOffset="33-38" id="s1547.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1547.e0" e2="s1547.e1" id="s1547.p0" relation="true"/>
  </sentence>
  <sentence id="s1548" text="Thus, chronic colonization with &lt;i&gt;ETEC&lt;/i&gt; producing ST could contribute to endemic cancer resistance in developing countries, reinforcing a novel paradigm of colorectal cancer chemoprevention with oral digestion-targeted agents">
    <entity charOffset="85-91" id="s1548.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="204-213" id="s1548.e1" ontology_id="GO_0007586" text="digestion" type="GO"/>
    <pair e1="s1548.e0" e2="s1548.e1" id="s1548.p0" relation="true"/>
  </sentence>
  <sentence id="s1549" text="Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (MAPK cascade) are rare tumors with distinct sets of morphological features, both characterized by maintenance of gastrointestinal epithelium immunoreactivity.">
    <entity charOffset="22-29" id="s1549.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="79-91" id="s1549.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s1549.e0" e2="s1549.e1" id="s1549.p0" relation="false"/>
  </sentence>
  <sentence id="s1550" text="Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (MAPK cascade) are rare tumors with distinct sets of morphological features, both characterized by maintenance of gastrointestinal epithelium immunoreactivity.">
    <entity charOffset="79-91" id="s1550.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="102-108" id="s1550.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1550.e0" e2="s1550.e1" id="s1550.p0" relation="false"/>
  </sentence>
  <sentence id="s1551" text="Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (MAPK cascade) are rare tumors with distinct sets of morphological features, both characterized by maintenance of gastrointestinal epithelium immunoreactivity.">
    <entity charOffset="102-108" id="s1551.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="177-219" id="s1551.e1" ontology_id="GO_0030277" text="maintenance of gastrointestinal epithelium" type="GO"/>
    <pair e1="s1551.e0" e2="s1551.e1" id="s1551.p0" relation="true"/>
  </sentence>
  <sentence id="s1552" text="Although disruption of the G1/S transition of mitotic cell cycle (INK4A/ARF) locus has been reported in end-stage disease, information is lacking on the status of this key tumor suppressor gene in pleural lesions preceding mesothelioma.">
    <entity charOffset="27-64" id="s1552.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="172-177" id="s1552.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1552.e0" e2="s1552.e1" id="s1552.p0" relation="true"/>
  </sentence>
  <sentence id="s1553" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly, protein targeting to membrane, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="21-34" id="s1553.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="222-249" id="s1553.e1" ontology_id="GO_0017004" text="cytochrome complex assembly" type="GO"/>
    <pair e1="s1553.e0" e2="s1553.e1" id="s1553.p0" relation="false"/>
  </sentence>
  <sentence id="s1554" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly, protein targeting to membrane, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="21-34" id="s1554.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="291-386" id="s1554.e1" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <pair e1="s1554.e0" e2="s1554.e1" id="s1554.p0" relation="true"/>
  </sentence>
  <sentence id="s1555" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly, protein targeting to membrane, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="161-180" id="s1555.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="251-280" id="s1555.e1" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <pair e1="s1555.e0" e2="s1555.e1" id="s1555.p0" relation="true"/>
  </sentence>
  <sentence id="s1556" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly, protein targeting to membrane, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="161-180" id="s1556.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="291-386" id="s1556.e1" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <pair e1="s1556.e0" e2="s1556.e1" id="s1556.p0" relation="true"/>
  </sentence>
  <sentence id="s1557" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly, protein targeting to membrane, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="161-180" id="s1557.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="222-249" id="s1557.e1" ontology_id="GO_0017004" text="cytochrome complex assembly" type="GO"/>
    <pair e1="s1557.e0" e2="s1557.e1" id="s1557.p0" relation="true"/>
  </sentence>
  <sentence id="s1558" text="Human kallikrein-related peptidases biological_process-15 provide a rich source of serine protease-type biomarkers associated with tumor growth and cancer progression for a variety of malignant diseases.">
    <entity charOffset="36-54" id="s1558.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="131-136" id="s1558.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1558.e0" e2="s1558.e1" id="s1558.p0" relation="true"/>
  </sentence>
  <sentence id="s1559" text="Human kallikrein-related peptidases biological_process-15 provide a rich source of serine protease-type biomarkers associated with tumor growth and cancer progression for a variety of malignant diseases.">
    <entity charOffset="36-54" id="s1559.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="148-154" id="s1559.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1559.e0" e2="s1559.e1" id="s1559.p0" relation="true"/>
  </sentence>
  <sentence id="s1560" text="For this, amelogenesis protein expression was assessed by immunohistochemistry in primary tumor tissue sections (tissue microarrays) of 188 TNBC patients, mainly treated with anthracycline- or CMF-based polychemotherapy.">
    <entity charOffset="10-22" id="s1560.e0" ontology_id="GO_0097186" text="amelogenesis" type="GO"/>
    <entity charOffset="90-95" id="s1560.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1560.e0" e2="s1560.e1" id="s1560.p0" relation="true"/>
  </sentence>
  <sentence id="s1561" text="In this study, recombinant amelogenesis protein was generated and affinity-purified KLK4-directed polyclonal antibody pAb587 established to allow localization of KLK4 protein expression in tumor cell lines and archived formalin-fixed, paraffin-embedded TNBC tumor tissue specimens.">
    <entity charOffset="27-39" id="s1561.e0" ontology_id="GO_0097186" text="amelogenesis" type="GO"/>
    <entity charOffset="189-194" id="s1561.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1561.e0" e2="s1561.e1" id="s1561.p0" relation="true"/>
  </sentence>
  <sentence id="s1562" text="Using exome sequencing, we discovered missense mutations in transcription by RNA polymerase II, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).">
    <entity charOffset="60-94" id="s1562.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="409-427" id="s1562.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s1562.e0" e2="s1562.e1" id="s1562.p0" relation="true"/>
  </sentence>
  <sentence id="s1563" text="positive regulation of peptidyl-tyrosine phosphorylation and PRND are significantly over-expressed in osteosarcoma.">
    <entity charOffset="0-56" id="s1563.e0" ontology_id="GO_0050731" text="positive regulation of peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="102-114" id="s1563.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s1563.e0" e2="s1563.e1" id="s1563.p0" relation="true"/>
  </sentence>
  <sentence id="s1564" text="PRNP and acrosome reaction appear involved with some important genes related to tumorigenesis and apoptosis.">
    <entity charOffset="9-26" id="s1564.e0" ontology_id="GO_0007340" text="acrosome reaction" type="GO"/>
    <entity charOffset="80-85" id="s1564.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1564.e0" e2="s1564.e1" id="s1564.p0" relation="true"/>
  </sentence>
  <sentence id="s1565" text="Alazami syndrome (AS) (negative regulation of epithelial cell proliferation# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in RNA processing.">
    <entity charOffset="195-218" id="s1565.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="268-282" id="s1565.e1" ontology_id="GO_0006396" text="RNA processing" type="GO"/>
    <pair e1="s1565.e0" e2="s1565.e1" id="s1565.p0" relation="true"/>
  </sentence>
  <sentence id="s1566" text="We identified the first de novo variant in response to hypoxia (c.2984A&amp;gt;G (p.(N995S)))-encoding the BK channel-that causes epilepsy, but not paroxysmal dyskinesia, in two independent families.">
    <entity charOffset="43-62" id="s1566.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="147-168" id="s1566.e1" ontology_id="HP_0007166" text="paroxysmal dyskinesia" type="HP"/>
    <pair e1="s1566.e0" e2="s1566.e1" id="s1566.p0" relation="true"/>
  </sentence>
  <sentence id="s1567" text="In the present study, we revealed that TMEM165 is overexpressed in phosphatidylinositol phosphorylation and its depletion weakens the invasive activity of cancer cells through suppression of matrix metalloproteinase2 (MMP2) expression.">
    <entity charOffset="67-103" id="s1567.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="155-161" id="s1567.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1567.e0" e2="s1567.e1" id="s1567.p0" relation="false"/>
  </sentence>
  <sentence id="s1568" text="The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or negative regulation of transcription by RNA polymerase II rearrangements (double-hit, DH).">
    <entity charOffset="76-85" id="s1568.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="181-238" id="s1568.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1568.e0" e2="s1568.e1" id="s1568.p0" relation="true"/>
  </sentence>
  <sentence id="s1569" text="Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of clathrin coat assembly with early-onset hearing loss, we identified two heterozygous mutations affecting Arg391 in -tubulin 4B isotype-encoding (G2/M transition of mitotic cell cycle).">
    <entity charOffset="109-131" id="s1569.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="149-161" id="s1569.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1569.e0" e2="s1569.e1" id="s1569.p0" relation="true"/>
  </sentence>
  <sentence id="s1570" text="Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of clathrin coat assembly with early-onset hearing loss, we identified two heterozygous mutations affecting Arg391 in -tubulin 4B isotype-encoding (G2/M transition of mitotic cell cycle).">
    <entity charOffset="149-161" id="s1570.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="255-292" id="s1570.e1" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <pair e1="s1570.e0" e2="s1570.e1" id="s1570.p0" relation="false"/>
  </sentence>
  <sentence id="s1571" text="Independent and pooled analyses verified that higher proline biosynthetic process mRNA levels were significantly associated with poor survival of breast cancer patients, regardless of estrogen receptor (ER) status.">
    <entity charOffset="53-81" id="s1571.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="153-159" id="s1571.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1571.e0" e2="s1571.e1" id="s1571.p0" relation="true"/>
  </sentence>
  <sentence id="s1572" text="For in vitro studies, inhibition of proline biosynthetic process by small-hairpin RNA significantly reduced the growth and invasion capabilities of the cells, while enhancing the cytotoxicity of doxorubicin in breast cancer cell lines MCF-7 (ER positive) and MDA-MB-231 (ER negative).">
    <entity charOffset="36-64" id="s1572.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="217-223" id="s1572.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1572.e0" e2="s1572.e1" id="s1572.p0" relation="true"/>
  </sentence>
  <sentence id="s1573" text="In response to surgical induction of endometriosis, regulation of transcription involved in G1/S transition of mitotic cell cycle-/- female mice develop significant fibrosis in contrast to wild-type mice.">
    <entity charOffset="37-50" id="s1573.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="52-129" id="s1573.e1" ontology_id="GO_0000083" text="regulation of transcription involved in G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s1573.e0" e2="s1573.e1" id="s1573.p0" relation="false"/>
  </sentence>
  <sentence id="s1574" text="The present study aimed to molecularly define and determine the contribution of two rare, apparently novel regulation of transcription, DNA-templated LGRs, among Greek breast cancer patients.">
    <entity charOffset="107-149" id="s1574.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="175-181" id="s1574.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1574.e0" e2="s1574.e1" id="s1574.p0" relation="true"/>
  </sentence>
  <sentence id="s1575" text="Patients with HCP show &amp;lt;50% of normal activity and those with the rare autosomal recessive harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the heme biosynthetic process reaction.">
    <entity charOffset="74-93" id="s1575.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="177-202" id="s1575.e1" ontology_id="GO_0006783" text="heme biosynthetic process" type="GO"/>
    <pair e1="s1575.e0" e2="s1575.e1" id="s1575.p0" relation="true"/>
  </sentence>
  <sentence id="s1576" text="To identify the disease-causing defect in these families, we first analysed embryo development ending in birth or egg hatching gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and embryo development ending in birth or egg hatching) previously implicated in different forms of microphthalmia.">
    <entity charOffset="76-126" id="s1576.e0" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <entity charOffset="328-342" id="s1576.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s1576.e0" e2="s1576.e1" id="s1576.p0" relation="true"/>
  </sentence>
  <sentence id="s1577" text="To identify the disease-causing defect in these families, we first analysed embryo development ending in birth or egg hatching gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and embryo development ending in birth or egg hatching) previously implicated in different forms of microphthalmia.">
    <entity charOffset="232-282" id="s1577.e0" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <entity charOffset="328-342" id="s1577.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s1577.e0" e2="s1577.e1" id="s1577.p0" relation="false"/>
  </sentence>
  <sentence id="s1578" text="The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (Tperipheral nervous system development-)], myeloperoxidase (low-density lipoprotein particle remodeling) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the LPS group compared to the PBS group.">
    <entity charOffset="95-100" id="s1578.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="181-224" id="s1578.e1" ontology_id="GO_0034374" text="low-density lipoprotein particle remodeling" type="GO"/>
    <pair e1="s1578.e0" e2="s1578.e1" id="s1578.p0" relation="true"/>
  </sentence>
  <sentence id="s1579" text="The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (Tperipheral nervous system development-)], myeloperoxidase (low-density lipoprotein particle remodeling) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the LPS group compared to the PBS group.">
    <entity charOffset="95-100" id="s1579.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="121-158" id="s1579.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s1579.e0" e2="s1579.e1" id="s1579.p0" relation="false"/>
  </sentence>
  <sentence id="s1580" text="Another clinically relevant form of regulation of phosphate transport-related hypophosphatemic disease is tumor-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.">
    <entity charOffset="36-69" id="s1580.e0" ontology_id="GO_0010966" text="regulation of phosphate transport" type="GO"/>
    <entity charOffset="106-111" id="s1580.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1580.e0" e2="s1580.e1" id="s1580.p0" relation="true"/>
  </sentence>
  <sentence id="s1581" text="Another clinically relevant form of regulation of phosphate transport-related hypophosphatemic disease is tumor-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.">
    <entity charOffset="36-69" id="s1581.e0" ontology_id="GO_0010966" text="regulation of phosphate transport" type="GO"/>
    <entity charOffset="120-132" id="s1581.e1" ontology_id="HP_0002749" text="osteomalacia" type="HP"/>
    <pair e1="s1581.e0" e2="s1581.e1" id="s1581.p0" relation="true"/>
  </sentence>
  <sentence id="s1582" text="Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, acetyl-CoA biosynthetic process) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.">
    <entity charOffset="52-83" id="s1582.e0" ontology_id="GO_0006085" text="acetyl-CoA biosynthetic process" type="GO"/>
    <entity charOffset="196-215" id="s1582.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1582.e0" e2="s1582.e1" id="s1582.p0" relation="false"/>
  </sentence>
  <sentence id="s1583" text="We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in adenylate cyclase-activating G protein-coupled receptor signaling pathway, which were sometimes found with accelerated growth rather than short stature as described previously.">
    <entity charOffset="42-49" id="s1583.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="102-175" id="s1583.e1" ontology_id="GO_0007189" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s1583.e0" e2="s1583.e1" id="s1583.p0" relation="false"/>
  </sentence>
  <sentence id="s1584" text="Besides the hallmark features, this patient also presents problems not previously associated with small GTPase mediated signal transduction syndrome, including cervical vertebral fusion, mild hearing loss, and colonic fibrosis.">
    <entity charOffset="98-139" id="s1584.e0" ontology_id="GO_0007264" text="small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="192-204" id="s1584.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1584.e0" e2="s1584.e1" id="s1584.p0" relation="false"/>
  </sentence>
  <sentence id="s1585" text="Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving regulation of transcription, DNA-templated in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.">
    <entity charOffset="308-350" id="s1585.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="429-452" id="s1585.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1585.e0" e2="s1585.e1" id="s1585.p0" relation="true"/>
  </sentence>
  <sentence id="s1586" text="Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving regulation of transcription, DNA-templated in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.">
    <entity charOffset="308-350" id="s1586.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="511-519" id="s1586.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1586.e0" e2="s1586.e1" id="s1586.p0" relation="true"/>
  </sentence>
  <sentence id="s1587" text="The spontaneous mutant mouse staggerer, with an ataxic gait caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades ago to result from homozygous intragenic regulation of transcription, DNA-templated deletions.">
    <entity charOffset="48-59" id="s1587.e0" ontology_id="HP_0002066" text="ataxic gait" type="HP"/>
    <entity charOffset="186-228" id="s1587.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1587.e0" e2="s1587.e1" id="s1587.p0" relation="false"/>
  </sentence>
  <sentence id="s1588" text="siRNA-mediated suppression of protein monoubiquitination inhibited gastric cancer cell proliferation and colony formation by promoting cell cycle arrest at G2/M phase and increasing apoptosis.">
    <entity charOffset="30-56" id="s1588.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="75-81" id="s1588.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1588.e0" e2="s1588.e1" id="s1588.p0" relation="true"/>
  </sentence>
  <sentence id="s1589" text="protein monoubiquitination was highly expressed in gastric tumors and gastric cancer cells.">
    <entity charOffset="0-26" id="s1589.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="78-84" id="s1589.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1589.e0" e2="s1589.e1" id="s1589.p0" relation="true"/>
  </sentence>
  <sentence id="s1590" text="Overexpression of L-serine biosynthetic process in CK5-positive cell lineages, and differential protein isoform expression, was additionally found in other tissues and cancer types, suggesting that overexpression of Phgdh is generally associated with CK5 cells, and that oncogenic function may be determined by isoform expression.">
    <entity charOffset="18-47" id="s1590.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="168-174" id="s1590.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1590.e0" e2="s1590.e1" id="s1590.p0" relation="true"/>
  </sentence>
  <sentence id="s1591" text="CONCLUSIONS osteoblast differentiation-1 is highly expressed in human esophageal carcinoma, and could be a marker for use in assessing tumor stage and the deciding on treatment target">
    <entity charOffset="12-38" id="s1591.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="70-90" id="s1591.e1" ontology_id="HP_0011459" text="esophageal carcinoma" type="HP"/>
    <pair e1="s1591.e0" e2="s1591.e1" id="s1591.p0" relation="false"/>
  </sentence>
  <sentence id="s1592" text="CONCLUSIONS osteoblast differentiation-1 is highly expressed in human esophageal carcinoma, and could be a marker for use in assessing tumor stage and the deciding on treatment target">
    <entity charOffset="12-38" id="s1592.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="135-140" id="s1592.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1592.e0" e2="s1592.e1" id="s1592.p0" relation="true"/>
  </sentence>
  <sentence id="s1593" text="RESULTS osteoblast differentiation-1 was associated with patient age, gender, lymphatic metastasis, tumor recurrence, and stage, with significantly (P&amp;lt;0.05) positive correlations with age, lymphatic metastasis, tumor recurrence, and stage.">
    <entity charOffset="8-34" id="s1593.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="100-105" id="s1593.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1593.e0" e2="s1593.e1" id="s1593.p0" relation="true"/>
  </sentence>
  <sentence id="s1594" text="We investigated glioma-associated oncogene protein-1 (osteoblast differentiation-1) expression in human esophageal carcinoma tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.">
    <entity charOffset="54-80" id="s1594.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="104-124" id="s1594.e1" ontology_id="HP_0011459" text="esophageal carcinoma" type="HP"/>
    <pair e1="s1594.e0" e2="s1594.e1" id="s1594.p0" relation="true"/>
  </sentence>
  <sentence id="s1595" text="Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in mitochondrial tRNA modification.">
    <entity charOffset="51-59" id="s1595.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="88-119" id="s1595.e1" ontology_id="GO_0070900" text="mitochondrial tRNA modification" type="GO"/>
    <pair e1="s1595.e0" e2="s1595.e1" id="s1595.p0" relation="false"/>
  </sentence>
  <sentence id="s1596" text="Our results recognize the sensitivity of tumor cell types to GANT61 in cell culture and support a critical role for osteoblast differentiation factors in tumor progression through restraining apoptosis.">
    <entity charOffset="41-46" id="s1596.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="116-142" id="s1596.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s1596.e0" e2="s1596.e1" id="s1596.p0" relation="false"/>
  </sentence>
  <sentence id="s1597" text="In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and SOCS boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and positive regulation of protein phosphorylation tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral IAP repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.">
    <entity charOffset="34-42" id="s1597.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="430-476" id="s1597.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1597.e0" e2="s1597.e1" id="s1597.p0" relation="false"/>
  </sentence>
  <sentence id="s1598" text="In this study, we focused on colon cancer with peritoneal metastasis and investigated the association between the expression of CD133, aldehyde dehydrogenase-1(oxidation-reduction process) and leucine-rich repeating G-protein coupled receptor-5(positive regulation of canonical Wnt signaling pathway), and disease prognosis.">
    <entity charOffset="35-41" id="s1598.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="247-301" id="s1598.e1" ontology_id="GO_0090263" text="positive regulation of canonical Wnt signaling pathway" type="GO"/>
    <pair e1="s1598.e0" e2="s1598.e1" id="s1598.p0" relation="true"/>
  </sentence>
  <sentence id="s1599" text="In this study, we focused on colon cancer with peritoneal metastasis and investigated the association between the expression of CD133, aldehyde dehydrogenase-1(oxidation-reduction process) and leucine-rich repeating G-protein coupled receptor-5(positive regulation of canonical Wnt signaling pathway), and disease prognosis.">
    <entity charOffset="35-41" id="s1599.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-188" id="s1599.e1" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <pair e1="s1599.e0" e2="s1599.e1" id="s1599.p0" relation="true"/>
  </sentence>
  <sentence id="s1600" text="Here we used an integrative strategy to examine the hypothesis that genetic variants at response to estradiol/2 binding elements may be associated with sexual dimorphism of hepatocellular carcinoma (HCC) risk.">
    <entity charOffset="88-109" id="s1600.e0" ontology_id="GO_0032355" text="response to estradiol" type="GO"/>
    <entity charOffset="173-197" id="s1600.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1600.e0" e2="s1600.e1" id="s1600.p0" relation="false"/>
  </sentence>
  <sentence id="s1601" text="Limb girdle muscular dystrophy muscle organ development 2I (protein O-linked mannosylation) is a progressive disorder caused by mutations in the FuKutin-Related Protein gene (FKRP).">
    <entity charOffset="12-30" id="s1601.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="60-90" id="s1601.e1" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <pair e1="s1601.e0" e2="s1601.e1" id="s1601.p0" relation="false"/>
  </sentence>
  <sentence id="s1602" text="Human genetic and pharmacological animal studies support this hypothesis, but no studies have explored G protein-coupled glutamate receptor signaling pathway dysfunction at the molecular level in the postmortem schizophrenia brain.">
    <entity charOffset="103-157" id="s1602.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="211-224" id="s1602.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1602.e0" e2="s1602.e1" id="s1602.p0" relation="true"/>
  </sentence>
  <sentence id="s1603" text="Conversely, G protein-coupled glutamate receptor signaling pathway regulatory proteins were expressed at lower levels in schizophrenia subjects compared to controls (Norbin -37%, p &amp;lt; 0.001; Tamalin -30%, p = 0.084; Preso1 -29%, p = 0.001).">
    <entity charOffset="12-66" id="s1603.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="121-134" id="s1603.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1603.e0" e2="s1603.e1" id="s1603.p0" relation="true"/>
  </sentence>
  <sentence id="s1604" text="We assessed G protein-coupled glutamate receptor signaling pathway mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (GRASP-1), and Preso1 (FRMPD4), which regulate mGluR5 localization, internalization and signaling.">
    <entity charOffset="12-66" id="s1604.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="161-174" id="s1604.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1604.e0" e2="s1604.e1" id="s1604.p0" relation="true"/>
  </sentence>
  <sentence id="s1605" text="While G protein-coupled glutamate receptor signaling pathway mRNA expression was unchanged, mGluR5 protein levels were significantly higher in schizophrenia subjects compared to controls (total: +22%; dimer: +54%; p &amp;lt; 0.001).">
    <entity charOffset="6-60" id="s1605.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="143-156" id="s1605.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1605.e0" e2="s1605.e1" id="s1605.p0" relation="true"/>
  </sentence>
  <sentence id="s1606" text="In the present study, we examined whether centriole replication expression is abnormally regulated in colorectal cancers (CRCs).">
    <entity charOffset="42-63" id="s1606.e0" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <entity charOffset="113-119" id="s1606.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1606.e0" e2="s1606.e1" id="s1606.p0" relation="false"/>
  </sentence>
  <sentence id="s1607" text="Next, using DLD-1 colon cancer cells inducibly expressing centriole replication, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes.">
    <entity charOffset="24-30" id="s1607.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="58-79" id="s1607.e1" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <pair e1="s1607.e0" e2="s1607.e1" id="s1607.p0" relation="true"/>
  </sentence>
  <sentence id="s1608" text="To date, the genetic alteration of centriole replication has not been reported in human cancers.">
    <entity charOffset="35-56" id="s1608.e0" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <entity charOffset="88-94" id="s1608.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1608.e0" e2="s1608.e1" id="s1608.p0" relation="true"/>
  </sentence>
  <sentence id="s1609" text="Here, we show that human spnegative regulation of peptidase activity tumours also feature strong nuclear localisation of regulation of cell cycle and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in mice.">
    <entity charOffset="69-76" id="s1609.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="121-145" id="s1609.e1" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <pair e1="s1609.e0" e2="s1609.e1" id="s1609.p0" relation="true"/>
  </sentence>
  <sentence id="s1610" text="The aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (tRNA aminoacylation for protein translation) splice variant designated DX2 is induced by cigarette smoke carcinogens and is often detected in human lung cancer specimens.">
    <entity charOffset="77-120" id="s1610.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="230-236" id="s1610.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1610.e0" e2="s1610.e1" id="s1610.p0" relation="true"/>
  </sentence>
  <sentence id="s1611" text="The aetiology of L-phenylalanine catabolic process is heterogeneous, and genetics play an important role in some cases.">
    <entity charOffset="17-50" id="s1611.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="54-67" id="s1611.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1611.e0" e2="s1611.e1" id="s1611.p0" relation="true"/>
  </sentence>
  <sentence id="s1612" text="Group 1 pulmonary hypertension or pulmonary arterial hypertension (L-phenylalanine catabolic process) is a rare disease characterized by proliferation and occlusion of small pulmonary arterioles, leading to progressive elevation of pulmonary artery pressure and pulmonary vascular resistance, and right ventricular failure.">
    <entity charOffset="34-65" id="s1612.e0" ontology_id="HP_0002092" text="pulmonary arterial hypertension" type="HP"/>
    <entity charOffset="67-100" id="s1612.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s1612.e0" e2="s1612.e1" id="s1612.p0" relation="false"/>
  </sentence>
  <sentence id="s1613" text="The aim of our study was to determine the impact of genetic polymorphisms in the caspase (protein stabilization) genes on prognosis of hepatocellular carcinoma (HCC).">
    <entity charOffset="90-111" id="s1613.e0" ontology_id="GO_0050821" text="protein stabilization" type="GO"/>
    <entity charOffset="135-159" id="s1613.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1613.e0" e2="s1613.e1" id="s1613.p0" relation="true"/>
  </sentence>
  <sentence id="s1614" text="In addition, we demonstrated that positive regulation of protein ubiquitination-enhanced tumor growth is dependent on depletion of p62 in vivo.">
    <entity charOffset="34-79" id="s1614.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="89-94" id="s1614.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1614.e0" e2="s1614.e1" id="s1614.p0" relation="true"/>
  </sentence>
  <sentence id="s1615" text="Furthermore, positive regulation of protein ubiquitination enhanced cancer cell proliferation, viability, and colony formation in vitro via suppression of p62.">
    <entity charOffset="13-58" id="s1615.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="68-74" id="s1615.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1615.e0" e2="s1615.e1" id="s1615.p0" relation="true"/>
  </sentence>
  <sentence id="s1616" text="In this study, we aimed to clarify the phenotypic spectrum of branching involved in blood vessel morphogenesis/A2 mutations in the context of cortical malformations that include schizencephaly, polymicrogyria and/or heterotopia">
    <entity charOffset="62-110" id="s1616.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="178-192" id="s1616.e1" ontology_id="HP_0010636" text="schizencephaly" type="HP"/>
    <pair e1="s1616.e0" e2="s1616.e1" id="s1616.p0" relation="true"/>
  </sentence>
  <sentence id="s1617" text="Functional studies support intraocular pressure-related influences of FMNL2 and regulation of transcription, DNA-templated, with certain regulation of transcription, DNA-templated mutations causing high IOP and glaucoma resembling POAG in mice.">
    <entity charOffset="80-122" id="s1617.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="211-219" id="s1617.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1617.e0" e2="s1617.e1" id="s1617.p0" relation="true"/>
  </sentence>
  <sentence id="s1618" text="Functional studies support intraocular pressure-related influences of FMNL2 and regulation of transcription, DNA-templated, with certain regulation of transcription, DNA-templated mutations causing high IOP and glaucoma resembling POAG in mice.">
    <entity charOffset="137-179" id="s1618.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="211-219" id="s1618.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1618.e0" e2="s1618.e1" id="s1618.p0" relation="true"/>
  </sentence>
  <sentence id="s1619" text="Our results demonstrated pairwise epistatic interactions between response to oxidative stress and protein polyubiquitination SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric cancer.">
    <entity charOffset="65-93" id="s1619.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="273-279" id="s1619.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1619.e0" e2="s1619.e1" id="s1619.p0" relation="true"/>
  </sentence>
  <sentence id="s1620" text="Our results demonstrated pairwise epistatic interactions between response to oxidative stress and protein polyubiquitination SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric cancer.">
    <entity charOffset="98-124" id="s1620.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="273-279" id="s1620.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1620.e0" e2="s1620.e1" id="s1620.p0" relation="false"/>
  </sentence>
  <sentence id="s1621" text="In conclusion, response to oxidative stress rs1917799, protein polyubiquitination rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric cancer risk.">
    <entity charOffset="15-43" id="s1621.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="206-212" id="s1621.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1621.e0" e2="s1621.e1" id="s1621.p0" relation="true"/>
  </sentence>
  <sentence id="s1622" text="In conclusion, response to oxidative stress rs1917799, protein polyubiquitination rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric cancer risk.">
    <entity charOffset="55-81" id="s1622.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="206-212" id="s1622.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1622.e0" e2="s1622.e1" id="s1622.p0" relation="true"/>
  </sentence>
  <sentence id="s1623" text="In situ response to oxidative stress and protein polyubiquitination protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric cancer cases.">
    <entity charOffset="8-36" id="s1623.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="210-216" id="s1623.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1623.e0" e2="s1623.e1" id="s1623.p0" relation="true"/>
  </sentence>
  <sentence id="s1624" text="In situ response to oxidative stress and protein polyubiquitination protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric cancer cases.">
    <entity charOffset="41-67" id="s1624.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="210-216" id="s1624.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1624.e0" e2="s1624.e1" id="s1624.p0" relation="true"/>
  </sentence>
  <sentence id="s1625" text="ERCC6 rs1917799 also showed a significant interaction with protein polyubiquitination rs158916 to reduce gastric cancer risk.">
    <entity charOffset="59-85" id="s1625.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="113-119" id="s1625.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1625.e0" e2="s1625.e1" id="s1625.p0" relation="true"/>
  </sentence>
  <sentence id="s1626" text="phosphatidylserine catabolic process mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.">
    <entity charOffset="0-36" id="s1626.e0" ontology_id="GO_0006660" text="phosphatidylserine catabolic process" type="GO"/>
    <entity charOffset="187-198" id="s1626.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s1626.e0" e2="s1626.e1" id="s1626.p0" relation="true"/>
  </sentence>
  <sentence id="s1627" text="phosphatidylserine catabolic process mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.">
    <entity charOffset="0-36" id="s1627.e0" ontology_id="GO_0006660" text="phosphatidylserine catabolic process" type="GO"/>
    <entity charOffset="122-128" id="s1627.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1627.e0" e2="s1627.e1" id="s1627.p0" relation="true"/>
  </sentence>
  <sentence id="s1628" text="BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and regulation of megakaryocyte differentiation (90%) mutations by exome sequencing, similar to human MIBC.">
    <entity charOffset="4-10" id="s1628.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="144-187" id="s1628.e1" ontology_id="GO_0045652" text="regulation of megakaryocyte differentiation" type="GO"/>
    <pair e1="s1628.e0" e2="s1628.e1" id="s1628.p0" relation="true"/>
  </sentence>
  <sentence id="s1629" text="Here, we report that mitotic spindle assembly checkpoint is highly overexpressed in multiple lung adenocarcinoma cell lines and tumor tissues.">
    <entity charOffset="21-56" id="s1629.e0" ontology_id="GO_0007094" text="mitotic spindle assembly checkpoint" type="GO"/>
    <entity charOffset="128-133" id="s1629.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1629.e0" e2="s1629.e1" id="s1629.p0" relation="true"/>
  </sentence>
  <sentence id="s1630" text="Our study indicates the novel nucleus organization p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.">
    <entity charOffset="30-50" id="s1630.e0" ontology_id="GO_0006997" text="nucleus organization" type="GO"/>
    <entity charOffset="128-149" id="s1630.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s1630.e0" e2="s1630.e1" id="s1630.p0" relation="true"/>
  </sentence>
  <sentence id="s1631" text="Our study indicates the novel nucleus organization p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.">
    <entity charOffset="30-50" id="s1631.e0" ontology_id="GO_0006997" text="nucleus organization" type="GO"/>
    <entity charOffset="100-123" id="s1631.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1631.e0" e2="s1631.e1" id="s1631.p0" relation="true"/>
  </sentence>
  <sentence id="s1632" text="Our study indicates the novel nucleus organization p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.">
    <entity charOffset="30-50" id="s1632.e0" ontology_id="GO_0006997" text="nucleus organization" type="GO"/>
    <entity charOffset="163-182" id="s1632.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s1632.e0" e2="s1632.e1" id="s1632.p0" relation="false"/>
  </sentence>
  <sentence id="s1633" text="Our findings imply that microcephaly is a variable phenomuscle organ development in nucleus organization-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease">
    <entity charOffset="24-36" id="s1633.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="84-104" id="s1633.e1" ontology_id="GO_0006997" text="nucleus organization" type="GO"/>
    <pair e1="s1633.e0" e2="s1633.e1" id="s1633.p0" relation="true"/>
  </sentence>
  <sentence id="s1634" text="In Chinese siblings with late-onset ubiquitin-dependent protein catabolic process, the main clinic manifestation and abnormal radioimaging were cognitive decline and cerebral atrophy respectively.">
    <entity charOffset="36-81" id="s1634.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="166-182" id="s1634.e1" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <pair e1="s1634.e0" e2="s1634.e1" id="s1634.p0" relation="false"/>
  </sentence>
  <sentence id="s1635" text="Subsequent quantitative PCR experiments confirmed that PRDX4, regulation of transcription by RNA polymerase II, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.">
    <entity charOffset="62-110" id="s1635.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="216-222" id="s1635.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1635.e0" e2="s1635.e1" id="s1635.p0" relation="true"/>
  </sentence>
  <sentence id="s1636" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, transcription, DNA-templated, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="236-250" id="s1636.e0" ontology_id="HP_0002311" text="incoordination" type="HP"/>
    <entity charOffset="319-347" id="s1636.e1" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <pair e1="s1636.e0" e2="s1636.e1" id="s1636.p0" relation="false"/>
  </sentence>
  <sentence id="s1637" text="Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &amp;lt;0.15), including markers within genes associated with monogenic diabetes (regulation of transcription by RNA polymerase II) or obesity (positive regulation of transcription by RNA polymerase II).">
    <entity charOffset="170-218" id="s1637.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="223-230" id="s1637.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1637.e0" e2="s1637.e1" id="s1637.p0" relation="false"/>
  </sentence>
  <sentence id="s1638" text="Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &amp;lt;0.15), including markers within genes associated with monogenic diabetes (regulation of transcription by RNA polymerase II) or obesity (positive regulation of transcription by RNA polymerase II).">
    <entity charOffset="223-230" id="s1638.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="232-289" id="s1638.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1638.e0" e2="s1638.e1" id="s1638.p0" relation="false"/>
  </sentence>
  <sentence id="s1639" text="CD164 was co-expressed with negative regulation of neuron death on circulating CD4&lt;sup&gt;+&lt;/sup&gt; T cells from high tumor burden SS patients, further providing strong support for CD164 as a disease relevant surface biomarker">
    <entity charOffset="28-63" id="s1639.e0" ontology_id="GO_1901215" text="negative regulation of neuron death" type="GO"/>
    <entity charOffset="113-118" id="s1639.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1639.e0" e2="s1639.e1" id="s1639.p0" relation="true"/>
  </sentence>
  <sentence id="s1640" text="Oropharyngeal cancer associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301-HLA-DQA1*0103-immunoglobulin production involved in immunoglobulin mediated immune response*0603 (odds ratio (OR) = 0.59, P = 2.7  10&lt;sup&gt;-9&lt;/sup&gt;).">
    <entity charOffset="14-20" id="s1640.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="216-293" id="s1640.e1" ontology_id="GO_0002381" text="immunoglobulin production involved in immunoglobulin mediated immune response" type="GO"/>
    <pair e1="s1640.e0" e2="s1640.e1" id="s1640.p0" relation="true"/>
  </sentence>
  <sentence id="s1641" text="Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, phosphate-containing compound metabolic process) and 11p15.4 (rs1453414, OR52N2-TRIM5).">
    <entity charOffset="20-26" id="s1641.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="120-167" id="s1641.e1" ontology_id="GO_0006796" text="phosphate-containing compound metabolic process" type="GO"/>
    <pair e1="s1641.e0" e2="s1641.e1" id="s1641.p0" relation="false"/>
  </sentence>
  <sentence id="s1642" text="The contiguous deletion of positive regulation of transcription, DNA-templated and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="27-78" id="s1642.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="237-260" id="s1642.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1642.e0" e2="s1642.e1" id="s1642.p0" relation="true"/>
  </sentence>
  <sentence id="s1643" text="The contiguous deletion of positive regulation of transcription, DNA-templated and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="118-165" id="s1643.e0" ontology_id="GO_1990830" text="cellular response to leukemia inhibitory factor" type="GO"/>
    <entity charOffset="223-235" id="s1643.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1643.e0" e2="s1643.e1" id="s1643.p0" relation="true"/>
  </sentence>
  <sentence id="s1644" text="Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize retrograde transport, endosome to Golgi deletions and PHP1b as a rare cause for early onset obesity and macrosomia.">
    <entity charOffset="94-133" id="s1644.e0" ontology_id="GO_0042147" text="retrograde transport, endosome to Golgi" type="GO"/>
    <entity charOffset="186-193" id="s1644.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1644.e0" e2="s1644.e1" id="s1644.p0" relation="false"/>
  </sentence>
  <sentence id="s1645" text="Here, we identified three families with mutations in transmembrane transport, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.">
    <entity charOffset="53-76" id="s1645.e0" ontology_id="GO_0055085" text="transmembrane transport" type="GO"/>
    <entity charOffset="107-130" id="s1645.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1645.e0" e2="s1645.e1" id="s1645.p0" relation="false"/>
  </sentence>
  <sentence id="s1646" text="Here, we identified three families with mutations in transmembrane transport, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.">
    <entity charOffset="53-76" id="s1646.e0" ontology_id="GO_0055085" text="transmembrane transport" type="GO"/>
    <entity charOffset="132-144" id="s1646.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1646.e0" e2="s1646.e1" id="s1646.p0" relation="true"/>
  </sentence>
  <sentence id="s1647" text="We report a novel gene duplication syndrome (10q21.2q21.3 microduplication) and present a new evidence for signal transduction duplication, as a candidate gene for autism.">
    <entity charOffset="107-126" id="s1647.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="164-170" id="s1647.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1647.e0" e2="s1647.e1" id="s1647.p0" relation="true"/>
  </sentence>
  <sentence id="s1648" text="This review reflects the existing positive regulation of cell-matrix adhesion/ephrin littranscription by RNA polymerase IIture while focusing on breast cancer heterogeneity.">
    <entity charOffset="34-77" id="s1648.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="152-158" id="s1648.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1648.e0" e2="s1648.e1" id="s1648.p0" relation="false"/>
  </sentence>
  <sentence id="s1649" text="Depletion of the exon 3-containing long isoform of mitochondrial translational elongation (MRPL33-L) led to impaired proliferation and increased apoptosis in cancer cell lines and in a xenograft model.">
    <entity charOffset="51-89" id="s1649.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="158-164" id="s1649.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1649.e0" e2="s1649.e1" id="s1649.p0" relation="true"/>
  </sentence>
  <sentence id="s1650" text="In summary, our findings underscore the biological significance of mitochondrial translational elongation-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells">
    <entity charOffset="67-105" id="s1650.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="219-225" id="s1650.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1650.e0" e2="s1650.e1" id="s1650.p0" relation="true"/>
  </sentence>
  <sentence id="s1651" text="More importantly, overexpression of mitochondrial translational elongation-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.">
    <entity charOffset="36-74" id="s1651.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="92-97" id="s1651.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1651.e0" e2="s1651.e1" id="s1651.p0" relation="false"/>
  </sentence>
  <sentence id="s1652" text="Glutaric aciduria muscle organ development I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase).">
    <entity charOffset="62-78" id="s1652.e0" ontology_id="HP_0001992" text="organic aciduria" type="HP"/>
    <entity charOffset="165-219" id="s1652.e1" ontology_id="GO_0033539" text="fatty acid beta-oxidation using acyl-CoA dehydrogenase" type="GO"/>
    <pair e1="s1652.e0" e2="s1652.e1" id="s1652.p0" relation="false"/>
  </sentence>
  <sentence id="s1653" text="Glutaric aciduria muscle organ development I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase).">
    <entity charOffset="93-112" id="s1653.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="165-219" id="s1653.e1" ontology_id="GO_0033539" text="fatty acid beta-oxidation using acyl-CoA dehydrogenase" type="GO"/>
    <pair e1="s1653.e0" e2="s1653.e1" id="s1653.p0" relation="false"/>
  </sentence>
  <sentence id="s1654" text="The correlations between the expressions of CTHRC1 with clinicopathologic features,E-integrin-mediated signaling pathway and Vimentin expression were analyzed.&lt;b&gt;Result:&lt;/b&gt;CTHRC1 protein expression levels in papillary thyroid carcinoma tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.05).">
    <entity charOffset="85-120" id="s1654.e0" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <entity charOffset="209-236" id="s1654.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s1654.e0" e2="s1654.e1" id="s1654.p0" relation="true"/>
  </sentence>
  <sentence id="s1655" text="&lt;b&gt;Objective:&lt;/b&gt;To investigate the expression and significance of cell migration in patients with papillary thyroid cancinoma.&lt;b&gt;Method:&lt;/b&gt;We collected 63 specimens of papillary thyroid carcinoma tissue with 36 specimens of the adjacent normal thyroid tissue and 23 specimens of thyroid nodular goiter.">
    <entity charOffset="67-81" id="s1655.e0" ontology_id="GO_0016477" text="cell migration" type="GO"/>
    <entity charOffset="170-197" id="s1655.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s1655.e0" e2="s1655.e1" id="s1655.p0" relation="false"/>
  </sentence>
  <sentence id="s1656" text="Finally, we show evidence that abnormal protein homeostasis is a prevalent mechanism responsible for uroporphyrinogen III biosynthetic process deficiency and that modulators of UROS proteolysis such as proteasome inhibitors or chemical chaperones may represent an attractive therapeutic option to reduce porphyrin accumulation and prevent skin photosensitivity in CEP patients when the genotype includes a missense variant">
    <entity charOffset="101-142" id="s1656.e0" ontology_id="GO_0006780" text="uroporphyrinogen III biosynthetic process" type="GO"/>
    <entity charOffset="339-360" id="s1656.e1" ontology_id="HP_0000992" text="skin photosensitivity" type="HP"/>
    <pair e1="s1656.e0" e2="s1656.e1" id="s1656.p0" relation="false"/>
  </sentence>
  <sentence id="s1657" text="Here, we show that breast-ovarian cancer susceptibility 1 (double-strand break repair via homologous recombination) interacts directly with actin cytoskeleton reorganization-interacting protein (ATRIP), an obligate partner of ATR.">
    <entity charOffset="34-40" id="s1657.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="59-114" id="s1657.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s1657.e0" e2="s1657.e1" id="s1657.p0" relation="true"/>
  </sentence>
  <sentence id="s1658" text="Here, we show that breast-ovarian cancer susceptibility 1 (double-strand break repair via homologous recombination) interacts directly with actin cytoskeleton reorganization-interacting protein (ATRIP), an obligate partner of ATR.">
    <entity charOffset="34-40" id="s1658.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="140-173" id="s1658.e1" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <pair e1="s1658.e0" e2="s1658.e1" id="s1658.p0" relation="false"/>
  </sentence>
  <sentence id="s1659" text="Single marker-based association tests for corneal astigmatism identified four genome-wide significant loci (P&amp;lt;510&lt;sup&gt;-8&lt;/sup&gt;) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), cellular response to DNA damage stimulus/OCA2 (15q13.1) and NPLOC4/TSPAN10 (17q25.3).">
    <entity charOffset="50-61" id="s1659.e0" ontology_id="HP_0000483" text="astigmatism" type="HP"/>
    <entity charOffset="187-227" id="s1659.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s1659.e0" e2="s1659.e1" id="s1659.p0" relation="false"/>
  </sentence>
  <sentence id="s1660" text="These loci have previously demonstrated association with axial length (ZC3H11B), myopia (ubiquitin-dependent protein catabolic process), spherical equivalent refractive error (LINC00340) and eye colour (HERC2).">
    <entity charOffset="81-87" id="s1660.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="89-134" id="s1660.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s1660.e0" e2="s1660.e1" id="s1660.p0" relation="false"/>
  </sentence>
  <sentence id="s1661" text="Aim of this study was to analyze the reproductive process mRNA and protein expression in soft tissue sarcoma and their association with patient outcome.">
    <entity charOffset="37-57" id="s1661.e0" ontology_id="GO_0022414" text="reproductive process" type="GO"/>
    <entity charOffset="101-108" id="s1661.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1661.e0" e2="s1661.e1" id="s1661.p0" relation="true"/>
  </sentence>
  <sentence id="s1662" text="reproductive process mRNA was measured in 121 tumor samples of soft tissue sarcoma patients using quantitative real-time PCR.">
    <entity charOffset="0-20" id="s1662.e0" ontology_id="GO_0022414" text="reproductive process" type="GO"/>
    <entity charOffset="75-82" id="s1662.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1662.e0" e2="s1662.e1" id="s1662.p0" relation="true"/>
  </sentence>
  <sentence id="s1663" text="As the first report in Korea, this study identified three vesicle-mediated transport mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenomuscle organ development.">
    <entity charOffset="58-84" id="s1663.e0" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <entity charOffset="140-150" id="s1663.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1663.e0" e2="s1663.e1" id="s1663.p0" relation="true"/>
  </sentence>
  <sentence id="s1664" text="As the first report in Korea, this study identified three vesicle-mediated transport mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenomuscle organ development.">
    <entity charOffset="58-84" id="s1664.e0" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <entity charOffset="129-139" id="s1664.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s1664.e0" e2="s1664.e1" id="s1664.p0" relation="false"/>
  </sentence>
  <sentence id="s1665" text="Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy muscle organ development 2 (microtubule-based movement).">
    <entity charOffset="17-43" id="s1665.e0" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <entity charOffset="149-159" id="s1665.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s1665.e0" e2="s1665.e1" id="s1665.p0" relation="true"/>
  </sentence>
  <sentence id="s1666" text="The p.Arg204Trp mutation was identified from a microtubule-based movement patient with additional complex phenotypes of HSP, ataxia, fatigability and pyramidal sign, but the p.Arg280His and p.Leu588Pro mutations were identified in each axonal CMT2 patient.">
    <entity charOffset="47-73" id="s1666.e0" ontology_id="GO_0007018" text="microtubule-based movement" type="GO"/>
    <entity charOffset="125-131" id="s1666.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1666.e0" e2="s1666.e1" id="s1666.p0" relation="true"/>
  </sentence>
  <sentence id="s1667" text="Here, we show that biallelic &lt;i&gt;production of siRNA involved in RNA interference&lt;/i&gt; deletion with &lt;i&gt;aP2-Cre&lt;/i&gt; drives aggressive and metastatic angiosarcoma independent of other genetically engineered oncogenes or tumor suppressor loss.">
    <entity charOffset="32-80" id="s1667.e0" ontology_id="GO_0030422" text="production of siRNA involved in RNA interference" type="GO"/>
    <entity charOffset="147-159" id="s1667.e1" ontology_id="HP_0200058" text="angiosarcoma" type="HP"/>
    <pair e1="s1667.e0" e2="s1667.e1" id="s1667.p0" relation="false"/>
  </sentence>
  <sentence id="s1668" text="Here, we show that biallelic &lt;i&gt;production of siRNA involved in RNA interference&lt;/i&gt; deletion with &lt;i&gt;aP2-Cre&lt;/i&gt; drives aggressive and metastatic angiosarcoma independent of other genetically engineered oncogenes or tumor suppressor loss.">
    <entity charOffset="32-80" id="s1668.e0" ontology_id="GO_0030422" text="production of siRNA involved in RNA interference" type="GO"/>
    <entity charOffset="217-222" id="s1668.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1668.e0" e2="s1668.e1" id="s1668.p0" relation="true"/>
  </sentence>
  <sentence id="s1669" text="These studies illustrate that production of siRNA involved in RNA interference can function as a traditional loss-of-function tumor suppressor gene, and they provide a fully penetrant animal model for the study of angiosarcoma development and metastasis.">
    <entity charOffset="30-78" id="s1669.e0" ontology_id="GO_0030422" text="production of siRNA involved in RNA interference" type="GO"/>
    <entity charOffset="126-131" id="s1669.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1669.e0" e2="s1669.e1" id="s1669.p0" relation="true"/>
  </sentence>
  <sentence id="s1670" text="Functional studies suggested that cell cycle arrest functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.">
    <entity charOffset="34-51" id="s1670.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="67-72" id="s1670.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1670.e0" e2="s1670.e1" id="s1670.p0" relation="true"/>
  </sentence>
  <sentence id="s1671" text="Functional studies suggested that cell cycle arrest functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.">
    <entity charOffset="34-51" id="s1671.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="146-152" id="s1671.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1671.e0" e2="s1671.e1" id="s1671.p0" relation="true"/>
  </sentence>
  <sentence id="s1672" text="Our data demonstrate that CAB39L is a novel tumor suppressor which suppresses tumorigenesis by promoting LKB1-lipid biosynthetic process-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.">
    <entity charOffset="44-49" id="s1672.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="110-136" id="s1672.e1" ontology_id="GO_0008610" text="lipid biosynthetic process" type="GO"/>
    <pair e1="s1672.e0" e2="s1672.e1" id="s1672.p0" relation="true"/>
  </sentence>
  <sentence id="s1673" text="Moreover, knockdown of LKB1 reversed growth inhibitory effect of cell cycle arrest, indicating that tumor suppression by CAB39L depended on LKB1-AMPK.">
    <entity charOffset="65-82" id="s1673.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="100-105" id="s1673.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1673.e0" e2="s1673.e1" id="s1673.p0" relation="true"/>
  </sentence>
  <sentence id="s1674" text="This disease is an autosomal recessive disorder, and the gene negative regulation of peptidase activity, which encodes cystatin B, a cysteine protease inhibitor, is the only gene known to be associated with ULD.">
    <entity charOffset="19-38" id="s1674.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="62-103" id="s1674.e1" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <pair e1="s1674.e0" e2="s1674.e1" id="s1674.p0" relation="true"/>
  </sentence>
  <sentence id="s1675" text="activation of MAPK activity was identified from MS analysis, and its level was revealed to be correlated with the disease grade, clinical severity, and survival rate of patients with gliomas.">
    <entity charOffset="0-27" id="s1675.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="183-190" id="s1675.e1" ontology_id="HP_0009733" text="gliomas" type="HP"/>
    <pair e1="s1675.e0" e2="s1675.e1" id="s1675.p0" relation="true"/>
  </sentence>
  <sentence id="s1676" text="Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the gap junction-mediated intercellular transport gene or, less commonly, the apoptotic process gene.">
    <entity charOffset="21-29" id="s1676.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="189-206" id="s1676.e1" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <pair e1="s1676.e0" e2="s1676.e1" id="s1676.p0" relation="true"/>
  </sentence>
  <sentence id="s1677" text="Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the gap junction-mediated intercellular transport gene or, less commonly, the apoptotic process gene.">
    <entity charOffset="21-29" id="s1677.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="115-160" id="s1677.e1" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <pair e1="s1677.e0" e2="s1677.e1" id="s1677.p0" relation="true"/>
  </sentence>
  <sentence id="s1678" text="DNA strand renaturationR2 overexpression is associated with increased risk of pelvic lymph node metastasis (PLNM, p = 0.001) and cancer relapse (p = 0.009).">
    <entity charOffset="0-23" id="s1678.e0" ontology_id="GO_0000733" text="DNA strand renaturation" type="GO"/>
    <entity charOffset="129-135" id="s1678.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1678.e0" e2="s1678.e1" id="s1678.p0" relation="true"/>
  </sentence>
  <sentence id="s1679" text="regulation of transcription, DNA-templated (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.">
    <entity charOffset="0-42" id="s1679.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="93-100" id="s1679.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s1679.e0" e2="s1679.e1" id="s1679.p0" relation="true"/>
  </sentence>
  <sentence id="s1680" text="regulation of transcription, DNA-templated (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.">
    <entity charOffset="0-42" id="s1680.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="101-115" id="s1680.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s1680.e0" e2="s1680.e1" id="s1680.p0" relation="true"/>
  </sentence>
  <sentence id="s1681" text="In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in regulation of transcription, DNA-templated deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary">
    <entity charOffset="86-100" id="s1681.e0" ontology_id="HP_0000053" text="macroorchidism" type="HP"/>
    <entity charOffset="104-146" id="s1681.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1681.e0" e2="s1681.e1" id="s1681.p0" relation="true"/>
  </sentence>
  <sentence id="s1682" text="Our report of variant in cilium assembly Leading to Joubert syndrome phenotype (JS30), elucidates the genetic heterogeneity of Joubert syndrome, and expands the gene list for ciliopathies">
    <entity charOffset="25-40" id="s1682.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="110-123" id="s1682.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1682.e0" e2="s1682.e1" id="s1682.p0" relation="false"/>
  </sentence>
  <sentence id="s1683" text="The mitochondrial protein mitochondrial membrane fission has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="26-56" id="s1683.e0" ontology_id="GO_0090149" text="mitochondrial membrane fission" type="GO"/>
    <entity charOffset="294-315" id="s1683.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s1683.e0" e2="s1683.e1" id="s1683.p0" relation="false"/>
  </sentence>
  <sentence id="s1684" text="The mitochondrial protein mitochondrial membrane fission has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="26-56" id="s1684.e0" ontology_id="GO_0090149" text="mitochondrial membrane fission" type="GO"/>
    <entity charOffset="179-192" id="s1684.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s1684.e0" e2="s1684.e1" id="s1684.p0" relation="true"/>
  </sentence>
  <sentence id="s1685" text="In summary, our results reveal that rare loss-of-function variants in biological_process increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern">
    <entity charOffset="70-88" id="s1685.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="146-169" id="s1685.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1685.e0" e2="s1685.e1" id="s1685.p0" relation="true"/>
  </sentence>
  <sentence id="s1686" text="In these tumors, regulation of cell adhesion gene fusion product provides a constitutively active tyrosine kinase (glucose catabolic process), leading to uncontrolled cellular proliferation, differentiation, and migration.">
    <entity charOffset="9-15" id="s1686.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="115-140" id="s1686.e1" ontology_id="GO_0006007" text="glucose catabolic process" type="GO"/>
    <pair e1="s1686.e0" e2="s1686.e1" id="s1686.p0" relation="true"/>
  </sentence>
  <sentence id="s1687" text="In these tumors, regulation of cell adhesion gene fusion product provides a constitutively active tyrosine kinase (glucose catabolic process), leading to uncontrolled cellular proliferation, differentiation, and migration.">
    <entity charOffset="9-15" id="s1687.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="17-44" id="s1687.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s1687.e0" e2="s1687.e1" id="s1687.p0" relation="true"/>
  </sentence>
  <sentence id="s1688" text="RESULTS For those 384 cases, 7 (1.82%) cases had tumors with identified regulation of cell adhesion rearrangement.">
    <entity charOffset="49-55" id="s1688.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="72-99" id="s1688.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s1688.e0" e2="s1688.e1" id="s1688.p0" relation="true"/>
  </sentence>
  <sentence id="s1689" text="BACKGROUND regulation of cell adhesion rearrangements have been reported in 30% of papillary thyroid carcinomas and 1-2% of non-small cell lung cancer (NSCLC).">
    <entity charOffset="11-38" id="s1689.e0" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <entity charOffset="144-150" id="s1689.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1689.e0" e2="s1689.e1" id="s1689.p0" relation="false"/>
  </sentence>
  <sentence id="s1690" text="positive regulation of apoptotic process mRNA is induced by peripheral nervous system development-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many cancers.">
    <entity charOffset="0-40" id="s1690.e0" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <entity charOffset="180-186" id="s1690.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1690.e0" e2="s1690.e1" id="s1690.p0" relation="true"/>
  </sentence>
  <sentence id="s1691" text="positive regulation of apoptotic process mRNA is induced by peripheral nervous system development-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many cancers.">
    <entity charOffset="60-97" id="s1691.e0" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <entity charOffset="180-186" id="s1691.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1691.e0" e2="s1691.e1" id="s1691.p0" relation="false"/>
  </sentence>
  <sentence id="s1692" text="Depending on the tumor cell type, knockdown of positive regulation of apoptotic process was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, homophilic cell adhesion via plasma membrane adhesion molecules, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, response to estradiol, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s1692.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="391-412" id="s1692.e1" ontology_id="GO_0032355" text="response to estradiol" type="GO"/>
    <pair e1="s1692.e0" e2="s1692.e1" id="s1692.p0" relation="true"/>
  </sentence>
  <sentence id="s1693" text="Depending on the tumor cell type, knockdown of positive regulation of apoptotic process was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, homophilic cell adhesion via plasma membrane adhesion molecules, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, response to estradiol, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s1693.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="209-272" id="s1693.e1" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <pair e1="s1693.e0" e2="s1693.e1" id="s1693.p0" relation="true"/>
  </sentence>
  <sentence id="s1694" text="Depending on the tumor cell type, knockdown of positive regulation of apoptotic process was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, homophilic cell adhesion via plasma membrane adhesion molecules, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, response to estradiol, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s1694.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="47-87" id="s1694.e1" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <pair e1="s1694.e0" e2="s1694.e1" id="s1694.p0" relation="true"/>
  </sentence>
  <sentence id="s1695" text="Downregulation of positive regulation of apoptotic process expression has been associated with decreased pulmonary colonization of human tumor cells, and enhanced sensitivities of tumor xenografts to radiation and docetaxel.">
    <entity charOffset="18-58" id="s1695.e0" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <entity charOffset="137-142" id="s1695.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1695.e0" e2="s1695.e1" id="s1695.p0" relation="true"/>
  </sentence>
  <sentence id="s1696" text="Here we have investigated the effects of depletion of positive regulation of apoptotic process on the mRNA, microRNA and protein expression profiles in prostate and breast cancers and melanoma.">
    <entity charOffset="54-94" id="s1696.e0" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <entity charOffset="172-178" id="s1696.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1696.e0" e2="s1696.e1" id="s1696.p0" relation="true"/>
  </sentence>
  <sentence id="s1697" text="We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, neuron projection development, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.">
    <entity charOffset="61-90" id="s1697.e0" ontology_id="GO_0031175" text="neuron projection development" type="GO"/>
    <entity charOffset="224-232" id="s1697.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1697.e0" e2="s1697.e1" id="s1697.p0" relation="true"/>
  </sentence>
  <sentence id="s1698" text="Bio-functional investigation revealed that sequestering of TGFbeta in extracellular matrix inhibited cell proliferation in HCC cell lines, suggesting its potential role as a tumor suppressor in HCC.">
    <entity charOffset="43-90" id="s1698.e0" ontology_id="GO_0035583" text="sequestering of TGFbeta in extracellular matrix" type="GO"/>
    <entity charOffset="174-179" id="s1698.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1698.e0" e2="s1698.e1" id="s1698.p0" relation="true"/>
  </sentence>
  <sentence id="s1699" text="Reduced representation bisulfite sequencing (RRBS) and gene expression microarrays were performed in the phosphatidylinositol phosphorylation tumor and non-HCC liver tissues to investigate the molecular mechanisms of generation of precursor metabolites and energy-2-driven HCC.">
    <entity charOffset="142-147" id="s1699.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="217-263" id="s1699.e1" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <pair e1="s1699.e0" e2="s1699.e1" id="s1699.p0" relation="true"/>
  </sentence>
  <sentence id="s1700" text="In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing positive regulation of cell proliferation, silencing tumor-suppressive genes and activating key oncogenic pathways.">
    <entity charOffset="187-228" id="s1700.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="240-245" id="s1700.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1700.e0" e2="s1700.e1" id="s1700.p0" relation="true"/>
  </sentence>
  <sentence id="s1701" text="We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of profound spasticity not previously associated with the protein tetramerization phenotype.">
    <entity charOffset="113-121" id="s1701.e0" ontology_id="HP_0012829" text="profound" type="HP"/>
    <entity charOffset="168-191" id="s1701.e1" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <pair e1="s1701.e0" e2="s1701.e1" id="s1701.p0" relation="false"/>
  </sentence>
  <sentence id="s1702" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="106-161" id="s1702.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="660-679" id="s1702.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1702.e0" e2="s1702.e1" id="s1702.p0" relation="false"/>
  </sentence>
  <sentence id="s1703" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="172-220" id="s1703.e0" ontology_id="GO_0006139" text="nucleobase-containing compound metabolic process" type="GO"/>
    <entity charOffset="776-797" id="s1703.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1703.e0" e2="s1703.e1" id="s1703.p0" relation="false"/>
  </sentence>
  <sentence id="s1704" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="172-220" id="s1704.e0" ontology_id="GO_0006139" text="nucleobase-containing compound metabolic process" type="GO"/>
    <entity charOffset="660-679" id="s1704.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1704.e0" e2="s1704.e1" id="s1704.p0" relation="false"/>
  </sentence>
  <sentence id="s1705" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="222-240" id="s1705.e0" ontology_id="GO_0006829" text="zinc ion transport" type="GO"/>
    <entity charOffset="776-797" id="s1705.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1705.e0" e2="s1705.e1" id="s1705.p0" relation="false"/>
  </sentence>
  <sentence id="s1706" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="260-300" id="s1706.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="660-679" id="s1706.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1706.e0" e2="s1706.e1" id="s1706.p0" relation="false"/>
  </sentence>
  <sentence id="s1707" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="316-346" id="s1707.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="776-797" id="s1707.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1707.e0" e2="s1707.e1" id="s1707.p0" relation="true"/>
  </sentence>
  <sentence id="s1708" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="357-372" id="s1708.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="660-679" id="s1708.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1708.e0" e2="s1708.e1" id="s1708.p0" relation="true"/>
  </sentence>
  <sentence id="s1709" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="374-423" id="s1709.e0" ontology_id="GO_0006851" text="mitochondrial calcium ion transmembrane transport" type="GO"/>
    <entity charOffset="776-797" id="s1709.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1709.e0" e2="s1709.e1" id="s1709.p0" relation="true"/>
  </sentence>
  <sentence id="s1710" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="374-423" id="s1710.e0" ontology_id="GO_0006851" text="mitochondrial calcium ion transmembrane transport" type="GO"/>
    <entity charOffset="660-679" id="s1710.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1710.e0" e2="s1710.e1" id="s1710.p0" relation="false"/>
  </sentence>
  <sentence id="s1711" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="425-445" id="s1711.e0" ontology_id="GO_0007338" text="single fertilization" type="GO"/>
    <entity charOffset="776-797" id="s1711.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1711.e0" e2="s1711.e1" id="s1711.p0" relation="false"/>
  </sentence>
  <sentence id="s1712" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="449-500" id="s1712.e0" ontology_id="GO_0033617" text="mitochondrial respiratory chain complex IV assembly" type="GO"/>
    <entity charOffset="776-797" id="s1712.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1712.e0" e2="s1712.e1" id="s1712.p0" relation="false"/>
  </sentence>
  <sentence id="s1713" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="502-546" id="s1713.e0" ontology_id="GO_0070373" text="negative regulation of ERK1 and ERK2 cascade" type="GO"/>
    <entity charOffset="776-797" id="s1713.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1713.e0" e2="s1713.e1" id="s1713.p0" relation="true"/>
  </sentence>
  <sentence id="s1714" text="Our case presented the specific characteristics: macrocephaly, midline cleft-nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, cleft palate, polydactyly of both hands and feet but without occipitoschisis, considered as the pathognomonic sign of the syndrome.">
    <entity charOffset="77-144" id="s1714.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="146-158" id="s1714.e1" ontology_id="HP_0000175" text="cleft palate" type="HP"/>
    <pair e1="s1714.e0" e2="s1714.e1" id="s1714.p0" relation="false"/>
  </sentence>
  <sentence id="s1715" text="visual perception overexpression promoted, whereas Zic2 knockdown inhibited, cell proliferation and migration invitro as well as tumor growth and metastasis invivo.">
    <entity charOffset="0-17" id="s1715.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="130-135" id="s1715.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1715.e0" e2="s1715.e1" id="s1715.p0" relation="true"/>
  </sentence>
  <sentence id="s1716" text="visual perception has been shown to be crucial to the progression of human cancers.">
    <entity charOffset="0-17" id="s1716.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="75-81" id="s1716.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1716.e0" e2="s1716.e1" id="s1716.p0" relation="true"/>
  </sentence>
  <sentence id="s1717" text="Our data showed that visual perception expression gradually increased from normal to cancer to metastatic tissues.">
    <entity charOffset="21-38" id="s1717.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="85-91" id="s1717.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1717.e0" e2="s1717.e1" id="s1717.p0" relation="true"/>
  </sentence>
  <sentence id="s1718" text="In a tumor with inv(12), exon 3 of negative regulation of transcription by RNA polymerase II was fused to a sequence in intron 1 of the positive regulation of apoptotic process gene from 12q22.">
    <entity charOffset="5-10" id="s1718.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="136-176" id="s1718.e1" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <pair e1="s1718.e0" e2="s1718.e1" id="s1718.p0" relation="true"/>
  </sentence>
  <sentence id="s1719" text="In a tumor with inv(12), exon 3 of negative regulation of transcription by RNA polymerase II was fused to a sequence in intron 1 of the positive regulation of apoptotic process gene from 12q22.">
    <entity charOffset="5-10" id="s1719.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="35-92" id="s1719.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1719.e0" e2="s1719.e1" id="s1719.p0" relation="true"/>
  </sentence>
  <sentence id="s1720" text="In the leiomyomas with 12q rearrangements, both negative regulation of transcription by RNA polymerase II and PLAG1 were expressed whereas in the tumors with 8q aberrations, only PLAG1 was expressed.">
    <entity charOffset="48-105" id="s1720.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="146-151" id="s1720.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1720.e0" e2="s1720.e1" id="s1720.p0" relation="true"/>
  </sentence>
  <sentence id="s1721" text="We extend the negative regulation of microtubule depolymerization associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation">
    <entity charOffset="14-65" id="s1721.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="140-148" id="s1721.e1" ontology_id="HP_0003510" text="dwarfism" type="HP"/>
    <pair e1="s1721.e0" e2="s1721.e1" id="s1721.p0" relation="true"/>
  </sentence>
  <sentence id="s1722" text="We extend the negative regulation of microtubule depolymerization associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation">
    <entity charOffset="14-65" id="s1722.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="150-163" id="s1722.e1" ontology_id="HP_0001339" text="lissencephaly" type="HP"/>
    <pair e1="s1722.e0" e2="s1722.e1" id="s1722.p0" relation="true"/>
  </sentence>
  <sentence id="s1723" text="We extend the negative regulation of microtubule depolymerization associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation">
    <entity charOffset="14-65" id="s1723.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="185-201" id="s1723.e1" ontology_id="HP_0000164" text="dental anomalies" type="HP"/>
    <pair e1="s1723.e0" e2="s1723.e1" id="s1723.p0" relation="true"/>
  </sentence>
  <sentence id="s1724" text="Interestingly, de novo loss-of-function and missense variants in histone H3-K4 demethylation were identified in patients with intellectual disability (ID) and autism spectrum disorder (ASD) but also in unaffected individuals.">
    <entity charOffset="65-92" id="s1724.e0" ontology_id="GO_0034720" text="histone H3-K4 demethylation" type="GO"/>
    <entity charOffset="126-149" id="s1724.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1724.e0" e2="s1724.e1" id="s1724.p0" relation="true"/>
  </sentence>
  <sentence id="s1725" text="Proteomic analysis of 12 tumours from an regulation of cell growth-driven hepatocellular carcinoma mouse model revealed that NME1 and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="41-66" id="s1725.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="74-98" id="s1725.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1725.e0" e2="s1725.e1" id="s1725.p0" relation="true"/>
  </sentence>
  <sentence id="s1726" text="Proteomic analysis of 12 tumours from an regulation of cell growth-driven hepatocellular carcinoma mouse model revealed that NME1 and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="74-98" id="s1726.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="134-172" id="s1726.e1" ontology_id="GO_0006165" text="nucleoside diphosphate phosphorylation" type="GO"/>
    <pair e1="s1726.e0" e2="s1726.e1" id="s1726.p0" relation="true"/>
  </sentence>
  <sentence id="s1727" text="Finally, in patients with hepatocellular carcinoma, low expression of phosphate-containing compound metabolic process correlated with increased tumour severity and reduced overall survival.">
    <entity charOffset="26-50" id="s1727.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="70-117" id="s1727.e1" ontology_id="GO_0006796" text="phosphate-containing compound metabolic process" type="GO"/>
    <pair e1="s1727.e0" e2="s1727.e1" id="s1727.p0" relation="true"/>
  </sentence>
  <sentence id="s1728" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, protein phosphorylation, MAP3K12, MAPK3, protein phosphorylation, MAPK7 and negative regulation of transcription by RNA polymerase II), were calculated.">
    <entity charOffset="201-207" id="s1728.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="228-251" id="s1728.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1728.e0" e2="s1728.e1" id="s1728.p0" relation="true"/>
  </sentence>
  <sentence id="s1729" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, protein phosphorylation, MAP3K12, MAPK3, protein phosphorylation, MAPK7 and negative regulation of transcription by RNA polymerase II), were calculated.">
    <entity charOffset="201-207" id="s1729.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="269-292" id="s1729.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1729.e0" e2="s1729.e1" id="s1729.p0" relation="true"/>
  </sentence>
  <sentence id="s1730" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, protein phosphorylation, MAP3K12, MAPK3, protein phosphorylation, MAPK7 and negative regulation of transcription by RNA polymerase II), were calculated.">
    <entity charOffset="201-207" id="s1730.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="304-361" id="s1730.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1730.e0" e2="s1730.e1" id="s1730.p0" relation="true"/>
  </sentence>
  <sentence id="s1731" text="A large, complex, and robust gene network containing well-known lung cancer-related genes, including positive regulation of protein phosphorylation and transcription, RNA-templated, was identified from combined gene lists for lung adenocarcinoma.">
    <entity charOffset="69-75" id="s1731.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="152-180" id="s1731.e1" ontology_id="GO_0001172" text="transcription, RNA-templated" type="GO"/>
    <pair e1="s1731.e0" e2="s1731.e1" id="s1731.p0" relation="true"/>
  </sentence>
  <sentence id="s1732" text="A large, complex, and robust gene network containing well-known lung cancer-related genes, including positive regulation of protein phosphorylation and transcription, RNA-templated, was identified from combined gene lists for lung adenocarcinoma.">
    <entity charOffset="101-147" id="s1732.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="226-245" id="s1732.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1732.e0" e2="s1732.e1" id="s1732.p0" relation="false"/>
  </sentence>
  <sentence id="s1733" text="Further generation of precursor metabolites and energy proportional hazard models analysis revealed that the reduced expression of PLIN1 is an independent predictor of overall survival in estrogen receptor positive (p &amp;lt; 0.0001, HR = 0.87, 95% CI = 0.81-0.92, N = 3,600) and luminal A-subtype (p = 0.02, HR = 0.88, 95% CI = 0.78-0.98, N = 1,469) breast cancer patients.">
    <entity charOffset="8-54" id="s1733.e0" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <entity charOffset="355-361" id="s1733.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1733.e0" e2="s1733.e1" id="s1733.p0" relation="true"/>
  </sentence>
  <sentence id="s1734" text="Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&amp;gt;C, p.V378L) action potential mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.">
    <entity charOffset="93-109" id="s1734.e0" ontology_id="GO_0001508" text="action potential" type="GO"/>
    <entity charOffset="197-214" id="s1734.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s1734.e0" e2="s1734.e1" id="s1734.p0" relation="true"/>
  </sentence>
  <sentence id="s1735" text="Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&amp;gt;C, p.V378L) action potential mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.">
    <entity charOffset="93-109" id="s1735.e0" ontology_id="GO_0001508" text="action potential" type="GO"/>
    <entity charOffset="234-242" id="s1735.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1735.e0" e2="s1735.e1" id="s1735.p0" relation="true"/>
  </sentence>
  <sentence id="s1736" text="action potential mutations are known to cause early-onset infantile epilepsy.">
    <entity charOffset="0-16" id="s1736.e0" ontology_id="GO_0001508" text="action potential" type="GO"/>
    <entity charOffset="68-76" id="s1736.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1736.e0" e2="s1736.e1" id="s1736.p0" relation="true"/>
  </sentence>
  <sentence id="s1737" text="We present a case of a patient with long-standing hyperpigmented macules and erythematous papules over his chest, abdomen, back and positive regulation of neuron projection development, suggestive of Dowling-Degos disease (DDD).">
    <entity charOffset="77-97" id="s1737.e0" ontology_id="HP_0030350" text="erythematous papules" type="HP"/>
    <entity charOffset="132-184" id="s1737.e1" ontology_id="GO_0010976" text="positive regulation of neuron projection development" type="GO"/>
    <pair e1="s1737.e0" e2="s1737.e1" id="s1737.p0" relation="false"/>
  </sentence>
  <sentence id="s1738" text="Familial adenomatous polyposis (proteolysis) is an autosomal dominantinherited colorectal cancer.">
    <entity charOffset="32-43" id="s1738.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="91-97" id="s1738.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1738.e0" e2="s1738.e1" id="s1738.p0" relation="false"/>
  </sentence>
  <sentence id="s1739" text="We present a case of myoclonus-dystonia syndrome illustrated by three videos in which we found a novel cell-matrix adhesion mutation.">
    <entity charOffset="21-30" id="s1739.e0" ontology_id="HP_0001336" text="myoclonus" type="HP"/>
    <entity charOffset="103-123" id="s1739.e1" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <pair e1="s1739.e0" e2="s1739.e1" id="s1739.p0" relation="true"/>
  </sentence>
  <sentence id="s1740" text="PRUNE is a member of the osteoblast differentiation (Asp-His-His) phosphoesterase protein superfamily of molecules important for cell motility, and implicated in cancer progression.">
    <entity charOffset="25-51" id="s1740.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="162-168" id="s1740.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1740.e0" e2="s1740.e1" id="s1740.p0" relation="true"/>
  </sentence>
  <sentence id="s1741" text="In this study, we have found that glyceraldehyde-3-phosphate biosynthetic process expression was greatly decreased in clinical HCC samples, positively correlated with overall survival, and negatively associated with histological differentiation, tumor size and organ metastasis.">
    <entity charOffset="34-81" id="s1741.e0" ontology_id="GO_0046166" text="glyceraldehyde-3-phosphate biosynthetic process" type="GO"/>
    <entity charOffset="246-251" id="s1741.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1741.e0" e2="s1741.e1" id="s1741.p0" relation="true"/>
  </sentence>
  <sentence id="s1742" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="127-155" id="s1742.e0" ontology_id="GO_0001172" text="transcription, RNA-templated" type="GO"/>
    <entity charOffset="371-377" id="s1742.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1742.e0" e2="s1742.e1" id="s1742.p0" relation="true"/>
  </sentence>
  <sentence id="s1743" text="We noted that Sirtuin 1 (negative regulation of transcription by RNA polymerase II) is overexpressed in HPV-infected cervical cancer cells and hypothesized that SIRT1 counteracts antiviral immunity.">
    <entity charOffset="25-82" id="s1743.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="126-132" id="s1743.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1743.e0" e2="s1743.e1" id="s1743.p0" relation="true"/>
  </sentence>
  <sentence id="s1744" text="In conclusion, SIRT1 enabled HPV-infected cervical cancer cells to continue growing by nullifying activation of innate immune response inflammasome-mediated immunity.">
    <entity charOffset="51-57" id="s1744.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="98-134" id="s1744.e1" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <pair e1="s1744.e0" e2="s1744.e1" id="s1744.p0" relation="true"/>
  </sentence>
  <sentence id="s1745" text="Without SIRT1, cervical cancer cells could no longer survive because of the derepression of the activation of innate immune response inflammasome.">
    <entity charOffset="24-30" id="s1745.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="96-132" id="s1745.e1" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <pair e1="s1745.e0" e2="s1745.e1" id="s1745.p0" relation="true"/>
  </sentence>
  <sentence id="s1746" text="Furthermore, the growth of cervical cancer xenografts was significantly inhibited by either negative regulation of transcription by RNA polymerase II-targeting siRNAs or SIRT1-knockdown-derived extracellular vesicles.">
    <entity charOffset="36-42" id="s1746.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="92-149" id="s1746.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1746.e0" e2="s1746.e1" id="s1746.p0" relation="true"/>
  </sentence>
  <sentence id="s1747" text="However, the functions of negative regulation of transcription by RNA polymerase II in the thyroid gland and the mechanism by which GLIS3 dysfunction causes hypothyroidism are unknown.">
    <entity charOffset="26-83" id="s1747.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="157-171" id="s1747.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s1747.e0" e2="s1747.e1" id="s1747.p0" relation="false"/>
  </sentence>
  <sentence id="s1748" text="Deficiency in Krppel-like zinc finger transcription factor GLI-similar 3 (negative regulation of transcription by RNA polymerase II) in humans is associated with the development of congenital hypothyroidism.">
    <entity charOffset="75-132" id="s1748.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="193-207" id="s1748.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s1748.e0" e2="s1748.e1" id="s1748.p0" relation="true"/>
  </sentence>
  <sentence id="s1749" text="We found that activation of JUN kinase activity was markedly increased in TLE patients and a mouse model of epileptic seizures; mice underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.">
    <entity charOffset="14-47" id="s1749.e0" ontology_id="GO_0007257" text="activation of JUN kinase activity" type="GO"/>
    <entity charOffset="118-126" id="s1749.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1749.e0" e2="s1749.e1" id="s1749.p0" relation="true"/>
  </sentence>
  <sentence id="s1750" text="Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), MITF (p=.0165) BRCA2 (p=.0206), and nicotinamide riboside catabolic process (p=.0393).">
    <entity charOffset="17-25" id="s1750.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="148-187" id="s1750.e1" ontology_id="GO_0006738" text="nicotinamide riboside catabolic process" type="GO"/>
    <pair e1="s1750.e0" e2="s1750.e1" id="s1750.p0" relation="false"/>
  </sentence>
  <sentence id="s1751" text="The data indicate a significant role of histone deacetylation for mitotic cell cycle progression and survival of MYCN-amplified neuroblastoma cells, and suggests that HDAC11 could be a valuable drug target">
    <entity charOffset="40-61" id="s1751.e0" ontology_id="GO_0016575" text="histone deacetylation" type="GO"/>
    <entity charOffset="128-141" id="s1751.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1751.e0" e2="s1751.e1" id="s1751.p0" relation="true"/>
  </sentence>
  <sentence id="s1752" text="Mutations in gap junction-mediated intercellular transport or GJB6 and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -hearing loss syndromes were not detected by Sanger sequencing.">
    <entity charOffset="13-58" id="s1752.e0" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <entity charOffset="183-195" id="s1752.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1752.e0" e2="s1752.e1" id="s1752.p0" relation="true"/>
  </sentence>
  <sentence id="s1753" text="Although ABCD1 is responsible for X-linked fatty acid beta-oxidation (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="43-68" id="s1753.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="238-255" id="s1753.e1" ontology_id="HP_0001410" text="liver dysfunction" type="HP"/>
    <pair e1="s1753.e0" e2="s1753.e1" id="s1753.p0" relation="false"/>
  </sentence>
  <sentence id="s1754" text="The positive regulation of transcription by RNA polymerase II-expressing cancer cells coexpressed vimentin but repressed E-cadherin and exhibited invasive behavior.">
    <entity charOffset="4-61" id="s1754.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="73-79" id="s1754.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1754.e0" e2="s1754.e1" id="s1754.p0" relation="true"/>
  </sentence>
  <sentence id="s1755" text="Markers such as SERPINI1, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other central nervous system development inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="26-44" id="s1755.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="210-216" id="s1755.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1755.e0" e2="s1755.e1" id="s1755.p0" relation="true"/>
  </sentence>
  <sentence id="s1756" text="Markers such as SERPINI1, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other central nervous system development inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="50-87" id="s1756.e0" ontology_id="GO_0030336" text="negative regulation of cell migration" type="GO"/>
    <entity charOffset="210-216" id="s1756.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1756.e0" e2="s1756.e1" id="s1756.p0" relation="true"/>
  </sentence>
  <sentence id="s1757" text="Markers such as SERPINI1, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other central nervous system development inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="125-159" id="s1757.e0" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <entity charOffset="210-216" id="s1757.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1757.e0" e2="s1757.e1" id="s1757.p0" relation="false"/>
  </sentence>
  <sentence id="s1758" text="Until recently, four loci (DFN2, cochlea morphogenesis, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (purine nucleobase metabolic process-5) has been proposed to reduce confusion in the terminology.">
    <entity charOffset="33-54" id="s1758.e0" ontology_id="GO_0090103" text="cochlea morphogenesis" type="GO"/>
    <entity charOffset="117-129" id="s1758.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1758.e0" e2="s1758.e1" id="s1758.p0" relation="true"/>
  </sentence>
  <sentence id="s1759" text="Until recently, four loci (DFN2, cochlea morphogenesis, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (purine nucleobase metabolic process-5) has been proposed to reduce confusion in the terminology.">
    <entity charOffset="117-129" id="s1759.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="162-197" id="s1759.e1" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <pair e1="s1759.e0" e2="s1759.e1" id="s1759.p0" relation="true"/>
  </sentence>
  <sentence id="s1760" text="To better understand regulation of proteolysis and its role in modifying muscular dystrophy, we created transgenic epidermis development overexpressing the protective murine allele of LTBP4 specifically in mature myofibers using the human skeletal actin promoter.">
    <entity charOffset="21-46" id="s1760.e0" ontology_id="GO_0030162" text="regulation of proteolysis" type="GO"/>
    <entity charOffset="73-91" id="s1760.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1760.e0" e2="s1760.e1" id="s1760.p0" relation="true"/>
  </sentence>
  <sentence id="s1761" text="Several myotubularins have been genetically linked to human diseases: protein dephosphorylation is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while phosphatidylinositol dephosphorylation and myelination are mutated in Charcot-Marie-Tooth (CMT) neuropathies.">
    <entity charOffset="70-95" id="s1761.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="125-133" id="s1761.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1761.e0" e2="s1761.e1" id="s1761.p0" relation="true"/>
  </sentence>
  <sentence id="s1762" text="Several myotubularins have been genetically linked to human diseases: protein dephosphorylation is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while phosphatidylinositol dephosphorylation and myelination are mutated in Charcot-Marie-Tooth (CMT) neuropathies.">
    <entity charOffset="125-133" id="s1762.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="267-305" id="s1762.e1" ontology_id="GO_0046856" text="phosphatidylinositol dephosphorylation" type="GO"/>
    <pair e1="s1762.e0" e2="s1762.e1" id="s1762.p0" relation="true"/>
  </sentence>
  <sentence id="s1763" text="Several myotubularins have been genetically linked to human diseases: protein dephosphorylation is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while phosphatidylinositol dephosphorylation and myelination are mutated in Charcot-Marie-Tooth (CMT) neuropathies.">
    <entity charOffset="125-133" id="s1763.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="310-321" id="s1763.e1" ontology_id="GO_0042552" text="myelination" type="GO"/>
    <pair e1="s1763.e0" e2="s1763.e1" id="s1763.p0" relation="true"/>
  </sentence>
  <sentence id="s1764" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (transcription by RNA polymerase II: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), signal transduction rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), DNA repair rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s1764.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="151-185" id="s1764.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1764.e0" e2="s1764.e1" id="s1764.p0" relation="false"/>
  </sentence>
  <sentence id="s1765" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (transcription by RNA polymerase II: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), signal transduction rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), DNA repair rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s1765.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="233-252" id="s1765.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s1765.e0" e2="s1765.e1" id="s1765.p0" relation="true"/>
  </sentence>
  <sentence id="s1766" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (transcription by RNA polymerase II: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), signal transduction rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), DNA repair rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s1766.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="390-400" id="s1766.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s1766.e0" e2="s1766.e1" id="s1766.p0" relation="true"/>
  </sentence>
  <sentence id="s1767" text="We found that rs1042752-located in the 3'-UTR of positive regulation of transcription by RNA polymerase II, which plays a vital role in lymphomagenesis-was significantly associated with lymphoma risk in a case-control study with 793 patients and 939 controls.">
    <entity charOffset="49-106" id="s1767.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="136-144" id="s1767.e1" ontology_id="HP_0002665" text="lymphoma" type="HP"/>
    <pair e1="s1767.e0" e2="s1767.e1" id="s1767.p0" relation="false"/>
  </sentence>
  <sentence id="s1768" text="Cystinuria is a heterogeneous, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: cellular amino acid metabolic process and SLC7A9.">
    <entity charOffset="16-29" id="s1768.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="119-156" id="s1768.e1" ontology_id="GO_0006520" text="cellular amino acid metabolic process" type="GO"/>
    <pair e1="s1768.e0" e2="s1768.e1" id="s1768.p0" relation="true"/>
  </sentence>
  <sentence id="s1769" text="These studies suggest that compound 4d behaves well in lowering body weight and maintaining energy expenditure without a chance of hyperglycaemia, 4d has strong clinical potential as an efficient GLP-1/adenylate cyclase-activating G protein-coupled receptor signaling pathway agonist in the prevention and treatment of obesity and dyslipidemia">
    <entity charOffset="202-275" id="s1769.e0" ontology_id="GO_0007189" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="319-326" id="s1769.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1769.e0" e2="s1769.e1" id="s1769.p0" relation="false"/>
  </sentence>
  <sentence id="s1770" text="We conducted further optimization of dual enzymatic inhibitions towards positive regulation of cell proliferation and DDR2, two important kinases in lung squamous cell carcinoma.">
    <entity charOffset="72-113" id="s1770.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="154-177" id="s1770.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1770.e0" e2="s1770.e1" id="s1770.p0" relation="true"/>
  </sentence>
  <sentence id="s1771" text="Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (intestinal cholesterol absorption) mutations and results in an increased risk of early-onset cardiovascular disease due to marked elevation of LDL cholesterol (LDL-C) in blood.">
    <entity charOffset="89-122" id="s1771.e0" ontology_id="GO_0030299" text="intestinal cholesterol absorption" type="GO"/>
    <entity charOffset="182-204" id="s1771.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s1771.e0" e2="s1771.e1" id="s1771.p0" relation="true"/>
  </sentence>
  <sentence id="s1772" text="Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced epidermis development are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a tumor-associated antigen (e.g. signal transduction or GPC3) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.">
    <entity charOffset="245-250" id="s1772.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="276-295" id="s1772.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s1772.e0" e2="s1772.e1" id="s1772.p0" relation="true"/>
  </sentence>
  <sentence id="s1773" text="In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in osteoblast differentiation or OTX2 being the most common.">
    <entity charOffset="27-39" id="s1773.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="198-224" id="s1773.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s1773.e0" e2="s1773.e1" id="s1773.p0" relation="true"/>
  </sentence>
  <sentence id="s1774" text="In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in osteoblast differentiation or OTX2 being the most common.">
    <entity charOffset="50-64" id="s1774.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="198-224" id="s1774.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s1774.e0" e2="s1774.e1" id="s1774.p0" relation="true"/>
  </sentence>
  <sentence id="s1775" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, sensory perception of sound, Bcl2 modifying factor (BMF), endothelial cell morphogenesis, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s1775.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="124-151" id="s1775.e1" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <pair e1="s1775.e0" e2="s1775.e1" id="s1775.p0" relation="true"/>
  </sentence>
  <sentence id="s1776" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, sensory perception of sound, Bcl2 modifying factor (BMF), endothelial cell morphogenesis, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s1776.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="182-212" id="s1776.e1" ontology_id="GO_0001886" text="endothelial cell morphogenesis" type="GO"/>
    <pair e1="s1776.e0" e2="s1776.e1" id="s1776.p0" relation="false"/>
  </sentence>
  <sentence id="s1777" text="Consistent with our description of this pathway and the phenotype of patients with actin cytoskeleton organization mutations, mice with a targeted deletion of Mlk3 displayed multiple skeletal defects, including dental abnormalities, deficient calvarial mineralization, and reduced bone mass.">
    <entity charOffset="83-114" id="s1777.e0" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <entity charOffset="211-231" id="s1777.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s1777.e0" e2="s1777.e1" id="s1777.p0" relation="true"/>
  </sentence>
  <sentence id="s1778" text="We describe two families in which two different homozygous negative regulation of translation mutations (missense and frameshift deletion) segregate with a phenotype comprising intellectual disability and progressive microcephaly.">
    <entity charOffset="59-93" id="s1778.e0" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <entity charOffset="217-229" id="s1778.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1778.e0" e2="s1778.e1" id="s1778.p0" relation="true"/>
  </sentence>
  <sentence id="s1779" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="12-17" id="s1779.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="202-226" id="s1779.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s1779.e0" e2="s1779.e1" id="s1779.p0" relation="true"/>
  </sentence>
  <sentence id="s1780" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="147-174" id="s1780.e0" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <entity charOffset="370-391" id="s1780.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s1780.e0" e2="s1780.e1" id="s1780.p0" relation="false"/>
  </sentence>
  <sentence id="s1781" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="176-200" id="s1781.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="370-391" id="s1781.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s1781.e0" e2="s1781.e1" id="s1781.p0" relation="false"/>
  </sentence>
  <sentence id="s1782" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="176-200" id="s1782.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="318-331" id="s1782.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s1782.e0" e2="s1782.e1" id="s1782.p0" relation="true"/>
  </sentence>
  <sentence id="s1783" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="176-200" id="s1783.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="332-349" id="s1783.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s1783.e0" e2="s1783.e1" id="s1783.p0" relation="true"/>
  </sentence>
  <sentence id="s1784" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="202-226" id="s1784.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="318-331" id="s1784.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s1784.e0" e2="s1784.e1" id="s1784.p0" relation="true"/>
  </sentence>
  <sentence id="s1785" text="Three loci with high mutation frequencies, the 138665410 negative regulation of transcription, DNA-templated gene variant, the 23862952 MYH6 gene variant, and the 71098693 HYDIN gene variant were found to be significantly associated with sporadic ASD (P&amp;lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&amp;lt;510^-4).">
    <entity charOffset="57-108" id="s1785.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="238-246" id="s1785.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1785.e0" e2="s1785.e1" id="s1785.p0" relation="true"/>
  </sentence>
  <sentence id="s1786" text="A principal feature of AD is the presence of neurofibrillary tangles (NFT) induced by the aberrant phosphorylation of the microtubule-associated protein microtubule cytoskeleton organization in the brains of affected individuals.">
    <entity charOffset="45-68" id="s1786.e0" ontology_id="HP_0002185" text="neurofibrillary tangles" type="HP"/>
    <entity charOffset="153-190" id="s1786.e1" ontology_id="GO_0000226" text="microtubule cytoskeleton organization" type="GO"/>
    <pair e1="s1786.e0" e2="s1786.e1" id="s1786.p0" relation="false"/>
  </sentence>
  <sentence id="s1787" text="Pre-treatment testing of the localized cutaneous tumor lesion on a lymphoid amplicon panel demonstrated an &lt;i&gt;3'-UTR-mediated mRNA stabilization&lt;/i&gt; p.L265P mutation.">
    <entity charOffset="49-54" id="s1787.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="110-144" id="s1787.e1" ontology_id="GO_0070935" text="3'-UTR-mediated mRNA stabilization" type="GO"/>
    <pair e1="s1787.e0" e2="s1787.e1" id="s1787.p0" relation="true"/>
  </sentence>
  <sentence id="s1788" text="The expression pattern of ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway in gastric cancer tissue and adjacent non-cancerous tissue was detected by immunohistochemistry.">
    <entity charOffset="26-115" id="s1788.e0" ontology_id="GO_0043162" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="127-133" id="s1788.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1788.e0" e2="s1788.e1" id="s1788.p0" relation="true"/>
  </sentence>
  <sentence id="s1789" text="These protein polyubiquitinationNAs may play a role in pathways previously implicated in glaucoma and coenzyme A biosynthetic process as biomarkers for disease pathogenesis">
    <entity charOffset="6-32" id="s1789.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="89-97" id="s1789.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1789.e0" e2="s1789.e1" id="s1789.p0" relation="false"/>
  </sentence>
  <sentence id="s1790" text="While none of these miRNAs have been previously linked to glaucoma, miR-122-5p may target three glaucoma-associated genes: positive regulation of autophagy, ER overload response and TGF-1.">
    <entity charOffset="58-66" id="s1790.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="157-177" id="s1790.e1" ontology_id="GO_0006983" text="ER overload response" type="GO"/>
    <pair e1="s1790.e0" e2="s1790.e1" id="s1790.p0" relation="false"/>
  </sentence>
  <sentence id="s1791" text="While none of these miRNAs have been previously linked to glaucoma, miR-122-5p may target three glaucoma-associated genes: positive regulation of autophagy, ER overload response and TGF-1.">
    <entity charOffset="58-66" id="s1791.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="123-155" id="s1791.e1" ontology_id="GO_0010508" text="positive regulation of autophagy" type="GO"/>
    <pair e1="s1791.e0" e2="s1791.e1" id="s1791.p0" relation="true"/>
  </sentence>
</document>
